# ::snt BMP Receptor Signaling Is Required for Postnatal Maintenance of Articular Cartilage .
# ::tok BMP Receptor Signaling Is Required for Postnatal Maintenance of Articular Cartilage .
# ::alignments 6-11|0.0.0.4+0.0.0.3+0.0.0.2+0.0.0.1+0.0.0.0+0.0.0+0.0 0-5|0.1.4+0.1.3+0.1.2+0.1.1+0.1.0+0.1+0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:00.470
(o2 / organization 
      :beneficiary (o / organization 
            :name (n / name 
                  :op1 "Postnatal" 
                  :op2 "Maintenance" 
                  :op3 "of" 
                  :op4 "Articular" 
                  :op5 "Cartilage")) 
      :name (n2 / name 
            :op1 "BMP" 
            :op2 "Receptor" 
            :op3 "Signaling" 
            :op4 "Is" 
            :op5 "Required"))

# ::snt Articular cartilage plays an essential role in health and mobility , but is frequently damaged or lost in millions of people that develop arthritis .
# ::tok Articular cartilage plays an essential role in health and mobility , but is frequently damaged or lost in millions of people that develop arthritis .
# ::alignments 23-24|0.2.2.1 22-23|0.2.2 20-21|0.2.2.0 18-19|0.1.0 16-17|0.1.2.0 15-16|0.1.2 14-15|0.1 13-14|0.1.1 11-12|0 9-10|0.2.1 8-9|0.2 7-8|0.2.0 5-6|0.0.1 4-5|0.0.1.0 2-3|0.0 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:01.793
(c / contrast-01 
      :ARG1 (p2 / play-02 
            :ARG0 (c2 / cartilage 
                  :mod (a3 / articular)) 
            :ARG1 (r / role 
                  :mod (e / essential))) 
      :ARG2 (d2 / damage-01 
            :ARG0 (m / million) 
            :ARG1-of (f / frequent-02) 
            :op1-of (o / or 
                  :op2 (l / lose-02))) 
      :op3-of (a2 / and 
            :op1 (h / health) 
            :op2 (m2 / mobility) 
            :op4 (d / develop-02 
                  :ARG0 (p / person) 
                  :ARG1 (a / arthritis))))

# ::snt The molecular mechanisms that create and maintain this thin layer of cartilage that covers the surface of bones in joint regions are poorly understood , in part because tools to manipulate gene expression specifically in this tissue have not been available .
# ::tok The molecular mechanisms that create and maintain this thin layer of cartilage that covers the surface of bones in joint regions are poorly understood , in part because tools to manipulate gene expression specifically in this tissue have not been available .
# ::alignments 40-41|0.0.0.1.0.0.0.0.0 38-39|0.0.0.0.0 36-37|0.0.0.1.0.0.0.0.1 35-36|0.0.0.1.0.0.0.0.1.0 33-34|0.0.0.1.0.0.0.1 32-33|0.0.0.1.0.0 31-32|0.0.0.1.0.0.1 30-31|0.0.0.1.0.0.0 28-29|0.0.0.1.0.0.0.0 27-28|0.0.0.1.0.0.0.0.0.0 23-24|0.0.0.1.0.0.0.0.0.0.0 22-23|0.0.0.1.0.0.0.0.0.0.0.1 20-21|0.0.0.1.0.0.0.0.0.0.0.0 19-20|0.0.0.1.0.0.0.0.0.1 17-18|0 15-16|0.1 13-14|0.0 11-12|0.0.0.1.0.1.1 9-10|0.0.0 8-9|0.0.0.0 7-8|0.0.0.2 6-7|0.0.0.1 5-6|0.0.0.1.0 4-5|0.0.0.1.0.1 2-3|0.0.0.1.0.1.0 1-2|0.0.0.1.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:03.027
(b / bone 
      :ARG1-of (c2 / cover-01 
            :ARG0 (l / layer 
                  :ARG1-of (t4 / thin-03 
                        :ARG0 -) 
                  :ARG1-of (m2 / maintain-01 
                        :op2-of (a2 / and 
                              :ARG1-of (e / express-01 
                                    :ARG1-of (m / manipulate-01 
                                          :ARG0 (t3 / tool 
                                                :ARG2-of (a / available-02 
                                                      :ARG0-of (c / cause-01 
                                                            :ARG1 (u / understand-01 
                                                                  :ARG1 (r / region) 
                                                                  :manner (p / poor))) 
                                                      :ARG1 (j / joint)) 
                                                :poss (t / tissue 
                                                      :mod (t2 / this))) 
                                          :manner (s / specific-02)) 
                                    :mod (g / gene)) 
                              :op1 (c4 / create-01 
                                    :ARG0 (m3 / mechanism 
                                          :mod (m4 / molecule)) 
                                    :ARG1 (c3 / cartilage)))) 
                  :mod (t5 / this))) 
      :mod-of (s2 / surface))

# ::snt Here we use regulatory information from the mouse Gdf5 gene ( a bone morphogenetic protein [ BMP ] family member ) to develop new mouse lines that can be used to either activate or inactivate genes specifically in developing joints .
# ::tok Here we use regulatory information from the mouse Gdf5 gene ( a bone morphogenetic protein [ BMP ] family member ) to develop new mouse lines that can be used to either activate or inactivate genes specifically in developing joints .
# ::alignments 39-40|0.0.1.0.1.0 38-39|0.0.1.0.1 36-37|0.0.1.0.1.1 35-36|0.4 34-35|0.3 33-34|0 32-33|0.2 31-32|0.1 29-30|0.0 27-28|0.0.2 25-26|0.0.1 24-25|0.0.1.2 23-24|0.0.1.1 22-23|0.0.1.0 19-20|0.0.0.0.1+0.0.0.0 18-19|0.0.0.0.0 16-17|0.0.0.1.0+0.0.0.1+0.0.0 14-15|0.0.1.0.0.0.0.0.0 12-13|0.0.1.0.1.1.0 9-10|0.0.1.0.0.0.1 8-9|0.0.1.0.0.0.1.0 7-8|0.0.1.0.0.0.1.0.0 4-5|0.0.1.0.0.0.0 3-4|0.0.1.0.0.0.0.0 2-3|0.0.1.0.0.0 1-2|0.0.1.0.0 0-1|0.0.1.0.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:06.238
(o / or 
      :ARG2-of (u / use-01 
            :ARG0 (o2 / organization 
                  :ARG0-of (h / have-org-role-91 
                        :ARG1 (f / family) 
                        :ARG2 (m2 / member)) 
                  :name (n2 / name 
                        :op1 "BMP")) 
            :ARG1 (l / line 
                  :ARG1-of (d2 / develop-02 
                        :ARG0 (w / we 
                              :ARG0-of (u2 / use-01 
                                    :ARG1 (i2 / information 
                                          :ARG0-of (r / regulate-01 
                                                :ARG1 (p2 / protein))) 
                                    :ARG2 (g2 / gene 
                                          :mod (g3 / Gdf5 
                                                :mod (m3 / mouse))) 
                                    :location (h2 / here))) 
                        :ARG2 (d / develop-02 
                              :ARG1 (j / joint) 
                              :ARG2-of (s / specific-02 
                                    :ARG1 (b / bone)))) 
                  :mod (n / new) 
                  :mod (m / mouse)) 
            :ARG1-of (p / possible-01)) 
      :mod (e / either) 
      :op1 (a / activate-01) 
      :op2 (i / inactivate) 
      :op3 (g / gene))

# ::snt Expression of Cre recombinase from Gdf5 bacterial artificial chromosome clones leads to specific activation or inactivation of floxed target genes in developing joints , including early joint interzones , adult articular cartilage , and the joint capsule .
# ::tok Expression of Cre recombinase from Gdf5 bacterial artificial chromosome clones leads to specific activation or inactivation of floxed target genes in developing joints , including early joint interzones , adult articular cartilage , and the joint capsule .
# ::alignments 36-37|0.2.1.0.0.1.0.0.0.1.1 35-36|0.2.1.0.0.1.0.0.0.1.1.0 33-34|0.2.1.0.0.1.0.0.0.1 31-32|0.2.1.0.0.1.0.0.0.1.0 30-31|0.2.1.0.0.1.0.0.0.1.0.0 29-30|0.1 27-28|0.2.1.0.0.1.0.0.0 26-27|0.2.1.0.0.1.0.0.0.0 25-26|0.2.1.0.0.1.0.0 22-23|0.2.1.0.0.1 21-22|0.2.1.0.0.1.0 19-20|0.2.1.0 18-19|0.2.1.0.0 17-18|0.2.1.0.0.0 15-16|0.2.1 14-15|0.2 13-14|0.2.0 12-13|0.2.0.0 10-11|0 9-10|0.2.0.0.0 8-9|0.2.0.0.0.0 7-8|0.2.0.0.0.1 6-7|0.2.0.0.0.2 2-4|0.0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:08.316
(l / lead-03 
      :ARG0 (e2 / expression 
            :poss (t2 / thing 
                  :name (n / name 
                        :op1 (c5 / Cre) 
                        :op2 (r / recombinase)))) 
      :ARG1 (a3 / adult) 
      :ARG2 (o / or 
            :op1 (a4 / activation 
                  :ARG1-of (s / specific-02 
                        :ARG0 (c3 / clone-01 
                              :ARG1 (c4 / chromosome) 
                              :mod (a5 / artificial) 
                              :mod (b / bacterial)))) 
            :op2 (i2 / inactivation 
                  :poss (g / gene 
                        :ARG1-of (t / target-01 
                              :ARG0 (f / flox) 
                              :mod (j3 / joint 
                                    :ARG0-of (d / develop-02 
                                          :ARG1 (e / early 
                                                :mod-of (i / interzon 
                                                      :mod (j2 / joint) 
                                                      :op1-of (a / and 
                                                            :op2 (c2 / cartilage 
                                                                  :mod (a2 / articular)) 
                                                            :op3 (c / capsule 
                                                                  :mod (j / joint))))))))))))

# ::snt We have used this system to test the role of BMP receptor signaling in joint development .
# ::tok We have used this system to test the role of BMP receptor signaling in joint development .
# ::alignments 15-16|0.1 14-15|0.1.0 12-13|0 11-12|0.0 10-11|0.0.0.0.0+0.0.0.0+0.0.0 8-9|0.0.1 6-7|0.0.1.0 4-5|0.0.1.0.1.0 3-4|0.0.1.0.1.0.0 2-3|0.0.1.0.1 0-1|0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:08.415
(s / signal-01 
      :ARG1 (r / receptor 
            :mod (o / organization 
                  :name (n / name 
                        :op1 "BMP")) 
            :poss-of (r2 / role 
                  :ARG1-of (t / test-01 
                        :ARG0 (w / we) 
                        :ARG2-of (u / use-01 
                              :ARG1 (s2 / system 
                                    :mod (t2 / this)) 
                              :ARG0 w)))) 
      :ARG2 (d / develop-02 
            :manner (j / joint)))

# ::snt Mice with null mutations in Bmpr1a are known to die early in embryogenesis with multiple defects .
# ::tok Mice with null mutations in Bmpr1a are known to die early in embryogenesis with multiple defects .
# ::alignments 15-16|0.0.2 14-15|0.0.2.1 12-13|0.0.2.0 10-11|0.0.3 9-10|0.0 7-8|0 5-6|0.0.1.1.0+0.0.1.1+0.0.1 3-4|0.0.1.0 2-3|0.0.1.0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:08.647
(k / know-02 
      :ARG1 (d2 / die-01 
            :ARG0 (m3 / mouse) 
            :ARG1 (c / country 
                  :location-of (m2 / mutate-01 
                        :ARG1-of (n2 / null-02)) 
                  :name (n / name 
                        :op1 "Bmpr1a")) 
            :ARG2 (d / defect-01 
                  :ARG1 (e / embryogenesi) 
                  :quant (m / multiple)) 
            :time (e2 / early)))

# ::snt However , combining a floxed Bmpr1a allele with the Gdf5-Cre driver bypasses this embryonic lethality , and leads to birth and postnatal development of mice missing the Bmpr1a gene in articular regions .
# ::tok However , combining a floxed Bmpr1a allele with the Gdf5-Cre driver bypasses this embryonic lethality , and leads to birth and postnatal development of mice missing the Bmpr1a gene in articular regions .
# ::alignments 31-32|0.0.0.1.1.0.0.2 30-31|0.0.0.1.1.0.0.2.0 28-29|0.0.0.1.1.0.0.1 25-26|0.0.0.1.1.0.0 24-25|0.0.0.1.1.0.0.0 22-23|0.0.0.1.1.0.2 21-22|0.0.0.1.1.0.2.0 20-21|0.0.0.1.1.0 19-20|0.0.0.1.1.0.1 17-18|0.0.0.1.1 16-17|0.0.0.1 14-15|0.0.0.0 13-14|0.0.0.0.1 12-13|0.0.0.0.0 11-12|0.0.0 10-11|0.0.0.1.0.0+0.0.0.1.0 6-7|0 5-6|0.1.0.0+0.1.0+0.1 4-5|0.2 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:09.864
(a4 / allele 
      :ARG1-of (c2 / combine-01 
            :ARG0-of (b2 / bypass-01 
                  :ARG1 (l2 / lethality 
                        :mod (t / this) 
                        :mod (e / embryonic)) 
                  :op2-of (a3 / and 
                        :op1 (p2 / person 
                              :ARG0-of (d2 / drive-01)) 
                        :op3 (l / lead-03 
                              :op1-of (a2 / and 
                                    :ARG2-of (m / miss-01 
                                          :ARG0 (m2 / mouse) 
                                          :ARG1 (g / gene) 
                                          :location (r / region 
                                                :mod (a / articular))) 
                                    :op2 (b / birth-01) 
                                    :op3 (d / develop-02 
                                          :ARG1 (p / postnatal))))))) 
      :mod (c / country 
            :name (n / name 
                  :op1 "Bmpr1a")) 
      :mod (f / flox))

# ::snt Most joints in the body form normally in the absence of Bmpr1a receptor function .
# ::tok Most joints in the body form normally in the absence of Bmpr1a receptor function .
# ::alignments 13-14|0.1 12-13|0.1.0 11-12|0.1.1.0.0+0.1.1.0+0.1.1 9-10|0 6-7|0.1.0.0 5-6|0.1.0.0.0 4-5|0.0.0 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:10.085
(a / absent-01 
      :ARG0 (j / joint 
            :mod (b / body) 
            :mod (m / most)) 
      :ARG1 (f / function-01 
            :ARG0 (r / receptor 
                  :ARG0-of (n2 / normal-02 
                        :ARG1 (f2 / form))) 
            :ARG1 (c / country 
                  :name (n / name 
                        :op1 "Bmpr1a"))))

# ::snt However , articular cartilage within the joints gradually wears away in receptor-deficient mice after birth in a process resembling human osteoarthritis .
# ::tok However , articular cartilage within the joints gradually wears away in receptor-deficient mice after birth in a process resembling human osteoarthritis .
# ::alignments 20-21|0.4.0.2 19-20|0.4.0.2.0 18-19|0.4.0 17-18|0.4.0.1.0 14-15|0.4.0.1 13-14|0.4 12-13|0.1 9-10|0.2 8-9|0 7-8|0.3 6-7|0.0 3-4|0.4.0.0 2-3|0.4.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:10.658
(w / wear-01 
      :ARG0 (j / joint) 
      :ARG1 (m / mouse) 
      :ARG3 (a2 / away) 
      :manner (g / gradual) 
      :time (a / after 
            :op1 (r / resemble-01 
                  :ARG0 (c / cartilage 
                        :mod (a3 / articular)) 
                  :ARG1 (b / birth-01 
                        :ARG1 (p / process-02)) 
                  :ARG2 (o / osteoarthriti 
                        :mod (h / human)))))

# ::snt Gdf5-Cre mice provide a general system that can be used to test the role of genes in articular regions .
# ::tok Gdf5-Cre mice provide a general system that can be used to test the role of genes in articular regions .
# ::alignments 18-19|0.0 17-18|0 15-16|0.0.0 13-14|0.0.0.0 11-12|0.0.0.0.0 9-10|0.0.0.0.0.0 7-8|0.0.0.0.0.0.1 5-6|0.0.0.0.0.0.0 4-5|0.0.0.0.0.0.0.1 2-3|0.0.0.0.0.0.0.0 1-2|0.0.0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:10.798
(a / articular 
      :mod-of (r / region 
            :location-of (g / gene 
                  :poss-of (r2 / role 
                        :ARG1-of (t / test-01 
                              :ARG2-of (u / use-01 
                                    :ARG1 (s / system 
                                          :ARG1-of (p2 / provide-01 
                                                :ARG0 (m / mouse)) 
                                          :ARG1-of (g2 / general-02)) 
                                    :ARG1-of (p / possible-01)))))))

# ::snt BMP receptor signaling is required not only for early development and creation of multiple tissues , but also for ongoing maintenance of articular cartilage after birth .
# ::tok BMP receptor signaling is required not only for early development and creation of multiple tissues , but also for ongoing maintenance of articular cartilage after birth .
# ::alignments 25-26|0.0.0.1.0 24-25|0.0.0.1 23-24|0.0.0.1.0.1.0 22-23|0.0.0.1.0.1.0.0 20-21|0.0.0.1.0.1 19-20|0.0.0.1.0.1.1 17-18|0.0.0.0.1.0 16-17|0 14-15|0.0.0.0.0 13-14|0.0.0.0.0.0 11-12|0.0 10-11|0.0.0 9-10|0.0.0.0 8-9|0.0.0.0.2 6-7|0.0.0.1.0.0.0 5-6|0.0.0.1.0.0 4-5|0.0.0.0.1 2-3|0.0.0.0.1.1 1-2|0.0.0.0.1.1.1 0-1|0.0.0.0.1.1.0.0.0+0.0.0.0.1.1.0.0+0.0.0.0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:11.537
(c2 / contrast-01 
      :ARG1-of (c3 / create-01 
            :op2-of (a4 / and 
                  :op1 (d / develop-02 
                        :ARG1 (t / tissue 
                              :quant (m2 / multiple)) 
                        :ARG2-of (r / require-01 
                              :ARG0 (a3 / also) 
                              :ARG1 (s / signal-01 
                                    :ARG0 (o3 / organization 
                                          :name (n / name 
                                                :op1 "BMP")) 
                                    :ARG1 (r2 / receptor))) 
                        :mod (e / early)) 
                  :op3 (a / after 
                        :op1 (b / birth-01 
                              :ARG1 (- / - 
                                    :polarity-of (o2 / only)) 
                              :ARG2-of (m / maintain-01 
                                    :ARG1 (c / cartilage 
                                          :mod (a2 / articular)) 
                                    :mod (o / ongo)))))))

# ::snt Genetic variation in the strength of BMP receptor signaling may be an important risk factor in human osteoarthritis , and treatments that mimic or augment BMP receptor signaling should be investigated as a possible therapeutic strategy for maintaining the health of joint linings .
# ::tok Genetic variation in the strength of BMP receptor signaling may be an important risk factor in human osteoarthritis , and treatments that mimic or augment BMP receptor signaling should be investigated as a possible therapeutic strategy for maintaining the health of joint linings .
# ::alignments 42-43|0.1.1.0.0.0.0.0 41-42|0.1.1.0.0.0.0.0.0 39-40|0.1.1.0.0.0.0 37-38|0.1.1.0.0.0 35-36|0.1.1.0.0 34-35|0.1.1.0.0.2 33-34|0.1.1.0.0.1 30-31|0.1.1.0 28-29|0.1.1 27-28|0.1.0.1.0.0.0 26-27|0.1.0.1.0.0 24-25|0.1.0.1.0 23-24|0.1.0.1 22-23|0.1.0 20-21|0.1.0.0 19-20|0.1 17-18|0.0.3 16-17|0.0.3.0 14-15|0.0 13-14|0.0.0 12-13|0.0.2 9-10|0 8-9|0.1.0.0.0 7-8|0.1.0.0.0.1 6-7|0.1.0.0.0.0.0.0+0.1.0.0.0.0.0+0.1.0.0.0.0 4-5|0.1.0.0.0.2 1-2|0.0.1 0-1|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:13.794
(p2 / possible-01 
      :ARG1 (f / factor 
            :ARG1-of (r3 / risk-01) 
            :domain (v / variation 
                  :mod (g / genetic)) 
            :mod (i2 / important) 
            :mod (o2 / osteoarthriti 
                  :mod (h2 / human))) 
      :op1-of (a2 / and 
            :ARG1-of (m2 / mimic-01 
                  :ARG0 (t2 / treat-03 
                        :ARG1 (s3 / signal-01 
                              :ARG0 (o3 / organization 
                                    :name (n / name 
                                          :op1 "BMP")) 
                              :ARG1 (r4 / receptor) 
                              :poss-of (s4 / strength))) 
                  :op1-of (o / or 
                        :op2 (a / augment-01 
                              :ARG1 (r2 / receptor 
                                    :ARG1-of (s2 / signal-01))))) 
            :op2 (r / recommend-01 
                  :ARG1 (i / investigate-01 
                        :ARG2 (s / strategy 
                              :ARG0-of (m / maintain-01 
                                    :ARG1 (h / health 
                                          :mod (l / lining 
                                                :mod (j / joint)))) 
                              :ARG1-of (p / possible-01) 
                              :mod (t / therapeutic))))))

# ::snt Thin layers of articular cartilage line the bones of synovial joints and provide a smooth , wear-resistant structure that reduces friction and absorbs impact forces ( Brandt et al. 1998 ) .
# ::tok Thin layers of articular cartilage line the bones of synovial joints and provide a smooth , wear-resistant structure that reduces friction and absorbs impact forces ( Brandt et al. 1998 ) .
# ::alignments 29-30|0.0.0.1.0.0.0.0+0.0.0.1.0.0.0 26-29|0.1.0.0.0.0.2+0.1.0.0.0.0.1+0.1.0.0.0.0.0+0.1.0.0.0.0+0.1.0.0.0 24-25|0.1.0 23-24|0.1.0.0 22-23|0.1 21-22|0 20-21|0.0.1 19-20|0.0 17-18|0.0.0 14-15|0.0.0.0 12-13|0.0.0.1 11-12|0.0.0.1.1 10-11|0.0.0.1.1.0.0.0 9-10|0.0.0.1.1.0.0.0.0 7-8|0.0.0.1.1.0.0 5-6|0.0.0.1.1.0 4-5|0.0.0.1.0.1 3-4|0.0.0.1.0.1.0 1-2|0.0.0.1.0 0-1|0.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:15.191
(a2 / and 
      :op1 (r / reduce-01 
            :ARG0 (s / structure 
                  :ARG1-of (s2 / smooth-06) 
                  :ARG1-of (p / provide-01 
                        :ARG0 (l2 / layer 
                              :ARG0-of (t2 / thin-01 
                                    :ARG1 (d / date-entity 
                                          :year 1998)) 
                              :mod (c / cartilage 
                                    :mod (a4 / articular))) 
                        :op2-of (a3 / and 
                              :op1 (l / line 
                                    :op1 (b / bone 
                                          :mod (j / joint 
                                                :mod (s3 / synovial))))))) 
            :ARG1 (f2 / friction)) 
      :op2 (a / absorb-01 
            :ARG1 (f / force 
                  :mod (i / impact-01 
                        :ARG0 (t / thing 
                              :name (n / name 
                                    :op1 "Brandt" 
                                    :op2 "et" 
                                    :op3 "al."))))))

# ::snt Loss or damage to articular cartilage is a hallmark of arthritic diseases and is one of the most common reasons that both young and old adults seek medical care .
# ::tok Loss or damage to articular cartilage is a hallmark of arthritic diseases and is one of the most common reasons that both young and old adults seek medical care .
# ::alignments 28-29|0.0.0 27-28|0.0.0.1 26-27|0 25-26|0.0 24-25|0.0.1 23-24|0.1 22-23|0.1.1 21-22|0.1.0 19-20|0.3 18-19|0.3.0 17-18|0.3.0.0 12-13|0.2 11-12|0.2.1.0 10-11|0.0.0.0 8-9|0.2.1 5-6|0.2.0.0 4-5|0.2.0.1 2-3|0.2.0 1-2|0.2.0.2 0-1|0.2.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:17.697
(s / seek-01 
      :ARG0 (a / adult 
            :ARG0-of (c / care-03 
                  :ARG1 (a4 / arthritic) 
                  :mod (m / medicine)) 
            :mod (o / old)) 
      :ARG1 (a2 / and 
            :mod (b / both) 
            :op1 (y / young)) 
      :op3-of (a3 / and 
            :op1 (d2 / damage-01 
                  :ARG1 (c3 / cartilage) 
                  :ARG2 (a5 / articular) 
                  :op2-of (o2 / or 
                        :op1 (l / los))) 
            :op2 (h / hallmark 
                  :quant-of (d / disease))) 
      :time (r / reason 
            :mod (c2 / common 
                  :degree (m2 / most))))

# ::snt Millions of people are afflicted with arthritis , and it ultimately affects more than half of people over the age of 65 ( Badley 1995 ; Yelin and Callahan 1995 ) .
# ::tok Millions of people are afflicted with arthritis , and it ultimately affects more than half of people over the age of 65 ( Badley 1995 ; Yelin and Callahan 1995 ) .
# ::alignments 29-30|0.1.0+0.1 28-29|0.0.0.1.1.0.0+0.0.0.1.1.0+0.0.0.1.1 27-28|0.0.0.1.1.1 26-27|0.0.0.1.1.1.1.0.0+0.0.0.1.1.1.1.0+0.0.0.1.1.1.1 25-26|0.0.0.1.1.1.2 24-25|0.0.0.1.1.1.2.1.0+0.0.0.1.1.1.2.1 21-22|0.0.0.1.0.2 19-20|0 16-17|0.0.0.1.1.1.0 14-15|0.0 12-13|0.0.1 11-12|0.0.0 10-11|0.0.0.0 8-9|0.0.0.1 6-7|0.0.0.1.0.0 4-5|0.0.0.1.0 2-3|0.0.0.1.1.1.2.0 0-1|0.0.0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:19.001
(a3 / age-01 
      :ARG0 (h / half 
            :ARG1-of (a4 / affect-01 
                  :mod (u / ultimate) 
                  :op2-of (a5 / and 
                        :op1 (a7 / afflict-01 
                              :ARG0 (a6 / arthritis) 
                              :ARG1 (m2 / million) 
                              :ARG2 65) 
                        :op3 (p / person 
                              :name (n / name 
                                    :op1 "Callahan") 
                              :op3-of (a / and 
                                    :op1 (p3 / person) 
                                    :op2 (p2 / person 
                                          :name (n2 / name 
                                                :op1 "Yelin")) 
                                    :op3-of (a2 / and 
                                          :op1 (p4 / person) 
                                          :op2 (d2 / date-entity 
                                                :year 1995)))))) 
            :degree-of (m / more)) 
      :ARG1 (d / date-entity 
            :year 1995))

# ::snt A better understanding of the molecular mechanisms that create and maintain articular cartilage is crucial for discovering the causes of joint disorders and providing useful medical treatments .
# ::tok A better understanding of the molecular mechanisms that create and maintain articular cartilage is crucial for discovering the causes of joint disorders and providing useful medical treatments .
# ::alignments 26-27|0.0.1.0.0 25-26|0.0.1.0.0.2 24-25|0.0.1.0.0.1 23-24|0.0.1.0 22-23|0.0.1.0.1 21-22|0.0.1.0.1.0.0.0 20-21|0.0.1.0.1.0.0.0.0 18-19|0.0.1.0.1.0.0 16-17|0.0.1.0.1.0 14-15|0.0.1.0.1.0.1 12-13|0.0.1 11-12|0.0.1.0.0.0 10-11|0.1 9-10|0 8-9|0.0 6-7|0.0.0 5-6|0.0.0.1 2-3|0.0.0.0 1-2|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:19.336
(a3 / and 
      :op1 (c4 / create-01 
            :ARG0 (m3 / mechanism 
                  :ARG1-of (u2 / understand-01 
                        :mod (g / good)) 
                  :mod (m4 / molecule)) 
            :ARG1 (c3 / cartilage 
                  :ARG0-of (p / provide-01 
                        :ARG1 (t / treat-03 
                              :ARG1 (a2 / articular) 
                              :ARG1-of (u / useful-05) 
                              :mod (m / medicine)) 
                        :op2-of (a / and 
                              :op1 (d2 / discover-01 
                                    :ARG1 (c / cause-01 
                                          :ARG1 (d / disorder 
                                                :mod (j / joint))) 
                                    :purpose-of (c2 / crucial)))))) 
      :op2 (m2 / maintain-01 
            :ARG1 c3))

# ::snt Joint formation begins during embryogenesis , when stripes of high cell density called interzones form across developing skeletal precursors ( Haines 1947 ) .
# ::tok Joint formation begins during embryogenesis , when stripes of high cell density called interzones form across developing skeletal precursors ( Haines 1947 ) .
# ::alignments 21-22|0.1.0.0.0.1.0+0.1.0.0.0.1 20-21|0.1.0.1.0.0.0.0.0+0.1.0.1.0.0.0.0+0.1.0.1.0.0.0 18-19|0.1.0.1.1 17-18|0.1.0.1.1.0 16-17|0.1.0.1 15-16|0.1.0.1.2 14-15|0.1.0 13-14|0.1.0.1.0 12-13|0.1.0.1.0.0 11-12|0 10-11|0.1 9-10|0.0 7-8|0.1.0.1.0.0.1 4-5|0.1.0.0 2-3|0.1.0.0.0 1-2|0.1.0.0.0.0 0-1|0.1.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:19.762
(d3 / density 
      :ARG1-of (h / high-02) 
      :mod (c2 / cell 
            :ARG1-of (f / form-01 
                  :ARG0 (e / embryogenesi 
                        :time-of (b / begin-01 
                              :ARG1 (f2 / form-01 
                                    :mod (j / joint)) 
                              :time (d / date-entity 
                                    :year 1947))) 
                  :ARG2 (d2 / develop-02 
                        :ARG0 (i / interzon 
                              :ARG2-of (c / call-01 
                                    :ARG0 (p / person 
                                          :name (n / name 
                                                :op1 "Haines")) 
                                    :ARG1 (s2 / stripe))) 
                        :ARG1 (p2 / precursor 
                              :mod (s / skeletal)) 
                        :op1-of (a / across)))))

# ::snt Programmed cell death occurs within the interzone , and a three-layered interzone forms that has two layers of higher cell density flanking a region of lower cell density .
# ::tok Programmed cell death occurs within the interzone , and a three-layered interzone forms that has two layers of higher cell density flanking a region of lower cell density .
# ::alignments 27-28|0.0.1.1.1.0 26-27|0.0.1.1.1.0.0 25-26|0.0.1.1.1 23-24|0.0.0 21-22|0.0 20-21|0 19-20|0.2 18-19|0.1 16-17|0.0.2 15-16|0.0.2.0 12-13|0.0.1.0 10-11|0.0.1.0.0 8-9|0.0.1.1.0.0 6-7|0.0.1.1.0.0.0 3-4|0.0.1.1.0 2-3|0.0.1.1 1-2|0.0.1.1.2 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:20.689
(d2 / density 
      :ARG0-of (f / flank-01 
            :ARG1 (r / region) 
            :ARG2 (p / program-01 
                  :ARG0 (f2 / form 
                        :mod (t / three-layer)) 
                  :ARG1 (d3 / die-01 
                        :ARG0-of (o / occur-01 
                              :ARG1 (a / and 
                                    :op1 (i / interzone))) 
                        :ARG1 (l / low-04 
                              :ARG1 (d / density 
                                    :mod (c / cell))) 
                        :mod (c3 / cell))) 
            :purpose-of (l2 / layer 
                  :quant 2)) 
      :ARG1-of (h / high-02) 
      :mod (c2 / cell))

# ::snt Non-joint precursors of the skeleton typically develop into cartilage , which hypertrophies and is replaced by bone .
# ::tok Non-joint precursors of the skeleton typically develop into cartilage , which hypertrophies and is replaced by bone .
# ::alignments 16-17|0 14-15|0.0 12-13|0.0.1 8-9|0.0.0 6-7|0.0.0.0 5-6|0.0.0.0.2 4-5|0.0.0.0.0 1-2|0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:20.784
(b / bone 
      :ARG0-of (r / replace-01 
            :ARG1 (c / cartilage 
                  :ARG1-of (d / develop-02 
                        :ARG0 (s / skeleton) 
                        :ARG2 (p / precursor) 
                        :manner (t / typical-02))) 
            :op1-of (a / and)))

# ::snt However , cells within the high-density layers of the interzone are excluded from this process and develop into the permanent layers of articular cartilage found in the mature joint ( Mitrovic 1978 ) .
# ::tok However , cells within the high-density layers of the interzone are excluded from this process and develop into the permanent layers of articular cartilage found in the mature joint ( Mitrovic 1978 ) .
# ::alignments 31-32|0.0.1.0.0+0.0.1.0 30-31|0.2.0.0+0.2.0+0.2 28-29|0.1.0.2 27-28|0.1.0.2.0 24-25|0.1.0 23-24|0.1.0.1 22-23|0.1.0.1.0 20-21|0.1.1 19-20|0.1.1.0 16-17|0.1 15-16|0 14-15|0.0.1 13-14|0.0.1.2 11-12|0.0 9-10|0.1.0.0 6-7|0.0.1.1 2-3|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:21.494
(a2 / and 
      :op1 (e / exclude-01 
            :ARG1 (c2 / cell) 
            :ARG2 (p3 / process-02 
                  :ARG0 (d / date-entity 
                        :year 1978) 
                  :ARG1 (l2 / layer) 
                  :mod (t / this))) 
      :op2 (d2 / develop-02 
            :ARG1 (f / find-01 
                  :ARG0 (i / interzone) 
                  :ARG1 (c / cartilage 
                        :mod (a / articular)) 
                  :location (j / joint 
                        :ARG1-of (m / mature-02))) 
            :ARG2 (l / layer 
                  :mod (p2 / permanent))) 
      :op3 (p / person 
            :name (n / name 
                  :op1 "Mitrovic")))

# ::snt Studies over the last 10 y have begun to elucidate some of the signaling pathways that contribute to the early stages of joint formation .
# ::tok Studies over the last 10 y have begun to elucidate some of the signaling pathways that contribute to the early stages of joint formation .
# ::alignments 23-24|0 22-23|0.1 20-21|0.2 19-20|0.2.1 16-17|0.2.0 14-15|0.2.0.0 13-14|0.2.0.0.0 10-11|0.2.0.1.1 9-10|0.2.0.1 7-8|0.2.0.1.2 5-6|0.2.0.1.0 4-5|0.0 3-4|0.2.0.1.0.0 0-1|0.2.0.1.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:22.335
(f / form-01 
      :ARG1 10 
      :manner (j / joint) 
      :mod (s / stage 
            :ARG2-of (c / contribute-01 
                  :ARG0 (p / pathway 
                        :ARG1-of (s2 / signal-01)) 
                  :ARG1 (e2 / elucidate-01 
                        :ARG0 (y / y 
                              :mod (l / last)) 
                        :ARG1 (s3 / some) 
                        :ARG1-of (b / begin-01 
                              :ARG0 (s4 / study-01)))) 
            :time (e / early)))

# ::snt Wnt14 is expressed in stripes at the sites where joints will form , and it is capable of inducing expression of other joint markers when misexpressed at new locations in the limb ( Hartmann and Tabin 2001 ) .
# ::tok Wnt14 is expressed in stripes at the sites where joints will form , and it is capable of inducing expression of other joint markers when misexpressed at new locations in the limb ( Hartmann and Tabin 2001 ) .
# ::alignments 36-37|0.2.0.1.0.1.0.0.1.0+0.2.0.1.0.1.0.0.1 35-36|0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 34-35|0.0.1 33-34|0.0.0.0+0.0.0+0.0 31-32|0.2.0.0.0.0 28-29|0.2.0.0.0 27-28|0.2.0.0 23-24|0.1 22-23|0.1.1 21-22|0.1.0 19-20|0 18-19|0.2 16-17|0.2.0 13-14|0.2.0.1 11-12|0.2.0.1.0.1.0.0 9-10|0.2.0.1.0.1.0.0.0 7-8|0.2.0.1.0.1.0 4-5|0.2.0.1.0.1 2-3|0.2.0.1.0 0-1|0.2.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:23.060
(e / express-01 
      :ARG0 (p / person 
            :name (n2 / name 
                  :op1 "Hartmann") 
            :op1-of (a / and 
                  :op2 (c / country 
                        :name (n / name 
                              :op1 "Tabin")))) 
      :ARG1 (m / marker 
            :mod (o / other) 
            :mod (j / joint)) 
      :ARG1-of (i / induce-01 
            :ARG2-of (c2 / capable-01 
                  :ARG1 (n3 / new 
                        :mod-of (l2 / location 
                              :location (l / limb))) 
                  :op2-of (a2 / and 
                        :op1 (e2 / express-01 
                              :ARG1 (w / Wnt14) 
                              :manner (s2 / stripe 
                                    :location (s / site 
                                          :ARG1-of (f / form-01 
                                                :ARG0 (j2 / joint) 
                                                :time (d / date-entity 
                                                      :year 2001)))))))))

# ::snt Several members of the bone morphogenetic protein ( BMP ) family of secreted signaling molecules are also expressed in stripes at sites where joints will form , including those encoded by the genes Gdf5 , Gdf6 , Gdf7 , Bmp2 , and Bmp4 ( Storm and Kingsley 1996 ; Wolfman et al. 1997 ; Francis-West et al. 1999 ; Settle et al. 2003 ) .
# ::tok Several members of the bone morphogenetic protein ( BMP ) family of secreted signaling molecules are also expressed in stripes at sites where joints will form , including those encoded by the genes Gdf5 , Gdf6 , Gdf7 , Bmp2 , and Bmp4 ( Storm and Kingsley 1996 ; Wolfman et al. 1997 ; Francis-West et al. 1999 ; Settle et al. 2003 ) .
# ::alignments 62-63|0.2.0.0.5.0+0.2.0.0.5 59-61|0.0.1.6.0.1+0.0.1.6.0.0+0.0.1.6.0+0.0.1.6 57-58|0.2.0.0.4.0+0.2.0.0.4 54-56|0.0.1.5.0.1+0.0.1.5.0.0+0.0.1.5.0+0.0.1.5 52-53|0.2.0.0.3.0+0.2.0.0.3 49-52|0.1.1.0.0.2+0.1.1.0.0.1+0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 48-49|0.1.1 47-48|0.2.0.0.2.0+0.2.0.0.2 45-46|0.1.2 44-45|0.1.2.0.0.0+0.1.2.0.0+0.1.2.0 42-43|0.0.0.0+0.0.0+0.0 41-42|0.0.1 39-40|0.0.1.4 37-38|0.0.1.3 35-36|0.0.1.2 33-34|0.0.1.1 32-33|0.0.1.0.0 29-30|0.0.1.0 25-26|0.2.0.0 23-24|0.2.0.0.0 21-22|0.2.0 19-20|0.2 17-18|0 16-17|0.3 14-15|0.1.0.0.1 13-14|0.1.0.0.1.0 12-13|0.1.0.0.1.1 10-11|0.1.0.0 8-9|0.0.1.0.1.0.0+0.0.1.0.1.0+0.0.1.0.1 6-7|0.1.0.0.0 4-5|0.2.0.0.1 1-2|0.1.0.1+0.1.0+0.1 0-1|0.1.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:27.303
(e4 / express-01 
      :ARG0 (p / person 
            :name (n5 / name 
                  :op1 "Bmp4") 
            :op5-of (a3 / and 
                  :ARG1-of (e3 / encode-01 
                        :ARG0 (g4 / gene) 
                        :ARG2 (o2 / organization 
                              :name (n6 / name 
                                    :op1 "BMP"))) 
                  :op1 (g3 / Gdf5) 
                  :op2 (g2 / Gdf6) 
                  :op3 (g / Gdf7) 
                  :op4 (b / Bmp2) 
                  :op6 (t2 / thing 
                        :name (n2 / name 
                              :op1 (f / Francis-West) 
                              :op2 (e2 / et))) 
                  :op7 (t / thing 
                        :name (n / name 
                              :op1 (s / Settle) 
                              :op2 (e / et))))) 
      :ARG1 (p3 / person 
            :ARG0-of (h / have-org-role-91 
                  :ARG1 (f3 / family 
                        :mod (p2 / protein) 
                        :poss (m / molecule 
                              :ARG1-of (s4 / signal-01) 
                              :ARG1-of (s5 / secrete-01))) 
                  :ARG2 (m2 / member)) 
            :op1-of (a / and 
                  :op2 (t3 / thing 
                        :name (n3 / name 
                              :op1 "Wolfman" 
                              :op2 "et" 
                              :op3 "al."))) 
            :op1-of (a2 / and 
                  :op2 (o / organization 
                        :name (n4 / name 
                              :op1 "Storm"))) 
            :quant (s6 / several)) 
      :manner (s3 / stripe 
            :location (s2 / site 
                  :ARG1-of (f2 / form-01 
                        :ARG0 (j / joint) 
                        :ARG2 (b2 / bone) 
                        :time (d4 / date-entity 
                              :year 1996) 
                        :time (d3 / date-entity 
                              :year 1997) 
                        :time (d2 / date-entity 
                              :year 1999) 
                        :time (d / date-entity 
                              :year 2003)))) 
      :mod (a4 / also))

# ::snt Of these , Gdf5 expression is most strikingly limited to regions where joints will develop and is one of the earliest known markers of joint formation .
# ::tok Of these , Gdf5 expression is most strikingly limited to regions where joints will develop and is one of the earliest known markers of joint formation .
# ::alignments 25-26|0 24-25|0.1 22-23|0.2 21-22|0.2.0 20-21|0.2.1.0+0.2.1 15-16|0.0.1.1 14-15|0.0.1.0.0 12-13|0.0.1.0.0.0 10-11|0.0.1.0 8-9|0.0.1 7-8|0.0.1.2 6-7|0.0.1.2.0 4-5|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:27.719
(f / form-01 
      :ARG1 (e2 / express-01 
            :ARG1 (t / this) 
            :ARG1-of (l / limit-01 
                  :ARG2 (r / region 
                        :ARG1-of (d / develop-02 
                              :ARG0 (j2 / joint))) 
                  :op1-of (a / and) 
                  :time (s / strikingly 
                        :degree (m3 / most)))) 
      :manner (j / joint) 
      :mod-of (m / marker 
            :ARG1-of (k / know-02) 
            :mod (e / early 
                  :degree (m2 / most))))

# ::snt Mutations in either Gdf5 or the closely related Gdf6 gene also block formation of joints at specific locations , providing strong evidence that these molecules are essential for the joint formation process ( Storm et al. 1994 ; Settle et al. 2003 ) .
# ::tok Mutations in either Gdf5 or the closely related Gdf6 gene also block formation of joints at specific locations , providing strong evidence that these molecules are essential for the joint formation process ( Storm et al. 1994 ; Settle et al. 2003 ) .
# ::alignments 41-42|0.0.0.0.0.2.0.0+0.0.0.0.0.2.0 38-39|0.0.0.0.0.0 37-38|0 36-37|0.0.0.0.0.1.0.0.0+0.0.0.0.0.1.0.0 33-36|0.0.0.0.0.0.0.0.2+0.0.0.0.0.0.0.0.1+0.0.0.0.0.0.0.0.0+0.0.0.0.0.0.0.0+0.0.0.0.0.0.0 31-32|0.0.0 30-31|0.0 29-30|0.0.1 26-27|0.0.0.0.1 24-25|0.0.0.0 23-24|0.0.0.0.2 21-22|0.0.0.0.0 20-21|0.0.0.0.0.2 19-20|0.0.0.0.0.1 17-18|0.0.0.0.0.1.1.2 16-17|0.0.0.0.0.1.1.2.0 14-15|0.0.0.0.0.1.1.1 12-13|0.0.0.0.0.1.0 11-12|0.0.0.0.0.1.1 10-11|0.0.0.0.0.1.1.3 9-10|0.0.0.0.0.1.1.0.0.2 7-8|0.0.0.0.0.1.1.0.0.2.0 6-7|0.0.0.0.0.1.1.0.0.2.0.0 4-5|0.0.0.0.0.1.1.0.0 3-4|0.0.0.0.0.1.1.0.0.1 2-3|0.0.0.0.0.1.1.0.0.0 0-1|0.0.0.0.0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:31.029
(a / and 
      :op1 (f / form-01 
            :ARG1-of (p / process-02 
                  :ARG0 (m / molecule 
                        :ARG0-of (e2 / evidence-01 
                              :ARG1 (s / settle-01 
                                    :ARG1 (t / thing 
                                          :name (n / name 
                                                :op1 "Storm" 
                                                :op2 "et" 
                                                :op3 "al."))) 
                              :ARG1-of (p2 / provide-01 
                                    :ARG0 (f2 / form-01 
                                          :time (d2 / date-entity 
                                                :year 1994)) 
                                    :purpose-of (b / block-01 
                                          :ARG0 (m2 / mutation 
                                                :op1-of (o / or 
                                                      :mod (e3 / either) 
                                                      :op2 (g2 / Gdf5) 
                                                      :op3 (g / gene 
                                                            :ARG1-of (r / relate-01 
                                                                  :manner (c / close))))) 
                                          :ARG1 (j2 / joint) 
                                          :location (l / location 
                                                :ARG1-of (s3 / specific-02)) 
                                          :mod (a2 / also))) 
                              :ARG1-of (s2 / strong-02 
                                    :ARG0 (d / date-entity 
                                          :year 2003))) 
                        :domain-of (e / essential) 
                        :mod (t2 / this))) 
            :mod (j / joint)))

# ::snt However , mutations in Bmp2 or Bmp4 cause early embryonic lethality , making it difficult to test their role in joint formation ( Winnier et al. 1995 ; Zhang and Bradley 1996 ) .
# ::tok However , mutations in Bmp2 or Bmp4 cause early embryonic lethality , making it difficult to test their role in joint formation ( Winnier et al. 1995 ; Zhang and Bradley 1996 ) .
# ::alignments 31-32|0.2.1.2.1.0+0.2.1.2.1 30-31|0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 29-30|0.0 27-28|0.0.1 26-27|0.2.1.2.0.0+0.2.1.2.0 23-26|0.2.1.3.0.2+0.2.1.3.0.1+0.2.1.3.0.0+0.2.1.3.0+0.2.1.3 21-22|0.2.0.0.0 20-21|0.0.1.0 18-19|0.2.0.0 16-17|0.2.0 14-15|0.2.0.0.0.0 10-11|0.1 9-10|0.1.0 8-9|0.2.1.2 7-8|0 6-7|0.2.1.1.0.0+0.2.1.1.0+0.2.1.1 5-6|0.2.1 4-5|0.2.1.0 2-3|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:31.874
(c / cause-01 
      :ARG0 (a / and 
            :op1 (p / person 
                  :name (n / name 
                        :op1 "Bradley") 
                  :wiki -) 
            :op2-of (a2 / and 
                  :op1 (j / joint))) 
      :ARG1 (l / lethality 
            :mod (e / embryonic)) 
      :ARG2 (m / mutate-01 
            :ARG0-of (t2 / test-01 
                  :ARG1 (r / role 
                        :mod (f / form-01 
                              :ARG1 (d3 / difficult)))) 
            :ARG1 (o / or 
                  :op1 (b / Bmp2) 
                  :op2 (p2 / person 
                        :name (n3 / name 
                              :op1 "Bmp4")) 
                  :op3 (e2 / early 
                        :op1 (d2 / date-entity 
                              :year 1995) 
                        :op2 (d / date-entity 
                              :year 1996)) 
                  :op4 (t / thing 
                        :name (n2 / name 
                              :op1 "Winnier" 
                              :op2 "et" 
                              :op3 "al.")))))

# ::snt Much less is known about how signaling pathways function during the subsequent maturation and maintenance of adult joint structures .
# ::tok Much less is known about how signaling pathways function during the subsequent maturation and maintenance of adult joint structures .
# ::alignments 18-19|0.0.2.0.1 17-18|0.0.0 16-17|0.1 14-15|0.0.2.0 13-14|0.0.2 12-13|0.0.3 11-12|0.0.3.0 8-9|0.0.1 7-8|0.0.1.0 6-7|0.0 3-4|0 1-2|0.0.2.0.0 0-1|0.0.2.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:32.095
(k / know-02 
      :ARG1 (s3 / signal-01 
            :ARG0 (j / joint) 
            :ARG1 (f / function-01 
                  :ARG1 (p / pathway)) 
            :op1-of (a2 / and 
                  :op2 (m / maintain-01 
                        :ARG1 (l / less 
                              :mod (m3 / much)) 
                        :ARG2 (s / structure))) 
            :time (m2 / maturation 
                  :mod (s2 / subsequent))) 
      :ARG2 (a / adult))

# ::snt Importantly , BMP signaling components are present in adult articular cartilage , suggesting that they may function during the late development or maintenance of this critical structure ( Erlacher et al. 1998 ; Chubinskaya et al. 2000 ; Muehleman et al. 2002 ; Bau et al. 2002 ; Bobacz et al. 2003 ) .
# ::tok Importantly , BMP signaling components are present in adult articular cartilage , suggesting that they may function during the late development or maintenance of this critical structure ( Erlacher et al. 1998 ; Chubinskaya et al. 2000 ; Muehleman et al. 2002 ; Bau et al. 2002 ; Bobacz et al. 2003 ) .
# ::alignments 51-52|0.0.1.0.1.0.3.4.0+0.0.1.0.1.0.3.4 46-47|0.0.1.0.1.0.3.3.0+0.0.1.0.1.0.3.3 41-42|0.0.1.0.1.0.3.2.0+0.0.1.0.1.0.3.2 38-40|0.0.1.0.0.0.1+0.0.1.0.0.0.0+0.0.1.0.0.0+0.0.1.0.0 36-37|0.0.1.0.1.0.3.1.0+0.0.1.0.1.0.3.1 33-35|0.1.0.1+0.1.0.0+0.1.0+0.1 32-33|0 31-32|0.0.1.0.1.0.3.0.0+0.0.1.0.1.0.3.0 28-31|0.0.1.0.1.0.0.0.2+0.0.1.0.1.0.0.0.1+0.0.1.0.1.0.0.0.0+0.0.1.0.1.0.0.0+0.0.1.0.1.0.0 26-27|0.0.1 25-26|0.0 24-25|0.0.1.1 22-23|0.0.1.0 21-22|0.0.1.0.1 20-21|0.0.1.0.1.0 19-20|0.0.1.0.1.0.3 16-17|0.0.1.0.1.0.2 15-16|0.0.1.0.1.0.2.1 14-15|0.0.1.0.1.0.2.0 12-13|0.0.1.0.1.0.2.1.0 10-11|0.0.1.0.1.0.2.1.0.0.1.0 9-10|0.0.1.0.1.0.2.1.0.0.1.0.0 8-9|0.0.1.0.1.0.1 6-7|0.0.1.0.1.0.2.1.0.0.1 4-5|0.0.1.0.1.0.2.1.0.0 3-4|0.0.1.0.1.0.2.1.0.0.0 2-3|0.0.1.0.1.0.2.1.0.0.0.0.0.0+0.0.1.0.1.0.2.1.0.0.0.0.0+0.0.1.0.1.0.2.1.0.0.0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:35.026
(a / and 
      :op1 (c2 / critical-02 
            :ARG0 (i / importantly) 
            :ARG1 (s / structure 
                  :ARG1-of (m2 / maintain-01 
                        :ARG0 (t / thing 
                              :name (n / name 
                                    :op1 (m / Muehleman) 
                                    :op2 (e / et))) 
                        :op2-of (o / or 
                              :op1 (d6 / develop-02 
                                    :ARG0 (t3 / thing 
                                          :name (n3 / name 
                                                :op1 "Erlacher" 
                                                :op2 "et" 
                                                :op3 "al.")) 
                                    :ARG1 (a3 / adult) 
                                    :ARG1-of (f / function-01 
                                          :ARG0 (t5 / they) 
                                          :ARG1-of (p / possible-01 
                                                :ARG1-of (s2 / suggest-01 
                                                      :ARG0 (c4 / component 
                                                            :ARG1-of (s3 / signal-01 
                                                                  :ARG0 (o2 / organization 
                                                                        :name (n4 / name 
                                                                              :op1 "BMP"))) 
                                                            :domain-of (p2 / present 
                                                                  :topic (c3 / cartilage 
                                                                        :mod (a2 / articular))))))) 
                                    :time (l / late 
                                          :op1 (d5 / date-entity 
                                                :year 1998) 
                                          :op2 (d4 / date-entity 
                                                :year 2000) 
                                          :op3 (d3 / date-entity 
                                                :year 2002) 
                                          :op4 (d2 / date-entity 
                                                :year 2002) 
                                          :op5 (d / date-entity 
                                                :year 2003))))) 
                  :mod (t4 / this))) 
      :op2 (t2 / thing 
            :name (n2 / name 
                  :op1 (c / Chubinskaya) 
                  :op2 (e2 / et))))

# ::snt BMPs bind tetrameric complexes of two type I and two type II transmembrane serine-threonine kinase receptors .
# ::tok BMPs bind tetrameric complexes of two type I and two type II transmembrane serine-threonine kinase receptors .
# ::alignments 15-16|0.0 14-15|0 10-11|0.0.0.2 9-10|0.0.0.2.0 8-9|0.0.0 7-8|0.0.0.1 6-7|0.0.0.0.1.0 5-6|0.0.0.0.1.0.0 3-4|0.0.0.0.1 1-2|0.0.0.0 0-1|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:35.516
(k / kinase 
      :mod-of (r / receptor 
            :op3-of (a / and 
                  :ARG2-of (b / bind-01 
                        :ARG0 (b2 / bmp) 
                        :ARG3 (c / complex 
                              :consist-of (t2 / type 
                                    :quant 2))) 
                  :op1 (i / i) 
                  :op2 (t / type 
                        :quant 2))))

# ::snt Upon BMP binding , these complexes transduce a signal by phosphorylating members of the Smad family of transcription factors ( Massague 1996 ) .
# ::tok Upon BMP binding , these complexes transduce a signal by phosphorylating members of the Smad family of transcription factors ( Massague 1996 ) .
# ::alignments 21-22|0.0.0.0.0.0.0.1.0+0.0.0.0.0.0.0.1 18-19|0.0 17-18|0 15-16|0.0.1.1 11-12|0.0.1.2+0.0.1+0.0.1.0 8-9|0.0.0.0.0.0 6-7|0.0.0.0.0 5-6|0.0.0.0 4-5|0.0.0 2-3|0.0.0.0.0.0.0 1-2|0.0.0.0.0.0.0.0.0.0+0.0.0.0.0.0.0.0.0+0.0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:36.143
(t / transcription 
      :mod-of (f / factor 
            :domain (t3 / this 
                  :mod-of (c / complex 
                        :mod-of (t2 / transduce 
                              :op1 (s / signal 
                                    :ARG1-of (b / binding-07 
                                          :ARG0 (o / organization 
                                                :name (n / name 
                                                      :op1 "BMP")) 
                                          :ARG2 (d / date-entity 
                                                :year 1996)))))) 
            :prep-with-of (h / have-org-role-91 
                  :ARG0 (p / person) 
                  :ARG1 (f2 / family) 
                  :ARG2 (m / member))))

# ::snt Recent experiments have implicated two different BMP type I receptors in skeletal patterning , BMPR1A and BMPR1B .
# ::tok Recent experiments have implicated two different BMP type I receptors in skeletal patterning , BMPR1A and BMPR1B .
# ::alignments 16-17|0.1.1.1.1.0.0+0.1.1.1.1.0+0.1.1.1.1 15-16|0.1.1.1 14-15|0.1.1.1.0.0.0+0.1.1.1.0.0+0.1.1.1.0 12-13|0.1.1 11-12|0.1.1.0 8-9|0.0.0 7-8|0.1 6-7|0.1.2.0.0+0.1.2.0+0.1.2 5-6|0.1.0 4-5|0.1.3 3-4|0 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:36.361
(i2 / implicate-01 
      :ARG0 (e / experiment-01 
            :ARG1 (i / i) 
            :time (r / recent)) 
      :ARG1 (t / type 
            :ARG1-of (d / differ-02) 
            :ARG1-of (p / pattern-01 
                  :mod (s / skeletal) 
                  :op1-of (a / and 
                        :op2 (c / country 
                              :name (n2 / name 
                                    :op1 "BMPR1A")) 
                        :op3 (o / organization 
                              :name (n / name 
                                    :op1 "BMPR1B")))) 
            :mod (o2 / organization 
                  :name (n3 / name 
                        :op1 "BMP")) 
            :quant 2))

# ::snt Both receptors can bind BMP2 , BMP4 , and GDF5 , although GDF5 shows higher affinity for BMPR1B ( Koenig et al. 1994 ; ten Dijke et al. 1994 ; Yamaji et al. 1994 ; Nishitoh et al. 1996 ; Chalaux et al. 1998 ) .
# ::tok Both receptors can bind BMP2 , BMP4 , and GDF5 , although GDF5 shows higher affinity for BMPR1B ( Koenig et al. 1994 ; ten Dijke et al. 1994 ; Yamaji et al. 1994 ; Nishitoh et al. 1996 ; Chalaux et al. 1998 ) .
# ::alignments 43-44|0.1.1.0.0.2.0+0.1.1.0.0.2 38-39|0.1.1.0.0.0.0+0.1.1.0.0.0 35-37|0.1.1.0.0.1.0.1+0.1.1.0.0.1.0.0+0.1.1.0.0.1.0+0.1.1.0.0.1 33-34|0.1.1.3.0+0.1.1.3 30-32|0.1.0.1.1.2.0.1+0.1.0.1.1.2.0.0+0.1.0.1.1.2.0+0.1.0.1.1.2 28-29|0.1.1.2.0+0.1.1.2 24-26|0.3.0.1+0.3.0.0+0.3.0+0.3 23-24|0 22-23|0.2.0+0.2 19-22|0.1.0.1.1.1.0.2+0.1.0.1.1.1.0.1+0.1.0.1.1.1.0.0+0.1.0.1.1.1.0+0.1.0.1.1.1 17-18|0.1.1.1.0.0+0.1.1.1.0+0.1.1.1 15-16|0.1.1.0 14-15|0.1.1.0.0 13-14|0.1.1 9-10|0.1.0.1.1.0.0.0+0.1.0.1.1.0.0+0.1.0.1.1.0 8-9|0.1.0.1.1 4-5|0.1.0.1.0.0+0.1.0.1.0+0.1.0.1 3-4|0.1.0 2-3|0.1 1-2|0.1.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:43.275
(a / and 
      :mod (b2 / both) 
      :op1 (p / possible-01 
            :ARG1 (b / bind-01 
                  :ARG0 (r / receptor) 
                  :ARG1 (t7 / thing 
                        :name (n8 / name 
                              :op1 "BMP2") 
                        :op1-of (a3 / and 
                              :op2 (t6 / thing 
                                    :name (n7 / name 
                                          :op1 "GDF5")) 
                              :op3 (t5 / thing 
                                    :name (n5 / name 
                                          :op1 "Koenig" 
                                          :op2 "et" 
                                          :op3 "al.")) 
                              :op4 (t2 / thing 
                                    :name (n3 / name 
                                          :op1 (y / Yamaji) 
                                          :op2 (e2 / et)))))) 
            :condition (s / show-01 
                  :ARG1 (a2 / affinity 
                        :ARG1-of (h / high-02 
                              :ARG2 (d2 / date-entity 
                                    :year 1996) 
                              :compared-to (t / thing 
                                    :name (n / name 
                                          :op1 (n2 / Nishitoh) 
                                          :op2 (e / et))) 
                              :op1-of (d / date-entity 
                                    :year 1998))) 
                  :ARG2 (o / organization 
                        :name (n6 / name 
                              :op1 "BMPR1B")) 
                  :time (d4 / date-entity 
                        :year 1994) 
                  :time (d3 / date-entity 
                        :year 1994))) 
      :op2 (d6 / date-entity 
            :year 1994) 
      :op3 (t3 / thing 
            :name (n4 / name 
                  :op1 (t4 / ten) 
                  :op2 (d5 / Dijke))))

# ::snt Both receptors are also expressed in dynamic patterns during normal development .
# ::tok Both receptors are also expressed in dynamic patterns during normal development .
# ::alignments 10-11|0.1.0 9-10|0.1.0.1 7-8|0.1 6-7|0.1.1 4-5|0 3-4|0.2 1-2|0.0 0-1|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:43.352
(e / express-01 
      :ARG1 (r / receptor) 
      :ARG2 (p / pattern-01 
            :ARG1 (d / develop-02 
                  :ARG1 (b / both) 
                  :ARG1-of (n / normal-02)) 
            :mod (d2 / dynamic)) 
      :mod (a / also))

# ::snt In limbs , Bmpr1a expression becomes restricted to joint interzones , perichondrium , periarticular cartilage , hypertrophic chondrocytes , and interdigital limb mesenchyme .
# ::tok In limbs , Bmpr1a expression becomes restricted to joint interzones , perichondrium , periarticular cartilage , hypertrophic chondrocytes , and interdigital limb mesenchyme .
# ::alignments 22-23|0.1.1.1.2 21-22|0.1.1.1.2.0 19-20|0.1.1.1 17-18|0.1.1.1.1 14-15|0.1.1.1.0 13-14|0.1.1.1.0.0 9-10|0.1.1 8-9|0.1.1.0 6-7|0.1 5-6|0 4-5|0.0 3-4|0.0.0.0.0+0.0.0.0+0.0.0 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:43.448
(b / become-01 
      :ARG1 (e / express-01 
            :ARG1 (c3 / country 
                  :name (n / name 
                        :op1 "Bmpr1a"))) 
      :ARG2 (r / restrict-01 
            :ARG0 (l2 / limb) 
            :ARG1 (i / interzon 
                  :mod (j / joint) 
                  :op1-of (a / and 
                        :op2 (c2 / cartilage 
                              :mod (p / periarticular)) 
                        :op3 (c / chondrocyt) 
                        :op4 (m / mesenchyme 
                              :mod (l / limb))))))

# ::snt In comparison , Bmpr1b expression is seen primarily in condensing precartilaginous mesenchymal cells , regions flanking joint interzones , perichondrium , and periarticular cartilage ( Dewulf et al. 1995 ; Mishina et al. 1995 ; Zou et al. 1997 ; Baur et al. 2000 ) .
# ::tok In comparison , Bmpr1b expression is seen primarily in condensing precartilaginous mesenchymal cells , regions flanking joint interzones , perichondrium , and periarticular cartilage ( Dewulf et al. 1995 ; Mishina et al. 1995 ; Zou et al. 1997 ; Baur et al. 2000 ) .
# ::alignments 43-44|0.0.4.0+0.0.4 40-43|0.2.0.2+0.2.0.1+0.2.0.0+0.2.0+0.2 38-39|0.0.3.0+0.0.3 35-37|0.0.0.0.0.2.0.1+0.0.0.0.0.2.0.0+0.0.0.0.0.2.0+0.0.0.0.0.2 33-34|0.0.2.0+0.0.2 30-32|0.1.0.1+0.1.0.0+0.1.0+0.1 29-30|0 28-29|0.0.1.0+0.0.1 25-28|0.0.0.2.0.0.2+0.0.0.2.0.0.1+0.0.0.2.0.0.0+0.0.0.2.0.0+0.0.0.2.0 23-24|0.0.0.0.0.1 22-23|0.0.0.0.0.1.0 21-22|0.0.0.0.0 19-20|0.0.0.0.0.0 17-18|0.0.0.0.2.1 16-17|0.0.0.0.2.1.0 15-16|0.0.0.0.2 14-15|0.0.0.0.2.0 12-13|0.0.0.0.1 11-12|0.0.0.0.1.0 10-11|0.0.0.0.1.1 9-10|0.0.0.0 7-8|0.0.0.1 6-7|0.0.0 4-5|0.0 1-2|0.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:50.937
(a2 / and 
      :ARG1-of (e4 / express-01 
            :ARG1-of (s / see-01 
                  :ARG0 (c3 / condense-01 
                        :ARG0 (a3 / and 
                              :op1 (p2 / perichondrium) 
                              :op2 (c / cartilage 
                                    :mod (p / periarticular)) 
                              :op3 (t2 / thing 
                                    :name (n2 / name 
                                          :op1 (z / Zou) 
                                          :op2 (e2 / et)))) 
                        :ARG1 (c2 / cell 
                              :mod (m2 / mesenchymal) 
                              :mod (p3 / precartilaginou)) 
                        :purpose (f / flank-01 
                              :ARG0 (r / region) 
                              :ARG1 (i / interzon 
                                    :mod (j / joint)))) 
                  :mod (p4 / primary) 
                  :time (c4 / compare-01 
                        :ARG1 (t4 / thing 
                              :name (n4 / name 
                                    :op1 "Dewulf" 
                                    :op2 "et" 
                                    :op3 "al.")))) 
            :time (d4 / date-entity 
                  :year 1995) 
            :time (d3 / date-entity 
                  :year 1995) 
            :time (d2 / date-entity 
                  :year 1997) 
            :time (d / date-entity 
                  :year 2000)) 
      :op1 (t3 / thing 
            :name (n3 / name 
                  :op1 (m / Mishina) 
                  :op2 (e3 / et))) 
      :op2 (t / thing 
            :name (n / name 
                  :op1 (b / Baur) 
                  :op2 (e / et) 
                  :op3 (a / al.))))

# ::snt Null mutations in the Bmpr1b gene produce viable mice with defects in bone and joint formation that closely resemble those seen in mice missing Gdf5 ( Storm and Kingsley 1996 ; Baur et al. 2000 ; Yi et al. 2000 ) .
# ::tok Null mutations in the Bmpr1b gene produce viable mice with defects in bone and joint formation that closely resemble those seen in mice missing Gdf5 ( Storm and Kingsley 1996 ; Baur et al. 2000 ; Yi et al. 2000 ) .
# ::alignments 39-40|0.1.1.0.0.3.0.0.0+0.1.1.0.0.3.0.0 36-37|0.2.1+0.2.0.0+0.2.0+0.2 34-35|0.1.1.0.0.3.3.0+0.1.1.0.0.3.3 31-34|0.1.2.0.2+0.1.2.0.1+0.1.2.0.0+0.1.2.0+0.1.2 30-31|0.1 29-30|0.1.1.0.0.3.2.0+0.1.1.0.0.3.2 27-28|0 26-27|0.0.0.0+0.0.0+0.0 24-25|0.1.1.1.0+0.1.1.1+0.1.1 23-24|0.1.0.0 22-23|0.1.0 20-21|0.1.1.0 18-19|0.1.1.0.0.3.0 17-18|0.1.1.0.0.3.0.1 15-16|0.1.1.0.0.3 14-15|0.1.1.0.0.3.1 13-14|0.1.1.0.0 12-13|0.1.1.0.0.2 10-11|0.1.1.0.0.0 8-9|0.1.1.0.0.1.0.0 7-8|0.1.1.0.0.1.0.0.0 6-7|0.1.1.0.0.1.0 5-6|0.1.1.0.0.1.1 1-2|0.1.1.0.0.1 0-1|0.1.1.0.0.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:51.522
(a2 / and 
      :op1 (o / organization 
            :name (n3 / name 
                  :op1 "Storm")) 
      :op2 (a / and 
            :op1 (m2 / mouse 
                  :ARG1-of (m / miss-01)) 
            :op2 (p2 / person 
                  :ARG0-of (s / see-01 
                        :ARG1 (a3 / and 
                              :ARG1-of (d4 / defect-01) 
                              :op1 (m4 / mutate-01 
                                    :ARG0-of (p3 / produce-01 
                                          :ARG1 (m3 / mouse 
                                                :mod (v / viable))) 
                                    :ARG1 (g / gene) 
                                    :mod (n5 / null)) 
                              :op2 (b / bone) 
                              :op3 (f / form-01 
                                    :ARG0-of (r / resemble-01 
                                          :ARG1 (d / date-entity 
                                                :year 2000) 
                                          :manner (c / close)) 
                                    :ARG1 (j / joint) 
                                    :time (d3 / date-entity 
                                          :year 1996) 
                                    :time (d2 / date-entity 
                                          :year 2000)))) 
                  :name (n4 / name 
                        :op1 "Gdf5")) 
            :op3 (t / thing 
                  :name (n2 / name 
                        :op1 "Baur" 
                        :op2 "et" 
                        :op3 "al."))) 
      :op3 (p / person 
            :name (n / name 
                  :op1 "Yi") 
            :wiki "Yi_Jianlian"))

# ::snt Null mutations in Bmpr1a cause early embryonic lethality , with defects in gastrulation similar to those seen in mice with mutations in Bmp4 ( Mishina et al. 1995 ; Winnier et al. 1995 ) .
# ::tok Null mutations in Bmpr1a cause early embryonic lethality , with defects in gastrulation similar to those seen in mice with mutations in Bmp4 ( Mishina et al. 1995 ; Winnier et al. 1995 ) .
# ::alignments 32-33|0.1.2.1.0+0.1.2.1 29-31|0.2.2.0.1+0.2.2.0.0+0.2.2.0+0.2.2 28-29|0.2 27-28|0.1.2.0.0+0.1.2.0 24-27|0.1.0.0.0.0.2+0.1.0.0.0.0.1+0.1.0.0.0.0.0+0.1.0.0.0.0+0.1.0.0.0 22-23|0.2.1.1.0+0.2.1.1+0.2.1 20-21|0.2.1.0 18-19|0.2.0.0 16-17|0.2.0 13-14|0.1.0.0 12-13|0.1.0.1 10-11|0.1.0 7-8|0.1 6-7|0.1.1 5-6|0.1.2 4-5|0 3-4|0.0.0.0.0+0.0.0.0+0.0.0 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:52.605
(c / cause-01 
      :ARG0 (m3 / mutate-01 
            :location (c2 / country 
                  :name (n4 / name 
                        :op1 "Bmpr1a")) 
            :mod (n5 / null)) 
      :ARG1 (l / lethality 
            :ARG1-of (d3 / defect-01 
                  :ARG1-of (r / resemble-01 
                        :ARG2 (t2 / thing 
                              :name (n2 / name 
                                    :op1 "Mishina" 
                                    :op2 "et" 
                                    :op3 "al."))) 
                  :location (g / gastrulation)) 
            :mod (e2 / embryonic) 
            :mod (e3 / early 
                  :op1 (d2 / date-entity 
                        :year 1995) 
                  :op2 (d / date-entity 
                        :year 1995))) 
      :op1-of (a / and 
            :ARG1-of (s / see-01 
                  :ARG0 (m2 / mouse)) 
            :op2 (p / person 
                  :ARG1-of (m / mutate-01) 
                  :name (n3 / name 
                        :op1 "Bmp4")) 
            :op3 (t / thing 
                  :name (n / name 
                        :op1 (w / Winnier) 
                        :op2 (e / et)))))

# ::snt Recent studies with floxed alleles suggest that Bmpr1a is also required for many later developmental events , but its roles in bone and joint formation have not yet been tested ( Mishina 2003 ) .
# ::tok Recent studies with floxed alleles suggest that Bmpr1a is also required for many later developmental events , but its roles in bone and joint formation have not yet been tested ( Mishina 2003 ) .
# ::alignments 32-33|0.0.1.2.0.0+0.0.1.2.0 31-32|0.2.2.0.0+0.2.2.0+0.2.2 29-30|0.2 27-28|0.2.4 26-27|0.2.3 24-25|0.2.1.0.1 23-24|0.2.1.0.1.0 22-23|0.2.1.0 21-22|0.2.1.0.0 19-20|0.2.1 17-18|0 15-16|0.0.1 14-15|0.0.1.0 13-14|0.0.1.2 12-13|0.0.1.1 10-11|0.0 9-10|0.0.2 7-8|0.2.0.0.0+0.2.0.0+0.2.0 5-6|0.1 4-5|0.0.0 3-4|0.0.0.0 1-2|0.1.0 0-1|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:53.714
(c / contrast-01 
      :ARG1 (r2 / require-01 
            :ARG1 (a3 / allel 
                  :mod (f2 / flox)) 
            :ARG2 (e / event 
                  :mod (d2 / developmental) 
                  :quant (m / many) 
                  :time (l / late 
                        :op1 (d / date-entity 
                              :year 2003))) 
            :mod (a2 / also)) 
      :ARG1-of (s / suggest-01 
            :ARG0 (s2 / study-01 
                  :time (r3 / recent))) 
      :ARG2 (t / test-01 
            :ARG0 (c2 / country 
                  :name (n2 / name 
                        :op1 "Bmpr1a")) 
            :ARG1 (r / role 
                  :op1-of (a / and 
                        :op2 (b / bone) 
                        :op3 (f / form-01 
                              :ARG1 (j / joint)))) 
            :ARG2 (p / person 
                  :name (n / name 
                        :op1 "Mishina")) 
            :polarity - 
            :time (y / yet)))

# ::snt A genetic system for activating or inactivating genes specifically in joint tissues would be particularly useful for further studies of joint formation and maintenance .
# ::tok A genetic system for activating or inactivating genes specifically in joint tissues would be particularly useful for further studies of joint formation and maintenance .
# ::alignments 23-24|0.0.1.0.0.0.1 22-23|0.0.1.0.0.0 21-22|0.0.1.0.0.0.0 20-21|0.0.1.0.0.0.0.0 18-19|0.0.1.0.0 17-18|0.0.1.0.0.1 15-16|0.0.1.0 14-15|0.0.1.0.1 11-12|0.0.0.0.0 10-11|0.0.0.0.0.0 8-9|0.0.0.0 7-8|0.0.0 5-6|0 4-5|0.0 2-3|0.0.1 1-2|0.0.1.0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:54.028
(o / or 
      :op1 (a2 / activate-01 
            :ARG1 (g / gene 
                  :ARG1-of (s2 / specific-02 
                        :ARG2 (t / tissue 
                              :mod (j2 / joint)))) 
            :mod-of (s3 / system 
                  :ARG1-of (u / useful-05 
                        :beneficiary (s / study-01 
                              :ARG1 (a / and 
                                    :op1 (f / form-01 
                                          :manner (j / joint)) 
                                    :op2 (m / maintain-01 
                                          :ARG1 (g2 / gene))) 
                              :degree (f2 / further)) 
                        :mod (p / particular)))))

# ::snt Here we take advantage of the tissue-specific expression pattern of the Gdf5 gene to engineer a Cre/loxP system ( Nagy 2000 ) , Gdf5-Cre , that can be used to remove or ectopically express genes in joints .
# ::tok Here we take advantage of the tissue-specific expression pattern of the Gdf5 gene to engineer a Cre/loxP system ( Nagy 2000 ) , Gdf5-Cre , that can be used to remove or ectopically express genes in joints .
# ::alignments 36-37|0.2 34-35|0.1 33-34|0 31-32|0.3 30-31|0.1.0 28-29|0.1.0.0 26-27|0.3.0 20-21|0.0.0.0.0+0.0.0.0 19-20|0.0.1.0+0.0.1+0.0 17-18|0.1.0.0.0 16-17|0.1.0.0.0.1.0.0+0.1.0.0.0.1.0+0.1.0.0.0.1 14-15|0.1.0.0.0.0 12-13|0.1.0.0.0.0.0 8-9|0.1.0.0.0.0.0.0 7-8|0.0.0 3-4|0.1.0.0.0.0.1.1 2-3|0.1.0.0.0.0.1 1-2|0.1.0.0.0.0.1.0 0-1|0.1.0.0.0.0.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:54.756
(e / express-01 
      :ARG0 (p2 / person 
            :ARG0-of (e3 / express-01 
                  :ARG1 (d / date-entity 
                        :year 2000)) 
            :name (n / name 
                  :op1 "Nagy")) 
      :ARG1 (g / gene 
            :ARG1-of (r / remove-01 
                  :ARG2-of (u / use-01 
                        :ARG1 (s / system 
                              :ARG1-of (e2 / engineer-01 
                                    :ARG0 (g2 / gene 
                                          :mod-of (p3 / pattern)) 
                                    :purpose-of (t / take-01 
                                          :ARG0 (w / we) 
                                          :ARG1 (a / advantage) 
                                          :location (h / here))) 
                              :mod (o2 / organization 
                                    :name (n2 / name 
                                          :op1 "Cre/loxP")))))) 
      :manner (j / joint) 
      :op1-of (o / or 
            :ARG1-of (p / possible-01)))

# ::snt Tests with reporter mice show that this system is capable of modifying genes in all of the structures of the mature synovial joint , including the ligaments of the joint capsule , the synovial membrane , and the articular cartilage .
# ::tok Tests with reporter mice show that this system is capable of modifying genes in all of the structures of the mature synovial joint , including the ligaments of the joint capsule , the synovial membrane , and the articular cartilage .
# ::alignments 39-40|0.1.2.2 38-39|0.1.2.2.0 36-37|0.1.2 34-35|0.1.2.1 33-34|0.1.2.1.1 30-31|0.1.2.0 29-30|0.1.2.1.2 26-27|0.0.0 22-23|0.0.2 21-22|0.0.2.0 20-21|0.1.2.1.0 17-18|0.1.2.1.0.0.0 14-15|0.1.2.1.0.0.0.0 12-13|0.1.1.0 11-12|0.1.1 9-10|0.1 7-8|0.1.0 6-7|0.1.0.0 4-5|0 3-4|0.0.1 2-3|0.1.2.1.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:55.608
(s5 / show-01 
      :ARG0 (t2 / test-01 
            :ARG1 (l / ligament) 
            :ARG2 (m4 / mouse) 
            :mod (j2 / joint 
                  :mod (s2 / synovial))) 
      :ARG1 (c3 / capable-01 
            :ARG1 (s4 / system 
                  :mod (t / this)) 
            :ARG2 (m3 / modify-01 
                  :ARG1 (g / gene)) 
            :op1-of (a2 / and 
                  :op2 (c2 / capsule) 
                  :op3 (m / membrane 
                        :mod (m2 / mature-02 
                              :ARG1 (r / report-01 
                                    :ARG1 (s3 / structure 
                                          :quant (a3 / all)))) 
                        :mod (s / synovial) 
                        :mod (j / joint)) 
                  :op4 (c / cartilage 
                        :mod (a / articular)))))

# ::snt Gdf5-Cre recombination bypasses the early embryonic lethality of null mutations in Bmpr1a , and shows that this receptor is required for early joint formation at some locations and for initiation of programmed cell death in webbing between digits .
# ::tok Gdf5-Cre recombination bypasses the early embryonic lethality of null mutations in Bmpr1a , and shows that this receptor is required for early joint formation at some locations and for initiation of programmed cell death in webbing between digits .
# ::alignments 37-38|0.1.1.0.0.0 33-34|0.1.1.0.0 32-33|0.1.1.0.0.2 31-32|0.1.1.0.0.1 29-30|0.1.1.0.0.3 27-28|0.1.1.2.0 26-27|0.1.1.2 25-26|0.1.1.2.1 23-24|0.1.1.0 22-23|0.1.1.0.1 21-22|0.1.1.0.2 19-20|0.1.1 17-18|0.1.1.1 16-17|0.1.1.1.0 14-15|0.1 13-14|0 11-12|0.1.1.2.0.0.1.0.0+0.1.1.2.0.0.1.0+0.1.1.2.0.0.1 9-10|0.1.1.2.0.0 8-9|0.1.1.2.0.0.0 6-7|0.0.0 5-6|0.0.0.0 4-5|0.0.0.1 2-3|0.0 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:56.644
(a2 / and 
      :op1 (b / bypass-01 
            :ARG1 (l2 / lethality 
                  :mod (e2 / embryonic) 
                  :mod (e3 / early))) 
      :op2 (s2 / show-01 
            :ARG0 (r3 / recombination) 
            :ARG1 (r / require-01 
                  :ARG1 (f / form-01 
                        :ARG1 (d2 / die-01 
                              :ARG1 (d / digit) 
                              :ARG1-of (p / program-01) 
                              :mod (c / cell) 
                              :mod-of (i / initiation)) 
                        :manner (j / joint) 
                        :time (e / early)) 
                  :ARG2 (r2 / receptor 
                        :mod (t / this)) 
                  :location (l / location 
                        :op1-of (a / and 
                              :ARG1-of (m / mutate-01 
                                    :ARG1-of (n2 / null-02) 
                                    :location (c2 / country 
                                          :name (n / name 
                                                :op1 "Bmpr1a")))) 
                        :quant (s / some)))))

# ::snt Interestingly , Bmpr1a is also required for postnatal maintenance of articular cartilage throughout most of the skeleton .
# ::tok Interestingly , Bmpr1a is also required for postnatal maintenance of articular cartilage throughout most of the skeleton .
# ::alignments 16-17|0.0 13-14|0.1.0 12-13|0.5 11-12|0.1.1 10-11|0.1.1.0 8-9|0.1 7-8|0.1.2 5-6|0 4-5|0.3 2-3|0.2.0.0+0.2.0+0.2 0-1|0.4 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:56.812
(r / require-01 
      :ARG0 (s / skeleton) 
      :ARG1 (m2 / maintain-01 
            :ARG0 (m / most) 
            :ARG1 (c / cartilage 
                  :mod (a / articular)) 
            :mod (p / postnatal)) 
      :ARG2 (c2 / country 
            :name (n / name 
                  :op1 "Bmpr1a")) 
      :mod (a2 / also) 
      :mod (i / interesting) 
      :time (t / throughout))

# ::snt In Gdf5-Cre/Bmpr1afloxP mice , articular cartilage initially forms normally , but subsequently loses expression of several key cartilage markers after birth .
# ::tok In Gdf5-Cre/Bmpr1afloxP mice , articular cartilage initially forms normally , but subsequently loses expression of several key cartilage markers after birth .
# ::alignments 20-21|0.1.0.1.0 19-20|0.1.0.1 18-19|0.1.0.0 17-18|0.1.0.0.1 16-17|0.1.0.0.0 15-16|0.1.0.0.2 13-14|0.1.0 12-13|0.1 11-12|0.1.1 10-11|0 8-9|0.0.2 7-8|0.0 6-7|0.0.3 5-6|0.0.0 4-5|0.0.1 2-3|0.0.4 1-2|0.0.4.0.0.0+0.0.4.0.0+0.0.4.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:56.949
(c2 / contrast-01 
      :ARG1 (f / form-02 
            :ARG0 (c3 / cartilage) 
            :ARG1 (a2 / articular) 
            :ARG1-of (n / normal-02) 
            :time (i / initial) 
            :time (m2 / mouse 
                  :mod (c4 / country 
                        :name (n2 / name 
                              :op1 "Gdf5-Cre/Bmpr1afloxP")))) 
      :ARG2 (l / lose-02 
            :ARG1 (e / express-01 
                  :ARG1 (m / marker 
                        :ARG1-of (k / key-02) 
                        :mod (c / cartilage) 
                        :quant (s / several)) 
                  :time (a / after 
                        :op1 (b / birth-01))) 
            :time (s2 / subsequent)))

# ::snt It ultimately fibrillates and degenerates , resulting in severe osteoarthritis and loss of mobility .
# ::tok It ultimately fibrillates and degenerates , resulting in severe osteoarthritis and loss of mobility .
# ::alignments 13-14|0.1.0.1 11-12|0.1.0.0 10-11|0.1.0 9-10|0.1.1 8-9|0.1.1.0 6-7|0.1 4-5|0.0 3-4|0 1-2|0.0.1 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:57.029
(a2 / and 
      :op1 (d / degenerate-01 
            :ARG0 (i / it) 
            :time (u / ultimate)) 
      :op2 (r / result-01 
            :ARG1 (a / and 
                  :op1 (l / loss) 
                  :op2 (m / mobility)) 
            :ARG2 (o / osteoarthriti 
                  :mod (s / severe))))

# ::snt These experiments suggest that BMP signaling is required for normal maintenance of postnatal articular cartilage , and that modulation of the BMP signaling pathway may play an important role in joint disease .
# ::tok These experiments suggest that BMP signaling is required for normal maintenance of postnatal articular cartilage , and that modulation of the BMP signaling pathway may play an important role in joint disease .
# ::alignments 31-32|0.1.1.3 30-31|0.1.1.3.0 28-29|0.1.1.1 27-28|0.1.1.1.0 25-26|0.1.1 24-25|0.1.1.2 23-24|0.0.0.0 22-23|0.0.0 18-19|0.1.1.0 16-17|0.1 14-15|0.1.0.0.0 13-14|0.1.0.0.0.0 12-13|0.1.0.1.1 10-11|0.1.0.0 9-10|0.1.0.0.1 7-8|0.1.0 5-6|0.1.0.1 4-5|0.1.0.1.0.0.0+0.1.0.1.0.0+0.1.0.1.0 2-3|0 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:57.558
(s3 / suggest-01 
      :ARG0 (e / experiment-01 
            :ARG1 (s / signal-01 
                  :ARG1 (p3 / pathway)) 
            :mod (t / this)) 
      :ARG1 (a / and 
            :op1 (r2 / require-01 
                  :ARG1 (m2 / maintain-01 
                        :ARG1 (c / cartilage 
                              :mod (a2 / articular)) 
                        :ARG1-of (n / normal-02)) 
                  :ARG2 (s2 / signal-01 
                        :ARG0 (o / organization 
                              :name (n2 / name 
                                    :op1 "BMP")) 
                        :ARG1 (p4 / postnatal))) 
            :op2 (p / play-01 
                  :ARG0 (m / modulation) 
                  :ARG1 (r / role 
                        :mod (i / important)) 
                  :ARG1-of (p2 / possible-01) 
                  :location (d / disease 
                        :mod (j / joint)))))

# ::snt Genetic System for Testing the Function of Genes in Joint Development .
# ::tok Genetic System for Testing the Function of Genes in Joint Development .
# ::alignments 9-11|0.0.0.1+0.0.0.0+0.0.0+0.0 0-8|0.1.7+0.1.6+0.1.5+0.1.4+0.1.3+0.1.2+0.1.1+0.1.0+0.1+0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:57.589
(o2 / organization 
      :location (o / organization 
            :name (n / name 
                  :op1 "Joint" 
                  :op2 "Development")) 
      :name (n2 / name 
            :op1 "Genetic" 
            :op2 "System" 
            :op3 "for" 
            :op4 "Testing" 
            :op5 "the" 
            :op6 "Function" 
            :op7 "of" 
            :op8 "Genes"))

# ::snt To generate a general system capable of specifically testing genes for functions in skeletal joint development , we engineered transgenic mice to express Cre recombinase in developing joints ( Figure 1 ) .
# ::tok To generate a general system capable of specifically testing genes for functions in skeletal joint development , we engineered transgenic mice to express Cre recombinase in developing joints ( Figure 1 ) .
# ::alignments 30-31|0.0.3.0.0 29-30|0.0.2.0 27-28|0.0.1.0.0.0.1.1.0 26-27|0.0.1.0.0.0.1.1 24-25|0.0.1.0.0.0.1.0 23-24|0.0.1.0.0.0.1.0.0.0.0+0.0.1.0.0.0.1.0.0.0+0.0.1.0.0.0.1.0.0 22-23|0.0.1.0.0.0.1 20-21|0.0.1.0.0.0.0.0 18-19|0.0.1.0.0.0.0 17-18|0.0.1.0.0.0 15-16|0.0.3.0 14-15|0.0.3.0.1 13-14|0 11-12|0.0.3 9-10|0.0.0 8-9|0.0 7-8|0.0.2 5-6|0.0.1 4-5|0.0.1.0 3-4|0.0.1.0.1 1-2|0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:58.129
(s / skeletal 
      :ARG0-of (t2 / test-01 
            :ARG1 (g / gene) 
            :ARG2-of (c / capable-01 
                  :ARG1 (s3 / system 
                        :ARG1-of (g3 / generate-01 
                              :ARG0 (w / we 
                                    :ARG0-of (e2 / engineer-01 
                                          :ARG1 (m / mouse)) 
                                    :ARG0-of (e / express-01 
                                          :ARG1 (r / recombinase 
                                                :mod (t / thing 
                                                      :name (n / name 
                                                            :op1 "Cre"))) 
                                          :ARG2 (d / develop-02 
                                                :ARG1 (j / joint))))) 
                        :ARG1-of (g2 / general-02))) 
            :manner (s2 / specific-02 
                  :ARG0 (f / figure)) 
            :purpose (f2 / function-01 
                  :ARG1 (d2 / develop-02 
                        :ARG1 1 
                        :manner (j2 / joint)))))

# ::snt Gdf5 is a gene strongly expressed in stripes across developing skeletal elements during embryonic joint formation .
# ::tok Gdf5 is a gene strongly expressed in stripes across developing skeletal elements during embryonic joint formation .
# ::alignments 15-16|0.0 14-15|0.0.0 13-14|0 11-12|0.0.1.0 10-11|0.0.1.0.0 9-10|0.0.1 8-9|0.0.1.1 7-8|0.0.1.1.0.2 5-6|0.0.1.1.0 4-5|0.0.1.1.0.1 3-4|0.0.1.1.0.0 0-1|0.0.1.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:58.193
(e / embryonic 
      :mod-of (f / form-01 
            :manner (j / joint) 
            :time-of (d / develop-02 
                  :ARG1 (e2 / element 
                        :mod (s / skeletal)) 
                  :op1-of (a / across 
                        :manner-of (e3 / express-01 
                              :ARG1 (g / gene 
                                    :domain (g2 / Gdf5)) 
                              :ARG1-of (s3 / strong-02) 
                              :manner (s2 / stripe))))))

# ::snt A bacterial artificial chromosome ( BAC ) containing the Gdf5 locus was modified by homologous recombination in bacteria to insert a cassette encoding Cre-internal ribosome entry site ( IRES ) - human placental alkaline phosphatase ( hPLAP ) into the translation start site of Gdf5 ( Figure 1A ) .
# ::tok A bacterial artificial chromosome ( BAC ) containing the Gdf5 locus was modified by homologous recombination in bacteria to insert a cassette encoding Cre-internal ribosome entry site ( IRES ) - human placental alkaline phosphatase ( hPLAP ) into the translation start site of Gdf5 ( Figure 1A ) .
# ::alignments 46-47|0.0.1.2 42-43|0.0.2 41-42|0.0 40-41|0.0.2.0.0+0.0.2.0 36-37|0 34-35|0.0.2.0.0.0 33-34|0.0.2.0.0.0.0 32-33|0.0.2.0.0.0.0.0.0 31-32|0.0.2.0.0.0.0.0 28-29|0.0.1.0.0.1.1.0.1 26-27|0.0.1.1 25-26|0.0.1.1.0 24-25|0.0.1.1.1 22-23|0.0.1 21-22|0.0.1.0 19-20|0.0.1.0.0 17-18|0.0.1.0.0.0 15-16|0.0.1.0.0.1.0 14-15|0.0.0 12-13|0.0.1.0.0.1 10-11|0.0.1.0.0.1.1.0.0 7-8|0.0.1.0.0.1.1.0 5-6|0.0.1.1.2.0.0+0.0.1.1.2.0+0.0.1.1.2 3-4|0.0.1.0.0.1.1 2-3|0.0.1.0.0.1.1.1 1-2|0.0.1.0.0.1.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:13:59.869
(h / hPLAP 
      :ARG1-of (s2 / start-01 
            :ARG0 (h3 / homologou) 
            :ARG2 (e2 / encode-01 
                  :ARG0 (c / cassette 
                        :ARG1-of (i2 / insert-01 
                              :ARG0 (b / bacteria) 
                              :ARG2-of (m / modify-01 
                                    :ARG0 (r2 / recombination) 
                                    :ARG1 (c3 / chromosome 
                                          :ARG0-of (c2 / contain-01 
                                                :ARG1 (l / locu) 
                                                :ARG2 (i / ir)) 
                                          :mod (a2 / artificial) 
                                          :mod (b2 / bacterial))))) 
                  :ARG1 (s3 / site 
                        :mod (e / entry) 
                        :mod (r / ribosome) 
                        :mod (o / organization 
                              :name (n / name 
                                    :op1 "BAC"))) 
                  :ARG2 (f / figure)) 
            :mod-of (s / site 
                  :mod (t / thing 
                        :ARG2-of (t2 / translate-01 
                              :ARG1 (p / phosphatase 
                                    :mod (a / alkaline 
                                          :mod (h2 / human 
                                                :mod-of (p2 / placental)))))))))

# ::snt This modified BAC was then used to make lines of transgenic mice .
# ::tok This modified BAC was then used to make lines of transgenic mice .
# ::alignments 11-12|0.1.0 8-9|0.1 5-6|0 4-5|0.2 2-3|0.0.2.0+0.0.2+0.0 1-2|0.0.1 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:00.045
(u / use-01 
      :ARG0 (o / organization 
            :mod (t2 / this) 
            :mod (m2 / modify-01) 
            :name (n / name 
                  :op1 "BAC")) 
      :ARG1 (l / line 
            :consist-of (m / mouse)) 
      :time (t / then))

# ::snt The resulting Gdf5-Cre transgenic mice were tested for transgene expression and Cre recombinase activity by crossing them to R26R reporter mice that activate the expression of lacZ after Cre-mediated removal of transcriptional stop sequences ( Soriano 1999 ) .
# ::tok The resulting Gdf5-Cre transgenic mice were tested for transgene expression and Cre recombinase activity by crossing them to R26R reporter mice that activate the expression of lacZ after Cre-mediated removal of transcriptional stop sequences ( Soriano 1999 ) .
# ::alignments 36-37|0.1.1.0.0.0.0.0.0.0+0.1.1.0.0.0.0.0.0 33-34|0.1.1.0.0 32-33|0.1.1.0.0.0 29-30|0.1.1.0 28-29|0.1.1.0.1 27-28|0.1.1 26-27|0.0 24-25|0 22-23|0.1 20-21|0.1.0 19-20|0.1.1.0.0.0.0 15-16|0.1.1.0.0.0.0.0 13-14|0.1.1.0.0.0.0.0.1.2.0 11-12|0.1.1.0.0.0.0.0.1.2.0.0.0.0+0.1.1.0.0.0.0.0.1.2.0.0.0+0.1.1.0.0.0.0.0.1.2.0.0 10-11|0.1.1.0.0.0.0.0.1.2 9-10|0.1.1.0.0.0.0.0.1.1 8-9|0.1.1.0.0.0.0.0.1.1.0 6-7|0.1.1.0.0.0.0.0.1 4-5|0.1.1.0.0.0.0.0.1.0 1-2|0.1.1.0.0.0.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:00.286
(e / express-01 
      :ARG1 (l / lacZ) 
      :ARG1-of (a2 / activate-01 
            :ARG0 (m / mouse) 
            :time (a / after 
                  :op1 (r / remove-01 
                        :ARG1 (s / sequence 
                              :ARG1-of (s2 / stop-01 
                                    :ARG1-of (r2 / report-01 
                                          :purpose-of (c2 / cross-02 
                                                :ARG1 (d / date-entity 
                                                      :year 1999) 
                                                :manner-of (t3 / test-01 
                                                      :ARG1 (m2 / mouse 
                                                            :ARG1-of (r3 / result-01)) 
                                                      :ARG2 (e2 / express-01 
                                                            :mod (t2 / transgene)) 
                                                      :op1-of (a4 / and 
                                                            :op2 (a3 / activity-06 
                                                                  :ARG0 (t / thing 
                                                                        :name (n / name 
                                                                              :op1 "Cre"))))))))) 
                        :mod (c / cre-mediat)))))

# ::snt The resulting progeny were analyzed both for expression of the transgene by assaying HPLAP activity and for recombination of DNA by assaying LACZ activity .
# ::tok The resulting progeny were analyzed both for expression of the transgene by assaying HPLAP activity and for recombination of DNA by assaying LACZ activity .
# ::alignments 23-24|0.0.2.0 22-23|0.0.2.0.1.0.0+0.0.2.0.1.0+0.0.2.0.1 19-20|0.0.2.0.0.0 17-18|0.0.2.0.0 15-16|0 14-15|0.1 10-11|0.0.1 7-8|0.0 5-6|0.0.0 4-5|0.0.2 2-3|0.0.2.1 1-2|0.0.2.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:00.549
(a2 / and 
      :op1 (e / express-01 
            :ARG0 (b / both) 
            :ARG1 (t2 / transgene) 
            :ARG2-of (a4 / analyze-01 
                  :ARG0 (a / activity-06 
                        :ARG0 (r / recombination 
                              :mod (d / DNA)) 
                        :ARG1 (t / thing 
                              :name (n / name 
                                    :op1 "LACZ"))) 
                  :ARG1 (p / progeny 
                        :ARG1-of (r2 / result-01)))) 
      :op2 (a3 / activity-06))

# ::snt The progeny from all three lines showed strong LACZ expression primarily in joints , and in two of three lines HPLAP expression could also be seen in joint regions .
# ::tok The progeny from all three lines showed strong LACZ expression primarily in joints , and in two of three lines HPLAP expression could also be seen in joint regions .
# ::alignments 28-29|0.2.0.3 27-28|0.2.0.3.0 25-26|0.2.0 23-24|0.2.0.4 22-23|0.2.0.2 21-22|0.2.0.1 19-20|0.2.0.1.0 18-19|0.2.0.1.0.0 16-17|0.1.1 14-15|0.2 12-13|0.2.0.1.1 10-11|0.2.0.2.0 9-10|0.1 8-9|0.1.0.0.0+0.1.0.0+0.1.0 7-8|0.1.2 6-7|0 5-6|0.2.0.0.0 4-5|0.2.0.0.0.0 3-4|0.2.0.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:02.003
(s3 / show-01 
      :ARG0 (p3 / progeny) 
      :ARG1 (e2 / express-01 
            :ARG0 (t / thing 
                  :name (n / name 
                        :op1 "LACZ")) 
            :ARG1 2 
            :ARG1-of (s2 / strong-02)) 
      :op1-of (a2 / and 
            :op2 (s / see-01 
                  :ARG0 (a3 / all 
                        :mod-of (l2 / line 
                              :quant 3)) 
                  :ARG1 (e / express-01 
                        :ARG0 (l / line 
                              :quant 3) 
                        :ARG1 (j2 / joint)) 
                  :ARG1-of (p / possible-01 
                        :ARG0 (p2 / primary)) 
                  :ARG2 (r / region 
                        :mod (j / joint)) 
                  :mod (a / also))))

# ::snt Interestingly , HPLAP expression in the Gdf5-Cre transgenic GAC ( A ) line used for all subsequent breeding experiments was seen to precede LACZ expression during successive development of joints in the digits ( Figure 1C ) ( unpublished data ) .
# ::tok Interestingly , HPLAP expression in the Gdf5-Cre transgenic GAC ( A ) line used for all subsequent breeding experiments was seen to precede LACZ expression during successive development of joints in the digits ( Figure 1C ) ( unpublished data ) .
# ::alignments 39-40|0.1.1.0 38-39|0.1.1.0.0 34-35|0.1.0.0.1.0.0 32-33|0.1.1.3 29-30|0.1.1.1 27-28|0.1.1 26-27|0.1.1.2 24-25|0.1.0 23-24|0.1.0.1.0.0+0.1.0.1.0+0.1.0.1 22-23|0.1 20-21|0 18-19|0.1.0.0 17-18|0.1.0.0.1 16-17|0.1.0.0.2 15-16|0.1.0.0.3 13-14|0.1.0.0.1.0 12-13|0.1.0.0.1.0.1 3-4|0.0 0-1|0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:02.972
(s2 / see-01 
      :ARG1 (e3 / express-01) 
      :purpose (p / precede-01 
            :ARG1 (e / express-01 
                  :ARG0 (e2 / experiment-01 
                        :ARG1 (i / interesting) 
                        :ARG1-of (b / breed-01 
                              :ARG2-of (u2 / use-01 
                                    :ARG0 (f / figure) 
                                    :ARG1 (l / line))) 
                        :mod (s3 / subsequent) 
                        :quant (a / all)) 
                  :ARG1 (t / thing 
                        :name (n / name 
                              :op1 "LACZ"))) 
            :time (d3 / develop-02 
                  :ARG0 (d / data 
                        :mod (u / unpublish)) 
                  :ARG1 (j / joint) 
                  :ARG1-of (s / succeed-03) 
                  :location (d2 / digit))))

# ::snt These experiments clearly demonstrate that the Gdf5-Cre transgene expresses Cre recombinase and causes DNA recombination in developing joint regions .
# ::tok These experiments clearly demonstrate that the Gdf5-Cre transgene expresses Cre recombinase and causes DNA recombination in developing joint regions .
# ::alignments 18-19|0.1.1.1.0 17-18|0.1.1.1.0.0 16-17|0.1.1.1 14-15|0.1.1.0 13-14|0.1.1.0.0 12-13|0.1.1 11-12|0.1 9-10|0.1.0.1.0.0+0.1.0.1.0+0.1.0.1 8-9|0.1.0 7-8|0.1.0.0 3-4|0 2-3|0.2 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:03.074
(d3 / demonstrate-01 
      :ARG0 (e2 / experiment-01 
            :mod (t3 / this)) 
      :ARG1 (a / and 
            :op1 (e / express-01 
                  :ARG0 (t2 / transgene) 
                  :ARG1 (t / thing 
                        :name (n / name 
                              :op1 "Cre"))) 
            :op2 (c / cause-01 
                  :ARG1 (r2 / recombination 
                        :mod (d2 / DNA)) 
                  :ARG2 (d / develop-02 
                        :ARG1 (r / region 
                              :mod (j / joint))))) 
      :ARG1-of (c2 / clear-06))

# ::snt GAC ( A ) mice were crossed with lacZ ROSA26 Cre reporter strain ( R26R ) mice to analyze the pattern of Cre-mediated lacZ recombination throughout development .
# ::tok GAC ( A ) mice were crossed with lacZ ROSA26 Cre reporter strain ( R26R ) mice to analyze the pattern of Cre-mediated lacZ recombination throughout development .
# ::alignments 26-27|0.0.0.1 25-26|0.0.0.1.1 24-25|0.0.0.0.0 22-23|0.0.0.0.0.0 20-21|0.0.0.0 18-19|0.0.0 16-17|0.1 14-15|0.0.0.1.0.0.0+0.0.0.1.0.0+0.0.0.1.0 12-13|0.1.0.1+0.1.0 11-12|0.1.0.0 9-11|0.1.0.0.1.0.1+0.1.0.0.1.0.0+0.1.0.0.1.0+0.1.0.0.1 8-9|0.1.0.0.0 6-7|0 4-5|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:03.552
(c2 / cross-02 
      :ARG1 (m2 / mouse 
            :ARG0-of (a / analyze-01 
                  :ARG1 (p / pattern 
                        :mod (r / recombination 
                              :mod (c / cre-mediat))) 
                  :ARG2 (d / develop-02 
                        :ARG1 (t2 / thing 
                              :name (n / name 
                                    :op1 "R26R")) 
                        :op1-of (t / throughout)))) 
      :manner (m / mouse 
            :mod (s / strain 
                  :mod (r2 / report-01 
                        :ARG0 (l / lacZ) 
                        :ARG1 (t3 / thing 
                              :name (n2 / name 
                                    :op1 "ROSA26" 
                                    :op2 "Cre"))) 
                  :wiki "Influenza_A_virus_subtype_H5N1")))

# ::snt Joints in developing limbs begin forming in a proximal-distal pattern such that the shoulder joint forms prior to the elbow joint .
# ::tok Joints in developing limbs begin forming in a proximal-distal pattern such that the shoulder joint forms prior to the elbow joint .
# ::alignments 20-21|0.0.1.0.2.0 19-20|0.0.1.0.2.0.0 16-17|0.0.1.0.2 15-16|0.0.1.0 14-15|0.0.1.0.1 13-14|0.0.1.0.0 10-11|0.0.1.1 9-10|0.0.1 5-6|0.0 4-5|0 3-4|0.0.0.0 2-3|0.0.0.0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:03.634
(b / begin-01 
      :ARG1 (f2 / form-01 
            :ARG0 (j3 / joint 
                  :location (l / limb 
                        :ARG1-of (d / develop-02))) 
            :ARG1 (p2 / pattern 
                  :example (f / form 
                        :mod (s / shoulder) 
                        :mod (j2 / joint) 
                        :mod (p / prior 
                              :op1 (j / joint 
                                    :mod (e / elbow)))) 
                  :mod-of (s2 / such))))

# ::snt In addition , three major stages of early joint development have been defined by histology as ( 1 ) interzone formation , ( 2 ) three-layer interzone formation , and ( 3 ) cavitation ( Mitrovic 1978 ) .
# ::tok In addition , three major stages of early joint development have been defined by histology as ( 1 ) interzone formation , ( 2 ) three-layer interzone formation , and ( 3 ) cavitation ( Mitrovic 1978 ) .
# ::alignments 36-37|0.0.1.1.3.0.0+0.0.1.1.3.0 35-36|0.4.0.0+0.4.0+0.4 33-34|0.3 31-32|0.0.1.1.0 29-30|0 27-28|0.2 25-26|0.2.2 23-24|0.2.1 20-21|0.1 17-18|0.0.1.1.1 14-15|0.0.0 12-13|0.0 9-10|0.0.1.1 8-9|0.0.1.1.2 7-8|0.0.1.1.3 5-6|0.0.1 4-5|0.0.1.0 3-4|0.0.1.2 1-2|0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:04.222
(a / and 
      :op1 (d2 / define-01 
            :ARG0 (h / histology) 
            :ARG1 (s / stage 
                  :ARG1-of (m / major-02) 
                  :mod-of (d3 / develop-02 
                        :ARG0 3 
                        :ARG1 1 
                        :manner (j / joint) 
                        :time (e / early 
                              :op1 (d / date-entity 
                                    :year 1978))) 
                  :quant 3)) 
      :op2 (f2 / form-01) 
      :op3 (f / form-01 
            :ARG0 (a2 / addition) 
            :ARG1 2 
            :mod (t / three-lay)) 
      :op4 (c / cavitation) 
      :op5 (p / person 
            :name (n / name 
                  :op1 "Mitrovic")))

# ::snt Consistent with the proximal-distal pattern of joint development in the limbs , LACZ activity is seen at embryonic day 12.5 ( E12 .5 ) in the more proximal joints , including the shoulder and knee ( unpublished data ) .
# ::tok Consistent with the proximal-distal pattern of joint development in the limbs , LACZ activity is seen at embryonic day 12.5 ( E12 .5 ) in the more proximal joints , including the shoulder and knee ( unpublished data ) .
# ::alignments 37-38|0.0.0 36-37|0.0 34-35|0.2.3.1 33-34|0.2.3 32-33|0.2.3.0 28-29|0.2.3.1.0 27-28|0.2.3.1.0.0 26-27|0.2.3.1.0.0.0 18-19|0.3 17-18|0.3.0 15-16|0 13-14|0.1 12-13|0.1.0 10-11|0.2.0 7-8|0.2 6-7|0.2.1 4-5|0.2.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:04.538
(s2 / see-01 
      :ARG0 (u / unpublish 
            :mod-of (d / data)) 
      :ARG1 (a2 / activity-06 
            :ARG1 (l / LACZ)) 
      :compared-to (d3 / develop-02 
            :ARG1 (l2 / limb) 
            :manner (j2 / joint) 
            :mod-of (p2 / pattern) 
            :op1-of (a / and 
                  :op2 (s / shoulder) 
                  :op3 (k / knee-01 
                        :ARG1 (j / joint 
                              :mod (p / proximal 
                                    :degree (m / more)))))) 
      :time (d2 / day 
            :mod (e / embryonic)))

# ::snt By E14 .5 , LACZ expression is typically seen in all but the most distal joints of the limbs ( Figure 1B and 1C ) , but with some variability in both strength and extent of expression from embryo to embryo .
# ::tok By E14 .5 , LACZ expression is typically seen in all but the most distal joints of the limbs ( Figure 1B and 1C ) , but with some variability in both strength and extent of expression from embryo to embryo .
# ::alignments 40-41|0.2.3.0.0 38-39|0.2.3.0.1 36-37|0.2.3.0 34-35|0.2.4 33-34|0.2 32-33|0.2.3 31-32|0.2.2 29-30|0.2.1 28-29|0.2.1.0 26-27|0.2.0 22-23|0.2.0.0.1.1 20-21|0.2.0.0.1.0 18-19|0.0.1 15-16|0.0 14-15|0.0.0 13-14|0.0.0.0 11-12|0 10-11|0.1 8-9|0.2.0.0 7-8|0.2.0.0.2 5-6|0.2.0.0.1 1-2|0.2.0.0.0.0.0+0.2.0.0.0.0+0.2.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:05.418
(c2 / contrast-01 
      :ARG0 (j / joint 
            :mod (d / distal 
                  :degree (m / most)) 
            :poss (l / limb)) 
      :ARG1 (a3 / all) 
      :ARG2 (a / and 
            :ARG2-of (c / contrast-01 
                  :ARG1 (s3 / see-01 
                        :ARG0 (c3 / country 
                              :name (n / name 
                                    :op1 "E14")) 
                        :ARG1 (e5 / express-01 
                              :ARG0 (f / figure) 
                              :ARG1 (a2 / and)) 
                        :ARG1-of (t / typical-02))) 
            :location-of (v / variability 
                  :quant (s2 / some)) 
            :mod (b / both) 
            :op1 (s / strength 
                  :op1 (e3 / express-01 
                        :ARG0 (e / embryo) 
                        :source (e2 / embryo))) 
            :op2 (e4 / extent)))

# ::snt The strongest-staining embryos often have additional staining in fingertips ( not seen in the E14 .5 embryo in Figure 1C , but clearly detectable in the E13 .5 embryo shown in Figure 2 ) .
# ::tok The strongest-staining embryos often have additional staining in fingertips ( not seen in the E14 .5 embryo in Figure 1C , but clearly detectable in the E13 .5 embryo shown in Figure 2 ) .
# ::alignments 32-33|0.0.2 31-32|0.0.0.0.0.2 29-30|0.0.0.0.0 28-29|0.0.0.0.0.1 26-27|0.0.0.0.0.0.0.0+0.0.0.0.0.0.0+0.0.0.0.0.0 23-24|0.1 22-23|0.1.0 21-22|0 18-19|0.0.1.0 16-17|0.0.1 14-15|0.0.1.1.0.0+0.0.1.1.0+0.0.1.1 11-12|0.0 10-11|0.0.3 8-9|0.0.0.0.1 6-7|0.0.0.0 5-6|0.0.0.0.2 3-4|0.2 2-3|0.0.0 1-2|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:06.138
(c3 / contrast-01 
      :ARG1 (s2 / see-01 
            :ARG0 (e3 / embryo 
                  :ARG0-of (s3 / stain-01 
                        :ARG2-of (s / show-01 
                              :ARG0 (c / country 
                                    :name (n / name 
                                          :op1 "E13")) 
                              :ARG1 (e / embryo) 
                              :time (f / figure)) 
                        :location (f3 / fingertip) 
                        :mod (a / additional)) 
                  :mod (s4 / strongest-stain)) 
            :ARG1 (e2 / embryo 
                  :location (f2 / figure) 
                  :mod (c4 / country 
                        :name (n2 / name 
                              :op1 "E14"))) 
            :ARG2 2 
            :polarity -) 
      :ARG2 (d / detectable 
            :ARG1-of (c2 / clear-06)) 
      :frequency (o / often))

# ::snt Sections through developing joints show that LACZ is present in many cells at the interzone stage ( unpublished data ) .
# ::tok Sections through developing joints show that LACZ is present in many cells at the interzone stage ( unpublished data ) .
# ::alignments 18-19|0.0.0 17-18|0.0.0.0 15-16|0.0.1.0.0 14-15|0.0.1.0.0.0 11-12|0.0.1.0.0.1 10-11|0.0.1.0.0.1.0 8-9|0.1 6-7|0.1.0.0.0+0.1.0.0+0.1.0 4-5|0 3-4|0.0.1 2-3|0.0.1.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:06.231
(s2 / show-01 
      :ARG0 (s3 / section-01 
            :ARG1 (d / data 
                  :mod (u / unpublish)) 
            :ARG2 (j / joint 
                  :ARG1-of (d2 / develop-02 
                        :mod (s / stage 
                              :mod (i / interzone) 
                              :part (c / cell 
                                    :quant (m / many)))))) 
      :ARG1 (p / present 
            :domain (p2 / person 
                  :name (n / name 
                        :op1 "LACZ"))))

# ::snt However , expression of LACZ in nearly 100 % of joint cells is not achieved until the three-layer interzone stage ( for example , in the knee joint at E14 .5 or in any of the phalangeal joints at E16 .5 ( unpublished data ) .
# ::tok However , expression of LACZ in nearly 100 % of joint cells is not achieved until the three-layer interzone stage ( for example , in the knee joint at E14 .5 or in any of the phalangeal joints at E16 .5 ( unpublished data ) .
# ::alignments 43-44|0.0.0.0.0.0.1.1.0.0 42-43|0.0.0.0.0.0.1.1.0.0.0 39-40|0.0.0.1.0+0.0.0.1+0.0.0 37-38|0.0 36-37|0 33-34|0.0.0.0.0.1 31-32|0.0.0.0.0.0.1 29-30|0.0.0.0.0.0.1.1.1.0.0+0.0.0.0.0.0.1.1.1.0+0.0.0.0.0.0.1.1.1 27-28|0.0.0.0.0.0.1.1 26-27|0.0.0.0.0.0.1.1.0 22-23|0.0.0.0.0.0.1.0 19-20|0.0.0.0.2.0 17-18|0.0.0.0.2.0.1 15-16|0.0.0.0.2 14-15|0.0.0.0 13-14|0.0.0.0.1 11-12|0.0.0.0.2.0.0 10-11|0.0.0.0.2.0.0.1 8-9|0.0.0.0.2.0.0.0 7-8|0.0.0.0.2.0.0.0.1 6-7|0.0.0.0.2.0.0.0.0 4-5|0.0.0.0.0.0.0.0+0.0.0.0.0.0.0+0.0.0.0.0.0 2-3|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:07.369
(p / phalangeal 
      :mod-of (j / joint 
            :location (c / country 
                  :ARG0-of (a2 / achieve-01 
                        :ARG1 (e2 / express-01 
                              :ARG0 (p3 / person 
                                    :name (n4 / name 
                                          :op1 "LACZ") 
                                    :op1-of (o / or 
                                          :op2 (e / example) 
                                          :op3 (j2 / joint 
                                                :ARG1-of (k / knee-01 
                                                      :ARG0 (d / data 
                                                            :mod (u / unpublish))) 
                                                :location (c2 / country 
                                                      :name (n2 / name 
                                                            :op1 "E14"))))) 
                              :ARG1 (a / any)) 
                        :polarity - 
                        :time (u2 / until 
                              :op1 (s / stage 
                                    :consist-of (c3 / cell 
                                          :domain-of (p2 / percentage-entity 
                                                :op1-of (n3 / nearly) 
                                                :value 100) 
                                          :mod (j3 / joint)) 
                                    :mod (t / three-lay)))) 
                  :name (n / name 
                        :op1 "E16"))))

# ::snt Within the developing skeleton , Cre-mediated expression of LACZ remains strikingly specific to joints throughout development .
# ::tok Within the developing skeleton , Cre-mediated expression of LACZ remains strikingly specific to joints throughout development .
# ::alignments 15-16|0.1.0.1 14-15|0.1.0.1.0 13-14|0.1.0.0 11-12|0.1.0 10-11|0.1.0.2 9-10|0.1 8-9|0.0.0.0+0.0.0+0.0 6-7|0 5-6|0.2 3-4|0.1.1.0 2-3|0.1.1.0.0 0-1|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:07.526
(e / express-01 
      :ARG0 (p / person 
            :name (n / name 
                  :op1 "LACZ")) 
      :ARG1-of (r / remain-01 
            :ARG3 (s / specific-02 
                  :ARG2 (j / joint) 
                  :compared-to (d / develop-02 
                        :op1-of (t / throughout)) 
                  :degree (s2 / strikingly)) 
            :time (w / within 
                  :op1 (s3 / skeleton 
                        :ARG1-of (d2 / develop-02)))) 
      :mod (c / cre-mediat))

# ::snt Furthermore , it is seen in all the structures of postnatal synovial joints including the articular cartilage , joint capsule , and synovial membrane ( Figure 1D and 1E ) ( unpublished data ) .
# ::tok Furthermore , it is seen in all the structures of postnatal synovial joints including the articular cartilage , joint capsule , and synovial membrane ( Figure 1D and 1E ) ( unpublished data ) .
# ::alignments 32-33|0.0.2.0 31-32|0.0.2 27-28|0 25-26|0.0.1 23-24|0.1.3 22-23|0.1.3.0 21-22|0.1 19-20|0.1.2 18-19|0.1.2.0 16-17|0.1.1 15-16|0.1.1.0 12-13|0.0.0.1 11-12|0.0.0.1.0 10-11|0.0.0.1.1 8-9|0.0.0 6-7|0.0.0.0 4-5|0.0 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:07.831
(a / and 
      :op1 (s4 / see-01 
            :ARG1 (s3 / structure 
                  :mod (a4 / all) 
                  :poss (j2 / joint 
                        :mod (s2 / synovial) 
                        :mod (p / postnatal))) 
            :ARG2 (f / figure) 
            :op1-of (u / unpublish 
                  :mod-of (d / data))) 
      :op2 (a2 / and 
            :mod (f2 / furthermore) 
            :op1 (c2 / cartilage 
                  :mod (a3 / articular)) 
            :op2 (c / capsule 
                  :mod (j / joint)) 
            :op3 (m / membrane 
                  :mod (s / synovial))))

# ::snt These patterns are consistent with the well-established expression of Gdf5 in interzone regions during embryonic development ( Storm and Kingsley 1996 ) .
# ::tok These patterns are consistent with the well-established expression of Gdf5 in interzone regions during embryonic development ( Storm and Kingsley 1996 ) .
# ::alignments 20-21|0.2.0.1.0.0.0+0.2.0.1.0.0 18-19|0 17-18|0.1.0.0+0.1.0+0.1 15-16|0.2.0.0 14-15|0.0 12-13|0.2.0.0.0 9-10|0.2.1.0+0.2.1+0.2 7-8|0.2.0 6-7|0.2.0.2 3-4|0.2.0.1 1-2|0.2.0.1.0 0-1|0.2.0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:08.015
(a / and 
      :op1 (e / embryonic) 
      :op2 (o / organization 
            :name (n / name 
                  :op1 "Storm")) 
      :poss-of (p / person 
            :ARG0-of (e2 / express-01 
                  :ARG1 (d2 / develop-02 
                        :ARG1 (r / region)) 
                  :ARG2-of (c / consistent-01 
                        :ARG1 (p2 / pattern-01 
                              :ARG1 (d / date-entity 
                                    :year 1996) 
                              :mod (t / this))) 
                  :mod (w / well-establish)) 
            :name (n2 / name 
                  :op1 "Gdf5")))

# ::snt Adult expression patterns of the Gdf5 gene are not as well characterized , but Gdf5 expression has previously been detected in adult articular cartilage using both RT-PCR and immunocytochemistry ( Chang et al. 1994 ; Erlacher et al. 1998 ; Bobacz et al. 2002 ) .
# ::tok Adult expression patterns of the Gdf5 gene are not as well characterized , but Gdf5 expression has previously been detected in adult articular cartilage using both RT-PCR and immunocytochemistry ( Chang et al. 1994 ; Erlacher et al. 1998 ; Bobacz et al. 2002 ) .
# ::alignments 43-44|0.1.0.1.0+0.1.0.1 40-43|0.0.1.2.0.1.0.2+0.0.1.2.0.1.0.1+0.0.1.2.0.1.0.0+0.0.1.2.0.1.0+0.0.1.2.0.1 38-39|0.1.0.0.0+0.1.0.0 35-37|0.0.1.2.0.0.0.1+0.0.1.2.0.0.0.0+0.0.1.2.0.0.0+0.0.1.2.0.0 34-35|0.0.1.2.0 33-34|0.0.0.0+0.0.0 30-33|0.1.1.1.3.0.2+0.1.1.1.3.0.1+0.1.1.1.3.0.0+0.1.1.1.3.0+0.1.1.1.3 28-29|0.1.1.1.2 27-28|0.1.1.1 26-27|0.1.1.1.1.0.0+0.1.1.1.1.0+0.1.1.1.1 25-26|0.1.1.1.0 24-25|0.1.1 23-24|0.1.1.0 22-23|0.1.1.0.0 21-22|0.0.1.0 19-20|0.1 17-18|0.1.2 15-16|0.1.0 13-14|0 11-12|0.0 8-9|0.0.2 6-7|0.0.1.1 2-3|0.0.1 1-2|0.0.1.2 0-1|0.0.1.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:14.540
(c2 / contrast-01 
      :ARG1 (c3 / characterize-01 
            :ARG0 (d3 / date-entity 
                  :year 1994) 
            :ARG1 (p2 / pattern-01 
                  :ARG0 (a5 / adult) 
                  :ARG1 (g / gene) 
                  :mod (e5 / express-01 
                        :ARG1 (a2 / and 
                              :op1 (t2 / thing 
                                    :name (n2 / name 
                                          :op1 (e2 / Erlacher) 
                                          :op2 (e3 / et))) 
                              :op2 (t / thing 
                                    :name (n / name 
                                          :op1 (b / Bobacz) 
                                          :op2 (e / et) 
                                          :op3 (a / al.))))) 
                  :mod (a6 / adult)) 
            :polarity -) 
      :ARG2 (d4 / detect-01 
            :ARG1 (e4 / express-01 
                  :ARG1 (d2 / date-entity 
                        :year 1998) 
                  :time (d / date-entity 
                        :year 2002)) 
            :manner (u / use-01 
                  :ARG0 (c / cartilage 
                        :mod (a4 / articular)) 
                  :ARG1 (a3 / and 
                        :mod (b2 / both) 
                        :op1 (t4 / thing 
                              :name (n4 / name 
                                    :op1 "RT-PCR")) 
                        :op2 (i / immunocytochemistry) 
                        :op3 (t3 / thing 
                              :name (n3 / name 
                                    :op1 "Chang" 
                                    :op2 "et" 
                                    :op3 "al.")))) 
            :time (p / previous)))

# ::snt Other sites besides limb joints also have Cre-mediated lacZ expression .
# ::tok Other sites besides limb joints also have Cre-mediated lacZ expression .
# ::alignments 9-10|0 8-9|0.0 5-6|0.2 4-5|0.1.0.0 3-4|0.1.0.0.0 2-3|0.1.0 1-2|0.1 0-1|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:14.616
(e / express-01 
      :ARG0 (l / lacZ) 
      :ARG1 (s / site 
            :location (b / besides 
                  :op1 (j / joint 
                        :mod (l2 / limb))) 
            :mod (o / other)) 
      :mod (a / also))

# ::snt Starting at E13 .5 , LACZ activity is detected in an anterior and posterior domain of the limb bud ( Figure 2C ) .
# ::tok Starting at E13 .5 , LACZ activity is detected in an anterior and posterior domain of the limb bud ( Figure 2C ) .
# ::alignments 20-21|0.1.0.0 18-19|0.4.0 17-18|0.4.0.0 14-15|0.4 13-14|0.3 12-13|0 11-12|0.2 8-9|0.1 6-7|0.1.0 2-3|0.0.0.0.0+0.0.0.0+0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:14.748
(a / and 
      :ARG1-of (s / start-01 
            :ARG2 (c / country 
                  :name (n / name 
                        :op1 "E13"))) 
      :op1 (d2 / detect-01 
            :ARG1 (a3 / activity-06 
                  :ARG0 (f / figure))) 
      :op2 (a2 / anterior) 
      :op3 (p / posterior) 
      :op4 (d / domain 
            :poss (b / bud-01 
                  :ARG1 (l / limb))))

# ::snt At E14 .5 , LACZ activity is detectable in the developing ear pinnae , ribs , sternum , tissues in the face , and some regions of the brain and spinal cord ( Figure 1B ) ( unpublished data ) .
# ::tok At E14 .5 , LACZ activity is detectable in the developing ear pinnae , ribs , sternum , tissues in the face , and some regions of the brain and spinal cord ( Figure 1B ) ( unpublished data ) .
# ::alignments 38-39|0.3.4.0.1.0 37-38|0.3.4.0.1 33-34|0.3.1.0.0 31-32|0.2 30-31|0.1 29-30|0 28-29|0.0 25-26|0.3.5 24-25|0.3.5.0 23-24|0.3 21-22|0.3.1.0.1 18-19|0.3.4 16-17|0.3.3 14-15|0.3.2 12-13|0.3.4.0.0 11-12|0.3.4.0.0.0 10-11|0.3.4.0 7-8|0.3.1 5-6|0.3.1.0 1-2|0.3.0.0.0+0.3.0.0+0.3.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:15.318
(a / and 
      :op1 (b / brain) 
      :op2 (s / spinal) 
      :op3 (c / cord) 
      :op7-of (a2 / and 
            :op1 (c2 / country 
                  :name (n / name 
                        :op1 "E14")) 
            :op2 (d3 / detectable 
                  :domain (a3 / activity-06 
                        :ARG0 (f / figure) 
                        :ARG1 (f2 / face))) 
            :op3 (r2 / rib) 
            :op4 (s3 / sternum) 
            :op5 (t / tissue 
                  :ARG1-of (d2 / develop-02 
                        :ARG0 (p / pinna 
                              :mod (e / ear)) 
                        :op1-of (u / unpublish 
                              :mod-of (d / data)))) 
            :op6 (r / region 
                  :mod (s2 / some))))

# ::snt At birth , LACZ is also expressed in tendons running along the vertebral column , regions of tendons in the wrist and ankle , and some tendon insertions ( Figure 1D ) ( unpublished data ) .
# ::tok At birth , LACZ is also expressed in tendons running along the vertebral column , regions of tendons in the wrist and ankle , and some tendon insertions ( Figure 1D ) ( unpublished data ) .
# ::alignments 34-35|0.0.0 33-34|0.0 29-30|0.2.0.1.1.3 27-28|0.2.0.1.1.1 26-27|0.2.0.1.1.2.3 25-26|0.4.0 24-25|0.2.0.1.1 22-23|0.2.0.1.1.2.2 21-22|0.2.0.1.1.2 20-21|0.2.0.1.1.2.1 17-18|0.2.0.1.1.2.0 15-16|0.2.0.1.1.0 13-14|0.2.0.1 12-13|0.2.0.1.0 10-11|0.2.0.0 9-10|0.2.0 8-9|0.2 6-7|0 5-6|0.3 3-4|0.1.0.0+0.1.0+0.1 1-2|0.4 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:15.830
(e / express-01 
      :ARG0 (u / unpublish 
            :mod-of (d / data)) 
      :ARG1 (p / person 
            :name (n / name 
                  :op1 "LACZ")) 
      :manner (t3 / tendon 
            :ARG0-of (r2 / run-01 
                  :ARG1 (a4 / along) 
                  :ARG2 (c / column 
                        :mod (v / vertebral) 
                        :op1-of (a / and 
                              :op2 (r / region) 
                              :op3 (i / insertion) 
                              :op3-of (a3 / and 
                                    :location-of (t2 / tendon) 
                                    :op1 (w / wrist) 
                                    :op2 (a2 / ankle) 
                                    :op4 (t / tendon)) 
                              :op4 (f / figure))))) 
      :mod (a5 / also) 
      :time (b / birth-01 
            :ARG0 (s / some)))

# ::snt By 5 wk of age , LACZ is also expressed in the hair follicles , ear cartilage , some cells in the growth plate of the long bones , and portions of the brain and spinal cord ( unpublished data ) .
# ::tok By 5 wk of age , LACZ is also expressed in the hair follicles , ear cartilage , some cells in the growth plate of the long bones , and portions of the brain and spinal cord ( unpublished data ) .
# ::alignments 39-40|0.1.0.2.1.1.0.0 38-39|0.1.0.2.1.1.0.0.0 36-37|0.1.0.2.1.1 35-36|0.1.0.2.1.1.0.2 34-35|0.1.0.2.1.1.0 33-34|0.1.0.2.1.1.0.1 30-31|0.1.0.2.1.0 29-30|0.1.0.2.1 27-28|0 26-27|0.0 23-24|0.1 22-23|0.1.0 19-20|0.1.0.2.1.1.0.1.0 18-19|0.1.0.2.1.1.0.1.0.0 16-17|0.1.0.1 15-16|0.1.0.1.0 13-14|0.1.0.2.2 12-13|0.1.0.0 9-10|0.1.0.2 8-9|0.1.0.2.3 6-7|0.1.0.2.0.0.0+0.1.0.2.0.0+0.1.0.2.0 4-5|0.0.1 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:17.115
(b2 / bone 
      :ARG1-of (l / long-03 
            :ARG0 5 
            :ARG1-of (a4 / age-01)) 
      :poss-of (p2 / plate 
            :mod (g / grow-01 
                  :ARG1 (h / hair) 
                  :ARG2 (c3 / cartilage 
                        :mod (e / ear)) 
                  :manner (e2 / express-01 
                        :ARG0 (p3 / person 
                              :name (n / name 
                                    :op1 "LACZ")) 
                        :ARG1 (a2 / and 
                              :op1 (p / portion) 
                              :op2 (c / cord 
                                    :op3-of (a / and 
                                          :domain (d / data 
                                                :mod (u / unpublish)) 
                                          :op1 (b / brain 
                                                :poss (c2 / cell 
                                                      :mod (s2 / some))) 
                                          :op2 (s / spinal)))) 
                        :manner (f / follicl) 
                        :mod (a3 / also)))))

# ::snt Surprisingly , 23 of 63 , or 37 % of transgenic mice analyzed also show some degree of wider `` ectopic '' LACZ expression , which can extend throughout many different tissues in the animal .
# ::tok Surprisingly , 23 of 63 , or 37 % of transgenic mice analyzed also show some degree of wider `` ectopic '' LACZ expression , which can extend throughout many different tissues in the animal .
# ::alignments 34-35|0.1.1.1 31-32|0.1.1 30-31|0.1.1.0 29-30|0.1.1.3 28-29|0.1.1.2 27-28|0.1 26-27|0 23-24|0.1.0 20-21|0.1.0.1.0 18-19|0.1.0.1 16-17|0.1.0.2 15-16|0.1.0.2.1 14-15|0.1.0.2.0 13-14|0.1.0.2.0.1 12-13|0.1.0.2.0.0 11-12|0.1.0.2.0.0.0 8-9|0.1.0.2.0.0.1 7-8|0.1.0.2.0.0.1.1 6-7|0.1.0.2.0.0.1.0 4-5|0.0 2-3|0.1.0.2.0.0.1.0.0 0-1|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:17.650
(p / possible-01 
      :ARG0 63 
      :ARG1 (e / extend-01 
            :ARG1 (e2 / express-01 
                  :ARG1 (s3 / surprisingly) 
                  :ARG1-of (w / wide-02 
                        :ARG0 (e3 / ectopic)) 
                  :degree (d2 / degree 
                        :ARG1-of (s2 / show-01 
                              :manner-of (a3 / analyze-01 
                                    :ARG0 (m2 / mouse) 
                                    :ARG1 (p2 / percentage-entity 
                                          :op2-of (o / or 
                                                :op1 23) 
                                          :value 37)) 
                              :mod (a2 / also)) 
                        :mod (s / some))) 
            :ARG4 (t / tissue 
                  :ARG1-of (d / differ-02) 
                  :location (a / animal) 
                  :op1-of (t2 / throughout) 
                  :quant (m / many))))

# ::snt However , sustained expression of the transgene itself , as assayed by HPLAP activity , is still restricted primarily to joints in animals that show evidence of more generalized recombination based on LACZ expression ( unpublished data ) .
# ::tok However , sustained expression of the transgene itself , as assayed by HPLAP activity , is still restricted primarily to joints in animals that show evidence of more generalized recombination based on LACZ expression ( unpublished data ) .
# ::alignments 36-37|0.0.0.0.0.0.0 35-36|0.0.0.0.0.0 33-34|0.0.0.0 30-31|0.0.0 29-30|0.0 28-29|0.0.1 27-28|0.0.2 25-26|0 24-25|0.1 22-23|0.1.0 20-21|0.1.0.0 18-19|0.1.0.0.0.1 17-18|0.1.0.0.0 16-17|0.1.0.0.0.2 13-14|0.0.0.0.0 10-11|0.0.0.0.0.1 6-7|0.1.0.0.0.0.0 3-4|0.1.0.0.0.0 2-3|0.1.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:18.870
(e2 / evidence-01 
      :ARG1 (r / recombination 
            :ARG1-of (b / base-02 
                  :ARG2 (e / express-01 
                        :ARG1 (a2 / activity-06 
                              :ARG1 (u / unpublish 
                                    :mod-of (d / data)) 
                              :topic-of (a3 / assay)))) 
            :ARG1-of (g / generalize-01) 
            :mod (m / more)) 
      :ARG1-of (s / show-01 
            :ARG0 (a / animal 
                  :location-of (j / joint 
                        :ARG2-of (r2 / restrict-01 
                              :ARG1 (e3 / express-01 
                                    :ARG1 (t / transgene) 
                                    :ARG1-of (s3 / sustain-01)) 
                              :mod (p / primary) 
                              :mod (s2 / still))))))

# ::snt This suggests that in a fraction of animals , sporadic expression of Cre at some time early in development is sufficient to lead to both ectopic recombination and LACZ expression .
# ::tok This suggests that in a fraction of animals , sporadic expression of Cre at some time early in development is sufficient to lead to both ectopic recombination and LACZ expression .
# ::alignments 29-30|0 28-29|0.0 27-28|0.1 26-27|0.1.1 25-26|0.1.1.0 24-25|0.2 22-23|0.1.0 20-21|0.1.0.2 18-19|0.1.0.2.1.0.0 16-17|0.1.0.2.1 15-16|0.1.0.2.1.0 14-15|0.1.0.2.1.0.1 12-13|0.1.0.1.0.0.0+0.1.0.1.0.0+0.1.0.1.0 10-11|0.1.0.1 9-10|0.1.0.1.1 7-8|0.1.0.0.0 5-6|0.1.0.0 1-2|0.1.0.2.0 0-1|0.1.0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:19.855
(e / express-01 
      :ARG0 (l / LACZ) 
      :ARG1 (a / and 
            :ARG2-of (l2 / lead-03 
                  :ARG0 (f / fraction 
                        :part-of (a2 / animal)) 
                  :ARG1 (e4 / express-01 
                        :ARG1 (t2 / thing 
                              :name (n / name 
                                    :op1 "Cre")) 
                        :mod (s3 / sporadic)) 
                  :ARG1-of (s / suffice-01 
                        :ARG1-of (s4 / suggest-01 
                              :ARG0 (t3 / this)) 
                        :time (e3 / early 
                              :mod-of (t / time 
                                    :ARG1-of (d / develop-02) 
                                    :quant (s2 / some))))) 
            :op1 (r / recombination 
                  :mod (e2 / ectopic))) 
      :op1-of (b / both))

# ::snt While the fraction of animals with broader recombination patterns must be tracked and accounted for during experiments , these animals offer the potential benefit of revealing additional new functions of target genes that could be subsequently studied with additional site-specific Cre drivers .
# ::tok While the fraction of animals with broader recombination patterns must be tracked and accounted for during experiments , these animals offer the potential benefit of revealing additional new functions of target genes that could be subsequently studied with additional site-specific Cre drivers .
# ::alignments 41-42|0.0.1.0+0.0.1 40-41|0.0.1.0.0.0.0+0.0.1.0.0.0+0.0.1.0.0 38-39|0.0.1.1 36-37|0.0 35-36|0.0.2 33-34|0 31-32|0.0.0.0 30-31|0.0.0.0.0 28-29|0.0.0 27-28|0.0.0.3 26-27|0.0.0.2 25-26|0.0.0.1 23-24|0.0.0.1.0 22-23|0.0.0.1.0.1 20-21|0.0.0.1.0.0.0 19-20|0.0.0.1.0.0 18-19|0.0.0.1.0.0.1 16-17|0.0.0.1.0.0.0.0.0 13-14|0.0.0.1.0.0.0.0.2 12-13|0.0.0.1.0.0.0.0 11-12|0.0.0.1.0.0.0.0.1 8-9|0.0.0.1.0.0.0.0.2.0 7-8|0.0.0.1.0.0.0.0.2.0.0 6-7|0.0.0.1.0.0.0.0.2.0.0.0 4-5|0.0.0.1.0.0.0.0.1.1.0 2-3|0.0.0.1.0.0.0.0.1.1 0-1|0.0.0.1.0.0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:20.986
(p2 / possible-01 
      :ARG1 (s / study-01 
            :ARG1 (f / function-01 
                  :ARG1 (g / gene 
                        :ARG1-of (t2 / target-01)) 
                  :ARG1-of (r / reveal-01 
                        :ARG2-of (b / benefit-01 
                              :ARG1 (a3 / animal 
                                    :ARG0-of (o / offer-01 
                                          :ARG1 (a5 / and 
                                                :ARG0-of (e / experiment-01) 
                                                :op1 (t4 / track-01 
                                                      :ARG0-of (w / while-01) 
                                                      :ARG1 (f2 / fraction 
                                                            :part-of (a6 / animal))) 
                                                :op2 (a4 / account-01 
                                                      :ARG1 (p4 / pattern-01 
                                                            :mod (r2 / recombination 
                                                                  :ARG1-of (b2 / broad-02)))))) 
                                    :mod (t3 / this)) 
                              :mod (p3 / potential))) 
                  :mod (a2 / additional) 
                  :mod (n2 / new)) 
            :ARG2 (p / person 
                  :ARG0-of (d / drive-01 
                        :ARG1 (t / thing 
                              :name (n / name 
                                    :op1 "Cre"))) 
                  :mod (a / additional)) 
            :time (s2 / subsequent)))

# ::snt Gdf5-Cre/Bmpr1afloxP Animals Survive to Adulthood with Ear , Webbing , and Joint Defects .
# ::tok Gdf5-Cre/Bmpr1afloxP Animals Survive to Adulthood with Ear , Webbing , and Joint Defects .
# ::alignments 12-13|0.3 11-12|0.3.0 10-11|0 8-9|0.2 6-7|0.1 4-5|0.0.1 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:21.041
(a / and 
      :op1 (s / survive-01 
            :ARG0 (a3 / animal) 
            :ARG2 (a2 / adulthood)) 
      :op2 (e / ear) 
      :op3 (w / web) 
      :op4 (d / defect-01 
            :ARG1 (j / joint)))

# ::snt We next used the Gdf5-Cre system to test the role of BMP signaling during normal joint development .
# ::tok We next used the Gdf5-Cre system to test the role of BMP signaling during normal joint development .
# ::alignments 16-17|0.2.0.0.0.0 15-16|0.2.0.0.0.0.1 14-15|0.2.0.0.0.0.0 12-13|0.2.0.0.0 11-12|0.2.0.0.1.0+0.2.0.0.1+0.2.0.0 9-10|0.2.0 7-8|0.2 5-6|0.1 2-3|0 1-2|0.3 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:21.109
(u / use-01 
      :ARG0 (w / we) 
      :ARG1 (s2 / system) 
      :ARG2 (t / test-01 
            :ARG1 (r / role 
                  :poss (o / organization 
                        :ARG0-of (s / signal-01 
                              :ARG1 (d / develop-02 
                                    :ARG1-of (n / normal-02) 
                                    :manner (j / joint))) 
                        :name (n2 / name 
                              :op1 "BMP")))) 
      :manner (n3 / next))

# ::snt Gdf5-Cre transgenic mice were bred to animals carrying a conditional floxed allele of the Bmpr1a locus ( Mishina et al. 2002 ) , usually in the presence of the R26R reporter allele to facilitate simultaneous visualization of Cre-mediated recombination patterns ( see typical cross in Figure 3 ) .
# ::tok Gdf5-Cre transgenic mice were bred to animals carrying a conditional floxed allele of the Bmpr1a locus ( Mishina et al. 2002 ) , usually in the presence of the R26R reporter allele to facilitate simultaneous visualization of Cre-mediated recombination patterns ( see typical cross in Figure 3 ) .
# ::alignments 46-47|0.2.2.1.1.0 45-46|0.1.3 43-44|0.1 42-43|0.1.1 41-42|0.1.2 39-40|0.2.2.1.1 38-39|0.2.2.1.1.1 37-38|0.2.2.1.1.2 35-36|0.2.2.1 34-35|0.2.2.1.0 33-34|0.2.2 31-32|0.2.2.0.0 30-31|0 26-27|0.2.2.0 23-24|0.2.0.0.0 20-21|0.1.2.0.0+0.1.2.0 17-20|0.1.0.0.2+0.1.0.0.1+0.1.0.0.0+0.1.0.0+0.1.0 15-16|0.2.1.2 14-15|0.0.0.0+0.0.0+0.0 11-12|0.2.1 10-11|0.2.1.0 9-10|0.2.1.1 7-8|0.2 6-7|0.2.0 4-5|0.2.0.0 2-3|0.2.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:22.563
(r2 / report-01 
      :ARG1 (t3 / thing 
            :name (n2 / name 
                  :op1 "Bmpr1a")) 
      :ARG1-of (c / cross-02 
            :ARG0 (t2 / thing 
                  :name (n / name 
                        :op1 "Mishina" 
                        :op2 "et" 
                        :op3 "al.")) 
            :ARG1-of (t / typical-02) 
            :ARG1-of (s / see-01 
                  :ARG0 (d / date-entity 
                        :year 2002)) 
            :location (f / figure)) 
      :ARG2 (c4 / carry-01 
            :ARG0 (a3 / animal 
                  :ARG2-of (b / breed-01 
                        :ARG0 (u / usual) 
                        :ARG1 (m / mouse))) 
            :ARG1 (a2 / allele 
                  :mod (f3 / flox) 
                  :mod (c3 / conditional) 
                  :poss (l / locu)) 
            :manner (f2 / facilitate-01 
                  :ARG0 (p2 / presence 
                        :poss (a / allele)) 
                  :ARG1 (v / visualization 
                        :mod (s2 / simultaneous) 
                        :mod (p / pattern-01 
                              :ARG0 3 
                              :mod (r / recombination) 
                              :mod (c2 / cre-mediat))))))

# ::snt PCR amplification confirmed that a key exon of the Bmpr1a gene was deleted in mice that also carried the Gdf5-Cre transgene ( unpublished data ) .
# ::tok PCR amplification confirmed that a key exon of the Bmpr1a gene was deleted in mice that also carried the Gdf5-Cre transgene ( unpublished data ) .
# ::alignments 23-24|0.1 22-23|0 20-21|0.0.0.0.1.0.0 17-18|0.0.0.0.1.0 16-17|0.0.0.0.1.0.1 14-15|0.0.0.0.1 12-13|0.0.0.0 10-11|0.0.0.1 9-10|0.0.0.1.0.0.0+0.0.0.1.0.0+0.0.0.1.0 6-7|0.0.0 5-6|0.0 2-3|0.0.0.0.0 1-2|0.0.0.0.0.0 0-1|0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:22.845
(u / unpublish 
      :ARG0-of (k / key-02 
            :ARG1 (e / exon 
                  :ARG1-of (d2 / delete-01 
                        :ARG1-of (c2 / confirm-01 
                              :ARG0 (a2 / amplification 
                                    :mod (p / PCR))) 
                        :location (m / mouse 
                              :ARG0-of (c / carry-01 
                                    :ARG1 (t / transgene) 
                                    :mod (a / also)))) 
                  :poss (g / gene 
                        :mod (t2 / thing 
                              :name (n / name 
                                    :op1 "Bmpr1a"))))) 
      :mod-of (d / data))

# ::snt Previous studies have shown that the recombined Bmpr1afloxP allele mimics a null allele of the Bmpr1a locus when transmitted through the germline ( Mishina et al. 2002 ) .
# ::tok Previous studies have shown that the recombined Bmpr1afloxP allele mimics a null allele of the Bmpr1a locus when transmitted through the germline ( Mishina et al. 2002 ) .
# ::alignments 26-27|0.1.0.1.0.0+0.1.0.1.0 23-26|0.1.0.0.0.0.2+0.1.0.0.0.0.1+0.1.0.0.0.0.0+0.1.0.0.0.0+0.1.0.0.0 21-22|0.1.0.0.1 18-19|0.1.0.0 16-17|0.1.1.1 15-16|0.1.1.1.0.0.0+0.1.1.1.0.0+0.1.1.1.0 12-13|0.1.1 11-12|0.1.1.0 9-10|0.1 8-9|0.1.0 7-8|0.1.0.2.0.0+0.1.0.2.0+0.1.0.2 6-7|0.1.0.1 3-4|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:23.548
(s / show-01 
      :ARG0 (s2 / study-01 
            :ARG1 (p / previou)) 
      :ARG1 (m / mimic-01 
            :ARG0 (a2 / allele 
                  :ARG0-of (t2 / transmit-01 
                        :ARG1 (t / thing 
                              :name (n / name 
                                    :op1 "Mishina" 
                                    :op2 "et" 
                                    :op3 "al.")) 
                        :path (g / germline)) 
                  :ARG1-of (r / recombine-01 
                        :ARG0 (d / date-entity 
                              :year 2002)) 
                  :mod (t4 / thing 
                        :name (n4 / name 
                              :op1 "Bmpr1afloxP"))) 
            :ARG1 (a / allele 
                  :ARG1-of (n3 / null-02) 
                  :poss (l / locu 
                        :mod (t3 / thing 
                              :name (n2 / name 
                                    :op1 "Bmpr1a"))))))

# ::snt The Gdf5-Cre/Bmpr1afloxP conditional knockout mice were viable and survived to adulthood , showing that the Gdf5-Cre driver can bypass the early embryonic lethality previously reported in animals with a null mutation in the Bmpr1a locus ( Mishina et al. 1995 ) .
# ::tok The Gdf5-Cre/Bmpr1afloxP conditional knockout mice were viable and survived to adulthood , showing that the Gdf5-Cre driver can bypass the early embryonic lethality previously reported in animals with a null mutation in the Bmpr1a locus ( Mishina et al. 1995 ) .
# ::alignments 39-40|0.0.1.0.1.0.0+0.0.1.0.1.0 36-39|0.1.0.0.0.2.0.2+0.1.0.0.0.2.0.1+0.1.0.0.0.2.0.0+0.1.0.0.0.2.0+0.1.0.0.0.2 34-35|0.1.0.0.0.0.0 33-34|0.1.0.0.0.1.0.0+0.1.0.0.0.1.0+0.1.0.0.0.1 30-31|0.0.1.1 29-30|0.0.1.1.0 26-27|0.1.0.0.0.0 24-25|0.0.1 23-24|0.0.1.2 22-23|0.0.1.0 21-22|0.0.1.0.0 20-21|0.0.1.0.1 18-19|0 17-18|0.1 16-17|0.0.0+0.0 12-13|0.1.0 8-9|0.1.0.0.0 7-8|0.1.0.0.0.3 6-7|0.1.0.0.1 4-5|0.1.0.0 3-4|0.1.0.0.2 2-3|0.1.0.0.3 1-2|0.1.0.0.0.3.0.0.0+0.1.0.0.0.3.0.0+0.1.0.0.0.3.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:25.143
(b / bypass 
      :ARG0 (p3 / person 
            :ARG0-of (d2 / drive-01) 
            :ARG0-of (r / report-01 
                  :ARG1 (l2 / lethality 
                        :mod (e / embryonic) 
                        :mod (e2 / early 
                              :op1 (d / date-entity 
                                    :year 1995))) 
                  :prep-in (m / mutation 
                        :ARG1-of (n3 / null-02)) 
                  :time (p / previous))) 
      :ARG1-of (p2 / possible-01 
            :ARG1-of (s / show-01 
                  :ARG0 (m2 / mouse 
                        :ARG1-of (s2 / survive-01 
                              :ARG0 (a / animal 
                                    :location-of (l / locu)) 
                              :manner (t2 / thing 
                                    :name (n2 / name 
                                          :op1 "Bmpr1a")) 
                              :manner (t / thing 
                                    :name (n / name 
                                          :op1 "Mishina" 
                                          :op2 "et" 
                                          :op3 "al.")) 
                              :op2-of (a2 / and 
                                    :op1 (t3 / thing 
                                          :name (n4 / name 
                                                :op1 "Gdf5-Cre/Bmpr1afloxP")))) 
                        :domain-of (v / viable) 
                        :mod (k / knockout) 
                        :mod (c / conditional)))))

# ::snt The viable Gdf5-Cre/Bmpr1afloxP mice showed several phenotypes .
# ::tok The viable Gdf5-Cre/Bmpr1afloxP mice showed several phenotypes .
# ::alignments 6-7|0.1 5-6|0.1.0 4-5|0 3-4|0.0 2-3|0.0.0.0.0+0.0.0.0+0.0.0 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:25.174
(s2 / show-01 
      :ARG0 (m / mouse 
            :mod (t / thing 
                  :name (n / name 
                        :op1 "Gdf5-Cre/Bmpr1afloxP")) 
            :mod (v / viable)) 
      :ARG1 (p / phenotyp 
            :quant (s / several)))

# ::snt First , the conditional knockout mice had shorter ears that often lay flatter against their heads than controls ( controls 13.1  0.1 mm long , n = 38 ; mutants 11.8  0.2 mm , n = 11 ; p < 0.0001 ) .
# ::tok First , the conditional knockout mice had shorter ears that often lay flatter against their heads than controls ( controls 13.1  0.1 mm long , n = 38 ; mutants 11.8  0.2 mm , n = 11 ; p < 0.0001 ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:25.176
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt BMP signaling is known to be required for growth of the external ear of mice ( Kingsley et al. 1992 ) , and this phenotype likely reflects loss of Bmpr1a function in the fraction of ear cells that express the Gdf5-Cre transgene .
# ::tok BMP signaling is known to be required for growth of the external ear of mice ( Kingsley et al. 1992 ) , and this phenotype likely reflects loss of Bmpr1a function in the fraction of ear cells that express the Gdf5-Cre transgene .
# ::alignments 41-42|0.1.1.0.0.0 38-39|0.1.1.0.0 36-37|0.1.1.0 35-36|0.1.1.0.2 33-34|0.1.1.0.1 30-31|0.1.1 27-28|0.1.3 26-27|0.1 25-26|0.1.2 24-25|0.1.0 23-24|0.1.0.0 22-23|0 19-20|0.0.0.2.0+0.0.0.2 16-19|0.0.0.1.1.0.0.2+0.0.0.1.1.0.0.1+0.0.0.1.1.0.0.0+0.0.0.1.1.0.0+0.0.0.1.1.0 14-15|0.0.0.1.0.1 12-13|0.0.0.1.0 11-12|0.0.0.1.0.0 8-9|0.0.0.1.1 6-7|0.0.0.1 3-4|0.0 1-2|0.0.0 0-1|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:27.728
(a / and 
      :ARG3-of (k / know-02 
            :ARG1 (s / signal-01 
                  :ARG0 (o / organization 
                        :name (n2 / name 
                              :op1 "BMP")) 
                  :ARG0-of (r2 / require-01 
                        :ARG3 (e3 / ear 
                              :mod (e4 / external) 
                              :mod (m / mouse)) 
                        :purpose (g / grow-01 
                              :ARG1 (t3 / thing 
                                    :name (n / name 
                                          :op1 "Kingsley" 
                                          :op2 "et" 
                                          :op3 "al.")))) 
                  :ARG1 (d / date-entity 
                        :year 1992))) 
      :op1 (r / reflect-01 
            :ARG0 (p / phenotype 
                  :mod (t2 / this)) 
            :ARG1 (f2 / function-01 
                  :ARG1 (c / cell 
                        :ARG0-of (e / express-01 
                              :ARG1 (t / transgene)) 
                        :domain-of (f / fraction) 
                        :mod (e2 / ear))) 
            :ARG1-of (l2 / likely-01) 
            :ARG2 (l / loss)))

# ::snt Most mutant mice also showed soft tissue syndactyly or retention of webbing between the first and second digits of their feet , a phenotype that was more frequent and more severe in the forelimbs ( 201 of 220 , or 91 % , of forefeet and 109 of 220 , or 50 % , of hindfeet ) .
# ::tok Most mutant mice also showed soft tissue syndactyly or retention of webbing between the first and second digits of their feet , a phenotype that was more frequent and more severe in the forelimbs ( 201 of 220 , or 91 % , of forefeet and 109 of 220 , or 50 % , of hindfeet ) .
# ::alignments 55-56|0.3.2.0.0.0 52-53|0.3.2.0.1.1 51-52|0.3.2.0.1.1.0 50-51|0.3.2.0.1 48-49|0.3.2.0.1.0 45-46|0.3.2 44-45|0.3.2.1 41-42|0.3.0.1 40-41|0.3.0.1.0 39-40|0.3.0 37-38|0.3.0.0 33-34|0.3.2.0.0.3 30-31|0.3.2.0.2 29-30|0.3.2.0.2.0 28-29|0.3.2.0 27-28|0.3.2.0.0 26-27|0.3.2.0.0.2 23-24|0.3.2.0.0.1 20-21|0.3.1.0 17-18|0.3.1 15-16|0.3 11-12|0.1.2 9-10|0.1.1 8-9|0.1 7-8|0.1.0 6-7|0.1.0.1 5-6|0.1.0.0 4-5|0 3-4|0.2 2-3|0.0 1-2|0.0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:29.287
(s4 / show-01 
      :ARG0 (m3 / mouse 
            :mod (m4 / mutant) 
            :mod (m5 / most)) 
      :ARG1 (o3 / or 
            :op1 (s2 / syndactyly 
                  :ARG1-of (s3 / soft-02) 
                  :mod (t / tissue)) 
            :op2 (r / retention) 
            :op3 (w / web)) 
      :mod (a4 / also) 
      :op1-of (a3 / and 
            :op1-of (o2 / or 
                  :op2 220 
                  :op3 (p2 / percentage-entity 
                        :value 91)) 
            :op2 (d / digit 
                  :poss (f4 / foot)) 
            :op3 (a / and 
                  :op1 (a2 / and 
                        :op1 (f3 / frequent-02 
                              :ARG0 (h / hindfeet) 
                              :ARG1 (p3 / phenotype) 
                              :degree (m2 / more) 
                              :manner (f2 / forelimb)) 
                        :op1-of (o / or 
                              :op2 220 
                              :op3 (p / percentage-entity 
                                    :value 50)) 
                        :op2 (s / severe 
                              :degree (m / more))) 
                  :op2 (f / forefoot))))

# ::snt Finally , mutant animals showed obvious skeletal changes in whole-mount skeletal preparations .
# ::tok Finally , mutant animals showed obvious skeletal changes in whole-mount skeletal preparations .
# ::alignments 11-12|0.1.0 10-11|0.1.0.0 7-8|0.1 6-7|0.1.2 5-6|0.1.1 4-5|0 3-4|0.0 2-3|0.0.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:29.347
(s3 / show-01 
      :ARG0 (a / animal 
            :mod (m / mutant)) 
      :ARG1 (c / change-01 
            :ARG1 (p / prepare-02 
                  :ARG1 (s / skeletal)) 
            :ARG1-of (o / obvious-01) 
            :mod (s2 / skeletal)) 
      :time (f / final))

# ::snt At some sites in the ankles , joints seemed to be missing entirely , with fusion of bones that would normally be separate .
# ::tok At some sites in the ankles , joints seemed to be missing entirely , with fusion of bones that would normally be separate .
# ::alignments 22-23|0.0.2.0.0 20-21|0.0.2.0.0.1 17-18|0.0.2.0 15-16|0.0.2 12-13|0.0.0 11-12|0.0 8-9|0 7-8|0.0.1 5-6|0.1.0 2-3|0.1 1-2|0.0.2.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:29.543
(s2 / seem-01 
      :ARG1 (m / miss-01 
            :ARG0 (e / entire) 
            :ARG1 (j / joint) 
            :ARG2 (f / fusion 
                  :mod (b / bone 
                        :ARG1-of (s / separate-02 
                              :ARG0 (s4 / some) 
                              :ARG1-of (n / normal-02))))) 
      :location (s3 / site 
            :location (a / ankl)))

# ::snt For example , the second distal tarsal was fused to the central tarsal bone in every conditional knockout animal examined ( 18 of 18 ) , a phenotype not observed in controls ( zero of 18 ) ( Figure 3B and 3C ) .
# ::tok For example , the second distal tarsal was fused to the central tarsal bone in every conditional knockout animal examined ( 18 of 18 ) , a phenotype not observed in controls ( zero of 18 ) ( Figure 3B and 3C ) .
# ::alignments 40-41|0 38-39|0.0.2 35-36|0.0.0.0.3 33-34|0.0.0.0.0 31-32|0.0.3.1 29-30|0.0.3 28-29|0.0.3.2 27-28|0.0.3.0 23-24|0.0.3.1.0 21-22|0.0.3.1.1 19-20|0.0 18-19|0.0.1 17-18|0.0.0.0.2 16-17|0.0.1.1 15-16|0.0.1.0 13-14|0.0.0 12-13|0.0.0.2 11-12|0.0.0.1 8-9|0.0.0.0 6-7|0.0.0.0.1 5-6|0.0.0.0.1.0 1-2|0.0.0.0.4 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:30.181
(a / and 
      :op1 (e / examine-01 
            :ARG0 (b / bone 
                  :ARG2-of (f2 / fuse-01 
                        :ARG0 (z / zero) 
                        :ARG1 (t2 / tarsal 
                              :mod (d / distal)) 
                        :manner (k / knockout) 
                        :op1-of 18 
                        :purpose (e3 / example)) 
                  :mod (c3 / central) 
                  :mod (t / tarsal)) 
            :ARG1 (a2 / animal 
                  :mod (e2 / every) 
                  :mod (c2 / conditional)) 
            :ARG2 (f / figure) 
            :purpose (o / observe-01 
                  :ARG0 (p / phenotype) 
                  :ARG2 (c / control-01 
                        :ARG0 18 
                        :ARG1 18) 
                  :polarity -)))

# ::snt At other locations , joints had clearly formed but showed dramatic loss of staining with the cartilage matrix marker Alcian blue ( Figure 3B -- 3E ) ( unpublished data ) .
# ::tok At other locations , joints had clearly formed but showed dramatic loss of staining with the cartilage matrix marker Alcian blue ( Figure 3B -- 3E ) ( unpublished data ) .
# ::alignments 29-30|0.1.1.0 28-29|0.1.1 22-23|0.0 20-21|0.2.0 18-19|0.2.0.0.1.0 17-18|0.2.0.0.1 16-17|0.2.0.0.0 13-14|0.2.0.0 11-12|0.2.1 10-11|0.2.1.0 9-10|0.2 8-9|0 7-8|0.1 6-7|0.1.2 4-5|0.1.0 2-3|0.1.3 1-2|0.1.3.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:30.454
(c2 / contrast-01 
      :ARG0 (f / figure) 
      :ARG1 (f2 / form-01 
            :ARG0 (j / joint) 
            :ARG1 (u / unpublish 
                  :mod-of (d / data)) 
            :ARG1-of (c3 / clear-06) 
            :location (l2 / location 
                  :mod (o / other))) 
      :ARG2 (s2 / show-01 
            :ARG0 (b / blue 
                  :ARG0-of (s / stain-01 
                        :ARG1 (c / cartilage) 
                        :location (m2 / matrix 
                              :ARG1-of (m / mark-01)))) 
            :ARG1 (l / loss 
                  :manner (d2 / dramatic))))

# ::snt Normal Alcian blue staining was seen in non-articular regions , such as the cartilaginous growth plate ( Figure 3D and 3E , asterisk ) .
# ::tok Normal Alcian blue staining was seen in non-articular regions , such as the cartilaginous growth plate ( Figure 3D and 3E , asterisk ) .
# ::alignments 22-23|0.0.0 19-20|0 18-19|0.0.3 17-18|0.0.1.0 15-16|0.0.1.4.1 14-15|0.0.1.4 13-14|0.0.1.4.0 10-11|0.0.1.2 8-9|0.0.2 5-6|0.0 3-4|0.0.1 2-3|0.0.1.3 0-2|0.0.1.1.0.1+0.0.1.1.0.0+0.0.1.1.0+0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:30.746
(a2 / and 
      :op1 (s2 / see-01 
            :ARG0 (a / asterisk) 
            :ARG1 (s3 / stain-01 
                  :ARG0 (f / figure) 
                  :ARG1 (t / thing 
                        :name (n / name 
                              :op1 (n2 / Normal) 
                              :op2 (a3 / Alcian))) 
                  :ARG2 (s / such) 
                  :mod (b / blue) 
                  :purpose (g / grow-01 
                        :ARG1 (c / cartilaginou) 
                        :mod-of (p / plate))) 
            :ARG2 (r / region) 
            :manner 3D))

# ::snt These data suggest that Bmpr1a function is required for the formation of specific joints in the ankle region and for either generation or maintenance of articular cartilage in most other joints of the limb .
# ::tok These data suggest that Bmpr1a function is required for the formation of specific joints in the ankle region and for either generation or maintenance of articular cartilage in most other joints of the limb .
# ::alignments 33-34|0.1.0.0.1.1.0 30-31|0.1.0.0.1.1 29-30|0.1.0.0.1 28-29|0.1.0.0.1.0 26-27|0.1.0.0 25-26|0.1.0.0.0 23-24|0.1.0 22-23|0.1.0.1 21-22|0.1.0.1.1 20-21|0.1.0.1.0 18-19|0.1 17-18|0.0.0.0.1 16-17|0.0.0.0.1.0 13-14|0.0.0.0.0 12-13|0.0.0.0.0.0 10-11|0.0.0.0 7-8|0.0.0 5-6|0.0.0.1 4-5|0.0.0.1.0.0.0+0.0.0.1.0.0+0.0.0.1.0 2-3|0 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:31.786
(s2 / suggest-01 
      :ARG0 (d / data 
            :ARG0-of (r2 / require-01 
                  :ARG1 (f / form-01 
                        :ARG1 (j2 / joint 
                              :ARG1-of (s / specific-02)) 
                        :location (r / region 
                              :mod (a3 / ankle))) 
                  :ARG2 (f2 / function-01 
                        :ARG1 (t / thing 
                              :name (n / name 
                                    :op1 "Bmpr1a")))) 
            :mod (t2 / this)) 
      :ARG1 (a2 / and 
            :op1 (m2 / maintain-01 
                  :ARG1 (c / cartilage 
                        :mod (a / articular) 
                        :op1-of (o / other 
                              :mod (m / most) 
                              :mod-of (j / joint 
                                    :poss (l / limb)))) 
                  :op2-of (o2 / or 
                        :mod (e / either) 
                        :op1 (g / generation)))))

# ::snt Developmental Origin of Webbing Phenotype .
# ::tok Developmental Origin of Webbing Phenotype .
# ::alignments 3-5|0.1.0.1+0.1.0.0+0.1.0+0.1 0-2|0.0.1+0.0.0+0.0+0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:31.816
(p2 / person 
      :name (n2 / name 
            :op1 "Developmental" 
            :op2 "Origin") 
      :poss (t / thing 
            :name (n / name 
                  :op1 (w / Webbing) 
                  :op2 (p / Phenotype))))

# ::snt Interdigital mesenchyme is normally eliminated by apoptosis during embryonic development , a process that can be stimulated by BMP beads , inhibited by Noggin , or blocked by overexpression of dominant-negative BMP receptors ( Garcia-Martinez et al. 1993 ; Yokouchi et al. 1996 ; Zou and Niswander 1996 ; Guha et al. 2002 ) .
# ::tok Interdigital mesenchyme is normally eliminated by apoptosis during embryonic development , a process that can be stimulated by BMP beads , inhibited by Noggin , or blocked by overexpression of dominant-negative BMP receptors ( Garcia-Martinez et al. 1993 ; Yokouchi et al. 1996 ; Zou and Niswander 1996 ; Guha et al. 2002 ) .
# ::alignments 52-53|0.0.0.1.1.1.0.0+0.0.0.1.1.1.0 47-48|0.0.0.1.1.2.0+0.0.0.1.1.2 45-46|0 42-43|0.0.0.1.0.1.0+0.0.0.1.0.1 39-41|0.0.1.0.1+0.0.1.0.0+0.0.1.0+0.0.1 38-39|0.0 37-38|0.0.0.1.1.1.2.2.0.1.0+0.0.0.1.1.1.2.2.0.1 34-37|0.0.0.1.1.1.2.2.0.0.2+0.0.0.1.1.1.2.2.0.0.1+0.0.0.1.1.1.2.2.0.0.0+0.0.0.1.1.1.2.2.0.0+0.0.0.1.1.1.2.2.0 32-33|0.0.0.1.1.0.0 28-29|0.0.0.1.1.0 26-27|0.0.0.1.1 25-26|0.0.0.1 23-24|0.0.0.1.0.0.0.0+0.0.0.1.0.0.0+0.0.0.1.0.0 21-22|0.0.0.1.0 19-20|0.0.0.0.0 18-19|0.0.0.0.0.0.0.0+0.0.0.0.0.0.0+0.0.0.0.0.0 16-17|0.0.0.0 14-15|0.0.0 12-13|0.0.0.1.1.1 9-10|0.0.0.1.1.1.2.2 8-9|0.0.0.1.1.1.2.2.1 6-7|0.0.0.1.1.1.2.0 4-5|0.0.0.1.1.1.2 3-4|0.0.0.1.1.1.2.1 1-2|0.0.0.1.1.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:35.041
(a / and 
      :op3-of (a2 / and 
            :op1 (p2 / possible-01 
                  :ARG1 (s / stimulate-01 
                        :ARG0 (b2 / bead-01 
                              :ARG0 (o3 / organization 
                                    :name (n4 / name 
                                          :op1 "BMP")))) 
                  :op1-of (o2 / or 
                        :op2 (i / inhibit-01 
                              :ARG0 (p / person 
                                    :name (n3 / name 
                                          :op1 "Noggin")) 
                              :ARG1 (d3 / date-entity 
                                    :year 1996)) 
                        :op3 (b / block-01 
                              :ARG0 (o / overexpression 
                                    :mod (r / receptor)) 
                              :ARG1 (p3 / process-02 
                                    :ARG0 (d / date-entity 
                                          :year 2002) 
                                    :ARG1 (m / mesenchyme) 
                                    :ARG1-of (e3 / eliminate-01 
                                          :ARG0 (a3 / apoptosi) 
                                          :ARG1-of (n5 / normal-02) 
                                          :time (d5 / develop-02 
                                                :ARG0 (t2 / thing 
                                                      :name (n2 / name 
                                                            :op1 "Garcia-Martinez" 
                                                            :op2 "et" 
                                                            :op3 "al.") 
                                                      :time (d4 / date-entity 
                                                            :year 1993)) 
                                                :ARG1 (e2 / embryonic)))) 
                              :ARG2 (d2 / date-entity 
                                    :year 1996)))) 
            :op2 (t / thing 
                  :name (n / name 
                        :op1 (y / Yokouchi) 
                        :op2 (e / et)))))

# ::snt Limbs of Gdf5-Cre/Bmpr1afloxP mutant embryos showed obvious retention of interdigital webbing between the first and second , but not other , digits of E14 .5 forelimbs ( Figure 2A and 2B ) , a pattern that corresponds to the presence or absence of webbing seen in the adult limb .
# ::tok Limbs of Gdf5-Cre/Bmpr1afloxP mutant embryos showed obvious retention of interdigital webbing between the first and second , but not other , digits of E14 .5 forelimbs ( Figure 2A and 2B ) , a pattern that corresponds to the presence or absence of webbing seen in the adult limb .
# ::alignments 48-49|0.1.0.1.1.1.0.1 47-48|0.0 44-45|0.1.0.1.1.1.0 43-44|0.1.0.1.1.1.0.0 41-42|0.1.0.1.1.1.3 40-41|0.1.0.1.1.1 39-40|0.1.0.1.1.1.2 36-37|0.1.0.1.1 34-35|0.1.0.1.1.0 29-30|0.1.1 27-28|0.1.0.1.0.0 25-26|0.1.2 21-22|0.1.0.1.1.1.3.0.0 19-20|0.1.0.1.1.1.3.0 18-19|0.1.0.1.1.1.3.0.1 17-18|0 14-15|0.1 10-11|0.1.0.0.0.0.0 7-8|0.1.0.1 6-7|0.1.0.1.0 5-6|0.1.0 4-5|0.1.0.0.0 3-4|0.1.0.0.0.0 2-3|0.1.0.1.1.1.1.0.0+0.1.0.1.1.1.1.0+0.1.0.1.1.1.1 0-1|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:36.981
(c2 / contrast-01 
      :ARG0 (a / adult) 
      :ARG2 (a4 / and 
            :op1 (s2 / show-01 
                  :ARG0 (l2 / limb 
                        :poss (e / embryo 
                              :mod (m / mutant 
                                    :mod-of (w2 / web)))) 
                  :ARG1 (r / retention 
                        :ARG1-of (o3 / obvious-01 
                              :ARG0 (f / figure)) 
                        :ARG1-of (c / correspond-01 
                              :ARG0 (p2 / pattern) 
                              :ARG2 (o / or 
                                    :ARG1-of (s / see-01 
                                          :ARG0 (w / web) 
                                          :location (l / limb)) 
                                    :op1 (t / thing 
                                          :name (n / name 
                                                :op1 "Gdf5-Cre/Bmpr1afloxP")) 
                                    :op2 (p / presence) 
                                    :op3 (a2 / absent-01 
                                          :ARG1 (o2 / other 
                                                :mod-of (d / digit) 
                                                :polarity -)))))) 
            :op2 (a3 / and) 
            :poss (f2 / forelimb)))

# ::snt They also showed excess tissue on the posterior margin of the fifth digit ( Figure 2B , arrow ) .
# ::tok They also showed excess tissue on the posterior margin of the fifth digit ( Figure 2B , arrow ) .
# ::alignments 17-18|0.1.0.1 14-15|0.1.0.0 12-13|0.2.1 11-12|0.2.1.0 8-9|0.2 7-8|0.2.0 4-5|0.1 3-4|0.1.0 2-3|0 1-2|0.3 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:37.171
(s / show-01 
      :ARG0 (t2 / they) 
      :ARG1 (t / tissue 
            :ARG1-of (e / exceed-01 
                  :ARG0 (f / figure) 
                  :op1-of (a / arrow))) 
      :ARG2 (m / margin 
            :mod (p / posterior) 
            :mod (d / digit 
                  :mod (f2 / fifth))) 
      :mod (a2 / also))

# ::snt Analysis of LACZ expression in Gdf5-Cre/R26R reporter embryos showed that Cre-mediated recombination has occurred by E13 .5 in the metacarpal-phalangeal joints , and in the interdigital region between the first and second , but not other , digits .
# ::tok Analysis of LACZ expression in Gdf5-Cre/R26R reporter embryos showed that Cre-mediated recombination has occurred by E13 .5 in the metacarpal-phalangeal joints , and in the interdigital region between the first and second , but not other , digits .
# ::alignments 37-38|0.1.0 35-36|0.1.0.0 34-35|0.1.0.0.0 33-34|0 30-31|0.1 26-27|0.0.0.1.0.0.0.0 22-23|0.0 20-21|0.0.0.3 15-16|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 13-14|0.0.0 11-12|0.0.0.1 10-11|0.0.0.1.1 8-9|0.0.0.2 7-8|0.0.0.1.0.0.0.1 6-7|0.0.0.1.0 5-6|0.0.0.1.0.0.1.0+0.0.0.1.0.0.1+0.0.0.1.0.0 3-4|0.0.0.1.0.0.0 0-1|0.0.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:38.189
(c / contrast-01 
      :ARG1 (a2 / and 
            :time-of (o2 / occur-01 
                  :ARG0 (t / thing 
                        :name (n / name 
                              :op1 "E13")) 
                  :ARG1 (r2 / recombination 
                        :ARG0-of (r3 / report-01 
                              :ARG1 (c3 / country 
                                    :location-of (e2 / express-01 
                                          :ARG0 (r / region) 
                                          :ARG1 (e / embryo)) 
                                    :name (n2 / name 
                                          :op1 "Gdf5-Cre/R26R"))) 
                        :mod (c2 / cre-mediat)) 
                  :ARG1-of (s / show-01 
                        :ARG0 (a3 / analysi)) 
                  :location (j / joint))) 
      :ARG2 (a / and 
            :op1 (d / digit 
                  :mod (o / other 
                        :polarity -))))

# ::snt In addition , a domain of recombination and expression of LACZ is also reproducibly seen in the posterior half of the fifth digit ( Figure 2C ) .
# ::tok In addition , a domain of recombination and expression of LACZ is also reproducibly seen in the posterior half of the fifth digit ( Figure 2C ) .
# ::alignments 24-25|0.0.0.2 22-23|0.1.1 21-22|0.1.1.0 18-19|0.1 17-18|0.1.0 14-15|0 13-14|0.3 12-13|0.2 8-9|0.0.0.1 7-8|0.0.0 6-7|0.0.0.0 4-5|0.0 1-2|0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:38.521
(s / see-01 
      :ARG1 (d2 / domain 
            :op1-of (a2 / and 
                  :op2 (r2 / recombination) 
                  :op3 (e / express-01 
                        :ARG0 (a3 / addition)) 
                  :op4 (f / figure))) 
      :location (h / half 
            :mod (p / posterior) 
            :poss (d / digit 
                  :mod (f2 / fifth))) 
      :mod (a / also) 
      :time (r / reproducibly))

# ::snt Terminal deoxynucleotidyl transferase -- mediated deoxyuridine triphosphate nick end labeling ( TUNEL ) staining of interdigital mesenchyme between the first and second digits ( Figure 2D and 2E ) and the fifth digit flanking mesenchyme showed a decreased number of dying cells in the regions where excess tissue is retained in the mutant limbs .
# ::tok Terminal deoxynucleotidyl transferase -- mediated deoxyuridine triphosphate nick end labeling ( TUNEL ) staining of interdigital mesenchyme between the first and second digits ( Figure 2D and 2E ) and the fifth digit flanking mesenchyme showed a decreased number of dying cells in the regions where excess tissue is retained in the mutant limbs .
# ::alignments 53-54|0.2.2.2.1 52-53|0.2.2.2.1.0 49-50|0.2.2.2 47-48|0.2.2.2.0 46-47|0.2.2.2.0.0 44-45|0.2.2.3 41-42|0.2.2.1.1 40-41|0.2.2.1.1.0 38-39|0.2.2.1 37-38|0.2.2.1.0 35-36|0.2.2 34-35|0.2.2.0 33-34|0.2.2.0.0 32-33|0.2.2.0.0.0 31-32|0.2.2.0.1 29-30|0.2 26-27|0.1 25-26|0.2.1.1.1.0 24-25|0.2.2.2.0.0.0 22-23|0.0 20-21|0 16-17|0.2.1.0.0 13-14|0.2.1.0 9-10|0.2.1 8-9|0.2.1.2 7-8|0.2.1.1 6-7|0.2.1.1.0 5-6|0.2.1.1.1.1 4-5|0.2.1.1.1 0-2|0.2.0.0.1+0.2.0.0.0+0.2.0.0+0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:41.254
(a3 / and 
      :op1 (d4 / digit) 
      :op2 (a2 / and) 
      :op3 (a / and 
            :op1 (t3 / thing 
                  :name (n3 / name 
                        :op1 (t4 / Terminal) 
                        :op2 (d6 / deoxynucleotidyl))) 
            :op2 (l2 / label-01 
                  :ARG0-of (s2 / stain-01 
                        :ARG1 (m3 / mesenchyme)) 
                  :ARG1 (n2 / nick-01 
                        :ARG1 (t2 / triphosphate) 
                        :ARG3-of (m4 / mediate-01 
                              :ARG0 2d 
                              :ARG1 (d5 / deoxyuridine))) 
                  :ARG1-of (e2 / end-01)) 
            :op3 (s / show-01 
                  :ARG0 (m2 / mesenchyme 
                        :ARG1-of (f / flank-01 
                              :ARG0 (d3 / digit)) 
                        :mod (f2 / fifth)) 
                  :ARG1 (n / number 
                        :ARG1-of (d2 / decrease-01) 
                        :domain (c / cell 
                              :ARG1-of (d / die-01))) 
                  :condition (r / retain-01 
                        :ARG1 (t / tissue 
                              :ARG1-of (e / exceed-01 
                                    :ARG0 (f3 / figure))) 
                        :ARG2 (l / limb 
                              :mod (m / mutant))) 
                  :location (r2 / region))))

# ::snt Numbers of phosphorylated histone H3-labeled proliferating cells were also elevated in these regions ( Figure 2F ) .
# ::tok Numbers of phosphorylated histone H3-labeled proliferating cells were also elevated in these regions ( Figure 2F ) .
# ::alignments 14-15|0.0.0.0.0.0 12-13|0.0.0.0.0.1 11-12|0.0.0.0.0.1.0 9-10|0.0.0.0.0 8-9|0.0.0.0.0.2 6-7|0.0.0 5-6|0.0 4-5|0.1.0+0.1+0 3-4|0.0.0.1 2-3|0.0.0.2 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:41.492
(t2 / thing 
      :ARG0-of (p / proliferate-01 
            :ARG1 (c / cell 
                  :ARG1-of (n2 / number-01 
                        :ARG1-of (e / elevate-01 
                              :ARG0 (f / figure) 
                              :ARG2 (r / region 
                                    :mod (t / this)) 
                              :mod (a / also))) 
                  :mod (h / histone) 
                  :mod (p2 / phosphorylat))) 
      :name (n / name 
            :op1 "H3-labeled"))

# ::snt Most cells found in the webbed region between the first and second digits at E15 .5 strongly expressed LACZ in Gdf5-Cre/Bmpr1afloxP mutant embryos ( Figure 2H ) .
# ::tok Most cells found in the webbed region between the first and second digits at E15 .5 strongly expressed LACZ in Gdf5-Cre/Bmpr1afloxP mutant embryos ( Figure 2H ) .
# ::alignments 24-25|0.0.0.0.1 22-23|0.1 21-22|0.1.0 20-21|0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 17-18|0 16-17|0.2 14-15|0.0.0.0.0.0.0.0+0.0.0.0.0.0.0+0.0.0.0.0.0 12-13|0.0.0.0.0 10-11|0.0.0.0 6-7|0.0.0.2 5-6|0.0.0.2.0 2-3|0.0.0 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:41.972
(e2 / express-01 
      :ARG0 (c2 / cell 
            :ARG1-of (f2 / find-01 
                  :ARG0 (a / and 
                        :op1 (d / digit 
                              :location (c / country 
                                    :name (n2 / name 
                                          :op1 "E15"))) 
                        :op2 (f / figure)) 
                  :ARG2 (t / thing 
                        :name (n / name 
                              :op1 "Gdf5-Cre/Bmpr1afloxP")) 
                  :location (r / region 
                        :mod (w / web))) 
            :mod (m2 / most)) 
      :ARG1 (e / embryo 
            :mod (m / mutant)) 
      :ARG1-of (s / strong-02))

# ::snt These data suggest that regional loss of BMPR1A receptor signaling blocks programmed cell death in interdigital mesenchyme , and that the recombined cells survive and proliferate in the absence of BMPR1A signaling .
# ::tok These data suggest that regional loss of BMPR1A receptor signaling blocks programmed cell death in interdigital mesenchyme , and that the recombined cells survive and proliferate in the absence of BMPR1A signaling .
# ::alignments 31-32|0.1.2 28-29|0.1.3.1 25-26|0.1.3.0.1.0 24-25|0.1.3.0.1 23-24|0.1.3.0 22-23|0.1.3.0.1.0.0 21-22|0.1.3.0.1.0.0.0 18-19|0.1.3 16-17|0.1.3.0.0.0 13-14|0.1.3.0.0 12-13|0.1.3.0.0.2 11-12|0.1.3.0.0.1 10-11|0.1 9-10|0.1.1 8-9|0.1.1.1 7-8|0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 5-6|0.1.0 4-5|0.1.0.0 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:42.417
(s4 / suggest-01 
      :ARG0 (d2 / data 
            :mod (t / this)) 
      :ARG1 (b / block-01 
            :ARG0 (l / loss 
                  :mod (r3 / region)) 
            :ARG1 (s3 / signal-01 
                  :ARG0 (o / organization 
                        :name (n / name 
                              :op1 "BMPR1A")) 
                  :ARG1 (r2 / receptor)) 
            :ARG1-of (s / signal-01) 
            :op1-of (a3 / and 
                  :op2 (s2 / survive-01 
                        :ARG1 (d / die-01 
                              :ARG1 (m / mesenchyme) 
                              :ARG1-of (p2 / program-01) 
                              :mod (c2 / cell)) 
                        :op1-of (a2 / and 
                              :op2 (p / proliferate-01 
                                    :ARG0 (c / cell 
                                          :ARG1-of (r / recombine-01))))) 
                  :time (a / absent-01))))

# ::snt Failure of Early Joint Formation in Ankle Regions .
# ::tok Failure of Early Joint Formation in Ankle Regions .
# ::alignments 6-8|0.1.0.1+0.1.0.0+0.1.0+0.1 4-5|0.0 3-4|0.0.0 2-3|0.0.0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:42.439
(f2 / fail-01 
      :ARG1 (f / formation 
            :mod (j / joint 
                  :mod (e / early))) 
      :location (c / country 
            :name (n / name 
                  :op1 "Ankle" 
                  :op2 "Regions")))

# ::snt The Bmpr1a gene is expressed in the interzone region of developing joints at E13 .5 ( Baur et al. 2000 ) .
# ::tok The Bmpr1a gene is expressed in the interzone region of developing joints at E13 .5 ( Baur et al. 2000 ) .
# ::alignments 19-20|0.3.0+0.3 16-19|0.0.0.2+0.0.0.1+0.0.0.0+0.0.0+0.0 13-14|0.2.0.0.0.0.0+0.2.0.0.0.0+0.2.0.0.0 11-12|0.2.0.0 10-11|0.2.0 8-9|0.2 4-5|0 2-3|0.1 1-2|0.1.0.0.0+0.1.0.0+0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:42.963
(e / express-01 
      :ARG0 (t / thing 
            :name (n / name 
                  :op1 "Baur" 
                  :op2 "et" 
                  :op3 "al.")) 
      :ARG1 (g / gene 
            :mod (t3 / thing 
                  :name (n3 / name 
                        :op1 "Bmpr1a"))) 
      :ARG2 (r / region 
            :ARG0-of (d2 / develop-02 
                  :ARG1 (j / joint 
                        :location (t2 / thing 
                              :name (n2 / name 
                                    :op1 "E13"))))) 
      :time (d / date-entity 
            :year 2000))

# ::snt In situ hybridization showed that the gene is also expressed in the interzones of ankle joints and prospective articular cartilage regions of digit joints at E15 .5 ( Figure 4 ) .
# ::tok In situ hybridization showed that the gene is also expressed in the interzones of ankle joints and prospective articular cartilage regions of digit joints at E15 .5 ( Figure 4 ) .
# ::alignments 29-30|0.1.0 28-29|0.2 23-24|0.1.2.2.2 22-23|0.1.2.2.2.0 20-21|0.1.2.2 19-20|0.1.2.2.1 18-19|0.1.2.2.1.0 17-18|0.1.2.2.0 16-17|0.1.2 15-16|0.1.2.1 14-15|0.1.2.0 12-13|0.1.3 9-10|0.1 8-9|0.1.4 6-7|0.1.1 3-4|0 2-3|0.0 1-2|0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:43.328
(s / show-01 
      :ARG0 (h / hybridization) 
      :ARG1 (e / express-01 
            :ARG0 4 
            :ARG1 (g / gene) 
            :ARG2 (a2 / and 
                  :mod (a3 / ankle) 
                  :op1 (j2 / joint) 
                  :op2 (r / region 
                        :mod (p / prospective) 
                        :mod (c / cartilage 
                              :mod (a / articular)) 
                        :quant-of (j / joint 
                              :mod (d / digit)))) 
            :manner (i / interzon) 
            :mod (a4 / also)) 
      :ARG2 (f / figure) 
      :manner (s2 / situ))

# ::snt LACZ staining indicated that Cre-mediated recombination begins to occur in ankle joints around E14 .5 , and is extensive by E15 .5 ( Figure 4G and 4J ) ( unpublished data ) .
# ::tok LACZ staining indicated that Cre-mediated recombination begins to occur in ankle joints around E14 .5 , and is extensive by E15 .5 ( Figure 4G and 4J ) ( unpublished data ) .
# ::alignments 30-31|0.1.0.0 29-30|0.1.0 25-26|0.2 23-24|0.0.0 18-19|0.1.2.0 16-17|0.1.2 13-14|0.1.1.1.0.0.0.0+0.1.1.1.0.0.0+0.1.1.1.0.0 12-13|0.1.1.1.0 11-12|0.1.1.1 10-11|0.1.2.0.0 8-9|0.1.1 6-7|0.1 5-6|0.1.1.0 4-5|0.1.1.0.0 2-3|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:43.819
(i / indicate-01 
      :ARG0 (s / stain-01 
            :ARG1 (f / figure)) 
      :ARG1 (b / begin-01 
            :ARG0 (u / unpublish 
                  :mod-of (d / data)) 
            :ARG1 (o / occur-01 
                  :ARG0 (r / recombination 
                        :mod (c2 / cre-mediat)) 
                  :ARG1 (j / joint 
                        :location (a3 / around 
                              :op1 (c / country 
                                    :name (n / name 
                                          :op1 "E14"))))) 
            :op1-of (a2 / and 
                  :op2 (e / extensive-03 
                        :ARG1 (a4 / ankle)))) 
      :op1-of (a / and))

# ::snt In the ankle joint regions that were obviously fused in postnatal mutant animals , alterations in early joint marker expression could also be seen by E15 .5 .
# ::tok In the ankle joint regions that were obviously fused in postnatal mutant animals , alterations in early joint marker expression could also be seen by E15 .5 .
# ::alignments 25-26|0.0.2.0.0.0.0+0.0.2.0.0.0+0.0.2.0.0 23-24|0.0.2.0 21-22|0.0.2.0.3 20-21|0.0.2.0.1 19-20|0.0 18-19|0 17-18|0.1 16-17|0.0.1 14-15|0.0.2 12-13|0.0.2.0.2.0.1 11-12|0.0.2.0.2.0.1.0 10-11|0.0.2.0.2.0.1.1 8-9|0.0.2.0.2.0 7-8|0.0.2.0.2.0.0 4-5|0.0.2.0.2 3-4|0.0.2.0.2.1 2-3|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:44.062
(m / mark-01 
      :ARG1 (e / express-01 
            :ARG1 (a4 / ankle) 
            :mod (e2 / early) 
            :mod-of (a2 / alteration 
                  :ARG1-of (s / see-01 
                        :ARG0 (c / country 
                              :name (n / name 
                                    :op1 "E15")) 
                        :ARG1-of (p / possible-01) 
                        :ARG2 (r / region 
                              :ARG1-of (f / fuse-01 
                                    :ARG1-of (o / obvious-01) 
                                    :ARG2 (a3 / animal 
                                          :mod (m2 / mutant) 
                                          :mod (p2 / postnatal))) 
                              :mod (j2 / joint)) 
                        :mod (a / also)))) 
      :mod (j / joint))

# ::snt At this stage , the Gdf5 gene is normally expressed in stripes that mark the sites of joint formation ( Figure 4F ) , and the gene for the major collagen protein of cartilage matrix ( Col2a1 ) is down-regulated in the interzone region ( Figure 4E ) .
# ::tok At this stage , the Gdf5 gene is normally expressed in stripes that mark the sites of joint formation ( Figure 4F ) , and the gene for the major collagen protein of cartilage matrix ( Col2a1 ) is down-regulated in the interzone region ( Figure 4E ) .
# ::alignments 45-46|0.3.3 43-44|0.3.2.0 39-40|0.3.2 34-35|0.3.0.2 33-34|0.3.0.2.0 31-32|0.3.0 30-31|0.3.0.1 29-30|0.3.0.0 26-27|0.3.1 24-25|0.3 20-21|0.1.0 18-19|0.2.0.0.0 17-18|0.2.0.0.0.0 15-16|0.2.0.0 13-14|0.2.0 11-12|0.2 9-10|0 8-9|0.1 6-7|0.0 2-3|0.4 1-2|0.4.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:44.520
(e / express-01 
      :ARG1 (g2 / gene) 
      :ARG1-of (n / normal-02 
            :ARG0 (f2 / figure)) 
      :manner (s2 / stripe 
            :ARG0-of (m3 / mark-01 
                  :ARG1 (s / site 
                        :consist-of (f3 / form-01 
                              :manner (j / joint))))) 
      :op1-of (a / and 
            :mod-of (p / protein 
                  :ARG1-of (m2 / major-02) 
                  :mod (c2 / collagen) 
                  :mod (m / matrix 
                        :mod (c / cartilage))) 
            :op2 (g / gene) 
            :op3 (d / down-regulat 
                  :domain (r / region)) 
            :op4 (f / figure)) 
      :time (s3 / stage 
            :mod (t / this)))

# ::snt In contrast , Col2a1 staining extended completely through the joint region between the second and central tarsal of Gdf5-Cre/Bmpr1afloxP mutants ( Figure 4H , black arrow ) , and Gdf5 expression was seen only as a small notch extending into where the joint should be forming ( Figure 4I , bracket ) .
# ::tok In contrast , Col2a1 staining extended completely through the joint region between the second and central tarsal of Gdf5-Cre/Bmpr1afloxP mutants ( Figure 4H , black arrow ) , and Gdf5 expression was seen only as a small notch extending into where the joint should be forming ( Figure 4I , bracket ) .
# ::alignments 50-51|0.1.2.1 47-48|0.0.3.0.1.0 45-46|0.1.2.0 43-44|0.1.2 42-43|0.1.2.0.0 38-39|0.0.3.0.1 37-38|0.0.3.0.1.1 36-37|0.0.3.0.1.1.0 33-34|0.0.3.0.2 32-33|0.0.3.0 30-31|0.0.3.0.0 28-29|0.0.3 25-26|0.1.2.0.1.0 24-25|0.1.2.0.1 21-22|0.0.1 19-20|0.1.1.0 18-19|0.1.1.0.0.0.0+0.1.1.0.0.0+0.1.1.0.0 16-17|0.1.1 15-16|0.1.0 14-15|0.1 10-11|0.0.3.0.0.0.0 9-10|0.0.3.0.0.0 6-7|0.0.2 5-6|0.0 4-5|0.0.0 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:45.243
(c3 / contrast-01 
      :ARG1 (e3 / extend-01 
            :ARG0 (s3 / stain-01) 
            :ARG1 (f3 / figure) 
            :ARG1-of (c2 / complete-02) 
            :op1-of (a / and 
                  :op2 (s2 / see-01 
                        :ARG1 (e2 / express-01 
                              :ARG1 (j2 / joint 
                                    :mod-of (r2 / region))) 
                        :ARG2 (e / extend-01 
                              :ARG1 (f / figure) 
                              :ARG2 (n / notch 
                                    :mod (s / small))) 
                        :mod (o / only)))) 
      :ARG2 (a3 / and 
            :op1 (c / central) 
            :op2 (t2 / tarsal 
                  :mod (m / mutant 
                        :mod (t / thing 
                              :name (n2 / name 
                                    :op1 "Gdf5-Cre/Bmpr1afloxP")))) 
            :op3 (r / recommend-01 
                  :ARG1 (f2 / form-01 
                        :ARG0 (j / joint) 
                        :ARG1 (b2 / black-04 
                              :ARG1 (a2 / arrow))) 
                  :ARG1-of (b / bracket-01))))

# ::snt These data suggest that the fusions seen between ankle bones in postnatal mutant skeletons are the result of incomplete segmentation of skeletal precursors during embryonic development , a defect confined to some locations in the ankle .
# ::tok These data suggest that the fusions seen between ankle bones in postnatal mutant skeletons are the result of incomplete segmentation of skeletal precursors during embryonic development , a defect confined to some locations in the ankle .
# ::alignments 35-36|0.0.0.0.0.0.0 32-33|0.0.0.0.1.0 31-32|0.0.0.0.1.0.0 29-30|0.0.0.0.1 28-29|0.0.0.0 25-26|0.0.0.0.0.0 24-25|0.0.0.0.0.0.1 22-23|0.0.0.0.0 21-22|0.0.0.0.0.1 19-20|0.0.0.1.1 18-19|0.0.0.1.1.0.0+0.0.0.1.1.0 16-17|0.0.0.1 13-14|0.0.0.1.0 12-13|0.0.0.1.0.0 11-12|0.0.0.1.0.1 9-10|0 8-9|0.1 6-7|0.0 5-6|0.0.0 2-3|0.0.0.0.1.1 1-2|0.0.0.0.1.1.0 0-1|0.0.0.0.1.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:45.982
(b / bone 
      :ARG0-of (s5 / see-01 
            :ARG1 (f / fusion 
                  :ARG0-of (d / defect-01 
                        :ARG1 (p / precursor 
                              :ARG1-of (d2 / develop-02 
                                    :ARG0 (a / ankle) 
                                    :mod (e / embryonic)) 
                              :mod (s2 / skeletal)) 
                        :ARG1-of (c / confine-01 
                              :ARG2 (l / location 
                                    :quant (s / some)) 
                              :purpose (s6 / suggest-01 
                                    :ARG1 (d3 / data 
                                          :mod (t / this))))) 
                  :ARG2-of (r / result-01 
                        :ARG0 (s4 / skeleton 
                              :mod (m / mutant) 
                              :mod (p2 / postnatal)) 
                        :ARG1 (s3 / segmentation 
                              :ARG1-of (c2 / complete-02 
                                    :polarity -))))) 
      :part-of (a2 / ankle))

# ::snt Failure to Maintain Articular Cartilage in Other Joints .
# ::tok Failure to Maintain Articular Cartilage in Other Joints .
# ::alignments 7-8|0.0.0 6-7|0.0 2-5|0.1.0.2+0.1.0.1+0.1.0.0+0.1.0+0.1 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:46.040
(f / fail-01 
      :ARG0 (o / other 
            :mod-of (j / joint)) 
      :ARG1 (t / thing 
            :name (n / name 
                  :op1 "Maintain" 
                  :op2 "Articular" 
                  :op3 "Cartilage")))

# ::snt In most joints of Bmpr1a conditional knockout mice , embryonic segmentation of skeletal precursors occurred normally .
# ::tok In most joints of Bmpr1a conditional knockout mice , embryonic segmentation of skeletal precursors occurred normally .
# ::alignments 15-16|0.2 14-15|0 13-14|0.1 12-13|0.1.0 10-11|0.0 9-10|0.0.0 7-8|0.2.0.0 6-7|0.2.0.0.0 5-6|0.2.0.0.1 4-5|0.2.0.1.0+0.2.0.1+0.2.0 2-3|0.2.0.0.2 1-2|0.2.0.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:46.304
(o / occur-01 
      :ARG0 (s2 / segmentation 
            :mod (e / embryonic)) 
      :ARG1 (p / precursor 
            :mod (s / skeletal)) 
      :ARG1-of (n / normal-02 
            :ARG0 (t / thing 
                  :mod-of (m / mouse 
                        :mod (k / knockout) 
                        :mod (c / conditional) 
                        :quant (j / joint 
                              :quant (m2 / most))) 
                  :name (n2 / name 
                        :op1 "Bmpr1a"))))

# ::snt Although Gdf5-Cre-mediated recombination was seen as early as E13 .5 in digit interzone regions ( see Figure 2C ) , no changes in cell death or cell proliferation could be seen in the metacarpal-phalangeal or metatarsal-phalangeal joints at E13 .5 or E14 .5 ( unpublished data ) .
# ::tok Although Gdf5-Cre-mediated recombination was seen as early as E13 .5 in digit interzone regions ( see Figure 2C ) , no changes in cell death or cell proliferation could be seen in the metacarpal-phalangeal or metatarsal-phalangeal joints at E13 .5 or E14 .5 ( unpublished data ) .
# ::alignments 45-46|0.0.0.0.0 44-45|0.0.0.0.0.0 40-41|0.0.0.0.2.1 36-37|0.0.1.0 34-35|0.0.1 30-31|0.0 28-29|0 27-28|0.0.0.1.0 26-27|0.0.0.1.0.1 25-26|0.0.0.1 24-25|0.0.0.0 23-24|0.0.0.0.1 21-22|0.0.0 20-21|0.0.0.2 16-17|0.0.0.0.2.0 15-16|0.0.0.0.2 13-14|0.0.0.1.0.0.0 12-13|0.0.0.1.0.0.0.0 11-12|0.0.0.1.0.0 6-7|0.1.1 4-5|0.1 2-3|0.1.0 1-2|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:47.731
(p / possible-01 
      :ARG1 (s / see-01 
            :ARG1 (c3 / change-01 
                  :ARG1 (d2 / die-01 
                        :ARG0 (d / data 
                              :mod (u / unpublish)) 
                        :mod (c2 / cell) 
                        :time-of (s2 / see-01 
                              :ARG1 (f / figure) 
                              :op1-of (o / or))) 
                  :op1-of (o3 / or 
                        :op2 (p2 / proliferate-01 
                              :ARG1 (d3 / digit 
                                    :mod-of (r / region 
                                          :mod (i / interzone))) 
                              :mod (c / cell))) 
                  :polarity -) 
            :ARG2 (o2 / or 
                  :op1 (j / joint))) 
      :condition (s3 / see-01 
            :ARG1 (r2 / recombination 
                  :mod (g / gdf5-cre-mediat)) 
            :time (e / early)))

# ::snt Similarly , although clear LACZ expression was seen by E15 .5 in interphalangeal joints and periarticular regions ( Figure 4D ) , no difference in morphology or expression of Col2a1 , Gdf5 , or Bmpr1b was seen in the articular regions of the phalanges at these stages ( unpublished data ) .
# ::tok Similarly , although clear LACZ expression was seen by E15 .5 in interphalangeal joints and periarticular regions ( Figure 4D ) , no difference in morphology or expression of Col2a1 , Gdf5 , or Bmpr1b was seen in the articular regions of the phalanges at these stages ( unpublished data ) .
# ::alignments 49-50|0.0.0.1.2.0 48-49|0.0.0.1.2 46-47|0.0.1 45-46|0.0.1.0 43-44|0.0.0.1.0.0.0.0 40-41|0.1 39-40|0.1.0 36-37|0 34-35|0.0.0.1.1.0.1 33-34|0.0.0.1.1.0 31-32|0.0.0.1.1.0.0 29-30|0.0.0.1.1 27-28|0.0.0.1 26-27|0.0.0 25-26|0.0.0.0 23-24|0.0 22-23|0.2 18-19|0.0.0.1.0.0.0.2.0 16-17|0.0.0.1.0.0.0.1.1 15-16|0.0.0.1.0.0.0.1.1.0 14-15|0.0.0.1.0.0.0.1 13-14|0.0.0.1.0.0.0.1.0 9-10|0.0.0.1.0.1.0+0.0.0.1.0.1+0.0.0.1.0 7-8|0.0.0.1.0.0 5-6|0.0.0.1.0.0.0 3-4|0.0.0.1.0.0.0.2 0-1|0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:49.371
(s2 / see-01 
      :ARG1 (d2 / differ-02 
            :ARG1 (o2 / or 
                  :op1 (m / morphology) 
                  :op2 (e / express-01 
                        :ARG0 (p3 / person 
                              :ARG0-of (s3 / see-01 
                                    :ARG1 (e2 / express-01 
                                          :ARG0 (p / phalanx) 
                                          :ARG1 (a2 / and 
                                                :op1 (j / joint) 
                                                :op2 (r2 / region 
                                                      :mod (p2 / periarticular))) 
                                          :ARG1-of (c2 / clear-06 
                                                :ARG0 (f / figure)))) 
                              :name (n / name 
                                    :op1 "E15")) 
                        :ARG1 (c / Col2a1 
                              :op1-of (o / or 
                                    :op2 (g / Gdf5) 
                                    :op3 (b / Bmpr1b))) 
                        :ARG2 (u / unpublish 
                              :mod-of (d / data)))) 
            :time (s / stage 
                  :mod (t / this))) 
      :location (r / region 
            :mod (a / articular)) 
      :polarity (- / - 
            :polarity-of (s4 / similarly)))

# ::snt At birth , digit joints were generally indistinguishable from those in control animals ; chondrocytes were abundant in articular regions and were surrounded by typical cartilage matrix with normal staining by Safranin O , a histological stain for proteoglycans ( Figure 5 ) .
# ::tok At birth , digit joints were generally indistinguishable from those in control animals ; chondrocytes were abundant in articular regions and were surrounded by typical cartilage matrix with normal staining by Safranin O , a histological stain for proteoglycans ( Figure 5 ) .
# ::alignments 41-42|0.0.1.0.0 40-41|0.0.0.0.1.0 38-39|0.0.0.0.1.1.0 36-37|0.0.0.0.1.1 35-36|0.0.0.0.1.1.1 31-33|0.0.0.0.2.0.1+0.0.0.0.2.0.0+0.0.0.0.2.0+0.0.0.0.2 29-30|0.0.0.0 28-29|0.0.0.0.1 26-27|0.0.1 25-26|0.0.1.1 24-25|0.0.1.0 22-23|0.0 20-21|0 19-20|0.0.0.2.0 18-19|0.0.0.2.0.0 16-17|0.0.0.2 14-15|0.0.0 13-14|0.0.0.3 12-13|0.0.0.1.0 11-12|0.0.0.1 7-8|0.0.0.0.0.0 6-7|0.0.0.0.0 4-5|0.0.0.0.0.0.0 3-4|0.0.0.0.0.0.0.0 1-2|0.0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:52.722
(a / and 
      :op1 (s3 / surround-01 
            :ARG0 (c2 / chondrocyt 
                  :ARG0-of (s2 / stain-01 
                        :ARG1 (g / general-02 
                              :ARG1 (i / indistinguishable 
                                    :domain (j / joint 
                                          :mod (d / digit)))) 
                        :ARG1-of (n2 / normal-02 
                              :ARG0 (f / figure) 
                              :time-of (s / stain-01 
                                    :ARG1 (p / proteoglycan) 
                                    :mod (h / histological))) 
                        :location (o / organization 
                              :name (n / name 
                                    :op1 "Safranin" 
                                    :op2 "O"))) 
                  :ARG2-of (c3 / control-01 
                        :ARG1 (a5 / animal)) 
                  :domain-of (a3 / abundance 
                        :location (r / region 
                              :mod (a2 / articular))) 
                  :op1-of (a4 / and)) 
            :ARG1 (m / matrix 
                  :ARG1-of (t / typical-02 
                        :ARG0 5 
                        :ARG1-of (b / birth-01)) 
                  :mod (c / cartilage))))

# ::snt At this stage , both wild-type and mutant cells in articular regions also expressed high levels of Col2a1 and Aggrecan ( Agg ) , the genes encoding the major structural proteins of cartilage matrix ( Figure 5B and 5G ) ( unpublished data ) .
# ::tok At this stage , both wild-type and mutant cells in articular regions also expressed high levels of Col2a1 and Aggrecan ( Agg ) , the genes encoding the major structural proteins of cartilage matrix ( Figure 5B and 5G ) ( unpublished data ) .
# ::alignments 42-43|0.3.1.0.0.0 41-42|0.3.1.0.0 37-38|0.0.1 35-36|0.1.0.0 33-34|0.3.1.2 32-33|0.3.1.2.0 30-31|0.3.1 29-30|0.3.1.1 28-29|0.3.1.0 26-27|0.3 25-26|0.3.0 19-20|0.1.1.1.0.0+0.1.1.1.0+0.1.1.1 18-19|0.1.1 17-18|0.1.1.0 15-16|0.1 14-15|0.1.0 13-14|0 12-13|0.2 11-12|0.0.2.0 10-11|0.0.2.0.0 8-9|0.0.2 7-8|0.0.0 6-7|0.0 4-5|0.0.1.0 2-3|0.4 1-2|0.4.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:53.767
(e2 / express-01 
      :ARG0 (a5 / and 
            :op1 (m3 / mutant) 
            :op1-of (a / and 
                  :mod (b / both)) 
            :op2 (c3 / cell 
                  :location (r / region 
                        :mod (a4 / articular)))) 
      :ARG1 (l / level 
            :ARG1-of (h / high-02 
                  :ARG0 (f / figure)) 
            :extent-of (a2 / and 
                  :op1 (c2 / Col2a1) 
                  :op2 (t / thing 
                        :name (n / name 
                              :op1 "Aggrecan")))) 
      :mod (a3 / also) 
      :purpose (e / encode-01 
            :ARG0 (g / gene) 
            :ARG1 (p / protein 
                  :ARG1-of (m2 / major-02 
                        :ARG0 (u / unpublish 
                              :mod-of (d / data))) 
                  :mod (s / structure) 
                  :mod (m / matrix 
                        :mod (c / cartilage)))) 
      :time (s2 / stage 
            :mod (t2 / this)))

# ::snt No alterations in cellular apoptosis or proliferation were observed ( unpublished data ) .
# ::tok No alterations in cellular apoptosis or proliferation were observed ( unpublished data ) .
# ::alignments 11-12|0.1 10-11|0.1.0 8-9|0 6-7|0.0.1 5-6|0.0 4-5|0.0.0 3-4|0.0.1.0 1-2|0.2.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:53.871
(o / observe-01 
      :ARG0 (o2 / or 
            :op1 (a / apoptosi) 
            :op2 (p / proliferate-01 
                  :mod (c / cell))) 
      :ARG1 (d / data 
            :mod (u / unpublish)) 
      :polarity (- / - 
            :polarity-of (a2 / alteration)))

# ::snt To determine whether articular cells were properly specified in mutants , we also analyzed expression of Matrilin-4 ( Mat4 ) , a gene expressed specifically in the periarticular and perichondral regions of developing joints ( Klatt et al. 2001 ) .
# ::tok To determine whether articular cells were properly specified in mutants , we also analyzed expression of Matrilin-4 ( Mat4 ) , a gene expressed specifically in the periarticular and perichondral regions of developing joints ( Klatt et al. 2001 ) .
# ::alignments 38-39|0.0.0.0.1.0+0.0.0.0.1 35-38|0.0.0.0.0.2+0.0.0.0.0.1+0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 33-34|0.0.2.0.0 32-33|0.0.2.0 30-31|0.0.2.1 28-29|0.0.2 27-28|0.2 24-25|0.3 23-24|0 22-23|0.1 16-17|0.0.1.0+0.0.1+0.0 14-15|0.0.0 13-14|0.0.0.1 12-13|0.0.0.1.1 11-12|0.0.0.1.0 9-10|0.0.0.1.0.0.0.1 7-8|0.0.0.1.0.0.0 6-7|0.0.0.1.0.0.0.2 4-5|0.0.0.1.0.0.0.0 3-4|0.0.0.1.0.0.0.0.0 1-2|0.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:54.850
(e / express-01 
      :ARG0 (p2 / person 
            :ARG0-of (e2 / express-01 
                  :ARG1 (t / thing 
                        :name (n / name 
                              :op1 "Klatt" 
                              :op2 "et" 
                              :op3 "al.") 
                        :time (d / date-entity 
                              :year 2001)) 
                  :ARG1-of (a2 / analyze-01 
                        :ARG0 (w / we 
                              :ARG0-of (d3 / determine-01 
                                    :ARG1 (s2 / specify-01 
                                          :ARG1 (c / cell 
                                                :mod (a4 / articular)) 
                                          :location (m / mutant) 
                                          :manner (p3 / proper)))) 
                        :mod (a3 / also))) 
            :name (n2 / name 
                  :op1 "Matrilin-4") 
            :op1-of (a / and 
                  :ARG0-of (d2 / develop-02 
                        :ARG1 (j / joint)) 
                  :op2 (r / region))) 
      :ARG1 (g / gene) 
      :manner (p / periarticular) 
      :manner (s / specific-02))

# ::snt In both control and mutant animals , transcription of Mat4 was clearly detectable in the articular cartilage layers of newborn joints ( Figure 5D and 5I ) .
# ::tok In both control and mutant animals , transcription of Mat4 was clearly detectable in the articular cartilage layers of newborn joints ( Figure 5D and 5I ) .
# ::alignments 24-25|0 22-23|0.0.0 20-21|0.0.1.1.1 19-20|0.0.1.1.1.0 17-18|0.0.1.1 16-17|0.0.1.1.0 15-16|0.0.1.1.2 12-13|0.0.1 11-12|0.0 9-10|0.0.1.0.0 7-8|0.0.1.0 5-6|0.1.2 4-5|0.1.2.0 3-4|0.1 2-3|0.1.1 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:55.115
(a / and 
      :ARG2-of (c2 / clear-06 
            :ARG0 (f / figure) 
            :ARG1 (d / detectable 
                  :domain (t / transcription 
                        :mod (m / Mat4)) 
                  :mod-of (l / layer 
                        :mod (c / cartilage) 
                        :mod (j / joint 
                              :mod (n / newborn)) 
                        :mod (a2 / articular)))) 
      :op1 (a4 / and 
            :mod (b / both) 
            :op1 (c3 / control-01) 
            :op2 (a3 / animal 
                  :mod (m2 / mutant))))

# ::snt In all experiments , expression of LACZ throughout articular regions indicated that Cre-mediated recombination had occurred throughout the articular regions ( Figure 5C , 5H , 5E , and 5J ) .
# ::tok In all experiments , expression of LACZ throughout articular regions indicated that Cre-mediated recombination had occurred throughout the articular regions ( Figure 5C , 5H , 5E , and 5J ) .
# ::alignments 28-29|0.2 21-22|0.0.0 19-20|0.1.2 18-19|0.1.2.0 16-17|0.1.2.1 15-16|0.1 13-14|0.1.0 12-13|0.1.0.0 10-11|0 9-10|0.0.1.0 8-9|0.0.1.0.0 7-8|0.0.1 4-5|0.0 2-3|0.1.1 1-2|0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:55.399
(i / indicate-01 
      :ARG0 (e / express-01 
            :ARG0 (f / figure) 
            :ARG1 (t2 / throughout 
                  :op1 (r3 / region 
                        :mod (a3 / articular)))) 
      :ARG1 (o / occur-01 
            :ARG0 (r2 / recombination 
                  :mod (c / cre-mediat)) 
            :ARG1-of (e2 / experiment-01 
                  :quant (a4 / all)) 
            :location (r / region 
                  :mod (a2 / articular) 
                  :op1-of (t / throughout))) 
      :op1-of (a / and))

# ::snt The normal histological appearance , staining properties , and marker gene expression patterns suggest that Bmpr1a is not required for the initial formation or specification of articular cartilage .
# ::tok The normal histological appearance , staining properties , and marker gene expression patterns suggest that Bmpr1a is not required for the initial formation or specification of articular cartilage .
# ::alignments 27-28|0.1.2.0.0.0 26-27|0.1.2.0.0.0.0 24-25|0.1.2.0.1 23-24|0.1.2.0 22-23|0.1.2.0.0 21-22|0.1.2.0.0.1 18-19|0.1.2 17-18|0.0.0.0 15-16|0.1.2.1.0.0+0.1.2.1.0+0.1.2.1 13-14|0 12-13|0.1.1 11-12|0.1.1.2 10-11|0.1.1.1 9-10|0.1.1.0 8-9|0.1 6-7|0.0 5-6|0.0.0 3-4|0.1.0 2-3|0.1.0.1 1-2|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:56.148
(s2 / suggest-01 
      :ARG0 (p3 / property 
            :ARG1-of (s3 / stain-01 
                  :ARG0 -)) 
      :ARG1 (a2 / and 
            :op1 (a3 / appear-01 
                  :ARG1-of (n2 / normal-02) 
                  :manner (h / histological)) 
            :op2 (p2 / pattern-01 
                  :ARG1-of (m / mark-01) 
                  :mod (g / gene) 
                  :mod (e / express-01)) 
            :op3 (r / require-01 
                  :ARG1 (o / or 
                        :op1 (f / form-01 
                              :ARG1 (c / cartilage 
                                    :mod (a / articular)) 
                              :time (i / initial)) 
                        :op2 (s / specification)) 
                  :ARG2 (p / person 
                        :name (n / name 
                              :op1 "Bmpr1a")))))

# ::snt By 1 wk after birth , obvious differences began to be detected in the articular regions of mutant animals .
# ::tok By 1 wk after birth , obvious differences began to be detected in the articular regions of mutant animals .
# ::alignments 18-19|0.0 17-18|0 15-16|0.1.1.0.1 14-15|0.1.1.0.1.0 11-12|0.1.1.0 8-9|0.1.1.0.0 7-8|0.1.1 6-7|0.1 4-5|0.1.1.0.0.0.0 3-4|0.1.1.0.0.0 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:56.373
(m / mutant 
      :mod-of (a / animal) 
      :op1 (o / obvious-01 
            :ARG0 1 
            :ARG1 (d2 / differ-01 
                  :ARG1-of (d / detect-01 
                        :ARG1-of (b / begin-01 
                              :time (a3 / after 
                                    :op1 (b2 / birth-01))) 
                        :ARG2 (r / region 
                              :mod (a2 / articular))))))

# ::snt The expression of Col2a1 was reduced throughout the articular surfaces of the carpals , metacarpals , and phalanges of the forefeet ( unpublished data ) .
# ::tok The expression of Col2a1 was reduced throughout the articular surfaces of the carpals , metacarpals , and phalanges of the forefeet ( unpublished data ) .
# ::alignments 23-24|0.1 22-23|0 20-21|0.0.2.0.1.0.1.0 17-18|0.0.2.0.1.0.1 16-17|0.0.2.0.1.0 14-15|0.0.2.0.1.0.0 12-13|0.0.2.0.1 9-10|0.0.2.0 8-9|0.0.2.0.0 6-7|0.0.2 5-6|0.0.1 3-4|0.0.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:56.630
(u / unpublish 
      :ARG0-of (e / express-01 
            :ARG1 (c2 / Col2a1) 
            :ARG1-of (r / reduce-01) 
            :time (t / throughout 
                  :op1 (s / surface-01 
                        :ARG0 (a2 / articular) 
                        :ARG1 (c / carpal 
                              :op1-of (a / and 
                                    :op2 (m / metacarpal) 
                                    :op3 (p / phalanx 
                                          :poss (f / forefoot))))))) 
      :mod-of (d / data))

# ::snt Less severe reductions were also seen in articular cells of tarsals and metatarsals in the hindfeet ( unpublished data ) .
# ::tok Less severe reductions were also seen in articular cells of tarsals and metatarsals in the hindfeet ( unpublished data ) .
# ::alignments 18-19|0.1.0 17-18|0.1.0.0 15-16|0.0.0 12-13|0.0.2 11-12|0.0 10-11|0.0.1 8-9|0.0.1.0 7-8|0.0.1.0.0 5-6|0 4-5|0.2 2-3|0.1 1-2|0.1.2 0-1|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:14:56.865
(s / see-01 
      :ARG0 (a / and 
            :example (h / hindfeet) 
            :op1 (t / tarsal 
                  :consist (c / cell 
                        :mod (a2 / articular))) 
            :op2 (m / metatarsal)) 
      :ARG1 (r / reduce-01 
            :ARG0 (d / data 
                  :mod (u / unpublish)) 
            :ARG1 (l / les) 
            :mod (s2 / severe)) 
      :mod (a3 / also))

# ::snt By 2 wk of age , Col2a1 expression was reduced in most cells of the articular region ( Figure 5L and 5Q ) , accompanied by markedly reduced Safranin O staining ( Figure 5K and 5P ) , and decreased expression of Agg and two genes normally expressed in more mature articular cartilage cells , Collagen 3 ( Col3a1 ) and Collagen 10 ( Col10a1 ) ( Figure 5M and 5R ) ( unpublished data ) ( Eyre 2002 ) .
# ::tok By 2 wk of age , Col2a1 expression was reduced in most cells of the articular region ( Figure 5L and 5Q ) , accompanied by markedly reduced Safranin O staining ( Figure 5K and 5P ) , and decreased expression of Agg and two genes normally expressed in more mature articular cartilage cells , Collagen 3 ( Col3a1 ) and Collagen 10 ( Col10a1 ) ( Figure 5M and 5R ) ( unpublished data ) ( Eyre 2002 ) .
# ::alignments 78-79|0.0.0.4.0+0.0.0.4 77-78|0.0.0.0.3.0.0+0.0.0.0.3.0+0.0.0.0.3 74-75|0.0.0.1.0.0 73-74|0.0.0.1.0 69-70|0 67-68|0.0.0.0.2 62-63|0.0.1.0 60-61|0.0.0.0 56-57|0.0.1.1.0 55-56|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 53-54|0.0.0.2 52-53|0.0.0.2.1 51-52|0.0.0.2.1.0 50-51|0.0.0.2.0 49-50|0.0.0.2.2 47-48|0.0.0 46-47|0.0.0.1 45-46|0.0.0.3.1 44-45|0.0.0.3.1.0 43-44|0.0 40-41|0.0.1 39-40|0.0.1.1 38-39|0.0.0.3 34-35|0.0.0.0.1 32-33|0.0.0.3.0.0 30-31|0.0.0.3.0.1.1.0.1.1 28-30|0.0.0.3.0.1.1.0.1.2.1+0.0.0.3.0.1.1.0.1.2.0+0.0.0.3.0.1.1.0.1.2+0.0.0.3.0.1.1.0.1 27-28|0.0.0.3.0.1.1.0 26-27|0.0.0.3.0.1.1.0.2 24-25|0.0.0.3.0.1.1.0.1.0 20-21|0.0.0.3.0.1.0 18-19|0.0.0.3.0.1.1.0.1.0.0 16-17|0.0.0.3.0.2.0 15-16|0.0.0.3.0.2.0.0 12-13|0.0.0.3.0.2 11-12|0.0.0.3.0.2.1 9-10|0.0.0.3.0 7-8|0.0.0.3.0.1 4-5|0.0.0.3.0.1.1 1-2|0.0.0.3.0.1.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:00.282
(a / and 
      :op1-of (a4 / and 
            :ARG0-of (e / express-01 
                  :ARG1 (a2 / and 
                        :op1 (o / organization 
                              :name (n2 / name 
                                    :op1 "Collagen")) 
                        :op1-of (a6 / and) 
                        :op2 (f / figure) 
                        :op3 (p / person 
                              :name (n / name 
                                    :op1 "Eyre"))) 
                  :ARG1-of (n3 / normal-02 
                        :ARG0 (u / unpublish 
                              :mod-of (d2 / data))) 
                  :manner (c / cell 
                        :ARG1-of (m / mature-02) 
                        :mod (c2 / cartilage 
                              :mod (a3 / articular)) 
                        :mod (m2 / more)) 
                  :op2-of (a5 / and 
                        :op1 (r3 / reduce-01 
                              :ARG0 (f2 / figure) 
                              :ARG1 (e3 / express-01 
                                    :ARG1 (a8 / and) 
                                    :ARG2-of (a10 / age-01 
                                          :ARG1 (r / reduce-01 
                                                :ARG0 2 
                                                :ARG1 (o2 / organization 
                                                      :ARG0-of (a7 / accompany-01 
                                                            :ARG1 (f3 / figure)) 
                                                      :ARG0-of (s / stain-01) 
                                                      :name (n4 / name 
                                                            :op1 "Safranin" 
                                                            :op2 "O")) 
                                                :degree (m3 / markedly)))) 
                              :ARG2 (c3 / cell 
                                    :part-of (r2 / region 
                                          :mod (a9 / articular)) 
                                    :quant (m4 / most))) 
                        :quant (g / gene 
                              :quant 2)) 
                  :time (d / date-entity 
                        :year 2002)) 
            :ARG1-of (e2 / express-01 
                  :ARG0 10 
                  :ARG1-of (d3 / decrease-01 
                        :ARG0 3))))

# ::snt Inhibition of BMP signaling in cultured chondrocytes has previously been reported to induce Collagen 1 ( Col1a1 ) expression , increase proliferation , and result in cells with flattened , fibroblast-like morphology ( Enomoto-Iwamoto et al. 1998 ) .
# ::tok Inhibition of BMP signaling in cultured chondrocytes has previously been reported to induce Collagen 1 ( Col1a1 ) expression , increase proliferation , and result in cells with flattened , fibroblast-like morphology ( Enomoto-Iwamoto et al. 1998 ) .
# ::alignments 36-37|0.1.0+0.1 33-36|0.0.2.0.0.2+0.0.2.0.0.1+0.0.2.0.0.0+0.0.2.0.0+0.0.2.0 31-32|0.0.1.0.0.1 28-29|0.0.1.0.0 26-27|0.0.2.1 24-25|0.0.2 23-24|0.0 21-22|0.0.1.0 20-21|0.0.1 18-19|0 14-15|0.0.1.0.0.0 13-14|0.0.0.1.1.0.0+0.0.0.1.1.0+0.0.0.1.1 12-13|0.0.0.1 10-11|0.0.0 8-9|0.0.0.2 6-7|0.0.0.0.0.0 5-6|0.0.0.0.0.0.0 3-4|0.0.0.0.0 2-3|0.0.0.0.1.0+0.0.0.0.1+0.0.0.0 0-1|0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:01.523
(e / express-01 
      :ARG1 (a / and 
            :ARG1-of (r2 / report-01 
                  :ARG0 (o2 / organization 
                        :ARG1-of (s / signal-01 
                              :ARG2 (c2 / chondrocyt 
                                    :ARG1-of (c3 / culture-01))) 
                        :name (n3 / name 
                              :op1 "BMP")) 
                  :ARG2 (i2 / induce-01 
                        :ARG0 (i3 / inhibition) 
                        :ARG1 (o / organization 
                              :name (n2 / name 
                                    :op1 "Collagen"))) 
                  :time (p2 / previous)) 
            :op1 (i / increase-01 
                  :ARG1 (p / proliferate-01 
                        :ARG1 (f / flatten-01 
                              :ARG0 1 
                              :ARG1 (m / morphology)))) 
            :op2 (r / result-01 
                  :ARG1 (t / thing 
                        :name (n / name 
                              :op1 "Enomoto-Iwamoto" 
                              :op2 "et" 
                              :op3 "al.")) 
                  :ARG2 (c / cell))) 
      :time (d / date-entity 
            :year 1998))

# ::snt However , we saw no increase in the expression of Col1a1 in mutant articular cartilage , and no proliferation was detected in articular cells of either mutant or control animals ( unpublished data ) .
# ::tok However , we saw no increase in the expression of Col1a1 in mutant articular cartilage , and no proliferation was detected in articular cells of either mutant or control animals ( unpublished data ) .
# ::alignments 32-33|0.0.0.0.1.1.0.0 31-32|0.0.0.0.1.1.0.0.0 29-30|0.0.0.0.1.1 28-29|0.0.0.0.1.1.0.3 27-28|0.0.0.0.1.1.0 26-27|0.0.0.0.1.1.0.2 25-26|0.0.0.0.1.1.0.1 23-24|0.0.0.0.1 22-23|0.0.0.0.1.0 20-21|0.0.0.0 18-19|0.0.0.0.0 17-18|0.0.0.0.0.1 16-17|0 14-15|0.0.0.0.0.0 13-14|0.0.0.0.0.0.0 12-13|0.0.0.0.1.1.0.3.0 10-11|0.0.1.0.0 8-9|0.0.1.0 5-6|0.0.1 4-5|0.0.1.1 3-4|0.0 2-3|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:02.160
(a3 / and 
      :op1 (s / see-01 
            :ARG0 (w / we 
                  :ARG0-of (d2 / detect-01 
                        :ARG1 (p / proliferate-01 
                              :ARG1 (c3 / cartilage 
                                    :mod (a4 / articular)) 
                              :polarity -) 
                        :source (c2 / cell 
                              :mod (a2 / articular) 
                              :part-of (a / animal 
                                    :op3-of (o / or 
                                          :domain (d / data 
                                                :mod (u / unpublish)) 
                                          :mod (e / either) 
                                          :op1 (m / mutant) 
                                          :op2 (c / control-01 
                                                :ARG1 (m2 / mutant))))))) 
            :ARG1 (i / increase-01 
                  :ARG1 (e2 / express-01 
                        :ARG1 (c4 / Col1a1)) 
                  :polarity -)))

# ::snt While recombined LACZ marker expression was detected in most articular cartilage cells , it was also observed in scattered subarticular chondrocytes , growth plate chondrocytes , and osteoblasts ( Figure 5O and 5T ) ( unpublished data ) .
# ::tok While recombined LACZ marker expression was detected in most articular cartilage cells , it was also observed in scattered subarticular chondrocytes , growth plate chondrocytes , and osteoblasts ( Figure 5O and 5T ) ( unpublished data ) .
# ::alignments 36-37|0.0.2.0.0 35-36|0.0.2.0 31-32|0 29-30|0.0.2.3.0 27-28|0.0.2.3.1.2 26-27|0.0.2.3.1 24-25|0.0.2.3.1.1 23-24|0.0.2.3.1.1.0 22-23|0.0.0.0 20-21|0.0.2.3.1.0 19-20|0.0.2.3.1.0.1 18-19|0.0.2.3.1.0.0 16-17|0.0.2.3 15-16|0.0.2.3.2 11-12|0.0.2.2 10-11|0.0.2.2.0 9-10|0.0.2.2.1 8-9|0.0.2.2.2 6-7|0.0.2 4-5|0.0 3-4|0.0.1 2-3|0.0.1.0 1-2|0.0.0 0-1|0.0.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:03.240
(a / and 
      :ARG1-of (e / express-01 
            :ARG1-of (r / recombine-01 
                  :ARG1-of (g / grow-01)) 
            :ARG1-of (m2 / mark-01 
                  :ARG0 (l / LACZ)) 
            :ARG1-of (d2 / detect-01 
                  :ARG0 (u / unpublish 
                        :mod-of (d / data)) 
                  :ARG1-of (w / while-01) 
                  :location (c3 / cell 
                        :mod (c4 / cartilage) 
                        :mod (a4 / articular) 
                        :quant (m / most)) 
                  :purpose-of (o2 / observe-01 
                        :ARG0 (f / figure) 
                        :ARG1 (a2 / and 
                              :op1 (c2 / chondrocyt 
                                    :ARG1-of (s2 / scatter-01) 
                                    :mod (s / subarticular)) 
                              :op2 (c / chondrocyt 
                                    :mod (p / plate)) 
                              :op3 (o / osteoblast)) 
                        :mod (a3 / also)))))

# ::snt Although this implies that BMP signaling was defective in multiple cell types , the observed defects were confined to the articular cartilage .
# ::tok Although this implies that BMP signaling was defective in multiple cell types , the observed defects were confined to the articular cartilage .
# ::alignments 21-22|0.0.1.1 20-21|0.0.1.1.0 17-18|0.0.1 15-16|0.0.1.0 14-15|0.0.1.0.0 11-12|0.2 10-11|0.2.0 9-10|0.2.0.0 7-8|0 5-6|0.1 4-5|0.1.0.0.0+0.1.0.0+0.1.0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:03.539
(d2 / defective 
      :ARG1-of (i / imply-01 
            :ARG0 (t2 / this) 
            :purpose-of (c2 / confine-01 
                  :ARG1 (d / defect-01 
                        :ARG1-of (o / observe-01)) 
                  :ARG2 (c / cartilage 
                        :mod (a / articular)))) 
      :domain (s / signal-01 
            :ARG0 (o2 / organization 
                  :name (n / name 
                        :op1 "BMP"))) 
      :location (t / type 
            :mod (c3 / cell 
                  :quant (m / multiple))))

# ::snt For example , Osteocalcin and Col1a1 expression appeared normal in osteoblasts ( unpublished data ) .
# ::tok For example , Osteocalcin and Col1a1 expression appeared normal in osteoblasts ( unpublished data ) .
# ::alignments 13-14|0.0.3.0 12-13|0.0.3.0.0 10-11|0.1 8-9|0.0.0 7-8|0 6-7|0.0.3 4-5|0.0 3-4|0.0.2.0.0+0.0.2.0+0.0.2 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:03.591
(a / appear-01 
      :ARG1 (a2 / and 
            :ARG1-of (n / normal-02) 
            :beneficiary (e2 / example) 
            :op1 (p / person 
                  :name (n2 / name 
                        :op1 "Osteocalcin")) 
            :op2 (e / express-01 
                  :ARG1 (d / data 
                        :mod (u / unpublish)))) 
      :medium (o / osteoblast))

# ::snt Together , these data suggest that BMPR1A activity is required in postnatal joint articular cartilage to maintain expression of many genes encoding structural components of cartilage matrix .
# ::tok Together , these data suggest that BMPR1A activity is required in postnatal joint articular cartilage to maintain expression of many genes encoding structural components of cartilage matrix .
# ::alignments 26-27|0.1.0.1.0.0.0.0.1 25-26|0.1.0.1.0.0.0.0.1.0 23-24|0.1.0.1.0.0.0.0 22-23|0.1.0.1.0.0.0.0.0 21-22|0.1.0.1.0.0.0 20-21|0.1.0.1.0.0 19-20|0.1.0.1.0.0.0.0.1.1 17-18|0.1.0.1.0 16-17|0.1.0.1 14-15|0.1.1 13-14|0.1.1.0 12-13|0.1.1.0.0 11-12|0.1.1.1 9-10|0.1 7-8|0.1.0 6-7|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 4-5|0 3-4|0.0 2-3|0.0.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:04.431
(s2 / suggest-01 
      :ARG0 (d / data 
            :mod (t / this)) 
      :ARG1 (r / require-01 
            :ARG1 (a2 / activity-06 
                  :ARG0 (o / organization 
                        :name (n / name 
                              :op1 "BMPR1A")) 
                  :ARG0-of (m3 / maintain-01 
                        :ARG1 (e2 / express-01 
                              :ARG1 (g / gene 
                                    :ARG0-of (e / encode-01 
                                          :ARG1 (c2 / component 
                                                :mod (s / structure) 
                                                :mod (m / matrix 
                                                      :mod (c / cartilage) 
                                                      :mod (m2 / many)))))))) 
            :ARG2 (c3 / cartilage 
                  :mod (a / articular 
                        :mod (j / joint)) 
                  :mod (p / postnatal))) 
      :mod (t2 / together))

# ::snt Previous studies have shown that Sox9 is required for normal cartilage differentiation , for expression of cartilage extracellular matrix ( ECM ) genes including Agg , and is a direct transcriptional regulator of the key cartilage matrix gene Col2a1 ( Bell et al. 1997 ; Lefebvre et al. 1997 ; Bi et al. 1999 ; Sekiya et al. 2000 ) .
# ::tok Previous studies have shown that Sox9 is required for normal cartilage differentiation , for expression of cartilage extracellular matrix ( ECM ) genes including Agg , and is a direct transcriptional regulator of the key cartilage matrix gene Col2a1 ( Bell et al. 1997 ; Lefebvre et al. 1997 ; Bi et al. 1999 ; Sekiya et al. 2000 ) .
# ::alignments 58-59|0.1.2.0.0.0.0+0.1.2.0.0.0 53-54|0.1.2.1.0.1.0+0.1.2.1.0.1 50-52|0.1.2.1.0.0.0.1+0.1.2.1.0.0.0.0+0.1.2.1.0.0.0+0.1.2.1.0.0 48-49|0.1.3.3.0+0.1.3.3 45-47|0.1.2.0.3.0.1+0.1.2.0.3.0.0+0.1.2.0.3.0+0.1.2.0.3 44-45|0.1.2.0 43-44|0.1.3.2.0+0.1.3.2 40-43|0.1.3.0.0.2+0.1.3.0.0.1+0.1.3.0.0.0+0.1.3.0.0+0.1.3.0 38-39|0.1.2.0.0.1 37-38|0.1.2.0.0.1.0 36-37|0.1.2.0.2 35-36|0.1.2.0.1 34-35|0.1.2.0.0 31-32|0.1.2.1 29-30|0.1.2.1.0 26-27|0.1.2 22-23|0.1.3.1 20-21|0.0.0.0.0+0.0.0.0+0.0.0 18-19|0.1.3.1.0 17-18|0.1.3.1.0.0 16-17|0.1.0.0.0 14-15|0.1.3 11-12|0.1.0 10-11|0.1.0.1 9-10|0.1.0.0 7-8|0.1 5-6|0.1.1.0.0+0.1.1.0+0.1.1 3-4|0 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:08.933
(s / show-01 
      :ARG0 (s2 / study-01 
            :ARG0 (o / organization 
                  :name (n4 / name 
                        :op1 "ECM")) 
            :ARG1 (p / previou)) 
      :ARG1 (r2 / require-01 
            :ARG0 (d6 / differentiation 
                  :ARG1-of (n5 / normal-02 
                        :ARG2 (c3 / cartilage)) 
                  :mod (c4 / cartilage)) 
            :ARG1 (t4 / thing 
                  :name (n6 / name 
                        :op1 "Sox9")) 
            :op1-of (a2 / and 
                  :op1-of (a / and 
                        :op2 (k / key-02 
                              :ARG0 (d / date-entity 
                                    :year 2000) 
                              :ARG1 (c / Col2a1 
                                    :mod (g / gene))) 
                        :op3 (c2 / cartilage) 
                        :op4 (m / matrix) 
                        :op5 (t2 / thing 
                              :name (n2 / name 
                                    :op1 (l / Lefebvre) 
                                    :op2 (e2 / et)))) 
                  :op2 (r / regulator 
                        :ARG1-of (d5 / direct-02 
                              :ARG0 (t / thing 
                                    :name (n / name 
                                          :op1 (b / Bi) 
                                          :op2 (e / et))) 
                              :ARG2 (d2 / date-entity 
                                    :year 1999)))) 
            :purpose (e4 / express-01 
                  :ARG0 (t3 / thing 
                        :name (n3 / name 
                              :op1 "Bell" 
                              :op2 "et" 
                              :op3 "al.")) 
                  :ARG1 (g2 / gene 
                        :mod (m2 / matrix 
                              :mod (e3 / extracellular))) 
                  :time (d4 / date-entity 
                        :year 1997) 
                  :time (d3 / date-entity 
                        :year 1997))))

# ::snt Notably , despite reduced expression of many cartilage matrix marker genes in Bmpr1a mutant mice , the SOX9 protein was present at normal levels in articular regions at all stages examined , including newborn , 2-wk-old , 7-wk-old , and 9-mo-old mice ( Figure 5N and 5S ) ( unpublished data ) .
# ::tok Notably , despite reduced expression of many cartilage matrix marker genes in Bmpr1a mutant mice , the SOX9 protein was present at normal levels in articular regions at all stages examined , including newborn , 2-wk-old , 7-wk-old , and 9-mo-old mice ( Figure 5N and 5S ) ( unpublished data ) .
# ::alignments 50-51|0.3.0.2.0.0.1.0 49-50|0.3.0.2.0.0.1 46-47|0.3.0.2.0.0.2 45-46|0.3 43-44|0.3.0.2.0.0.0 41-42|0.2 39-40|0 33-34|0.0.0.0 30-31|0.3.0 29-30|0.3.0.0 28-29|0.3.0.0.0 26-27|0.3.0.2 25-26|0.3.0.2.1 23-24|0.3.0.2.0 22-23|0.3.0.2.0.0 20-21|0.3.0.2.2.0 18-19|0.3.0.2.2 17-18|0.3.0.2.2.1.0.0+0.3.0.2.2.1.0+0.3.0.2.2.1 14-15|0.0.0.1.0.2.0 13-14|0.0.0.1.0.2 12-13|0.1.0.0+0.1.0+0.1 10-11|0.0.0.1 9-10|0.0.0.1.0 8-9|0.0.0.1.0.1 7-8|0.0.0.1.0.1.0 6-7|0.3.0.1 4-5|0.0.0 3-4|0.0 0-1|0.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:09.928
(a2 / and 
      :op1 (r2 / reduce-01 
            :ARG1 (e2 / express-01 
                  :ARG0 (n / newborn) 
                  :ARG1 (g / gene 
                        :mod (m4 / mark-01 
                              :ARG0 (n5 / notably) 
                              :ARG1 (m5 / matrix 
                                    :mod (c2 / cartilage)) 
                              :ARG2 (m3 / mutant 
                                    :mod-of (m2 / mouse)))))) 
      :op2 (t / thing 
            :name (n4 / name 
                  :op1 "Bmpr1a")) 
      :op3 (m / mouse) 
      :op4 (a / and 
            :op1 (e / examine-01 
                  :ARG1 (s / stage 
                        :mod (a3 / all)) 
                  :ARG2 (m6 / many) 
                  :manner (r / region 
                        :location-of (l / level 
                              :ARG1-of (n2 / normal-02 
                                    :ARG2 (f / figure) 
                                    :op1-of (u / unpublish 
                                          :mod-of (d / data)) 
                                    :op1-of 5)) 
                        :mod (a4 / articular) 
                        :mod-of (p2 / protein 
                              :domain-of (p / present) 
                              :mod (c / country 
                                    :name (n3 / name 
                                          :op1 "SOX9")))))))

# ::snt Synovial Hypertrophy , Cartilage Erosion , and Accelerated Cartilage Maturation .
# ::tok Synovial Hypertrophy , Cartilage Erosion , and Accelerated Cartilage Maturation .
# ::alignments 8-10|0.2.1.1+0.2.1.0+0.2.1+0.2 7-8|0.2.0 6-7|0 3-5|0.1.0.1+0.1.0.0+0.1.0+0.1 0-2|0.0.0.1+0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:09.968
(a2 / and 
      :op1 (p2 / person 
            :name (n3 / name 
                  :op1 "Synovial" 
                  :op2 "Hypertrophy")) 
      :op2 (p / person 
            :name (n2 / name 
                  :op1 "Cartilage" 
                  :op2 "Erosion")) 
      :op3 (t / thing 
            :ARG1-of (a / accelerate-01) 
            :name (n / name 
                  :op1 "Cartilage" 
                  :op2 "Maturation")))

# ::snt Conditional loss of Bmpr1a led to marked hypertrophy of the synovial membrane in the joint capsule of some joints , particularly in the ankle region .
# ::tok Conditional loss of Bmpr1a led to marked hypertrophy of the synovial membrane in the joint capsule of some joints , particularly in the ankle region .
# ::alignments 24-25|0.0.0.0.0.0.2 23-24|0.0.0.0.0.0.2.0 20-21|0.0.0.0.0.1 18-19|0.0.0.0.0.0.1.1 17-18|0.0.0.0.0.0.1.1.0 15-16|0.0.0.0.0.0.1 14-15|0.0.0.0.0.0.1.0 11-12|0.0 10-11|0 7-8|0.0.0 6-7|0.0.0.0 4-5|0.0.0.0.0.0 3-4|0.0.0.0.0.2.0+0.0.0.0.0.2+0.0.0.0.0 1-2|0.0.0.0.0.0.0 0-1|0.0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:10.515
(s2 / synovial 
      :mod-of (m / membrane 
            :poss-of (h / hypertrophy 
                  :ARG1-of (m2 / mark-01 
                        :ARG0 (p2 / person 
                              :ARG0-of (l / lead-02 
                                    :ARG1 (l2 / loss 
                                          :mod (c2 / conditional)) 
                                    :ARG2 (c / capsule 
                                          :mod (j2 / joint) 
                                          :poss (j / joint 
                                                :quant (s / some))) 
                                    :location (r / region 
                                          :mod (a / ankle))) 
                              :mod (p / particular) 
                              :name (n / name 
                                    :op1 "Bmpr1a"))))))

# ::snt In the most severely affected joints , the expanded synovial membrane grew into the joint space and was associated with obvious loss or erosion of the articular cartilage ( Figure 6A and 6B , asterisks , arrows ) .
# ::tok In the most severely affected joints , the expanded synovial membrane grew into the joint space and was associated with obvious loss or erosion of the articular cartilage ( Figure 6A and 6B , asterisks , arrows ) .
# ::alignments 36-37|0.0.1.0 34-35|0.0.0.0 31-32|0 29-30|0.0.0.1.0.0 27-28|0.0.1.1.1.1 26-27|0.0.1.1.1.1.0 23-24|0.0.1.1.1.0 22-23|0.0.1.1.1 21-22|0.0.1.1 20-21|0.0.1.1.0 18-19|0.0.1 16-17|0.0 15-16|0.0.0.2 14-15|0.0.0.2.0 11-12|0.0.0 10-11|0.0.0.1 9-10|0.0.0.1.1 8-9|0.0.0.1.0 5-6|0.0.0.3 4-5|0.0.0.3.0 3-4|0.0.0.3.0.0 2-3|0.0.0.3.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:10.892
(a3 / and 
      :op1 (a6 / and 
            :op1 (g / grow-01 
                  :ARG0 (a2 / asterisk) 
                  :ARG1 (m / membrane 
                        :ARG1-of (e2 / expand-01 
                              :ARG0 (f / figure)) 
                        :mod (s2 / synovial)) 
                  :ARG2 (s / space 
                        :mod (j / joint)) 
                  :time (j2 / joint 
                        :ARG1-of (a7 / affect-01 
                              :manner (s3 / severe 
                                    :degree (m2 / most))))) 
            :op2 (a5 / associate-01 
                  :ARG1 (a / arrow) 
                  :ARG2 (l / loss 
                        :ARG1-of (o2 / obvious-01) 
                        :op1-of (o / or 
                              :op2 (e / erosion) 
                              :poss (c / cartilage 
                                    :mod (a4 / articular)))))))

# ::snt Accelerated cartilage maturation and increased expression of Col10a1 was frequently seen in the chondrocytes underlying the articular erosions ( Figure 6C and 6D , brackets ) ( unpublished data ) .
# ::tok Accelerated cartilage maturation and increased expression of Col10a1 was frequently seen in the chondrocytes underlying the articular erosions ( Figure 6C and 6D , brackets ) ( unpublished data ) .
# ::alignments 28-29|0.0.0.0 27-28|0.0.0 24-25|0.0.1.2.1.0.0 21-22|0 19-20|0.0.1.0 17-18|0.0.1.2.0.0.0.0 16-17|0.0.1.2.0.0.0.0.0 14-15|0.0.1.2.0.0.0 13-14|0.0.1.2.0.0 10-11|0.0.1.2.0 9-10|0.0.1.2.0.1 7-8|0.0.1.1 5-6|0.0.1 4-5|0.0 3-4|0.0.1.2 2-3|0.0.1.2.1 1-2|0.0.1.2.1.1 0-1|0.0.1.2.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:11.646
(a / and 
      :op1 (i / increase-01 
            :ARG0 (u / unpublish 
                  :mod-of (d / data)) 
            :ARG1 (e2 / express-01 
                  :ARG0 (f / figure) 
                  :ARG1 (c2 / Col10a1) 
                  :op2-of (a3 / and 
                        :ARG1-of (s / see-01 
                              :ARG0 (c / chondrocyt 
                                    :ARG0-of (u2 / underlie-01 
                                          :ARG1 (e / erosion 
                                                :mod (a2 / articular)))) 
                              :ARG1-of (f2 / frequent-02)) 
                        :op1 (m / maturation 
                              :ARG1-of (a4 / accelerate-01 
                                    :ARG1-of (b / bracket-01)) 
                              :mod (c3 / cartilage))))))

# ::snt Interestingly , the regions of increased Col10a1 expression did not correspond to the regions that had undergone Cre-mediated recombination .
# ::tok Interestingly , the regions of increased Col10a1 expression did not correspond to the regions that had undergone Cre-mediated recombination .
# ::alignments 18-19|0.2.0.0 17-18|0.2.0.0.0 16-17|0.2.0 13-14|0.2 10-11|0 9-10|0.4 7-8|0.1 5-6|0.1.0 3-4|0.0 0-1|0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:11.759
(c2 / correspond-02 
      :ARG0 (r3 / region) 
      :ARG1 (e / express-01 
            :ARG1-of (i / increase-01)) 
      :ARG2 (r2 / region 
            :ARG1-of (u / undergo-28 
                  :ARG2 (r / recombination 
                        :mod (c / cre-mediat)))) 
      :manner (i2 / interesting) 
      :polarity -)

# ::snt Instead , increased expression of Col10a1 was seen in a zone of largely LACZ-negative cells stretching from the cartilage adjacent to the ossification front ( where Col10a1 is normally expressed in maturing cartilage cells ) , toward the regions where surface articular cartilage was severely eroded or missing ( Figure 6A and 6B , arrowheads ) .
# ::tok Instead , increased expression of Col10a1 was seen in a zone of largely LACZ-negative cells stretching from the cartilage adjacent to the ossification front ( where Col10a1 is normally expressed in maturing cartilage cells ) , toward the regions where surface articular cartilage was severely eroded or missing ( Figure 6A and 6B , arrowheads ) .
# ::alignments 54-55|0.1.0.1.3.0 51-52|0.1.0.1.1 49-50|0.1.0.1.2.0 47-48|0.1.0 46-47|0.1 45-46|0 44-45|0.0 42-43|0.1.0.0 41-42|0.1.0.0.1 40-41|0.1.0.0.0 38-39|0.1.0.1.1.0.0.1.0.0.0.2 33-34|0.1.0.1.3.1 32-33|0.1.0.1.3.1.0 31-32|0.1.0.1.3 29-30|0.1.0.1 28-29|0.1.0.1.2 23-24|0.1.0.1.1.0.0.1.0.0.0.0.0 22-23|0.1.0.1.1.0.0.1.1.0 19-20|0.1.0.1.1.0.0.1.0.0.0.0 18-19|0.1.0.1.1.0.0.1.0.0.0.1 15-16|0.1.0.1.1.0.0.1.0.0.0 14-15|0.1.0.1.1.0.0.1.0.0 12-13|0.1.0.1.0 10-11|0.1.0.1.1.0.0.1.0 7-8|0.1.0.1.1.0.0.1 5-6|0.1.0.1.1.0.0.0 3-4|0.1.0.1.1.0.0 2-3|0.1.0.1.1.0 0-1|0.1.0.1.1.0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:13.373
(e / erode-01 
      :manner (s / severe) 
      :op1-of (o / or 
            :op2 (m / miss-01 
                  :ARG0 (c / cartilage 
                        :mod (s2 / surface) 
                        :mod (a3 / articular)) 
                  :ARG1 (e2 / express-01 
                        :ARG0 (l / large) 
                        :ARG1 (a2 / and 
                              :op1 (i / increase-01 
                                    :ARG1 (e3 / express-01 
                                          :ARG1 (c6 / Col10a1) 
                                          :ARG1-of (s4 / see-01 
                                                :ARG0 (z / zone 
                                                      :domain (c5 / cell 
                                                            :ARG1-of (s3 / stretch-01 
                                                                  :ARG0 (a4 / adjacent 
                                                                        :op1 (f2 / front)) 
                                                                  :ARG2 (c4 / cartilage) 
                                                                  :beneficiary (r / region)))) 
                                                :ARG1-of (i2 / instead-of-91 
                                                      :ARG0 (o2 / ossification)))))) 
                        :ARG1-of (n / normal-02 
                              :ARG0 (f / figure)) 
                        :ARG2 (m2 / mature-01 
                              :ARG0 (a / arrowhead) 
                              :ARG1 (c2 / cell 
                                    :mod (c3 / cartilage)))))))

# ::snt Previous studies suggest that parathyroid hormone-related protein , a diffusible signal made in the articular surface , may normally inhibit maturation of underlying cartilage ( Vortkamp et al. 1996 ; Weir et al. 1996 ) .
# ::tok Previous studies suggest that parathyroid hormone-related protein , a diffusible signal made in the articular surface , may normally inhibit maturation of underlying cartilage ( Vortkamp et al. 1996 ; Weir et al. 1996 ) .
# ::alignments 33-34|0.1.0.3.0.0+0.1.0.3.0 30-31|0.1.1.1 29-30|0.1.1 28-29|0.1.1.0.0+0.1.1.0 25-28|0.0.0.0.2+0.0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 23-24|0.1.0.3.1 22-23|0.1.0.3 20-21|0.1.0.1 19-20|0.1.0 18-19|0.1.0.2 17-18|0.1 15-16|0.0.1.1.0 14-15|0.0.1.1 10-11|0.0.1.0 6-7|0.1.0.0 5-6|0.1.0.0.0 4-5|0.1.0.0.1 2-3|0 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:14.508
(s3 / suggest-01 
      :ARG0 (s4 / study-01 
            :ARG1 (t / thing 
                  :name (n / name 
                        :op1 "Vortkamp" 
                        :op2 "et" 
                        :op3 "al.")) 
            :mod (p4 / previou 
                  :mod-of (s2 / signal) 
                  :mod-of (a2 / articular 
                        :mod-of (s / surface)))) 
      :ARG1 (p / possible-01 
            :ARG1 (i / inhibit-01 
                  :ARG0 (p2 / protein 
                        :mod (h / hormone-relat) 
                        :mod (p3 / parathyroid)) 
                  :ARG1 (m / maturation) 
                  :ARG1-of (n2 / normal-02) 
                  :ARG2 (u / underlie-01 
                        :ARG0 (d / date-entity 
                              :year 1996) 
                        :ARG1 (c / cartilage))) 
            :op1-of (a / and 
                  :op2 (d2 / date-entity 
                        :year 1996) 
                  :op3 (w / weir))))

# ::snt Local loss of the articular surface could remove this inhibition and lead to a cell-nonautonomous acceleration of maturation in chondrocytes underlying points of articular erosion .
# ::tok Local loss of the articular surface could remove this inhibition and lead to a cell-nonautonomous acceleration of maturation in chondrocytes underlying points of articular erosion .
# ::alignments 24-25|0.0.1.1.1.0.0.1 23-24|0.0.1.1.1.0.0.1.0 21-22|0.0.1.1.1.0.0 20-21|0.0.1.1.1.0 19-20|0.0.1.1.1.0.0.0 17-18|0.0.1.1.1 15-16|0.0.1.1 14-15|0.0.1.1.0 11-12|0.0.1 10-11|0.0 9-10|0.0.0.1 8-9|0.0.0.1.0 7-8|0.0.0 6-7|0 5-6|0.0.1.0.0 4-5|0.0.1.0 1-2|0.0.0.0 0-1|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:14.987
(p2 / possible-01 
      :ARG1 (a3 / and 
            :op1 (r / remove-01 
                  :ARG0 (l2 / loss 
                        :ARG1-of (l3 / local-02)) 
                  :ARG1 (i / inhibition 
                        :mod (t / this))) 
            :op2 (l / lead-03 
                  :ARG1 (a4 / articular 
                        :mod-of (s / surface)) 
                  :ARG2 (a2 / acceleration-quantity 
                        :mod (c2 / cell-nonautonomou) 
                        :mod (m / maturation 
                              :ARG0-of (u / underlie-01 
                                    :ARG1 (p / point 
                                          :mod (c / chondrocyt) 
                                          :poss (e / erosion 
                                                :mod (a / articular)))))))))

# ::snt This synovial hypertrophy is associated with increased numbers of mononuclear cells resembling synoviocytes or macrophages , cell types that are difficult to distinguish even with surface markers at early postnatal stages .
# ::tok This synovial hypertrophy is associated with increased numbers of mononuclear cells resembling synoviocytes or macrophages , cell types that are difficult to distinguish even with surface markers at early postnatal stages .
# ::alignments 30-31|0.0.2 29-30|0.0.2.0 28-29|0.0.2.1 26-27|0.0.1 25-26|0.0.1.0 23-24|0.0.3 22-23|0.0 20-21|0 17-18|0.0.0 16-17|0.0.0.0 14-15|0.1.1 13-14|0.1 12-13|0.1.0 11-12|0.1.0.0 10-11|0.1.0.0.0 9-10|0.1.0.0.0.0 7-8|0.1.0.0.0.1 6-7|0.1.0.0.0.1.0 4-5|0.1.0.0.0.1.0.0.0 2-3|0.1.0.0.0.1.0.0 1-2|0.1.0.0.0.1.0.0.2 0-1|0.1.0.0.0.1.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:15.717
(d2 / difficult 
      :domain (d / distinguish-01 
            :ARG0 (t / type 
                  :mod (c / cell)) 
            :ARG1 (m / marker 
                  :mod (s2 / surface)) 
            :ARG2 (s / stage 
                  :mod (p / postnatal) 
                  :time (e / early)) 
            :mod (e2 / even)) 
      :op3-of (o / or 
            :op1 (s3 / synoviocyt 
                  :ARG2-of (r / resemble-01 
                        :ARG1 (c2 / cell 
                              :mod (m3 / mononuclear) 
                              :poss-of (n / number 
                                    :ARG1-of (i / increase-01 
                                          :ARG0 (h / hypertrophy 
                                                :ARG1-of (a / associate-01) 
                                                :mod (t2 / this) 
                                                :mod (s4 / synovial))))))) 
            :op2 (m2 / macrophag)))

# ::snt However , no neutrophils were observed , suggesting that there is little inflammation .
# ::tok However , no neutrophils were observed , suggesting that there is little inflammation .
# ::alignments 12-13|0.0.0 11-12|0.0.0.0 7-8|0.0 5-6|0 3-4|0.1 2-3|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:15.774
(o / observe-01 
      :ARG0-of (s / suggest-01 
            :ARG1 (i / inflammation 
                  :mod (l / little))) 
      :ARG1 (n / neutrophil 
            :polarity -))

# ::snt At later stages synovial hypertrophy is reduced .
# ::tok At later stages synovial hypertrophy is reduced .
# ::alignments 6-7|0 4-5|0.0 3-4|0.0.0 2-3|0.1 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:15.794
(r / reduce-01 
      :ARG1 (h / hypertrophy 
            :mod (s / synovial)) 
      :time (s2 / stage 
            :time (l / late)))

# ::snt Further work will be needed to determine whether synovial development is regulated by BMP signaling , or whether the synovium becomes enlarged as a response to nearby skeletal malformations ( such as fusion of the second and central tarsals or defects in the articular cartilage ) .
# ::tok Further work will be needed to determine whether synovial development is regulated by BMP signaling , or whether the synovium becomes enlarged as a response to nearby skeletal malformations ( such as fusion of the second and central tarsals or defects in the articular cartilage ) .
# ::alignments 44-45|0.1.2.0.1.1.1.0.0.0 43-44|0.1.2.0.1.1.1.0.0.0.0 40-41|0.1.2.0.1.1.1.0.0 39-40|0.1.2.0.1.1.1.0 38-39|0.1.2.0.1.1.1 37-38|0.1.2.0.1.1.0 36-37|0.1.2.0.1.1 32-33|0.1.2.0.1.1.1.0.1 30-31|0.1.2.0.0.1 28-29|0.0 27-28|0.0.0 26-27|0.1.2.0.2.0.0.0 24-25|0 21-22|0.1.1 20-21|0.1 19-20|0.1.0 16-17|0.1.2 14-15|0.1.2.0.0 13-14|0.1.2.0.0.0.0.0+0.1.2.0.0.0.0+0.1.2.0.0.0 11-12|0.1.2.0 9-10|0.1.2.0.1 8-9|0.1.2.0.1.0 6-7|0.1.2.0.2 4-5|0.1.2.0.2.0 1-2|0.1.2.0.2.0.0 0-1|0.1.2.0.2.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:16.792
(r / respond-01 
      :ARG1 (m / malformation 
            :mod (s2 / skeletal)) 
      :ARG2 (b / become-01 
            :ARG1 (s3 / synovium) 
            :ARG2 (e / enlarge-01) 
            :op2-of (o2 / or 
                  :op1 (r2 / regulate-01 
                        :ARG0 (s4 / signal-01 
                              :ARG0 (o3 / organization 
                                    :name (n2 / name 
                                          :op1 "BMP")) 
                              :ARG1 (s / such)) 
                        :ARG1 (d2 / develop-02 
                              :ARG1 (s5 / synovial) 
                              :op1-of (a2 / and 
                                    :op2 (c2 / central) 
                                    :op3 (t / tarsal 
                                          :op1-of (o / or 
                                                :op2 (d / defect-01 
                                                      :ARG1 (c / cartilage 
                                                            :mod (a / articular))) 
                                                :poss-of (f / fusion))))) 
                        :ARG1-of (d3 / determine-01 
                              :purpose-of (n3 / need-01 
                                    :ARG1 (w / work-01 
                                          :ARG1 (n / nearby) 
                                          :mod (f2 / further))))))))

# ::snt Noninflammatory Degeneration of Articular Cartilage in Digit and Knee Joints .
# ::tok Noninflammatory Degeneration of Articular Cartilage in Digit and Knee Joints .
# ::alignments 8-10|0.1.1.1.0.1+0.1.1.1.0.0+0.1.1.1.0+0.1.1.1 7-8|0.1.1 6-7|0.1.1.0 3-5|0.1.0.1+0.1.0.0+0.1.0+0.1 0-2|0.0.1+0.0.0+0.0+0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:16.851
(p2 / person 
      :name (n3 / name 
            :op1 "Noninflammatory" 
            :op2 "Degeneration") 
      :poss (t / thing 
            :name (n2 / name 
                  :op1 (a2 / Articular) 
                  :op2 (c / Cartilage)) 
            :op1-of (a / and 
                  :op2 (d / digit) 
                  :op3 (p / person 
                        :name (n / name 
                              :op1 "Knee" 
                              :op2 "Joints")))))

# ::snt Outside of the ankle region , little or no evidence was seen for expansion of the synovial membrane .
# ::tok Outside of the ankle region , little or no evidence was seen for expansion of the synovial membrane .
# ::alignments 17-18|0.0 16-17|0.0.1 13-14|0.0.0 11-12|0 9-10|0.1 8-9|0.1.2 7-8|0.1.1 6-7|0.1.1.0 4-5|0.1.0.0 3-4|0.1.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:17.033
(s2 / see-01 
      :ARG0 (m / membrane 
            :ARG1-of (e / expand-01) 
            :mod (s / synovial)) 
      :ARG1 (e2 / evidence-01 
            :ARG1 (a / ankle 
                  :mod-of (r / region)) 
            :op2-of (o / or 
                  :op1 (l / little)) 
            :polarity -) 
      :location (o2 / outside))

# ::snt Instead , mutant mice showed histological signs of osteoarthritis , such as fibrillation of the articular surface ( Figure 7 ) .
# ::tok Instead , mutant mice showed histological signs of osteoarthritis , such as fibrillation of the articular surface ( Figure 7 ) .
# ::alignments 19-20|0.3 18-19|0.2.0 16-17|0.2.1 15-16|0.2.1.0 12-13|0.2.1.1 10-11|0.2.1.0.0 8-9|0.1.0 6-7|0.1 5-6|0.3.0 4-5|0 3-4|0.0 2-3|0.0.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:17.220
(s4 / show-01 
      :ARG0 (m / mouse 
            :mod (m2 / mutant)) 
      :ARG1 (s3 / sign 
            :topic (o / osteoarthriti)) 
      :ARG1-of (i / instead-of-91 
            :ARG2 (f / figure) 
            :op1-of (s / surface 
                  :mod (a / articular 
                        :domain-of (s2 / such)) 
                  :poss-of (f2 / fibrillation))) 
      :ARG2 (7 / 7 
            :mod-of (h / histological)))

# ::snt As previously seen in 1 - and 2-wk-old animals , Safranin O staining and Agg and Col10 expression were all reduced in mutant articular regions of the forefeet and hindfeet by 7 wk of age , and the beginning signs of cartilage loss were observed ( unpublished data ) .
# ::tok As previously seen in 1 - and 2-wk-old animals , Safranin O staining and Agg and Col10 expression were all reduced in mutant articular regions of the forefeet and hindfeet by 7 wk of age , and the beginning signs of cartilage loss were observed ( unpublished data ) .
# ::alignments 47-48|0.1.1.0.2.1.1 46-47|0.1.1.0.2.1.1.0 44-45|0.1.1.0.2.1 42-43|0.1.1.0.2.1.0.1 41-42|0.1.1.0.2.1.0.1.0 39-40|0.1.1.0.2.1.0 38-39|0.1.1.0.2.1.0.0 36-37|0.1.1.0.2 34-35|0.1.1.0.2.1.0.0.0 31-32|0.1.0 29-30|0.1.1.0.2.0 28-29|0.1.1.0.2.0.0 27-28|0.1.1.0.2.0.0.0 24-25|0.1.1.0.1 23-24|0.1.1.0.1.0 22-23|0.1.1.0.2.1.0.0.0.0 20-21|0.1.1.0 19-20|0.0.0 17-18|0.1 15-16|0.1.1 14-15|0.1.1.1.1.0 13-14|0.1.1.1.1 12-13|0.1.1.1 10-12|0.1.1.1.0.0.1+0.1.1.1.0.0.0+0.1.1.1.0.0+0.1.1.1.0 8-9|0.1.1.0.0 6-7|0 4-5|0.0.2 2-3|0.0 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:18.752
(a10 / and 
      :ARG1-of (s3 / see-01 
            :ARG0 (a5 / all) 
            :time (p / previous) 
            :time 1) 
      :op1 (e / express-01 
            :ARG1 7 
            :op2-of (a6 / and 
                  :ARG1-of (r2 / reduce-01 
                        :ARG2 (a9 / animal) 
                        :location (r / region 
                              :mod (a4 / articular)) 
                        :op1-of (a / and 
                              :mod (h / hindfeet 
                                    :op2-of (a3 / and 
                                          :op1 (f / forefoot))) 
                              :op2 (o / observe-01 
                                    :ARG1 (s / sign 
                                          :ARG1-of (b / begin-01 
                                                :manner-of (a2 / age-01 
                                                      :ARG0 (m / mutant))) 
                                          :topic (l / loss 
                                                :mod (c / cartilage))) 
                                    :ARG2 (d / data 
                                          :mod (u / unpublish))))) 
                  :op1 (s2 / stain-01 
                        :ARG0 (o2 / organization 
                              :name (n / name 
                                    :op1 "Safranin" 
                                    :op2 "O")) 
                        :op1-of (a8 / and 
                              :op2 (a7 / Agg))))))

# ::snt By 9 mo of age , many regions of articular cartilage were completely missing or extremely fibrillated , leaving regions of exposed bone on the surface ( Figure 7A -- 7D ) .
# ::tok By 9 mo of age , many regions of articular cartilage were completely missing or extremely fibrillated , leaving regions of exposed bone on the surface ( Figure 7A -- 7D ) .
# ::alignments 28-29|0.1.4.0.0 27-28|0.1.4.0 25-26|0.1.3.1.0 22-23|0.1.3.2.1 21-22|0.1.3.2 19-20|0.1.3.1 18-19|0.1.3 16-17|0.2 15-16|0.2.0 14-15|0 13-14|0.1 12-13|0.1.2 10-11|0.1.1 9-10|0.1.1.0 7-8|0.1.3.0 6-7|0.0 4-5|0.1.4 2-3|0.1.0 1-2|0.1.3.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:19.193
(o / or 
      :op1 (m2 / many) 
      :op2 (m / miss-01 
            :ARG0 (m3 / mo) 
            :ARG1 (c2 / cartilage 
                  :mod (a / articular)) 
            :ARG1-of (c / complete-02) 
            :ARG2 (l / leave-11 
                  :ARG0 (r2 / region) 
                  :ARG1 (r / region 
                        :location (s / surface)) 
                  :ARG2 (e / expose-01 
                        :ARG0 9 
                        :ARG1 (b / bone))) 
            :time (a2 / age-01 
                  :ARG1 (f / figure 
                        :mod 7A))) 
      :op3 (f2 / fibrillate 
            :degree (e2 / extreme)))

# ::snt No alterations were seen in the expression of Osteocalcin , Col1a1 , or matrix metalloprotease-13 at either 7 wk or 9 mo. .
# ::tok No alterations were seen in the expression of Osteocalcin , Col1a1 , or matrix metalloprotease-13 at either 7 wk or 9 mo. .
# ::alignments 20-21|0.3.0 19-20|0.2 17-18|0.0 16-17|0.2.0 13-14|0.3.1.2 12-13|0.3.1 10-11|0.3.1.1 8-9|0.3.1.0.0.0+0.3.1.0.0+0.3.1.0 6-7|0.3 3-4|0 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:19.469
(s / see-01 
      :ARG0 7 
      :ARG1 (a / alteration 
            :polarity -) 
      :op1-of (o / or 
            :mod (e / either)) 
      :time (e2 / express-01 
            :ARG0 9 
            :ARG1 (o2 / or 
                  :op1 (p / person 
                        :name (n / name 
                              :op1 "Osteocalcin")) 
                  :op2 (c / Col1a1) 
                  :op3 (m / matrix))))

# ::snt The major weight-bearing joint of the hindlimb , the knee , showed changes that closely paralleled that seen in the foot joints .
# ::tok The major weight-bearing joint of the hindlimb , the knee , showed changes that closely paralleled that seen in the foot joints .
# ::alignments 21-22|0.1.0.0.0 20-21|0.1.0.0.0.0 17-18|0.1.0.0 15-16|0.1.0 14-15|0.1.0.2 12-13|0.1 11-12|0 9-10|0.1.0.1 6-7|0.0.2 3-4|0.0 2-3|0.0.1 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:19.615
(s2 / show-01 
      :ARG0 (j2 / joint 
            :ARG1-of (m / major-02) 
            :mod (w / weight-bear) 
            :poss (h / hindlimb)) 
      :ARG1 (c2 / change-01 
            :ARG0-of (p / parallel-01 
                  :ARG1 (s / see-01 
                        :ARG1 (j / joint 
                              :mod (f / foot))) 
                  :ARG1-of (k / knee-01) 
                  :manner (c / close))))

# ::snt All markers of cartilage matrix looked similar to controls at E16 .5 , suggesting that early stages of joint formation were not disrupted ( unpublished data ) .
# ::tok All markers of cartilage matrix looked similar to controls at E16 .5 , suggesting that early stages of joint formation were not disrupted ( unpublished data ) .
# ::alignments 25-26|0.0.0.1 24-25|0.0.0.1.0 22-23|0.0.0 21-22|0.0.0.0.0.0.0 19-20|0 18-19|0.1 16-17|0.0 15-16|0.0.1 13-14|0.0.0.0 8-9|0.0.0.0.0.0 6-7|0.0.0.0.0 5-6|0.0.0.0.0.1 4-5|0.0.0.0.0.1.0 3-4|0.0.0.0.0.1.0.0 1-2|0.0.0.0.0.1.1 0-1|0.0.0.0.0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:20.121
(f / form-01 
      :ARG1 (s / stage 
            :ARG1-of (d2 / disrupt-01 
                  :ARG1-of (s2 / suggest-01 
                        :ARG1-of (r / resemble-01 
                              :ARG2 (c / control-01 
                                    :ARG1 -) 
                              :ARG2-of (l / look-01 
                                    :ARG0 (m / matrix 
                                          :mod (c2 / cartilage)) 
                                    :ARG1 (m2 / marker 
                                          :quant (a / all))))) 
                  :ARG2 (d / data 
                        :mod (u / unpublish))) 
            :time (e / early)) 
      :manner (j / joint))

# ::snt By postnatal day 7 , Safranin O staining and Col2a1 and Agg expression were clearly reduced in the mutant , despite continued expression of Sox9 ( unpublished data ) .
# ::tok By postnatal day 7 , Safranin O staining and Col2a1 and Agg expression were clearly reduced in the mutant , despite continued expression of Sox9 ( unpublished data ) .
# ::alignments 27-28|0.0 26-27|0 24-25|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 22-23|0.0.0 21-22|0.0.0.1 18-19|0.0.0.1.0.2 15-16|0.0.0.1.0 14-15|0.0.0.1.0.1 12-13|0.0.0.1.0.0.0.2.1 10-11|0.0.0.1.0.0 9-10|0.0.0.1.0.0.0.2.0 8-9|0.0.0.1.0.0.0.2 7-8|0.0.0.1.0.0.0 5-7|0.0.0.1.0.0.0.0.0.1+0.0.0.1.0.0.0.0.0.0+0.0.0.1.0.0.0.0.0+0.0.0.1.0.0.0.0 3-4|0.0.0.1.0.0.0.2.1.0 2-3|0.0.0.1.0.0.0.1.0 1-2|0.0.0.1.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:20.837
(u / unpublish 
      :mod-of (d / data 
            :ARG0-of (e / express-01 
                  :ARG1 (t / thing 
                        :name (n / name 
                              :op1 "Sox9")) 
                  :ARG1-of (c / continue-01 
                        :ARG0 (r / reduce-01 
                              :ARG1 (a / and 
                                    :op1 (s / stain-01 
                                          :ARG0 (o / organization 
                                                :name (n2 / name 
                                                      :op1 "Safranin" 
                                                      :op2 "O")) 
                                          :ARG1 (p / postnatal 
                                                :time (d2 / day)) 
                                          :op1-of (a2 / and 
                                                :op2 (c3 / Col2a1) 
                                                :op3 (e2 / express-01 
                                                      :ARG0 7)))) 
                              :ARG1-of (c2 / clear-06) 
                              :location (m / mutant))))))

# ::snt The overall shape of mutant knee skeletal elements appeared similar to controls , although the fibrocartilaginous meniscus that resides between the femur and tibia appeared much less dense in mutants at E16 .5 .
# ::tok The overall shape of mutant knee skeletal elements appeared similar to controls , although the fibrocartilaginous meniscus that resides between the femur and tibia appeared much less dense in mutants at E16 .5 .
# ::alignments 31-32|0.0.0.0.2.1.0.0+0.0.0.0.2.1.0+0.0.0.0.2.1 29-30|0.0.0.0.2.2 27-28|0.0.0.0.2.0 26-27|0.0.0.0.2.0.0 25-26|0.0.0.0.2.0.0.1 24-25|0.0.0.0.2 23-24|0.2 22-23|0 21-22|0.1 18-19|0.0 16-17|0.0.0 15-16|0.0.0.0.2.0.0.0 11-12|0.0.0.0.1.0 9-10|0.0.0.0.1 8-9|0.0.0.0 7-8|0.0.0.0.0 6-7|0.0.0.0.0.2 5-6|0.0.0.0.0.0 4-5|0.0.0.0.0.0.0 2-3|0.0.0.0.0.1 1-2|0.0.0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:21.329
(a2 / and 
      :ARG0-of (r / reside-01 
            :ARG1 (m3 / meniscu 
                  :ARG0-of (a3 / appear-01 
                        :ARG1 (e / element 
                              :ARG1-of (k / knee-01 
                                    :ARG0 (m4 / mutant)) 
                              :ARG1-of (s2 / shape-01 
                                    :mod (o / overall)) 
                              :mod (s / skeletal)) 
                        :ARG2 (r2 / resemble-01 
                              :ARG2 (c2 / control-01)) 
                        :time (a / appear-01 
                              :ARG1 (d / dense 
                                    :degree (l / less 
                                          :degree-of (f2 / fibrocartilaginou) 
                                          :quant (m2 / much))) 
                              :location (c / country 
                                    :name (n / name 
                                          :op1 "E16")) 
                              :medium (m / mutant))))) 
      :op1 (f / femur) 
      :op2 (t / tibia))

# ::snt Some cartilage formed in the meniscus region , but the size of these elements was greatly reduced and contained abundant cells with fibrous , noncartilaginous appearance ( unpublished data ) .
# ::tok Some cartilage formed in the meniscus region , but the size of these elements was greatly reduced and contained abundant cells with fibrous , noncartilaginous appearance ( unpublished data ) .
# ::alignments 28-29|0.0.1.0 27-28|0.0.1 25-26|0.1.3 24-25|0.1.3.0 22-23|0.1.3.1 20-21|0.1.0 19-20|0.1.0.0 18-19|0.1.2.0 17-18|0.1.2 16-17|0.1 15-16|0.1.1 13-14|0.1.2.0.0.0 12-13|0.1.2.0.0.0.0 10-11|0.1.2.0.0 8-9|0 6-7|0.0.2 5-6|0.0.2.0 2-3|0.0 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:21.872
(c3 / contrast-01 
      :ARG1 (f2 / form-01 
            :ARG0 (c4 / cartilage 
                  :quant (s2 / some)) 
            :ARG1 (u / unpublish 
                  :mod-of (d / data)) 
            :location (r2 / region 
                  :mod (m / meniscu))) 
      :ARG2 (r / reduce-01 
            :ARG1 (c / cell 
                  :mod (a2 / abundance)) 
            :extent (g / great) 
            :op1-of (a3 / and 
                  :op2 (c2 / contain-01 
                        :ARG1 (s / size 
                              :poss (e / element 
                                    :mod (t / this))))) 
            :purpose (a / appear-01 
                  :manner (n / noncartilaginou) 
                  :mod (f / fibrou))))

# ::snt This reduction of the meniscus can also be seen in sections from 7-wk - and 9-mo-old animals ( Figure 7E , 7H , 7K , and 7N , arrows ) .
# ::tok This reduction of the meniscus can also be seen in sections from 7-wk - and 9-mo-old animals ( Figure 7E , 7H , 7K , and 7N , arrows ) .
# ::alignments 28-29|0.0.0 25-26|0 18-19|0.0.1.1.0 16-17|0.0.2.0 14-15|0.0.2 10-11|0.0.1.0 8-9|0.0.1 6-7|0.0.1.2 5-6|0.0 4-5|0.0.1.1.1 1-2|0.0.1.1 0-1|0.0.1.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:22.080
(a2 / and 
      :op1 (p / possible-01 
            :ARG0 (a / arrow) 
            :ARG1 (s2 / see-01 
                  :ARG0 (s / section) 
                  :ARG1 (r / reduce-01 
                        :ARG0 (f / figure) 
                        :ARG1 (m / meniscu) 
                        :mod (t / this)) 
                  :mod (a5 / also)) 
            :op1-of (a4 / and 
                  :op2 (a3 / animal))))

# ::snt At 7 wk of age the normally domed tibial epiphysis was flattened and depressed in the knees of mutant animals , markedly reducing the distance between the growth plate and articular surface ( Figure 7E and 7H , vertical bar ) .
# ::tok At 7 wk of age the normally domed tibial epiphysis was flattened and depressed in the knees of mutant animals , markedly reducing the distance between the growth plate and articular surface ( Figure 7E and 7H , vertical bar ) .
# ::alignments 39-40|0 38-39|0.1 35-36|0.0.1.2.0 33-34|0.0.1.0 31-32|0.0.0.0.0.1 30-31|0.0.0.0.0.1.0 29-30|0.0.0.0.0.2 28-29|0.0.0.0.0.0 27-28|0.0.0.0.0.0.0 24-25|0.0.0.0.0 22-23|0.0.0.0 21-22|0.0.0.0.1 19-20|0.0.0 18-19|0.0.0.1 16-17|0.0 13-14|0.0.1.2.1 12-13|0.0.1.2 11-12|0.0.1 9-10|0.0.1.1 8-9|0.0.1.1.0 7-8|0.0.1.1.1 6-7|0.0.1.1.1.1 4-5|0.0.1.1.1.0 1-2|0.0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:22.490
(b / bar-01 
      :ARG1 (k / kneel-01 
            :ARG1 (a4 / animal 
                  :ARG4-of (r / reduce-01 
                        :ARG1 (d / distance-01 
                              :ARG1 (p / plate 
                                    :mod (g / grow-01 
                                          :ARG1 7)) 
                              :ARG2 (s / surface 
                                    :mod (a2 / articular)) 
                              :op1-of (a3 / and)) 
                        :polarity (m / markedly)) 
                  :mod (m2 / mutant)) 
            :manner-of (f2 / flatten-01 
                  :ARG0 (f / figure) 
                  :ARG1 (e / epiphysi 
                        :mod (t / tibial) 
                        :mod (d3 / dom 
                              :ARG1-of (a6 / age-01) 
                              :ARG1-of (n / normal-02))) 
                  :op1-of (a5 / and 
                        :op1-of (a / and) 
                        :op2 (d2 / depress-01)))) 
      :mod (v / vertical))

# ::snt Articular cartilage was also thinner than in control animals , showed nearly complete absence of Safranin O staining , and was either acellular or beginning to fibrillate in many regions ( Figure 7F and 7I ) .
# ::tok Articular cartilage was also thinner than in control animals , showed nearly complete absence of Safranin O staining , and was either acellular or beginning to fibrillate in many regions ( Figure 7F and 7I ) .
# ::alignments 33-34|0 31-32|0.0.0.0.0.0.3.0 29-30|0.0.0.0.0 28-29|0.0.1.0.0 24-25|0.0.0.0.0.0.3 23-24|0.0.0.0.0.0 22-23|0.0.0.0.0.0.2 21-22|0.0.0.0.0.0.1 19-20|0.0.1 17-18|0.0.0.0 15-17|0.0.0.0.1.0.1+0.0.0.0.1.0.0+0.0.0.0.1.0+0.0.0.0.1 13-14|0.0.0 12-13|0.0.0.1 11-12|0.0.0.1.0 10-11|0.0 8-9|0.0.0.0.0.0.0.0 7-8|0.0.0.0.0.0.0 4-5|0.0.1.0 3-4|0.0.1.0.2 1-2|0.0.1.0.1 0-1|0.0.1.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:22.990
(a / and 
      :ARG0-of (s2 / show-01 
            :ARG1 (a4 / absent-01 
                  :ARG1 (s / stain-01 
                        :ARG0 (r / region 
                              :poss (o / or 
                                    :ARG0-of (c2 / control-01 
                                          :ARG1 (a5 / animal)) 
                                    :mod (e / either) 
                                    :op1 (a2 / acellular) 
                                    :op2 (b / begin-01 
                                          :ARG1 (f / figure)))) 
                        :ARG1 (o2 / organization 
                              :name (n / name 
                                    :op1 "Safranin" 
                                    :op2 "O"))) 
                  :ARG1-of (c / complete-02 
                        :degree (n2 / nearly))) 
            :op2-of (a3 / and 
                  :op1 (t / thin-01 
                        :ARG0 (m / many) 
                        :ARG1 (c3 / cartilage 
                              :mod (a7 / articular)) 
                        :degree (a6 / also)))))

# ::snt The few large Safranin O-stained cells still apparent in mutant articular regions appeared to correspond in position to rare LACZ-negative cells in adjacent sections , suggesting that Bmpr1a is required cell-autonomously in articular cartilage ( Figure 7I and 7J , white arrowheads ) .
# ::tok The few large Safranin O-stained cells still apparent in mutant articular regions appeared to correspond in position to rare LACZ-negative cells in adjacent sections , suggesting that Bmpr1a is required cell-autonomously in articular cartilage ( Figure 7I and 7J , white arrowheads ) .
# ::alignments 41-42|0.0.0.2.0.0.2.0.0.0 40-41|0.0.0.2.0.0.2.0.0 37-38|0 35-36|0.0.0.0 33-34|0.0.0.1 32-33|0.0.0.1.0 29-30|0.0.0 27-28|0.0.1.0+0.0.1+0.0 25-26|0.0.0.2 23-24|0.0.0.2.0.0.2.1 22-23|0.0.0.2.0.0.2.1.0 20-21|0.0.0.2.0.0.2 18-19|0.0.0.2.0.0.2.0 16-17|0.0.0.2.0.0.3 14-15|0.0.0.2.0.0 12-13|0.0.0.2.0 11-12|0.0.0.2.0.0.0 10-11|0.0.0.2.0.0.0.0 9-10|0.0.0.2.0.0.2.1.0.0 7-8|0.0.0.2.0.0.1.0 6-7|0.0.0.2.0.0.1.0.0 5-6|0.0.0.2.0.0.1 4-5|0.0.0.2.0.0.1.1 2-3|0.0.0.2.0.0.1.2 1-2|0.0.0.2.0.0.1.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:24.388
(a2 / and 
      :op1 (p / person 
            :ARG2-of (r / require-01 
                  :ARG0 (f / figure) 
                  :ARG1 (c / cartilage 
                        :mod (a3 / articular)) 
                  :ARG1-of (s / suggest-01 
                        :ARG2-of (a5 / appear-01 
                              :ARG1 (c3 / correspond-02 
                                    :ARG0 (r3 / region 
                                          :mod (a6 / articular)) 
                                    :ARG1 (c4 / cell 
                                          :mod (a7 / apparent 
                                                :time (s3 / still)) 
                                          :mod (o / o-stain) 
                                          :mod (l / large) 
                                          :quant (f2 / few)) 
                                    :ARG2 (c2 / cell 
                                          :ARG1-of (r2 / rare-02 
                                                :ARG0 (w / white 
                                                      :mod-of (a / arrowhead))) 
                                          :part-of (s2 / section 
                                                :mod (a4 / adjacent 
                                                      :poss-of (m / mutant)))) 
                                    :location (p2 / position))))) 
            :name (n / name 
                  :op1 "Bmpr1a")))

# ::snt By 9 mo , large areas of mutant knees were devoid of articular cells , and the bones of the femur and tibia appeared to rub directly against each other .
# ::tok By 9 mo , large areas of mutant knees were devoid of articular cells , and the bones of the femur and tibia appeared to rub directly against each other .
# ::alignments 29-30|0.0.0 28-29|0.0.0.0 26-27|0.2.1.2 25-26|0.2.1 23-24|0.2 22-23|0.2.1.1 21-22|0.2.1.1.0 20-21|0.2.1.1.0.0 17-18|0.2.1.0 15-16|0 13-14|0.1.0 12-13|0.1.0.0 10-11|0.1 8-9|0.0 7-8|0.0.1 5-6|0.2.0 4-5|0.2.0.0 1-2|0.2.1.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:25.583
(a3 / and 
      :ARG1-of (k / kneel-01 
            :ARG0 (o / other 
                  :mod (e / each)) 
            :mod (m / mutant)) 
      :op1 (d2 / devoid 
            :topic (c / cell 
                  :mod (a4 / articular))) 
      :op2 (a / appear-01 
            :ARG0 (a5 / area 
                  :mod (l / large)) 
            :ARG1 (r / rub-01 
                  :ARG0 (b / bone) 
                  :ARG1 (t / tibia 
                        :op2-of (a2 / and 
                              :op1 (f / femur))) 
                  :ARG1-of (d / direct-02 
                        :ARG0 9))))

# ::snt Furthermore , the epiphysis of the tibia was extremely depressed , to the point that growth plate cartilage was almost exposed through the surface of the bone ( Figure 7K , 7L , 7N , and 7O ) .
# ::tok Furthermore , the epiphysis of the tibia was extremely depressed , to the point that growth plate cartilage was almost exposed through the surface of the bone ( Figure 7K , 7L , 7N , and 7O ) .
# ::alignments 35-36|0.0.0.0.1.1 28-29|0.0.0.0.1.1.0 26-27|0 23-24|0.0 20-21|0.0.0 19-20|0.0.0.2 17-18|0.0.0.0 16-17|0.0.0.0.0 15-16|0.0.0.0.1 13-14|0.0.0.1 9-10|0.0.0.1.0 8-9|0.0.0.1.0.1 6-7|0.0.0.1.0.0 3-4|0.0.0.1.0.2 0-1|0.0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:25.792
(b / bone 
      :poss-of (s / surface 
            :path-of (e / expose-01 
                  :ARG1 (c / cartilage 
                        :mod (p / plate) 
                        :mod (g / grow-01 
                              :ARG1 (f2 / furthermore) 
                              :op1-of (a / and 
                                    :op2 (f / figure)))) 
                  :domain-of (p2 / point 
                        :ARG2-of (d / depress-01 
                              :ARG1 (t / tibia) 
                              :degree (e2 / extreme) 
                              :domain (e3 / epiphysi))) 
                  :manner (a2 / almost))))

# ::snt In addition , mutants at 7 wk and 9 mo showed subchondral sclerosis , especially in the epiphysis of the femur ( Figure 7E , 7H , 7K , and 7N , asterisks ) .
# ::tok In addition , mutants at 7 wk and 9 mo showed subchondral sclerosis , especially in the epiphysis of the femur ( Figure 7E , 7H , 7K , and 7N , asterisks ) .
# ::alignments 32-33|0.2 29-30|0.3 22-23|0.3.0.1 20-21|0.4.1 17-18|0.4 14-15|0.4.0 12-13|0.1 11-12|0.1.0 10-11|0 9-10|0.3.0.0 8-9|0.3.0.0.0 7-8|0.3.0 5-6|0.3.1 3-4|0.0 1-2|0.5 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:26.075
(s3 / show-01 
      :ARG0 (m2 / mutant) 
      :ARG1 (s / sclerosi 
            :mod (s2 / subchondral)) 
      :ARG2 (a / asterisk) 
      :op2-of (a2 / and 
            :op1 (a3 / and 
                  :op1 (m / mo 
                        :quant 9) 
                  :op2 (f / figure)) 
            :poss-of 7) 
      :time (e / epiphysi 
            :manner (e2 / especially) 
            :poss (f2 / femur)) 
      :time (a4 / addition))

# ::snt While subchondral sclerosis is commonly seen in cases of osteoarthritis , it is unclear in this case whether the sclerosis is mainly a response of bone formation to compensate for decreased articular cartilage , or whether it is the effect of loss of Bmpr1a signaling in some LACZ-positive cells that are also observed in these regions ( unpublished data ) .
# ::tok While subchondral sclerosis is commonly seen in cases of osteoarthritis , it is unclear in this case whether the sclerosis is mainly a response of bone formation to compensate for decreased articular cartilage , or whether it is the effect of loss of Bmpr1a signaling in some LACZ-positive cells that are also observed in these regions ( unpublished data ) .
# ::alignments 58-59|0.0.0.2.2.1.0.0.0.0 57-58|0.0.0.2.2.1.0.0.0.0.0 55-56|0.0.0.2.2.1.0.0.0.1 54-55|0.0.0.2.2.1.0.0.0.1.0 52-53|0.0.0.2.2.1.0.0.0 51-52|0.0.0.2.2.1.0.0.0.2 48-49|0.0.0.2.2.1.0.0 47-48|0.0.0.2.2.1.0.0.1.0.0+0.0.0.2.2.1.0.0.1.0+0.0.0.2.2.1.0.0.1 46-47|0.0.0.2.2.1.0.0.2 44-45|0.0.0.2.2.1.0 43-44|0.0.0.2.2.1.1.0+0.0.0.2.2.1.1+0.0.0.2.2.1 41-42|0.0.0.2.2.0 39-40|0.0.0.2.2 34-35|0.0.0.2 32-33|0.0.0.0.0 31-32|0.0.0.0.0.1 30-31|0.0.0.0.0.0 28-29|0.0.0.0 26-27|0.0 25-26|0 23-24|0.0.0 21-22|0.0.0.2.1 19-20|0.0.0.1 16-17|0.0.0.2.0 15-16|0.0.0.2.0.1 13-14|0.0.0.2.0.0.1+0.0.0.2.0.0 9-10|0.0.0.2.0.0.0.3.0 7-8|0.0.0.2.0.0.0.3 5-6|0.0.0.2.0.0.0 4-5|0.0.0.2.0.0.0.2 2-3|0.0.0.2.0.0.0.0 0-1|0.0.0.2.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:27.356
(b / bone 
      :ARG1-of (f / form-01 
            :ARG0-of (r2 / respond-01 
                  :ARG1 (c4 / compensate-01 
                        :ARG1 (c3 / cartilage 
                              :ARG1-of (d2 / decrease-01) 
                              :mod (a2 / articular))) 
                  :ARG2 (s3 / sclerosi) 
                  :op1-of (o2 / or 
                        :ARG1-of (c5 / case-03 
                              :ARG2-of (c6 / clear-06 
                                    :ARG1 (s4 / see-01 
                                          :ARG1 (s5 / sclerosi) 
                                          :ARG1-of (w / while-01) 
                                          :mod (c8 / common) 
                                          :time (c7 / case-03 
                                                :ARG1 (o3 / osteoarthriti))) 
                                    :polarity -) 
                              :mod (t2 / this)) 
                        :mod (m / main) 
                        :op2 (e / effect-03 
                              :ARG0 (l / loss) 
                              :ARG1 (p / person 
                                    :ARG0-of (s2 / signal-01 
                                          :ARG1 (c / cell 
                                                :ARG0-of (o / observe-01 
                                                      :ARG1 (d / data 
                                                            :mod (u / unpublish)) 
                                                      :ARG2 (r / region 
                                                            :mod (t / this)) 
                                                      :mod (a / also)) 
                                                :mod (c2 / country 
                                                      :name (n / name 
                                                            :op1 "LACZ-positive")) 
                                                :mod (s / some))) 
                                    :name (n2 / name 
                                          :op1 "Bmpr1a")))))))

# ::snt The histological signs of joint arthritis were accompanied by functional impairments in both grasping ability and range of motion in mutant animals .
# ::tok The histological signs of joint arthritis were accompanied by functional impairments in both grasping ability and range of motion in mutant animals .
# ::alignments 21-22|0.0.0.2.0.0 20-21|0.0.0.2.0.0.0 18-19|0.0.0.2.0 16-17|0.0.0.2 15-16|0.0.0 14-15|0.0.0.1 13-14|0.0.0.1.0 12-13|0.0.0.0 10-11|0.0 9-10|0.0.1 7-8|0 5-6|0.1 4-5|0.1.0 2-3|0.1.1 1-2|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:27.684
(a4 / accompany-01 
      :ARG0 (i / impairment 
            :location (a2 / and 
                  :mod (b / both) 
                  :op1 (a3 / ability 
                        :ARG1-of (g / grasp-01)) 
                  :op2 (r / range-01 
                        :ARG1 (m2 / motion 
                              :mod (a / animal 
                                    :mod (m / mutant))))) 
            :mod (f / functional) 
            :mod (h / histological)) 
      :ARG1 (a5 / arthritis 
            :mod (j / joint) 
            :topic-of (s / sign)))

# ::snt Gdf5-Cre/Bmpr1afloxP mutant animals showed a highly significantly reduced ability to grasp and remain suspended on a slender rod ( mean suspension time : controls 38  6 s , n = 39 ; mutants 6  3 s , n = 11 ; p < 0.0001 ) .
# ::tok Gdf5-Cre/Bmpr1afloxP mutant animals showed a highly significantly reduced ability to grasp and remain suspended on a slender rod ( mean suspension time : controls 38  6 s , n = 39 ; mutants 6  3 s , n = 11 ; p < 0.0001 ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:27.687
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Mutant mice also showed a clear decrease in the maximum range of mobility of two different joints in the digits , as assayed by passive manipulation ( MT/P1 joint : controls 100  0  , n = 26 ; mutants 82  3  , n = 8 ; p < 0.0003 ; P1/P2 joint : controls 152  1  , n = 23 ; mutants 140  5  , n = 6 ; p < 0.05 ) .
# ::tok Mutant mice also showed a clear decrease in the maximum range of mobility of two different joints in the digits , as assayed by passive manipulation ( MT/P1 joint : controls 100  0  , n = 26 ; mutants 82  3  , n = 8 ; p < 0.0003 ; P1/P2 joint : controls 152  1  , n = 23 ; mutants 140  5  , n = 6 ; p < 0.05 ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:27.697
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt The structural , histological , marker gene expression , and functional changes in mutant mice demonstrate that BMPR1A is required for normal postnatal maintenance of articular cartilage .
# ::tok The structural , histological , marker gene expression , and functional changes in mutant mice demonstrate that BMPR1A is required for normal postnatal maintenance of articular cartilage .
# ::alignments 26-27|0.1.0.1 25-26|0.1.0.1.0 23-24|0.1.0 22-23|0.1.0.0 21-22|0.1.0.2 19-20|0.1 17-18|0.1.1.0.0+0.1.1.0+0.1.1 15-16|0 14-15|0.0.1.0 13-14|0.0.1.0.0 11-12|0.0.1 10-11|0.0.1.1 9-10|0.0 7-8|0.0.0 6-7|0.0.0.2 5-6|0.0.0.1 3-4|0.0.0.3 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:28.129
(d / demonstrate-01 
      :ARG0 (a2 / and 
            :op1 (e / express-01 
                  :ARG1 (s / structure) 
                  :ARG1-of (m4 / mark-01) 
                  :mod (g / gene) 
                  :mod (h / histological)) 
            :op2 (c2 / change-01 
                  :ARG1 (m2 / mouse 
                        :mod (m3 / mutant)) 
                  :mod (f / functional))) 
      :ARG1 (r / require-01 
            :ARG1 (m / maintain-01 
                  :ARG0 (p / postnatal) 
                  :ARG1 (c / cartilage 
                        :mod (a / articular)) 
                  :ARG1-of (n / normal-02)) 
            :ARG2 (p2 / person 
                  :name (n2 / name 
                        :op1 "BMPR1A"))))

# ::snt Previous studies suggest that BMP signaling is involved in a large number of developmental events .
# ::tok Previous studies suggest that BMP signaling is involved in a large number of developmental events .
# ::alignments 14-15|0.1.1.1 13-14|0.1.1.1.0 11-12|0.1.1 10-11|0.1.1.0 7-8|0.1 5-6|0.1.0 4-5|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:28.267
(s2 / suggest-01 
      :ARG0 (s3 / study-01 
            :ARG1 (p / previou)) 
      :ARG1 (i / involve-01 
            :ARG1 (s / signal-01 
                  :ARG0 (o / organization 
                        :name (n2 / name 
                              :op1 "BMP"))) 
            :ARG2 (n / number 
                  :mod (l / large) 
                  :quant-of (e / event 
                        :mod (d / developmental)))))

# ::snt Many of these events occur early in embryogenesis , and complete inactivation of BMP receptors causes death by E9 .5 ( Mishina et al. 1995 ) .
# ::tok Many of these events occur early in embryogenesis , and complete inactivation of BMP receptors causes death by E9 .5 ( Mishina et al. 1995 ) .
# ::alignments 24-25|0.0.1.0.0+0.0.1.0 21-24|0.0.0.0.1.0.0.0.2+0.0.0.0.1.0.0.0.1+0.0.0.0.1.0.0.0.0+0.0.0.0.1.0.0.0+0.0.0.0.1.0.0 18-19|0.0.0.2.0.0+0.0.0.2.0+0.0.0.2 16-17|0.0.0.1 15-16|0.0.0.0 14-15|0.0.0.0.0 13-14|0.0.0.0.0.0.0.0+0.0.0.0.0.0.0+0.0.0.0.0.0 11-12|0.0.0.0.1 10-11|0.0.0.0.1.0 9-10|0.0.0 7-8|0.0.0.1.0 5-6|0.0.1 4-5|0.0 3-4|0 2-3|0.1 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:28.949
(e3 / event 
      :ARG0-of (o3 / occur-01 
            :op1-of (a / and 
                  :op2 (c / cause-01 
                        :ARG0 (r / receptor 
                              :mod (o2 / organization 
                                    :name (n3 / name 
                                          :op1 "BMP"))) 
                        :ARG1 (i / inactivation 
                              :ARG1-of (c2 / complete-02 
                                    :ARG0 (t / thing 
                                          :name (n / name 
                                                :op1 "Mishina" 
                                                :op2 "et" 
                                                :op3 "al."))))) 
                  :op3 (d2 / die-01 
                        :ARG1 (e / embryogenesi)) 
                  :op4 (o / organization 
                        :name (n2 / name 
                              :op1 "E9"))) 
            :time (e2 / early 
                  :op1 (d / date-entity 
                        :year 1995))) 
      :mod (t2 / this) 
      :quant (m / many))

# ::snt The Gdf5-Cre recombination system bypasses the early embryonic lethality of Bmpr1a mutations , and provides important new information about the role of this receptor in limb and skeletal development .
# ::tok The Gdf5-Cre recombination system bypasses the early embryonic lethality of Bmpr1a mutations , and provides important new information about the role of this receptor in limb and skeletal development .
# ::alignments 28-29|0.2.0 27-28|0.2 26-27|0 25-26|0.1 23-24|0.0.0 22-23|0.0.0.0 20-21|0.0 17-18|0.0.1 16-17|0.0.1.1 15-16|0.0.1.2 14-15|0.0.1.0 13-14|0.0.1.0.0 11-12|0.2.0.0.0 10-11|0.2.0.0.1.0+0.2.0.0.1+0.2.0.0 8-9|0.0.1.0.0.0.1 7-8|0.0.1.0.0.0.1.1 6-7|0.0.1.0.0.0.1.0 4-5|0.0.1.0.0.0 3-4|0.0.1.0.0.0.0 2-3|0.0.1.0.0.0.0.0 1-2|0.0.1.0.0.0.0.1.0.0+0.0.1.0.0.0.0.1.0+0.0.1.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:29.384
(a / and 
      :op1 (r2 / role 
            :poss (r / receptor 
                  :mod (t / this)) 
            :topic-of (i / information 
                  :ARG1-of (p / provide-01 
                        :op2-of (a2 / and 
                              :op1 (b / bypass-01 
                                    :ARG0 (s2 / system 
                                          :mod (r3 / recombination) 
                                          :mod (t2 / thing 
                                                :name (n3 / name 
                                                      :op1 "Gdf5-Cre"))) 
                                    :ARG1 (l2 / lethality 
                                          :mod (e2 / early) 
                                          :mod (e / embryonic))))) 
                  :mod (n / new) 
                  :mod (i2 / important))) 
      :op2 (l / limb) 
      :op3 (s / skeletal 
            :ARG1-of (d / develop-02 
                  :ARG0 (p2 / person 
                        :ARG0-of (m / mutate-01) 
                        :name (n2 / name 
                              :op1 "Bmpr1a")))))

# ::snt The three major limb phenotypes revealed by eliminating Bmpr1a with Gdf5-driven Cre include webbing between digits , lack of joint formation at specific locations in the ankle , and failure to maintain articular cartilage after birth , resulting in severe arthritis .
# ::tok The three major limb phenotypes revealed by eliminating Bmpr1a with Gdf5-driven Cre include webbing between digits , lack of joint formation at specific locations in the ankle , and failure to maintain articular cartilage after birth , resulting in severe arthritis .
# ::alignments 40-41|0.1 39-40|0.1.0 37-38|0 35-36|0.0.0.3.0 34-35|0.0.0.3 33-34|0.0 32-33|0.0.1 31-32|0.0.0 29-30|0.0.0.1.4 28-29|0.0.0.1 26-27|0.0.0.1.3 23-24|0.0.0.2 22-23|0.0.0.2.0 20-21|0.0.0.1.2.0 19-20|0.0.0.1.2.0.0 17-18|0.0.0.1.2 15-16|0.0.0.1.1 12-13|0.0.0.1.0 10-12|0.0.0.0.1.0.1.0.1+0.0.0.0.1.0.1.0.0+0.0.0.0.1.0.1.0+0.0.0.0.1.0.1 8-9|0.0.0.0.1.0.0.0.0+0.0.0.0.1.0.0.0+0.0.0.0.1.0.0 7-8|0.0.0.0.1.0 5-6|0.0.0.0.1 4-5|0.0.0.0 3-4|0.0.0.0.2 2-3|0.0.0.0.0 1-2|0.0.0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:30.286
(r / result-01 
      :ARG1 (c / cartilage 
            :ARG1-of (m / maintain-01 
                  :ARG0 (p3 / phenotyp 
                        :ARG1-of (m2 / major-02) 
                        :ARG1-of (r2 / reveal-01 
                              :ARG2 (e / eliminate-01 
                                    :ARG1 (p2 / person 
                                          :name (n2 / name 
                                                :op1 "Bmpr1a")) 
                                    :ARG3 (p / person 
                                          :name (n / name 
                                                :op1 "Gdf5-driven" 
                                                :op2 "Cre")))) 
                        :mod (l3 / limb)) 
                  :ARG2 (a4 / and 
                        :ARG1-of (i / include-01) 
                        :op1 (d / digit) 
                        :op2 (l2 / lack-01 
                              :ARG1 (f2 / form-01 
                                    :manner (j / joint))) 
                        :op3 (a5 / ankle) 
                        :op4 (f / fail-01)) 
                  :purpose-of (l / location 
                        :ARG1-of (s2 / specific-02 
                              :ARG0 3)) 
                  :time (a2 / after 
                        :op1 (b / birth-01))) 
            :mod (a3 / articular)) 
      :ARG2 (a / arthritis 
            :mod (s / severe)))

# ::snt Previous studies have shown that manipulation of BMP signaling alters interdigital apoptosis during development of the limb , but no experiment has identified a specific member of the BMP signaling pathway that is required for this process ( Yokouchi et al. 1996 ; Zou and Niswander 1996 ; Zou et al. 1997 ; Guha et al. 2002 ) .
# ::tok Previous studies have shown that manipulation of BMP signaling alters interdigital apoptosis during development of the limb , but no experiment has identified a specific member of the BMP signaling pathway that is required for this process ( Yokouchi et al. 1996 ; Zou and Niswander 1996 ; Zou et al. 1997 ; Guha et al. 2002 ) .
# ::alignments 56-57|0.0.1.1.0.0+0.0.1.1.0 51-52|0.0.1.0.0.0+0.0.1.0.0 48-50|0.0.1.2.0.1+0.0.1.2.0.0+0.0.1.2.0+0.0.1.2 46-47|0.0.1.2.1.0+0.0.1.2.1 45-46|0.1.1.2.1.0.0 44-45|0.1.1.2.1.0 42-43|0.1.1.2.1 41-42|0.0.0.0.0+0.0.0.0 38-41|0.0.0.1.0.2+0.0.0.1.0.1+0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 36-37|0.0.1.1.1 35-36|0.0.1.1.1.0 33-34|0.0.1.1 30-31|0.0.1.0.1 29-30|0.0.1.0 25-26|0.0.1.4+0.0.1 24-25|0.0.1.3 22-23|0.0 20-21|0.0.0 19-20|0.0.0.2 18-19|0 16-17|0.1.1.2.0 13-14|0.1.1.2 11-12|0.1.1.1 9-10|0.1.1 8-9|0.1.1.0.0 7-8|0.1.1.0.0.0.0.0+0.1.1.0.0.0.0+0.1.1.0.0.0 5-6|0.1.1.0 3-4|0.1 1-2|0.1.0 0-1|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:38.743
(c / contrast-01 
      :ARG1 (i / identify-01 
            :ARG0 (e2 / experiment-01 
                  :ARG0 (d4 / date-entity 
                        :year 1996) 
                  :ARG1 (t2 / thing 
                        :name (n3 / name 
                              :op1 "Yokouchi" 
                              :op2 "et" 
                              :op3 "al.")) 
                  :polarity -) 
            :ARG1 (h / have-org-role-91 
                  :ARG0 (s / signal-01 
                        :ARG1 (d2 / date-entity 
                              :year 1997) 
                        :manner (p2 / pathway)) 
                  :ARG0-of (r / require-01 
                        :ARG1 (d / date-entity 
                              :year 2002) 
                        :ARG2 (p / process-02 
                              :mod (t3 / this))) 
                  :ARG1 (t / thing 
                        :name (n / name 
                              :op1 (z / Zou) 
                              :op2 (e / et)) 
                        :quant (d3 / date-entity 
                              :year 1996)) 
                  :ARG1-of (s2 / specific-02) 
                  :ARG2 (m / member))) 
      :ARG2 (s4 / show-01 
            :ARG0 (s5 / study-01 
                  :ARG1 (p3 / previou)) 
            :ARG1 (a4 / alter-01 
                  :ARG0 (m2 / manipulate-01 
                        :ARG1 (s3 / signal-01 
                              :ARG0 (o / organization 
                                    :name (n4 / name 
                                          :op1 "BMP")))) 
                  :ARG1 (a3 / apoptosi) 
                  :ARG2 (d5 / develop-02 
                        :ARG1 (l / limb) 
                        :op1-of (a2 / and 
                              :op2 (a / and 
                                    :op1 (n2 / niswand)))))))

# ::snt Our new loss-of-function data confirm that BMP signaling is required for interdigital apoptosis and suggests that Bmpr1a is a critical component for mediating this signal .
# ::tok Our new loss-of-function data confirm that BMP signaling is required for interdigital apoptosis and suggests that Bmpr1a is a critical component for mediating this signal .
# ::alignments 24-25|0.2.0.1.0.0 23-24|0.2.0.1.0.0.0 22-23|0.2.0.1.0 20-21|0.2.0 19-20|0.2.0.0 16-17|0.2.0.1.1.0+0.2.0.1.1+0.2.0.1 14-15|0.2 13-14|0 12-13|0.1.0 9-10|0.1 7-8|0.1.1 6-7|0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 4-5|0.0 3-4|0.0.0 1-2|0.0.0.0 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:39.108
(a / and 
      :op1 (c3 / confirm-01 
            :ARG1 (d / data 
                  :mod (n3 / new) 
                  :poss (w / we))) 
      :op2 (r / require-01 
            :ARG1 (a2 / apoptosi) 
            :ARG2 (s3 / signal-01 
                  :ARG0 (o / organization 
                        :name (n2 / name 
                              :op1 "BMP")))) 
      :op3 (s2 / suggest-01 
            :ARG1 (c / component 
                  :ARG1-of (c2 / critical-02) 
                  :domain (p / person 
                        :ARG0-of (m / mediate-01 
                              :ARG1 (s / signal 
                                    :mod (t / this))) 
                        :name (n / name 
                              :op1 "Bmpr1a")))))

# ::snt At some sites , loss of Bmpr1a function leads to a defect in the early stages of joint formation , resulting in a complete failure to form a joint and fusion of bones in the ankle .
# ::tok At some sites , loss of Bmpr1a function leads to a defect in the early stages of joint formation , resulting in a complete failure to form a joint and fusion of bones in the ankle .
# ::alignments 35-36|0.0.0.2 32-33|0 30-31|0.0.0.0.0 29-30|0.0.0.0 28-29|0.0 26-27|0.0.0 24-25|0.0.0.1 23-24|0.0.0.1.1 20-21|0.0.0.1.2 18-19|0.0.0.1.2.0.0.1 17-18|0.0.0.1.2.0.0.1.1 15-16|0.0.0.1.2.0.0.1.0 14-15|0.0.0.1.2.0.0.1.0.0 11-12|0.0.0.1.2.0.0.0 8-9|0.0.0.1.2.0 7-8|0.0.0.1.2.0.0.0.0 6-7|0.0.0.1.2.0.0.0.0.0.0.0+0.0.0.1.2.0.0.0.0.0.0+0.0.0.1.2.0.0.0.0.0 4-5|0.0.0.1.2.0.0 2-3|0.0.0.1.2.0.1 1-2|0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:40.073
(b / bone 
      :op1-of (j / joint 
            :ARG0-of (f2 / form-01 
                  :ARG1 (a2 / and 
                        :op1 (f / fusion)) 
                  :ARG2-of (f3 / fail-01 
                        :ARG1 (s3 / some) 
                        :ARG1-of (c / complete-02) 
                        :ARG2-of (r / result-01 
                              :ARG2-of (l / lead-03 
                                    :ARG0 (l2 / loss 
                                          :ARG0-of (d / defect-01 
                                                :ARG1 (f5 / function-01 
                                                      :ARG1 (p / person 
                                                            :name (n / name 
                                                                  :op1 "Bmpr1a")))) 
                                          :ARG0-of (f4 / form-01 
                                                :ARG1 (s / stage 
                                                      :time (e / early)) 
                                                :manner (j2 / joint))) 
                                    :ARG1 (s2 / site)))) 
                  :medium (a / ankle))))

# ::snt Mutations in two different ligands in the BMP family , Gdf5 and Gdf6 , the Bmpr1b receptor , and in the human Noggin locus ( Storm and Kingsley 1996 ; Gong et al. 1999 ; Baur et al. 2000 ; Yi et al. 2000 ; Settle et al. 2003 ) also produce defects in joint formation at specific locations in the limbs .
# ::tok Mutations in two different ligands in the BMP family , Gdf5 and Gdf6 , the Bmpr1b receptor , and in the human Noggin locus ( Storm and Kingsley 1996 ; Gong et al. 1999 ; Baur et al. 2000 ; Yi et al. 2000 ; Settle et al. 2003 ) also produce defects in joint formation at specific locations in the limbs .
# ::alignments 61-62|0.0.1.0.1.0.0.1.3 58-59|0.0.1.0.1.0.1 57-58|0.0.1.0.1.0.1.0 55-56|0.0.1.0.1.0.0.1 54-55|0.0.1.0.1.0.0.1.1 52-53|0.0.1.0.1.0.0 51-52|0.0.1.0.1.0 50-51|0.0.1.0.1.0.2 48-49|0.0.1.0.1.0.0.1.4.0+0.0.1.0.1.0.0.1.4 45-46|0.0.1.0.1.0.0.2 43-44|0.0.1.0.1.0.0.1.5.0+0.0.1.0.1.0.0.1.5 40-42|0.0.1.0.1.0.0.1.0.0.1+0.0.1.0.1.0.0.1.0.0.0+0.0.1.0.1.0.0.1.0.0+0.0.1.0.1.0.0.1.0 38-39|0.0.1.0.1.0.0.1.6.0+0.0.1.0.1.0.0.1.6 35-37|0.0.1.0.2.0.1+0.0.1.0.2.0.0+0.0.1.0.2.0+0.0.1.0.2 33-34|0.0.1.0.1.0.0.1.2.0+0.0.1.0.1.0.0.1.2 30-33|0.1.0.2+0.1.0.1+0.1.0.0+0.1.0+0.1 29-30|0 28-29|0.0.1.0.1.0.0.1.7.0+0.0.1.0.1.0.0.1.7 26-27|0.0.1.2 25-26|0.0.1.2.0.0.0+0.0.1.2.0.0+0.0.1.2.0 23-24|0.0.1.1.0.1 22-23|0.0.1.1.0.2.0+0.0.1.1.0.2+0.0.1.1.0 21-22|0.0.1.1.0.0 18-19|0.0.1 16-17|0.0.1.1 15-16|0.0.1.0.1.0.0.2.0.0.0+0.0.1.0.1.0.0.2.0.0+0.0.1.0.1.0.0.2.0 12-13|0.0.0.0+0.0.0+0.0 11-12|0.0.1.0 10-11|0.0.1.0.1.1.0+0.0.1.0.1.1+0.0.1.0.1 8-9|0.0.1.0.0.1 7-8|0.0.1.0.0.1.0.0.0+0.0.1.0.0.1.0.0+0.0.1.0.0.1.0 4-5|0.0.1.0.0 3-4|0.0.1.0.0.0 2-3|0.0.1.0.0.2 0-1|0.0.1.0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:42.021
(a2 / and 
      :op1 (p2 / person 
            :name (n7 / name 
                  :op1 "Gdf6") 
            :op2-of (a4 / and 
                  :op1 (a5 / and 
                        :op1 (l4 / ligand 
                              :ARG1-of (d7 / differ-02) 
                              :part-of (f2 / family 
                                    :mod (o2 / organization 
                                          :name (n9 / name 
                                                :op1 "BMP"))) 
                              :quant 2) 
                        :op2 (p3 / person 
                              :ARG0-of (p / produce-01 
                                    :ARG1 (d / defect-01 
                                          :ARG0 (m / mutation) 
                                          :ARG1 (f / form-01 
                                                :ARG0 (t / thing 
                                                      :name (n / name 
                                                            :op1 (y / Yi) 
                                                            :op2 (e / et))) 
                                                :manner (j / joint) 
                                                :time (d5 / date-entity 
                                                      :year 1999) 
                                                :time (l / limb) 
                                                :time (d2 / date-entity 
                                                      :year 2003) 
                                                :time (d3 / date-entity 
                                                      :year 2000) 
                                                :time (d4 / date-entity 
                                                      :year 2000) 
                                                :time (d6 / date-entity 
                                                      :year 1996)) 
                                          :ARG1-of (s2 / settle-01 
                                                :ARG0 (t5 / thing 
                                                      :name (n6 / name 
                                                            :op1 "Bmpr1b")))) 
                                    :location (l2 / location 
                                          :ARG1-of (s / specific-02)) 
                                    :mod (a / also)) 
                              :name (n8 / name 
                                    :op1 "Gdf5")) 
                        :op3 (t2 / thing 
                              :name (n2 / name 
                                    :op1 (b / Baur) 
                                    :op2 (e2 / et)))) 
                  :op3 (r / receptor 
                        :mod-of (t4 / thing 
                              :mod (h / human) 
                              :mod-of (l3 / locu) 
                              :name (n5 / name 
                                    :op1 "Noggin"))) 
                  :op4 (a3 / and 
                        :op1 (o / organization 
                              :name (n4 / name 
                                    :op1 "Storm"))))) 
      :op2 (t3 / thing 
            :name (n3 / name 
                  :op1 "Gong" 
                  :op2 "et" 
                  :op3 "al.")))

# ::snt The joint defects associated with multiple components of the BMP pathway provide strong evidence that BMP signaling is required for early stages of joint formation at some anatomical locations .
# ::tok The joint defects associated with multiple components of the BMP pathway provide strong evidence that BMP signaling is required for early stages of joint formation at some anatomical locations .
# ::alignments 28-29|0.1 27-28|0.1.0 26-27|0.1.1 24-25|0 23-24|0.2 21-22|0.0 20-21|0.0.1 18-19|0.0.0 16-17|0.0.0.1 13-14|0.0.0.2 12-13|0.0.0.2.1 11-12|0.0.0.2.2 10-11|0.0.0.0 9-10|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 6-7|0.0.0.2.0.0.0 5-6|0.0.0.2.0.0.0.0 3-4|0.0.0.2.0.0 2-3|0.0.0.2.0 1-2|0.0.0.2.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:42.196
(f / form-01 
      :ARG1 (s2 / stage 
            :ARG2-of (r / require-01 
                  :ARG0 (p2 / pathway 
                        :mod (o / organization 
                              :name (n / name 
                                    :op1 "BMP"))) 
                  :ARG1 (s3 / signal-01) 
                  :ARG1-of (e2 / evidence-01 
                        :ARG0 (d / defect-01 
                              :ARG1-of (a2 / associate-01 
                                    :ARG2 (c / component 
                                          :quant (m / multiple))) 
                              :manner (j2 / joint)) 
                        :ARG1-of (s4 / strong-02) 
                        :ARG1-of (p / provide-01))) 
            :time (e / early)) 
      :ARG2 (l / location 
            :mod (a / anatomy) 
            :quant (s / some)) 
      :manner (j / joint))

# ::snt Most joints still form normally when Bmpr1a is knocked out in Gdf5 expression domains .
# ::tok Most joints still form normally when Bmpr1a is knocked out in Gdf5 expression domains .
# ::alignments 13-14|0.1 12-13|0 11-12|0.0.0.0.0.0.0.0.0+0.0.0.0.0.0.0.0+0.0.0.0.0.0.0 8-9|0.0.0 6-7|0.0.1.0+0.0.1+0.0 4-5|0.0.0.0.0.0 3-4|0.0.0.0.0 2-3|0.0.0.0.0.1 1-2|0.0.0.0 0-1|0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:42.336
(e / express-01 
      :ARG0 (p / person 
            :ARG1-of (k / knock-01 
                  :ARG0 (j / joint 
                        :domain-of (f / form 
                              :ARG1-of (n3 / normal-02 
                                    :ARG0 (t / thing 
                                          :name (n / name 
                                                :op1 "Gdf5"))) 
                              :mod (s / still)) 
                        :mod (m / most))) 
            :name (n2 / name 
                  :op1 "Bmpr1a")) 
      :ARG1 (d / domain))

# ::snt The lack of joint fusions outside the ankle region could be due to differences in requirement for BMP signaling in different joints , to compensating expression of other BMP receptors outside the ankles , or to differences in the detailed timing of Gdf5-Cre stimulated gene inactivation in ankles and other joint regions .
# ::tok The lack of joint fusions outside the ankle region could be due to differences in requirement for BMP signaling in different joints , to compensating expression of other BMP receptors outside the ankles , or to differences in the detailed timing of Gdf5-Cre stimulated gene inactivation in ankles and other joint regions .
# ::alignments 51-52|0.3 50-51|0.3.1 49-50|0.3.0 48-49|0.4.0 47-48|0.4 45-46|0.4.0.0.1 44-45|0.4.0.0.1.0 43-44|0.4.0.0 42-43|0.4.0.0.0.1.0+0.4.0.0.0.1+0.4.0.0.0 40-41|0.4.0.0.0.0 39-40|0.4.0.0.0.0.0 36-37|0.4.0.0.0.0.1 34-35|0.4.0.0.0.0.1.0 32-33|0.2.0 30-31|0.2 29-30|0.0 27-28|0.0.0 25-26|0 24-25|0.1 21-22|0.4.0.0.0.0.1.0.0.0 20-21|0.4.0.0.0.0.1.0.0 18-19|0.4.0.0.0.0.1.0.0.0.0 17-18|0.4.0.0.0.0.1.0.0.0.0.1.1.0+0.4.0.0.0.0.1.0.0.0.0.1.1+0.4.0.0.0.0.1.0.0.0.0.1 15-16|0.4.0.0.0.0.1.0.0.0.0.1.0.0 13-14|0.4.0.0.0.0.1.0.0.0.0.1.0 9-10|0.4.0.0.0.0.1.0.0.1 8-9|0.4.0.0.0.0.1.0.0.0.0.0 7-8|0.4.0.0.0.0.1.0.0.0.0.1.0.0.0 5-6|0.4.0.0.0.0.1.0.0.0.0.0.0 4-5|0.4.0.0.0.0.1.0.0.0.0.0.0.0 3-4|0.4.0.0.0.0.1.0.0.0.0.0.0.0.1 1-2|0.4.0.0.0.0.1.0.0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:43.749
(e / express-01 
      :ARG1 (r2 / receptor 
            :mod (o4 / other)) 
      :ARG1-of (c / compensate-01) 
      :location (o3 / outside 
            :op1 (a3 / ankl)) 
      :op1-of (r / region 
            :mod (o / other) 
            :mod (j / joint)) 
      :op1-of (a2 / ankl 
            :op1-of (a / and 
                  :location-of (s / stimulate-01 
                        :ARG0 (t / thing 
                              :ARG1-of (t2 / time-02 
                                    :ARG1-of (d / detail-01) 
                                    :ARG2-of (d2 / differ-01 
                                          :op2-of (o2 / or 
                                                :op1 (d3 / differ-02 
                                                      :ARG1 (j2 / joint 
                                                            :ARG2-of (s2 / signal-01 
                                                                  :ARG0 (r4 / region 
                                                                        :op1-of (o6 / outside 
                                                                              :location-of (f / fusion 
                                                                                    :ARG1-of (l / lack-01) 
                                                                                    :mod (j3 / joint)))) 
                                                                  :ARG1 (o5 / organization 
                                                                        :ARG1-of (d4 / differ-01 
                                                                              :ARG2 (r3 / require-01 
                                                                                    :ARG1 (a4 / ankle))) 
                                                                        :name (n2 / name 
                                                                              :op1 "BMP")))) 
                                                      :ARG1-of (p / possible-01))))) 
                              :name (n / name 
                                    :op1 "Gdf5-Cre")) 
                        :ARG1 (i / inactivation 
                              :mod (g / gene))))))

# ::snt Comparison of the expression of the HPLAP marker ( driven directly by Gdf5 control elements ) and the R26R LACZ marker ( expressed following Gdf5-Cre recombination ) suggests that recombination-stimulated changes in gene expression may be delayed for a 0.5 -- 1 d in the digit region ( see Figure 1C ) .
# ::tok Comparison of the expression of the HPLAP marker ( driven directly by Gdf5 control elements ) and the R26R LACZ marker ( expressed following Gdf5-Cre recombination ) suggests that recombination-stimulated changes in gene expression may be delayed for a 0.5 -- 1 d in the digit region ( see Figure 1C ) .
# ::alignments 49-50|0.1.0.0 48-49|0.1.0 46-47|0.0.3.1.0.2.0 45-46|0.0.3.1.0.2.0.0 42-43|0.0.3.1.0.2 41-42|0.0.0 39-40|0.0.1.1 36-37|0.0.3.1.0 34-35|0.0.3.1 33-34|0.0.3.1.0.0.0 32-33|0.0.3.1.0.0.0.0 30-31|0.0.3.1.0.0 29-30|0.0.3.1.0.0.1 27-28|0.0.3.1.0.1 25-26|0.1.1 24-25|0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 23-24|0.1 22-23|0 20-21|0.0 18-20|0.0.2.0.1+0.0.2.0.0+0.0.2.0+0.0.2 16-17|0.0.3 14-15|0.0.1.0 13-14|0.0.1.0.0 12-13|0.0.1.0.0.0.0.0+0.0.1.0.0.0.0+0.0.1.0.0.0 10-11|0.0.1.2 9-10|0.0.1 7-8|0.0.3.0 6-7|0.0.3.0.0.0.0+0.0.3.0.0.0+0.0.3.0.0 3-4|0.0.3.0.1 0-1|0.0.3.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:47.347
(e2 / express-01 
      :ARG1 (m / mark-01 
            :ARG0 1 
            :ARG1 (d5 / drive-02 
                  :ARG0 (e3 / element 
                        :mod (c2 / control-01 
                              :ARG1 (t3 / thing 
                                    :name (n3 / name 
                                          :op1 "Gdf5")))) 
                  :ARG1 0.5 
                  :ARG1-of (d4 / direct-02)) 
            :ARG2 (t2 / thing 
                  :name (n2 / name 
                        :op1 (r4 / R26R) 
                        :op2 (l / LACZ))) 
            :op2-of (a / and 
                  :op1 (m2 / mark-01 
                        :ARG1 (t4 / thing 
                              :name (n4 / name 
                                    :op1 "HPLAP")) 
                        :ARG1-of (e4 / express-01 
                              :topic-of (c3 / comparison))) 
                  :op3 (p / possible-01 
                        :ARG1 (d3 / delay-01 
                              :ARG1 (c / change-01 
                                    :ARG1 (e / express-01 
                                          :mod (g / gene)) 
                                    :mod (r2 / recombination-stimulat)) 
                              :ARG1-of (s2 / suggest-01) 
                              :ARG2 (d2 / d 
                                    :location (r / region 
                                          :mod (d / digit))))))) 
      :time (f2 / follow-01 
            :ARG1 (s / see-01 
                  :ARG1 (f / figure)) 
            :ARG2 (r3 / recombination 
                  :mod (t / thing 
                        :name (n / name 
                              :op1 "Gdf5-Cre")))))

# ::snt In addition , levels of Bmpr1a mRNA and protein may persist for some time following Gdf5-Cre stimulated recombination , making it possible to bypass an early requirement for Bmpr1a in joint formation at some locations .
# ::tok In addition , levels of Bmpr1a mRNA and protein may persist for some time following Gdf5-Cre stimulated recombination , making it possible to bypass an early requirement for Bmpr1a in joint formation at some locations .
# ::alignments 34-35|0.0.5.0.0.1 33-34|0.0.5.0.0.1.0 31-32|0.0.5.0.0.2 30-31|0.0.5.0.0.2.0 26-27|0.0.5.0.0 25-26|0.0.5.0.0.0 23-24|0.0.5.0 21-22|0.0.5 17-18|0.0.0.1 16-17|0.0.0 15-16|0.0.0.0.1.0+0.0.0.0.1+0.0.0.0 14-15|0.0.0.0.0 13-14|0.1 12-13|0.1.0 10-11|0 9-10|0.2 8-9|0.0.4 7-8|0.0 6-7|0.0.3 5-6|0.0.2.0.0+0.0.2.0+0.0.2 3-4|0.0.1 1-2|0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:48.907
(p2 / persist-01 
      :ARG0 (a / and 
            :ARG2-of (s2 / stimulate-01 
                  :ARG0 (t / thing 
                        :ARG2-of (f2 / follow-01 
                              :ARG1 (a2 / addition)) 
                        :name (n / name 
                              :op1 "Gdf5-Cre")) 
                  :ARG1 (r2 / recombination)) 
            :op1 (l2 / level) 
            :op2 (p5 / person 
                  :name (n2 / name 
                        :op1 "Bmpr1a")) 
            :op3 (m / mrna) 
            :op4 (p4 / protein) 
            :op5 (p / possible-01 
                  :ARG1 (b / bypass 
                        :ARG1 (r / require-01 
                              :ARG0 (e / early) 
                              :ARG1 (l / location 
                                    :quant (s / some)) 
                              :ARG1-of (f / form-01 
                                    :manner (j / joint)))))) 
      :ARG1 (t2 / time 
            :quant (s3 / some)) 
      :ARG1-of (p3 / possible-01))

# ::snt Following the decay of Bmpr1a mRNA and protein , the Gdf5-Cre strategy should result in permanent inactivation of Bmpr1a function in recombined cells .
# ::tok Following the decay of Bmpr1a mRNA and protein , the Gdf5-Cre strategy should result in permanent inactivation of Bmpr1a function in recombined cells .
# ::alignments 22-23|0.0.0.0.0.2.0 21-22|0.0.0.0.0.2.0.0 19-20|0.0.0.0.0.2.0.1 16-17|0.0.0.0.0.2 15-16|0.0.0.0.0.2.1 13-14|0.0.0.0.0 12-13|0.0.0.0.0.1 11-12|0.0.0.0.0.0 10-11|0.0.0.0.0.0.0.0.0+0.0.0.0.0.0.0.0+0.0.0.0.0.0.0 7-8|0 6-7|0.0 5-6|0.0.2 4-5|0.0.1.0.0+0.0.1.0+0.0.1 2-3|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:49.645
(p2 / protein 
      :op4-of (a / and 
            :op1 (d / decay-01 
                  :ARG2-of (f2 / follow-01 
                        :ARG1 (r2 / result-01 
                              :ARG1 (s / strategy 
                                    :mod (t / thing 
                                          :name (n / name 
                                                :op1 "Gdf5-Cre"))) 
                              :ARG1-of (r3 / recommend-01) 
                              :ARG2 (i / inactivation 
                                    :location (c / cell 
                                          :ARG1-of (r / recombine-01) 
                                          :ARG1-of (f / function-01)) 
                                    :mod (p / permanent))))) 
            :op2 (p3 / person 
                  :name (n2 / name 
                        :op1 "Bmpr1a")) 
            :op3 (m / mrna)))

# ::snt This system thus provides one of the first strong genetic tests of Bmpr1a function at later stages of joint development .
# ::tok This system thus provides one of the first strong genetic tests of Bmpr1a function at later stages of joint development .
# ::alignments 19-20|0.1.0.1 18-19|0.1.0.1.0 16-17|0.1.0.1.1 15-16|0.1.0.1.1.0 13-14|0.1.0 12-13|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 10-11|0.1 9-10|0.1.2 8-9|0.1.1 3-4|0 2-3|0.2 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:49.772
(p2 / provide-01 
      :ARG0 (s3 / system 
            :mod (t3 / this)) 
      :ARG1 (t / test-01 
            :ARG1 (f / function-01 
                  :ARG1 (p / person 
                        :name (n / name 
                              :op1 "Bmpr1a")) 
                  :ARG2 (d / develop-02 
                        :manner (j / joint) 
                        :mod (s / stage 
                              :time (l / late)))) 
            :ARG1-of (s2 / strong-02) 
            :mod (g / gene)) 
      :time (t2 / thus-far))

# ::snt Despite the normal appearance of articular regions and gene expression immediately after birth , Bmpr1a-deficient animals are unable to maintain the normal differentiated state of articular cartilage as they continue to develop and age .
# ::tok Despite the normal appearance of articular regions and gene expression immediately after birth , Bmpr1a-deficient animals are unable to maintain the normal differentiated state of articular cartilage as they continue to develop and age .
# ::alignments 33-34|0 32-33|0.0 31-32|0.0.1 29-30|0.0.0 28-29|0.0.1.0 26-27|0.0.0.0.1.2 25-26|0.0.0.0.1.2.0 23-24|0.0.0.0.1 22-23|0.0.0.0.1.1 21-22|0.0.0.0.1.0 19-20|0.0.0.0 15-16|0.0.0.0.0 12-13|0.0.1.1.1.0 11-12|0.0.1.1.1.0.0 10-11|0.0.1.1.1.0.0.0 9-10|0.0.1.1.1 8-9|0.0.1.1.1.1 7-8|0.0.1.1 6-7|0.0.1.1.0.0 5-6|0.0.1.1.0.0.0 3-4|0.0.1.1.0 2-3|0.0.1.1.0.1 0-1|0.0.1.1.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:50.840
(a / age-01 
      :op2-of (a2 / and 
            :ARG1-of (c / continue-01 
                  :condition-of (m / maintain-01 
                        :ARG0 (a4 / animal) 
                        :ARG1 (s / state 
                              :ARG1-of (n / normal-02) 
                              :ARG1-of (d2 / differentiate-01) 
                              :mod (c2 / cartilage 
                                    :mod (a3 / articular)))) 
                  :ARG0 t) 
            :op1 (d / develop-02 
                  :ARG0 (t / they) 
                  :op1-of (a6 / and 
                        :ARG0-of (a8 / appear-01 
                              :ARG1 (r / region 
                                    :mod (a7 / articular)) 
                              :ARG1-of (n2 / normal-02) 
                              :op1-of (d3 / despite)) 
                        :ARG1-of (e / express-01 
                              :ARG1-of (b / birth-01 
                                    :op1-of (a5 / after 
                                          :op1-of (i / immediate))) 
                              :mod (g / gene))))))

# ::snt These results suggest that BMP receptor signaling is essential for continued health and integrity of articular cartilage in the postnatal period .
# ::tok These results suggest that BMP receptor signaling is essential for continued health and integrity of articular cartilage in the postnatal period .
# ::alignments 20-21|0.2.0 19-20|0.2 16-17|0.1.1.0 15-16|0.1.1.0.0 13-14|0.1.0.0 12-13|0.1 11-12|0.1.1 10-11|0.1.0 8-9|0.1.1.1 6-7|0.1.1.1.0 5-6|0.1.1.1.0.1 4-5|0.1.1.1.0.0.0.0+0.1.1.1.0.0.0+0.1.1.1.0.0 2-3|0 1-2|0.0.0+0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:51.568
(s2 / suggest-01 
      :ARG0 (t / thing 
            :ARG2-of (r2 / result-01) 
            :mod (t2 / this)) 
      :ARG1 (a2 / and 
            :op1 (c2 / continue-01 
                  :ARG1 (i / integrity)) 
            :op2 (h / health 
                  :mod (c / cartilage 
                        :mod (a / articular)) 
                  :purpose-of (e / essential 
                        :domain (s / signal-01 
                              :ARG0 (o / organization 
                                    :name (n / name 
                                          :op1 "BMP")) 
                              :ARG1 (r / receptor))))) 
      :ARG2 (p2 / postnatal 
            :mod-of (p / period)))

# ::snt Articular cartilage is a key component of synovial joints and is one of the few regions in the skeleton where cartilage is maintained into adulthood .
# ::tok Articular cartilage is a key component of synovial joints and is one of the few regions in the skeleton where cartilage is maintained into adulthood .
# ::alignments 24-25|0.2.2 22-23|0.2 20-21|0.2.1 18-19|0.2.3 15-16|0.2.0 14-15|0.2.0.0 9-10|0 8-9|0.1 7-8|0.1.0 5-6|0.0 4-5|0.0.0 1-2|0.0.1 0-1|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:51.842
(a2 / and 
      :op1 (c2 / component 
            :ARG1-of (k / key-02) 
            :domain (c3 / cartilage 
                  :mod (a3 / articular))) 
      :op2 (j / joint 
            :mod (s2 / synovial)) 
      :op3 (m / maintain-01 
            :ARG0 (r / region 
                  :quant (f / few)) 
            :ARG1 (c / cartilage) 
            :ARG2 (a / adulthood) 
            :location (s / skeleton)))

# ::snt Despite the importance of articular cartilage in joint health and mobility , little is known about the factors that create and maintain it in thin layers at the ends of long bones .
# ::tok Despite the importance of articular cartilage in joint health and mobility , little is known about the factors that create and maintain it in thin layers at the ends of long bones .
# ::alignments 31-32|0 30-31|0.0 28-29|0.1 25-26|0.1.0.1.0.0 24-25|0.1.0.1.0.0.0 21-22|0.1.0.1.0 20-21|0.1.0.1 19-20|0.1.0 17-18|0.1.0.0 14-15|0.1.0.0.0 12-13|0.1.0.0.0.0 10-11|0.1.0.1.1.1 9-10|0.1.0.1.1 8-9|0.1.0.1.1.0 7-8|0.1.0.1.1.0.0 5-6|0.1.0.1.1.2 4-5|0.1.0.1.1.2.0 2-3|0.1.0.1.1.2.1 0-1|0.1.0.1.1.2.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:52.330
(b / bone 
      :ARG1-of (l / long-03) 
      :ARG1-of (e / end-01 
            :time-of (c / create-01 
                  :ARG1 (f / factor 
                        :ARG2-of (k / know-02 
                              :ARG1 (l3 / little))) 
                  :op1-of (a / and 
                        :op2 (m / maintain-01 
                              :ARG2 (l2 / layer 
                                    :ARG1-of (t / thin-03))) 
                        :op3-of (a2 / and 
                              :op1 (h / health 
                                    :mod (j / joint)) 
                              :op2 (m2 / mobility) 
                              :topic-of (c2 / cartilage 
                                    :mod (a3 / articular) 
                                    :mod-of (i / important 
                                          :op1-of (d / despite))))))))

# ::snt In our experiments , articular cartilage lacking Bmpr1a retains some normal characteristics , in that it maintains a very low proliferation rate , does not express Col1a1 , and continues to express SOX9 , a major transcription factor regulating expression of structural components of cartilage matrix .
# ::tok In our experiments , articular cartilage lacking Bmpr1a retains some normal characteristics , in that it maintains a very low proliferation rate , does not express Col1a1 , and continues to express SOX9 , a major transcription factor regulating expression of structural components of cartilage matrix .
# ::alignments 45-46|0.2.0 44-45|0.2 42-43|0.0 41-42|0.0.0 39-40|0 38-39|0.1 37-38|0.1.0 36-37|0.1.0.1 35-36|0.1.0.0 32-33|0.1.1.1.0.0+0.1.1.1.0+0.1.1.1 31-32|0.1.1 29-30|0.1.1.2 28-29|0.1.1.2.0 26-27|0.1.1.2.0.2.0.0.0+0.1.1.2.0.2.0.0+0.1.1.2.0.2.0 25-26|0.1.1.2.0.2 24-25|0.1.1.2.0.2.1 21-22|0.1.1.0.2.0 20-21|0.1.1.0.2.0.1 19-20|0.1.1.0.2.0.0 18-19|0.1.1.0.2.0.0.0 16-17|0.1.1.0.2 11-12|0.1.1.0.1+0.1.1.0 10-11|0.1.1.0.0 9-10|0.1.1.0.3 8-9|0.1.1.2.0.0 7-8|0.1.1.2.0.0.0.1.0+0.1.1.2.0.0.0.1+0.1.1.2.0.0.0 6-7|0.1.1.2.0.0.0.0 5-6|0.1.1.2.0.0.0.0.0 4-5|0.1.1.2.0.0.0.0.0.0 2-3|0.1.1.2.0.1 1-2|0.1.1.2.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:54.357
(e / express-01 
      :ARG1 (c2 / component 
            :mod (s / structure)) 
      :ARG1-of (r / regulate-01 
            :ARG0 (f / factor 
                  :ARG1-of (m2 / major-02) 
                  :mod (t / transcription)) 
            :ARG2-of (e2 / express-01 
                  :ARG0 (t4 / thing 
                        :ARG1-of (n3 / normal-02) 
                        :ARG2-of (c4 / characteristic-02) 
                        :ARG2-of (m3 / maintain-01 
                              :ARG1 (r2 / rate 
                                    :ARG1-of (l / low-04 
                                          :degree (v / very)) 
                                    :mod (p / proliferate-01))) 
                        :quant (s2 / some)) 
                  :ARG1 (t2 / thing 
                        :name (n / name 
                              :op1 "SOX9")) 
                  :ARG1-of (c3 / continue-01 
                        :op2-of (a / and 
                              :ARG1-of (r3 / retain-01 
                                    :ARG0 (p2 / person 
                                          :ARG1-of (l2 / lack-01 
                                                :ARG0 (c5 / cartilage 
                                                      :mod (a2 / articular))) 
                                          :name (n4 / name 
                                                :op1 "Bmpr1a"))) 
                              :ARG1-of (e4 / experiment-01 
                                    :ARG0 (w / we)) 
                              :op1 (e3 / express-01 
                                    :ARG1 (t3 / thing 
                                          :name (n2 / name 
                                                :op1 "Col1a1")) 
                                    :polarity -))))) 
      :location (c / cartilage 
            :mod-of (m / matrix)))

# ::snt However , several of the most prominent structural components of cartilage matrix fail to be maintained in mutant animals , resulting in decreased synthesis of Col2a1 , Agg , and proteoglycans .
# ::tok However , several of the most prominent structural components of cartilage matrix fail to be maintained in mutant animals , resulting in decreased synthesis of Col2a1 , Agg , and proteoglycans .
# ::alignments 30-31|0.2 29-30|0 25-26|0.1 23-24|0.0 22-23|0.0.0 20-21|0.0.0.0 18-19|0.0.0.0.0.2 17-18|0.0.0.0.0.2.0 15-16|0.0.0.0.0 12-13|0.0.0.0.0.3 11-12|0.0.0.0.0.1 10-11|0.0.0.0.0.1.0 8-9|0.0.0.0.0.3.0 7-8|0.0.0.0.0.3.0.1 6-7|0.0.0.0.0.3.0.0 5-6|0.0.0.0.0.3.0.0.0 2-3|0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:54.573
(a / and 
      :domain-of (s / synthesi 
            :ARG1-of (d / decrease-01 
                  :ARG2-of (r / result-01 
                        :ARG0 (m2 / maintain-01 
                              :ARG0 (s3 / several) 
                              :ARG1 (m3 / matrix 
                                    :mod (c2 / cartilage)) 
                              :ARG2 (a2 / animal 
                                    :mod (m / mutant)) 
                              :ARG2-of (f / fail-01 
                                    :ARG1 (c3 / component 
                                          :mod (p2 / prominent 
                                                :degree (m4 / most)) 
                                          :mod (s2 / structure))))))) 
      :op1 (c / Col2a1) 
      :op2 (p / proteoglycan))

# ::snt Therefore , BMPR1A appears to maintain articular cartilage primarily through inducing expression of key ECM components .
# ::tok Therefore , BMPR1A appears to maintain articular cartilage primarily through inducing expression of key ECM components .
# ::alignments 15-16|0.0.2.0.0 14-15|0.0.2.0.1 13-14|0.0.2.0.0.0 11-12|0.0.2.0 10-11|0.0.2 8-9|0.0.1.1 7-8|0.0.1 6-7|0.0.1.0 5-6|0.0 3-4|0 2-3|0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:54.747
(a2 / appear-02 
      :ARG1 (m / maintain-01 
            :ARG0 (p2 / person 
                  :name (n / name 
                        :op1 "BMPR1A")) 
            :ARG1 (c2 / cartilage 
                  :mod (a / articular) 
                  :mod (p / primary)) 
            :manner (i / induce-01 
                  :ARG1 (e2 / express-01 
                        :ARG1 (c / component 
                              :ARG1-of (k / key-02)) 
                        :ARG2 (e / ecm)))))

# ::snt It is interesting that the SOX9 transcription factor continues to be expressed in mutant cartilage despite loss of Col2a1 , a direct target of this transcription factor ( Bell et al. 1997 ; Lefebvre et al. 1997 ) .
# ::tok It is interesting that the SOX9 transcription factor continues to be expressed in mutant cartilage despite loss of Col2a1 , a direct target of this transcription factor ( Bell et al. 1997 ; Lefebvre et al. 1997 ) .
# ::alignments 36-37|0.0.2.0.0.3.0+0.0.2.0.0.3 33-35|0.0.0.1.0.1+0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 32-33|0.0.0 31-32|0.0.2.0.0.2.0.0+0.0.2.0.0.2.0 28-31|0.0.2.0.0.2.1.0.0.2+0.0.2.0.0.2.1.0.0.1+0.0.2.0.0.2.1.0.0.0+0.0.2.0.0.2.1.0.0+0.0.2.0.0.2.1.0 26-27|0 25-26|0.0.0.0 24-25|0.1 22-23|0.0 21-22|0.0.1 18-19|0.0.2.0.0.0.0 16-17|0.0.2.0.0.2.2 14-15|0.0.2.0 13-14|0.0.2 11-12|0.0.2.0.0 8-9|0.0.2.0.0.2 7-8|0.0.2.0.0.0 6-7|0.0.2.0.0.1 5-6|0.0.2.0.0.1.0.0.0+0.0.2.0.0.1.0.0+0.0.2.0.0.1.0 2-3|0.0.2.0.0.2.1 0-1|0.0.2.0.0.2.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:55.342
(f / factor 
      :ARG0-of (t5 / target-01 
            :ARG1 (a / and 
                  :op1 (t3 / transcription) 
                  :op2 (t / thing 
                        :name (n / name 
                              :op1 (l / Lefebvre) 
                              :op2 (e / et)))) 
            :ARG1-of (d3 / direct-02) 
            :time (m / mutant 
                  :mod-of (c2 / cartilage 
                        :ARG2-of (e2 / express-01 
                              :ARG0 (f2 / factor 
                                    :mod-of (c / Col2a1)) 
                              :ARG1 (t6 / transcription 
                                    :mod (t7 / thing 
                                          :name (n3 / name 
                                                :op1 "SOX9"))) 
                              :ARG1-of (c3 / continue-01 
                                    :ARG0 (d2 / date-entity 
                                          :year 1997) 
                                    :ARG2-of (i / interest-01 
                                          :ARG0 (t2 / thing 
                                                :name (n2 / name 
                                                      :op1 "Bell" 
                                                      :op2 "et" 
                                                      :op3 "al.")) 
                                          :ARG1 (i2 / it)) 
                                    :concession (l2 / loss)) 
                              :time (d / date-entity 
                                    :year 1997))))) 
      :mod (t4 / this))

# ::snt Previous studies suggest that SOX9 activity can be modified by protein kinase A ( PKA ) - dependent protein phosphorylation , or by coexpression of two related proteins , L-SOX5 and SOX6 ( Lefebvre et al. 1998 ; Huang et al. 2000 ) .
# ::tok Previous studies suggest that SOX9 activity can be modified by protein kinase A ( PKA ) - dependent protein phosphorylation , or by coexpression of two related proteins , L-SOX5 and SOX6 ( Lefebvre et al. 1998 ; Huang et al. 2000 ) .
# ::alignments 41-42|0.1.0.0.0.0.1.0.0+0.1.0.0.0.0.1.0 38-40|0.1.0.2.1.0.1+0.1.0.2.1.0.0+0.1.0.2.1.0+0.1.0.2.1 37-38|0.1.0.2 36-37|0.1.0.2.0.0+0.1.0.2.0 33-36|0.1.0.0.0.1.0.2+0.1.0.0.0.1.0.1+0.1.0.0.0.1.0.0+0.1.0.0.0.1.0+0.1.0.0.0.1 31-32|0.1.2.0.0+0.1.2.0+0.1.2 30-31|0.1 29-30|0.1.1.0.0+0.1.1.0+0.1.1 27-28|0 26-27|0.0 25-26|0.2 23-24|0.1.3 21-22|0.1.0.0.0 19-20|0.1.0.0.0.0 18-19|0.1.0.0.0.0.0 17-18|0.1.0.0.0.0.1 11-12|0.1.0.0.1.1 10-11|0.1.0.0.1.1.0 8-9|0.1.0.0 6-7|0.1.0 5-6|0.1.0.0.1 4-5|0.1.0.0.1.0.0.0+0.1.0.0.1.0.0+0.1.0.0.1.0 2-3|0.1.0.1 1-2|0.1.0.1.0 0-1|0.1.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:57.871
(p3 / protein 
      :ARG1-of (r / relate-01) 
      :op2-of (a2 / and 
            :op1 (p7 / possible-01 
                  :ARG1 (m / modify-01 
                        :ARG0 (o / or 
                              :op1 (p4 / phosphorylate-01 
                                    :ARG1 (p5 / protein) 
                                    :ARG1-of (d3 / depend-01 
                                          :time (d / date-entity 
                                                :year 2000))) 
                              :op2 (t2 / thing 
                                    :name (n2 / name 
                                          :op1 "Lefebvre" 
                                          :op2 "et" 
                                          :op3 "al."))) 
                        :ARG1 (a3 / activity-06 
                              :ARG0 (t3 / thing 
                                    :name (n5 / name 
                                          :op1 "SOX9")) 
                              :ARG1 (k / kinase 
                                    :mod (p6 / protein)))) 
                  :ARG1-of (s / suggest-01 
                        :ARG0 (s2 / study-01 
                              :ARG1 (p8 / previou))) 
                  :op1-of (a / and 
                        :op2 (d2 / date-entity 
                              :year 1998) 
                        :op3 (t / thing 
                              :name (n / name 
                                    :op1 (h / Huang) 
                                    :op2 (e / et))))) 
            :op3 (p2 / person 
                  :name (n4 / name 
                        :op1 "L-SOX5")) 
            :op4 (p / person 
                  :name (n3 / name 
                        :op1 "SOX6")) 
            :time (c / coexpression)) 
      :quant 2)

# ::snt In addition , close examination of the order of genes induced during chicken digit formation reveals that Sox9 turns on first , followed by Bmpr1b with L-Sox5 , and then Sox6 and the cartilage matrix structural components Col2a1 and Agg ( Chimal-Monroy et al. 2003 ) .
# ::tok In addition , close examination of the order of genes induced during chicken digit formation reveals that Sox9 turns on first , followed by Bmpr1b with L-Sox5 , and then Sox6 and the cartilage matrix structural components Col2a1 and Agg ( Chimal-Monroy et al. 2003 ) .
# ::alignments 44-45|0.1.2.0.0.0+0.1.2.0.0 41-44|0.1.0.0.2+0.1.0.0.1+0.1.0.0.0+0.1.0.0+0.1.0 38-39|0.1.3 37-38|0.1.3.0 36-37|0.0.1.2.0.0 35-36|0.0.1.2.0 34-35|0.1.2.2.0 33-34|0.1.2.2 31-32|0.1.2 30-31|0.1.2.1.0.0+0.1.2.1.0+0.1.2.1 29-30|0.1.2.1.1.0 28-29|0.1.2.1.1 26-27|0.0.0.0.0+0.0.0.0+0.0.0 24-25|0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 22-23|0.1.2.0 18-19|0.1 17-18|0.1.1.0.0+0.1.1.0+0.1.1 15-16|0 14-15|0.0.1.2 13-14|0.0.1.2.1 12-13|0.0.1.2.1.0 10-11|0.0.1 9-10|0.0.1.1 4-5|0.0 3-4|0.0.2 1-2|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:15:59.509
(r / reveal-01 
      :ARG0 (e / examine-01 
            :ARG0 (t3 / thing 
                  :name (n3 / name 
                        :op1 "L-Sox5")) 
            :ARG1 (i / induce-01 
                  :ARG0 (t4 / thing 
                        :name (n4 / name 
                              :op1 "Bmpr1b")) 
                  :ARG1 (g / gene) 
                  :time (f2 / form-01 
                        :ARG0 (s / structure 
                              :mod-of (c2 / component)) 
                        :ARG1 (d2 / digit 
                              :mod (c4 / chicken)))) 
            :manner (c5 / close)) 
      :ARG1 (t5 / turn-02 
            :ARG0 (t / thing 
                  :name (n / name 
                        :op1 "Chimal-Monroy" 
                        :op2 "et" 
                        :op3 "al.")) 
            :ARG1 (t6 / thing 
                  :name (n5 / name 
                        :op1 "Sox9")) 
            :op1-of (a2 / and 
                  :op2 (f / follow-01 
                        :ARG1 (d / date-entity 
                              :year 2003)) 
                  :op3 (p / person 
                        :name (n2 / name 
                              :op1 "Sox6") 
                        :op2-of (a3 / and 
                              :op1 (t2 / then))) 
                  :op4 (c3 / cartilage 
                        :mod-of (m / matrix))) 
            :op1-of (a / and 
                  :op2 (c / Col2a1))) 
      :time (a4 / addition))

# ::snt These results , together with the altered pattern of gene expression seen in our Bmpr1a-deficient mice , suggest that BMPR1A signaling may normally act to stimulate SOX9 by post-translational protein modification , or to induce L-Sox5 or Sox6 in cartilage to maintain expression of ECM components .
# ::tok These results , together with the altered pattern of gene expression seen in our Bmpr1a-deficient mice , suggest that BMPR1A signaling may normally act to stimulate SOX9 by post-translational protein modification , or to induce L-Sox5 or Sox6 in cartilage to maintain expression of ECM components .
# ::alignments 45-46|0.0 44-45|0.1.1.2.0.2.2.0 42-43|0 41-42|0.1 39-40|0.1.0 37-38|0.1.1.0.0.0.0+0.1.1.0.0.0+0.1.1.0.0 36-37|0.1.1.0 35-36|0.1.1.1.0.0+0.1.1.1.0+0.1.1.1 34-35|0.1.1 32-33|0.1.1.2 30-31|0.1.1.2.0.0 29-30|0.1.1.2.0.0.0 26-27|0.1.1.2.0.1.0.0+0.1.1.2.0.1.0+0.1.1.2.0.1 25-26|0.1.1.2.0 23-24|0.1.1.2.0.2 22-23|0.1.1.2.0.2.2 21-22|0.1.1.2.0.2.1 20-21|0.1.1.2.0.2.0 19-20|0.1.1.2.0.2.0.0.0.0+0.1.1.2.0.2.0.0.0+0.1.1.2.0.2.0.0 17-18|0.1.1.2.0.2.1.0 15-16|0.1.1.2.0.2.1.0.0.0.0.1 13-14|0.1.1.2.0.2.1.0.0.0.0.0 11-12|0.1.1.2.0.2.1.0.0.0.0 10-11|0.1.1.2.0.2.1.0.0.0 9-10|0.1.1.2.0.2.1.0.0.0.1 7-8|0.1.1.2.0.2.1.0.0.0.2 6-7|0.1.1.2.0.2.1.0.0.0.2.0 3-4|0.1.1.2.0.2.1.0.1 1-2|0.1.1.2.0.2.1.0.0.1+0.1.1.2.0.2.1.0.0 0-1|0.1.1.2.0.2.1.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:00.559
(e2 / express-01 
      :ARG1 (c / component) 
      :ARG1-of (m / maintain-01 
            :purpose-of (c2 / cartilage) 
            :purpose-of (i / induce-01 
                  :ARG1 (o / or 
                        :op1 (p / person 
                              :name (n / name 
                                    :op1 "Sox6"))) 
                  :ARG2 (t / thing 
                        :name (n2 / name 
                              :op1 "L-Sox5")) 
                  :op2-of (o2 / or 
                        :op1 (s / stimulate-01 
                              :ARG0 (m2 / modify-01 
                                    :ARG1 (p2 / protein)) 
                              :ARG1 (t2 / thing 
                                    :name (n3 / name 
                                          :op1 "SOX9")) 
                              :ARG1-of (a / act-02 
                                    :ARG0 (s2 / signal-01 
                                          :ARG1 (p4 / person 
                                                :name (n5 / name 
                                                      :op1 "BMPR1A"))) 
                                    :ARG1-of (p3 / possible-01 
                                          :ARG1-of (s3 / suggest-01 
                                                :ARG0 (t4 / thing 
                                                      :ARG1-of (e3 / express-01 
                                                            :ARG1-of (s4 / see-01 
                                                                  :ARG0 (w / we) 
                                                                  :ARG4 (m3 / mouse)) 
                                                            :mod (g / gene) 
                                                            :mod-of (p5 / pattern 
                                                                  :mod (a2 / alter-01))) 
                                                      :ARG2-of (r / result-01) 
                                                      :mod (t5 / this)) 
                                                :mod (t3 / together))) 
                                    :manner (n4 / normal-02 
                                          :ARG1 (e / ecm))))))))

# ::snt These models are consistent with the ability of BMP2 to both increase PKA activity and induce expression of Sox6 in tissue culture cells ( Lee and Chuong 1997 ; Fernandez-Lloris et al. 2003 ) .
# ::tok These models are consistent with the ability of BMP2 to both increase PKA activity and induce expression of Sox6 in tissue culture cells ( Lee and Chuong 1997 ; Fernandez-Lloris et al. 2003 ) .
# ::alignments 32-33|0.3.0+0.3 29-32|0.0.1.0.0.0.2+0.0.1.0.0.0.1+0.0.1.0.0.0.0+0.0.1.0.0.0+0.0.1.0.0 28-29|0.0.1.0 27-28|0.2.1.0.1.0.0+0.2.1.0.1.0 25-26|0.0.1 24-25|0.0.2+0.0.0.0+0.0.0+0.0 22-23|0.1.0 21-22|0.1.0.0 20-21|0.2.0 18-19|0.1.1.0+0.1.1+0.1 16-17|0 15-16|0.2 14-15|0.2.1 13-14|0.2.1.0.1 11-12|0.2.1.0 10-11|0.2.1.0.0 6-7|0.2.1.0.2.0.0 3-4|0.2.1.0.2.0 1-2|0.2.1.0.2 0-1|0.2.1.0.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:01.946
(e / express-01 
      :ARG0 (p / person 
            :name (n2 / name 
                  :op1 "Lee") 
            :op1-of (a2 / and 
                  :op2 (a / and 
                        :op1 (t / thing 
                              :name (n / name 
                                    :op1 "Fernandez-Lloris" 
                                    :op2 "et" 
                                    :op3 "al.")))) 
            :wiki -) 
      :ARG1 (p2 / person 
            :location (c / cell 
                  :mod (c2 / culture)) 
            :name (n3 / name 
                  :op1 "Sox6")) 
      :ARG2-of (i / induce-01 
            :ARG1 (t2 / tissue) 
            :op2-of (a3 / and 
                  :op1 (i2 / increase-01 
                        :ARG0 (b / both) 
                        :ARG1 (a4 / activity-06 
                              :ARG1 (d2 / date-entity 
                                    :year 1997)) 
                        :ARG2 (m / model 
                              :ARG1-of (c3 / consistent-01 
                                    :ARG2 (a5 / ability)) 
                              :mod (t3 / this))))) 
      :time (d / date-entity 
            :year 2003))

# ::snt Although we have tried to monitor the expression of L-Sox5 or Sox6 in postnatal articular cartilage , and test the phosphorylation state of SOX9 using previously described reagents ( Lefebvre et al. 1998 ; Huang et al. 2000 ) , we have been unable to obtain specific signal at the late postnatal stages required ( unpublished data ) .
# ::tok Although we have tried to monitor the expression of L-Sox5 or Sox6 in postnatal articular cartilage , and test the phosphorylation state of SOX9 using previously described reagents ( Lefebvre et al. 1998 ; Huang et al. 2000 ) , we have been unable to obtain specific signal at the late postnatal stages required ( unpublished data ) .
# ::alignments 56-57|0.1.0.2.1.1.0.0 55-56|0.1.0.2.1.1.0.0.0 53-54|0.1.0.2.1.2 52-53|0.1.0.2.1.2.1 51-52|0.1.0.2.1.2.1.0 50-51|0.1.0.2.1.2.1.1 47-48|0.1.0.2.1.1 46-47|0.1.0.2.1.1.0 45-46|0.1.0.2.1 40-41|0.1.0.2.1.0 37-38|0.1.0.2.1.2.1.1.0.0+0.1.0.2.1.2.1.1.0 34-36|0.1.0.0.1.0.0.1+0.1.0.0.1.0.0.0+0.1.0.0.1.0.0+0.1.0.0.1.0 33-34|0.1.0.0.1 32-33|0.1.0.2.1.2.0.0+0.1.0.2.1.2.0 29-32|0.1.0.0.0.0.2+0.1.0.0.0.0.1+0.1.0.0.0.0.0+0.1.0.0.0.0+0.1.0.0.0 27-28|0.1.0.2.0 26-27|0.1.0.0 25-26|0.1.0.0.2 24-25|0.1.0.2 23-24|0.1.0.3.1+0.1.0.3+0.1.0.3.0 21-22|0.1.0 20-21|0.1.0.1 18-19|0.1 17-18|0 15-16|0.0.0.0.1 14-15|0.0.0.0.1.0 13-14|0.0.0.0.1.1 11-12|0.0.0.0.0.0.1.0.0+0.0.0.0.0.0.1.0+0.0.0.0.0.0.1 10-11|0.0.0.0.0.0 9-10|0.0.0.0.0.0.0.0.0+0.0.0.0.0.0.0.0+0.0.0.0.0.0.0 7-8|0.0.0.0.0 5-6|0.0.0.0 3-4|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:06.036
(a2 / and 
      :ARG1-of (t6 / try-01 
            :ARG0 (w2 / we 
                  :ARG0-of (m / monitor-01 
                        :ARG1 (e2 / express-01 
                              :ARG1 (o2 / or 
                                    :op1 (t5 / thing 
                                          :name (n5 / name 
                                                :op1 "L-Sox5")) 
                                    :op2 (p5 / person 
                                          :name (n4 / name 
                                                :op1 "Sox6")))) 
                        :location (c / cartilage 
                              :mod (a3 / articular) 
                              :mod (p4 / postnatal))))) 
      :op1 (t4 / test-01 
            :ARG1 (s4 / state 
                  :ARG0-of (d4 / describe-01 
                        :ARG1 (t2 / thing 
                              :name (n2 / name 
                                    :op1 "Lefebvre" 
                                    :op2 "et" 
                                    :op3 "al.")) 
                        :op1-of (a / and 
                              :op2 (t / thing 
                                    :name (n / name 
                                          :op1 (h / Huang) 
                                          :op2 (e / et)))) 
                        :time (p2 / previous)) 
                  :ARG0-of (p3 / phosphorylate-01) 
                  :ARG0-of (u2 / use-01 
                        :ARG1 (r2 / reagent) 
                        :ARG2 (o / obtain-01 
                              :ARG0 (w / we) 
                              :ARG1 (s2 / signal 
                                    :ARG1-of (s3 / specific-02 
                                          :ARG0 (d / data 
                                                :mod (u / unpublish)))) 
                              :time (r / require-01 
                                    :ARG0 (d3 / date-entity 
                                          :year 1998) 
                                    :ARG1 (s / stage 
                                          :mod (p / postnatal) 
                                          :time (l / late 
                                                :op1 (d2 / date-entity 
                                                      :year 2000)))))) 
                  :name (n3 / name 
                        :name-of (t3 / thing) 
                        :op1 "SOX9"))))

# ::snt Furthermore , null mutations in L-Sox5 or Sox-6 cause lethality at or soon after birth , and no effect on cartilage maintenance has been reported ( Smits et al. 2001 ) .
# ::tok Furthermore , null mutations in L-Sox5 or Sox-6 cause lethality at or soon after birth , and no effect on cartilage maintenance has been reported ( Smits et al. 2001 ) .
# ::alignments 29-30|0.2.2.1.0+0.2.2.1 26-29|0.2.2.0.2+0.2.2.0.1+0.2.2.0.0+0.2.2.0+0.2.2 24-25|0.2.1 21-22|0.2.1.1.0 20-21|0.2.1.1.0.1 18-19|0.2.1.1 17-18|0.2.1.1.1 16-17|0.2 14-15|0.3.0 13-14|0.3 12-13|0.2.0 11-12|0.1 9-10|0.0 8-9|0 6-7|0.2.1.0.0 5-6|0.2.1.0.0.0.0.0+0.2.1.0.0.0.0+0.2.1.0.0.0 3-4|0.2.1.0 2-3|0.2.1.0.1 0-1|0.2.1.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:06.426
(c2 / cause-01 
      :ARG1 (l / lethality) 
      :op1-of (o / or) 
      :op1-of (a / and 
            :op2 (s / soon) 
            :op3 (r / report-01 
                  :ARG0 (m2 / mutate-01 
                        :ARG1 (o2 / or 
                              :op1 (t2 / thing 
                                    :name (n2 / name 
                                          :op1 "L-Sox5"))) 
                        :ARG1-of (n3 / null-02)) 
                  :ARG1 (e / effect-03 
                        :ARG1 (m / maintain-01 
                              :ARG0 (f / furthermore) 
                              :ARG1 (c / cartilage)) 
                        :polarity -)) 
            :op4 (t / thing 
                  :name (n / name 
                        :op1 "Smits" 
                        :op2 "et" 
                        :op3 "al.") 
                  :time (d / date-entity 
                        :year 2001))) 
      :time (a2 / after 
            :op1 (b / birth-01)))

# ::snt However , it seems likely that these or other processes regulated by BMP signaling cooperate with SOX9 to induce target genes in articular cartilage .
# ::tok However , it seems likely that these or other processes regulated by BMP signaling cooperate with SOX9 to induce target genes in articular cartilage .
# ::alignments 23-24|0.0.0.1.1.0.0.0.0.0 22-23|0.0.0.1.1.0.0.0.0.1 20-21|0.0.0.1.1 19-20|0.0.0.1.1.0 18-19|0.0.0.1 16-17|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 14-15|0.0.0 13-14|0.0.0.1.1.0.0 12-13|0.0.0.1.1.0.0.1.0.0+0.0.0.1.1.0.0.1.0+0.0.0.1.1.0.0.1 10-11|0.0.0.1.1.0.0.0 9-10|0.0.0.1.1.0.0.0.0 8-9|0.0.0.1.1.0.0.0.0.2 7-8|0.0.0.1.0 6-7|0.0.0.2 4-5|0.0 3-4|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:06.842
(s2 / seem-01 
      :ARG1 (l / likely-01 
            :ARG1 (c2 / cooperate-01 
                  :ARG1 (t2 / thing 
                        :name (n / name 
                              :op1 "SOX9")) 
                  :ARG2 (i / induce-01 
                        :ARG0 (o3 / or) 
                        :ARG1 (g / gene 
                              :ARG1-of (t / target-01 
                                    :ARG3-of (s / signal-01 
                                          :ARG0-of (r / regulate-01 
                                                :ARG1 (p / process-02 
                                                      :ARG0 (c / cartilage) 
                                                      :ARG1 (a / articular) 
                                                      :mod (o2 / other))) 
                                          :ARG1 (o / organization 
                                                :name (n2 / name 
                                                      :op1 "BMP")))))) 
                  :mod (t3 / this))))

# ::snt Mutation of Smad3 or expression of dominant negative transforming growth factor  ( TGF- ) type II receptor also disrupts normal articular cartilage maintenance ( Serra et al. 1997 ; Yang et al. 2001 ) .
# ::tok Mutation of Smad3 or expression of dominant negative transforming growth factor  ( TGF- ) type II receptor also disrupts normal articular cartilage maintenance ( Serra et al. 1997 ; Yang et al. 2001 ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:06.844
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Both manipulations should disrupt TGF rather than BMP signaling , and both manipulations cause articular cartilage to hypertrophy and be replaced by bone .
# ::tok Both manipulations should disrupt TGF rather than BMP signaling , and both manipulations cause articular cartilage to hypertrophy and be replaced by bone .
# ::alignments 22-23|0 20-21|0.0 18-19|0.0.1 17-18|0.0.1.2 15-16|0.0.0 13-14|0.0.1.0 12-13|0.0.1.0.0 11-12|0.0.1.0.0.0 10-11|0.0.1.0.1 8-9|0.0.1.0.1.1 7-8|0.0.1.0.1.1.0.0.0+0.0.1.0.1.1.0.0+0.0.1.0.1.1.0 4-5|0.0.1.0.1.0.0.1.0.0+0.0.1.0.1.0.0.1.0+0.0.1.0.1.0.0.1 3-4|0.0.1.0.1.0.0 2-3|0.0.1.0.1.0 1-2|0.0.1.0.1.0.0.0 0-1|0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:07.189
(b / bone 
      :ARG0-of (r / replace-01 
            :ARG1 (c / cartilage) 
            :op2-of (a / and 
                  :ARG1-of (c2 / cause-01 
                        :ARG0 (m / manipulation 
                              :mod (b2 / both)) 
                        :op3-of (a2 / and 
                              :op1 (r2 / recommend-01 
                                    :ARG1 (d / disrupt-01 
                                          :ARG0 (m2 / manipulation) 
                                          :ARG1 (o2 / organization 
                                                :name (n2 / name 
                                                      :op1 "TGF")))) 
                              :op2 (s / signal-01 
                                    :ARG0 (o / organization 
                                          :name (n / name 
                                                :op1 "BMP"))))) 
                  :mod (b3 / both) 
                  :op1 (h / hypertrophy))))

# ::snt In contrast , our analysis of Bmpr1a mutant articular cartilage showed a loss of ECM components , but no signs of hypertrophy or bone replacement .
# ::tok In contrast , our analysis of Bmpr1a mutant articular cartilage showed a loss of ECM components , but no signs of hypertrophy or bone replacement .
# ::alignments 24-25|0.1.0.1.0 23-24|0.1.0.1 22-23|0.1.0 21-22|0.1.0.0 19-20|0.1 18-19|0.0.0.1.0 17-18|0 15-16|0.0.1 14-15|0.0.1.0 12-13|0.0 10-11|0.0.0 9-10|0.0.0.0.1 8-9|0.0.0.0.1.0 7-8|0.0.0.0.1.1 6-7|0.1.0.1.0.0.0.0+0.1.0.1.0.0.0+0.1.0.1.0.0 4-5|0.0.0.0 3-4|0.0.0.0.0 1-2|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:07.821
(c / contrast-01 
      :ARG1 (l / loss 
            :ARG1-of (s2 / show-01 
                  :ARG0 (a2 / analyze-01 
                        :ARG0 (w / we) 
                        :ARG1 (c3 / cartilage 
                              :mod (a / articular) 
                              :mod (m / mutant))) 
                  :ARG1-of (c4 / contrast-01 
                        :compared-to -)) 
            :mod (c2 / component 
                  :mod (e / ecm))) 
      :ARG2 (s / sign 
            :poss (o / or 
                  :op1 (h / hypertrophy) 
                  :op2 (b / bone 
                        :mod-of (r / replace-01 
                              :ARG2 (p / person 
                                    :name (n / name 
                                          :op1 "Bmpr1a")))))))

# ::snt Therefore , TGF and BMP signaling are playing distinct but necessary roles to maintain articular cartilage .
# ::tok Therefore , TGF and BMP signaling are playing distinct but necessary roles to maintain articular cartilage .
# ::alignments 15-16|0.1.1 14-15|0.1.1.0 13-14|0.1 11-12|0.1.2 9-10|0 8-9|0.0 7-8|0.1.0.0 5-6|0.1.0.0.1 4-5|0.1.0.0.0.0.0.0+0.1.0.0.0.0.0+0.1.0.0.0.0 3-4|0.1.0.0.0 2-3|0.1.0.1.0+0.1.0.1+0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:08.728
(c2 / contrast-01 
      :ARG1 (d / distinct) 
      :purpose (m / maintain-01 
            :ARG0 (o2 / organization 
                  :ARG1-of (p / play-01 
                        :ARG0 (a2 / and 
                              :op1 (o / organization 
                                    :name (n / name 
                                          :op1 "BMP"))) 
                        :ARG1-of (s / signal-01)) 
                  :name (n2 / name 
                        :op1 "TGF")) 
            :ARG1 (c / cartilage 
                  :mod (a / articular)) 
            :purpose-of (r / role)))

# ::snt Although BMPs were originally isolated on the basis of their ability to induce ectopic bone formation , their presence in articular cartilage and strong effect on cartilage formation has stimulated interest in using them to repair or regenerate cartilage defects in adult animals ( Chang et al. 1994 ; Erlacher et al. 1998 ; Edwards and Francis-West 2001 ; Chubinskaya and Kuettner 2003 ) .
# ::tok Although BMPs were originally isolated on the basis of their ability to induce ectopic bone formation , their presence in articular cartilage and strong effect on cartilage formation has stimulated interest in using them to repair or regenerate cartilage defects in adult animals ( Chang et al. 1994 ; Erlacher et al. 1998 ; Edwards and Francis-West 2001 ; Chubinskaya and Kuettner 2003 ) .
# ::alignments 62-63|0.0.0.0.0.0.0.0.0.0.1.1.1.0.0+0.0.0.0.0.0.0.0.0.0.1.1.1.0 60-61|0.0.0.0.0.0.0.1.2.1 57-58|0.0.0.0.0.0.0.0.0.0.1.0.0+0.0.0.0.0.0.0.0.0.0.1.0 55-56|0.0.0.0.0.0.0.1.2.1.0.1 54-55|0.0.0.0.0.0.0.1.2.1.0.1.0 52-53|0.0.0.0.0.0.0.1.1.0.2.0+0.0.0.0.0.0.0.1.1.0.2 49-51|0.0.0.0.0.0.0.1.2.0.0.1+0.0.0.0.0.0.0.1.2.0.0.0+0.0.0.0.0.0.0.1.2.0.0+0.0.0.0.0.0.0.1.2.0 48-49|0.0.0.0.0.0.0.1.2 47-48|0.0.0.0.0.0.0.1.2.1.0.1.1.0+0.0.0.0.0.0.0.1.2.1.0.1.1 44-47|0.0.0.0.0.0.0.1.2.1.0.0.2+0.0.0.0.0.0.0.1.2.1.0.0.1+0.0.0.0.0.0.0.1.2.1.0.0.0+0.0.0.0.0.0.0.1.2.1.0.0+0.0.0.0.0.0.0.1.2.1.0 42-43|0.0.0.0.0.0.0.0.0.0.1.1.2 41-42|0.0.0.0.0.0.0.1.1.0.0 39-40|0.0.0.0.0.0.0.0.0.0.1.1 38-39|0.0.0.0.0.0.0.0.0.0.1.1.0 37-38|0.0.0.0.0.0.0.0.0.0.1.1.1 36-37|0.0.0.0.0.0.0.0.0.0.0 35-36|0.0.0.0.0.0.0.0.0.0.1 32-33|0.0.0.0.0.0.0.0.0.0 30-31|0.0.0.0.0.0.0.0 29-30|0.0.0.0.0.0.0.0.0 27-28|0.0.0.0.0.0.0.1.1.0 26-27|0.0.0.0.0.0.0.1.1.0.1 24-25|0.0.0.0.0.0.0.1.1 23-24|0.0.0.0.0.0.0.1.1.1 22-23|0.0.0.0.0.0.0.1 21-22|0.0.0.0.0.0.0.1.0 20-21|0.0.0.0.0.0.0.1.0.0 18-19|0.0.0.0.0.0.0 15-16|0.0 14-15|0 13-14|0.0.1 12-13|0.0.0 10-11|0.0.0.0 4-5|0.0.0.0.0.0 3-4|0.0.0.0.0.0.1 1-2|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:11.508
(b / bone 
      :ARG1-of (f2 / form-01 
            :ARG1-of (i2 / induce-01 
                  :purpose-of (a8 / ability 
                        :poss (b2 / bmp 
                              :ARG1-of (i3 / isolate-01 
                                    :ARG0 (p / presence 
                                          :ARG1-of (i / interest-01 
                                                :ARG1-of (s / stimulate-01 
                                                      :ARG2 (u / use-01 
                                                            :ARG1 (o / or) 
                                                            :ARG2 (r2 / repair-01 
                                                                  :ARG0 (d2 / date-entity 
                                                                        :year 2001) 
                                                                  :ARG1 (d5 / defect-01 
                                                                        :ARG1 (c / cartilage) 
                                                                        :ARG1-of (r / regenerate-01 
                                                                              :ARG0 (d / date-entity 
                                                                                    :year 2003)) 
                                                                        :location (a4 / animal)))))) 
                                          :location (a6 / and 
                                                :op1 (c3 / cartilage 
                                                      :mod (a7 / articular)) 
                                                :op2 (e4 / effect-03 
                                                      :ARG1 (f / form-01 
                                                            :ARG0 (a5 / adult) 
                                                            :ARG1 (c2 / cartilage) 
                                                            :time (d3 / date-entity 
                                                                  :year 1998)) 
                                                      :ARG1-of (s2 / strong-02)) 
                                                :op3 (a3 / and 
                                                      :op1 (t / thing 
                                                            :name (n / name 
                                                                  :op1 (e2 / Erlacher) 
                                                                  :op2 (e3 / et))) 
                                                      :op2-of (a / and 
                                                            :op1 (t2 / thing 
                                                                  :name (n2 / name 
                                                                        :op1 "Chang" 
                                                                        :op2 "et" 
                                                                        :op3 "al.") 
                                                                  :op1-of (a2 / and 
                                                                        :op2 (e / edward) 
                                                                        :time (d4 / date-entity 
                                                                              :year 1994))))))) 
                                    :mod (o2 / original))))) 
            :mod (e5 / ectopic)))

# ::snt The failure to maintain articular cartilage in the absence of normal BMPR1A function suggests that ligands or small molecule agonists that interact specifically with this receptor subtype may be particularly good candidates for designing new approaches to maintain or heal articular cartilage at postnatal stages .
# ::tok The failure to maintain articular cartilage in the absence of normal BMPR1A function suggests that ligands or small molecule agonists that interact specifically with this receptor subtype may be particularly good candidates for designing new approaches to maintain or heal articular cartilage at postnatal stages .
# ::alignments 44-45|0.0.1.0.0.0.2 43-44|0.0.1.0.0.0.2.0 41-42|0.0.1.0.0.0.0 40-41|0.0.1.0.0.0.0.1 39-40|0.0.1.0.0.0.0.0 38-39|0.0.1.0.0.0.0.0.0 37-38|0.0.1.0.0.0 35-36|0.0.1.0.0.0.1.0 34-35|0.0.1.0.0.0.1.0.0 33-34|0.0.1.0.0.0.1 31-32|0.0.1.0.0 30-31|0.0.1.0 29-30|0.2.0.1.0 27-28|0.0.1 26-27|0.2.0.0 25-26|0.2.0.0.0 24-25|0.2.0.0.1 22-23|0.2.0.1 21-22|0.2.0 19-20|0.2 18-19|0.2.2 17-18|0.2.1 16-17|0 15-16|0.1 13-14|0.0 12-13|0.0.0.0.1.0 11-12|0.0.0.0.1.0.0.0.0+0.0.0.0.1.0.0.0+0.0.0.0.1.0.0 10-11|0.0.0.0.1.0.1 8-9|0.0.0.0.1 5-6|0.0.0.0.0 4-5|0.0.0.0.0.0 3-4|0.0.0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:13.252
(o2 / or 
      :op1 (s5 / suggest-01 
            :ARG0 (f2 / fail-01 
                  :ARG2 (m3 / maintain-01 
                        :ARG1 (c3 / cartilage 
                              :mod (a5 / articular)) 
                        :location (a4 / absent-01 
                              :ARG1 (f / function-01 
                                    :ARG0 (o3 / organization 
                                          :name (n2 / name 
                                                :op1 "BMPR1A")) 
                                    :ARG1 (n3 / normal-02))))) 
            :ARG1 (p3 / possible-01 
                  :ARG1 (g / good 
                        :mod-of (c2 / candidate 
                              :ARG0-of (m / maintain-01 
                                    :ARG1 (c / cartilage 
                                          :ARG1-of (h / heal-01 
                                                :op1-of (o / or)) 
                                          :mod (a / articular)) 
                                    :purpose-of (d / design-01 
                                          :ARG1 (a2 / approach-02 
                                                :mod (n / new))) 
                                    :time (s / stage 
                                          :mod (p / postnatal))))))) 
      :op2 (l / ligand) 
      :op3 (a3 / agonist 
            :ARG0-of (i / interact-01 
                  :ARG1 (s2 / subtype 
                        :mod (r / receptor) 
                        :mod (t / this)) 
                  :manner (s3 / specific-02 
                        :ARG1 (p2 / particular))) 
            :mod (s4 / small) 
            :mod (m2 / molecule)))

# ::snt Lack of Bmpr1a function in articular cartilage results in severe fibrillation of the articular surface and loss of joint mobility .
# ::tok Lack of Bmpr1a function in articular cartilage results in severe fibrillation of the articular surface and loss of joint mobility .
# ::alignments 19-20|0.0.0.1.2.0 18-19|0.0.0.1.2.0.0 16-17|0.0.0.1.2 15-16|0.0.0.1 14-15|0.0.0.1.1 13-14|0.0.0.1.1.0 10-11|0.0.0.1.0 9-10|0.0.0.1.0.0 7-8|0.1.0+0.1 6-7|0.1.0.0 5-6|0.1.0.1 3-4|0 2-3|0.0.0.0.0+0.0.0.0+0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:13.546
(f2 / function-01 
      :ARG0 (l2 / lack-01 
            :ARG1 (p / person 
                  :name (n / name 
                        :op1 "Bmpr1a") 
                  :op1-of (a / and 
                        :op2 (f / fibrillation 
                              :mod (s2 / severe)) 
                        :op3 (s / surface 
                              :mod (a2 / articular)) 
                        :op4 (l / loss 
                              :poss (m / mobility 
                                    :mod (j / joint)))))) 
      :ARG1 (t / thing 
            :ARG2-of (r / result-01 
                  :ARG1 (c / cartilage) 
                  :mod (a3 / articular))))

# ::snt The development of severe arthritis symptoms in Bmpr1a-deficient mice raises the possibility that defects in BMP signaling also contribute to human joint disease .
# ::tok The development of severe arthritis symptoms in Bmpr1a-deficient mice raises the possibility that defects in BMP signaling also contribute to human joint disease .
# ::alignments 22-23|0.1.0.1 21-22|0.1.0.1.1 20-21|0.1.0.1.0 18-19|0.1.0 17-18|0.1.0.2 16-17|0 15-16|0.0.0.0+0.0.0+0.0 13-14|0.1 11-12|0.1.0.0 9-10|0.1.0.0.0 8-9|0.1.0.0.0.0.0.1 5-6|0.1.0.0.0.0.0 4-5|0.1.0.0.0.0.0.0 3-4|0.1.0.0.0.0.0.2 1-2|0.1.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:13.804
(s / signal-01 
      :ARG0 (o / organization 
            :name (n / name 
                  :op1 "BMP")) 
      :ARG1-of (d2 / defect-01 
            :ARG1-of (c / contribute-01 
                  :ARG1-of (p / possible-01 
                        :ARG1-of (r / raise-01 
                              :ARG0 (d3 / develop-02 
                                    :ARG1 (s2 / symptom 
                                          :mod (a2 / arthritis) 
                                          :mod (m / mouse) 
                                          :mod (s3 / severe))))) 
                  :ARG2 (d / disease 
                        :mod (h / human) 
                        :mod (j / joint)) 
                  :mod (a / also))))

# ::snt Osteoarthritis is known to have a significant genetic component , but it likely involves multiple genetic factors that have been difficult to identify ( Spector et al. 1996 ; Felson et al. 1998 ; Hirsch et al. 1998 ) .
# ::tok Osteoarthritis is known to have a significant genetic component , but it likely involves multiple genetic factors that have been difficult to identify ( Spector et al. 1996 ; Felson et al. 1998 ; Hirsch et al. 1998 ) .
# ::alignments 37-38|0.1.1.0.0.0.0+0.1.1.0.0.0 32-33|0.1.1.0.0.1.0+0.1.1.0.0.1 29-31|0.1.1.1.0.1.0.1+0.1.1.1.0.1.0.0+0.1.1.1.0.1.0+0.1.1.1.0.1 28-29|0.1.1.1.0 27-28|0.1.0.0.0.0+0.1.0.0.0 24-27|0.1.2.0.0.2+0.1.2.0.0.1+0.1.2.0.0.0+0.1.2.0.0+0.1.2.0 22-23|0.1.1.0.0 20-21|0.1.1.0 16-17|0.1.1 15-16|0.1.1.1 14-15|0.1.1.1.0.0 13-14|0.1 12-13|0.1.2 10-11|0 8-9|0.1.0 7-8|0.1.0.1 6-7|0.1.0.0 2-3|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:15.072
(c / contrast-01 
      :ARG1 (k / know-02 
            :ARG1 (o / osteoarthriti)) 
      :ARG2 (i2 / involve-01 
            :ARG0 (c2 / component 
                  :ARG1-of (s / significant-02 
                        :ARG0 (d3 / date-entity 
                              :year 1996)) 
                  :mod (g2 / gene)) 
            :ARG1 (f2 / factor 
                  :mod (d4 / difficult 
                        :domain (i / identify-01 
                              :ARG0 (d / date-entity 
                                    :year 1998) 
                              :ARG1 (d2 / date-entity 
                                    :year 1998))) 
                  :mod (g / gene 
                        :op2-of (a / and 
                              :op1 (m / multiple) 
                              :op3 (t / thing 
                                    :name (n / name 
                                          :op1 (f / Felson) 
                                          :op2 (e / et)))))) 
            :ARG1-of (l / likely-01 
                  :ARG0 (t2 / thing 
                        :name (n2 / name 
                              :op1 "Spector" 
                              :op2 "et" 
                              :op3 "al.")))))

# ::snt Humans that are heterozygous for loss-of-function mutations in BMPR1A are known to be at risk for juvenile polyposis ( Howe et al. 2001 ; Zhou et al. 2001 ) , but the risk of osteoarthritis for these people has not been reported .
# ::tok Humans that are heterozygous for loss-of-function mutations in BMPR1A are known to be at risk for juvenile polyposis ( Howe et al. 2001 ; Zhou et al. 2001 ) , but the risk of osteoarthritis for these people has not been reported .
# ::alignments 41-42|0.0 39-40|0.1.0.0.0.0 37-38|0.0.1.0 36-37|0.0.1.0.0 34-35|0.0.1.2 32-33|0.0.1 30-31|0 27-28|0.1.0.0.0.1.0+0.1.0.0.0.1 24-26|0.1.1.0.1+0.1.1.0.0+0.1.1.0+0.1.1 23-24|0.1 22-23|0.0.0.0+0.0.0 19-22|0.0.1.1.0.2+0.0.1.1.0.1+0.0.1.1.0.0+0.0.1.1.0+0.0.1.1 17-18|0.1.0.0 16-17|0.1.0 14-15|0.1.0.0.0 10-11|0.2 8-9|0.2.0.0.0.0+0.2.0.0.0+0.2.0.0 6-7|0.2.0 3-4|0.2.1.0 0-1|0.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:16.008
(c / contrast-01 
      :ARG1 (r / report-01 
            :ARG0 (d2 / date-entity 
                  :year 2001) 
            :ARG1 (r2 / risk-01 
                  :ARG0 (p / person 
                        :mod (t / this)) 
                  :ARG1 (t3 / thing 
                        :name (n2 / name 
                              :op1 "Howe" 
                              :op2 "et" 
                              :op3 "al.")) 
                  :ARG2 (o / osteoarthriti))) 
      :ARG2 (a / and 
            :op1 (j / juvenile 
                  :mod-of (p2 / polyposi 
                        :ARG2-of (r3 / risk-01 
                              :ARG0 - 
                              :ARG1 (d / date-entity 
                                    :year 2001)))) 
            :op2 (t2 / thing 
                  :name (n / name 
                        :op1 (z / Zhou) 
                        :op2 (e / et)))) 
      :ARG3-of (k / know-02 
            :ARG0-of (m / mutate-01 
                  :location (c2 / country 
                        :name (n3 / name 
                              :op1 "BMPR1A"))) 
            :ARG1 (h2 / human 
                  :domain-of (h / heterozygou))))

# ::snt However , the control mice used in this study were heterozygous for a null allele of Bmpr1a , and they showed little sign of osteoarthritis even late in life .
# ::tok However , the control mice used in this study were heterozygous for a null allele of Bmpr1a , and they showed little sign of osteoarthritis even late in life .
# ::alignments 28-29|0.0.0.1.0 26-27|0.1.2 25-26|0.0.0.0.0.0 24-25|0.1.1.0 22-23|0.1.1 21-22|0.1.1.2 20-21|0.1 19-20|0.1.0 18-19|0 16-17|0.1.1.1.0.0+0.1.1.1.0+0.1.1.1 14-15|0.0.0.0.0.1.0 13-14|0.0.0.0.0.1 10-11|0.0 8-9|0.0.0.0.0 7-8|0.0.0.0.0.2 5-6|0.0.0.0 4-5|0.0.0 3-4|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:16.657
(a / and 
      :op1 (h / heterozygou 
            :domain (m / mouse 
                  :ARG1-of (u / use-01 
                        :ARG2 (s3 / study-01 
                              :ARG1 (e / even) 
                              :ARG1-of (n2 / null-02 
                                    :ARG0 (a2 / allele)) 
                              :mod (t2 / this))) 
                  :mod (c / control-01 
                        :ARG1 (l / life)))) 
      :op2 (s2 / show-01 
            :ARG0 (t / they) 
            :ARG1 (s / sign-02 
                  :ARG1 (o / osteoarthriti) 
                  :mod (p / person 
                        :name (n / name 
                              :op1 "Bmpr1a")) 
                  :mod (l3 / little)) 
            :time (l2 / late)))

# ::snt Several chromosome regions have been previously linked to arthritis phenotypes in humans using either association studies in populations or linkage studies in families .
# ::tok Several chromosome regions have been previously linked to arthritis phenotypes in humans using either association studies in populations or linkage studies in families .
# ::alignments 22-23|0.0.0.1 20-21|0.2 19-20|0.2.0 18-19|0 17-18|0.1 15-16|0.0 14-15|0.0.1 13-14|0.0.2 12-13|0.0.0 11-12|0.0.0.0 9-10|0.0.0.2.1 8-9|0.0.0.2.2 6-7|0.0.0.2 5-6|0.0.0.2.3 2-3|0.0.0.2.0 1-2|0.0.0.2.0.0 0-1|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:17.366
(o / or 
      :ARG1-of (s2 / study-01 
            :ARG1-of (u / use-01 
                  :ARG0 (h / human) 
                  :ARG2 (f / family) 
                  :manner-of (l2 / link-01 
                        :ARG1 (r / region 
                              :mod (c / chromosome)) 
                        :ARG2 (p2 / phenotyp) 
                        :purpose (a2 / arthritis) 
                        :time (p3 / previous))) 
            :ARG2 (a / associate-01 
                  :ARG1 (s3 / several)) 
            :mod (e / either)) 
      :op1 (p / population) 
      :op2 (s / study-01 
            :ARG1 (l / linkage)))

# ::snt It is interesting to note that several of these chromosome regions contain genes encoding different members of the BMP signaling pathway , including the BMP5 gene on human chromosome 6p12 ( Loughlin et al. 2002 ) , the MADH1 gene on human chromosome 4q26 -- 4q31 ( Leppavuori et al. 1999 ; Kent et al. 2002 ) , and the BMPR2 receptor on human chromosome 2q33 ( Wright et al. 1996 ) .
# ::tok It is interesting to note that several of these chromosome regions contain genes encoding different members of the BMP signaling pathway , including the BMP5 gene on human chromosome 6p12 ( Loughlin et al. 2002 ) , the MADH1 gene on human chromosome 4q26 -- 4q31 ( Leppavuori et al. 1999 ; Kent et al. 2002 ) , and the BMPR2 receptor on human chromosome 2q33 ( Wright et al. 1996 ) .
# ::alignments 70-71|0.0.0.0.0.2.0+0.0.0.0.0.2 67-68|0.0.0.0.0.3 65-66|0.0.2.1.2.1.1 64-65|0.0.2.1.2.1 63-64|0.0.2.1.2.1.0 61-62|0.0.2.1.2 60-61|0.0.2.1.2.0 58-59|0.0.2.1 55-56|0.4.0+0.4 52-53|0.3 51-52|0 50-51|0.2.0+0.2 47-49|0.0.0.0.0.0.0.1+0.0.0.0.0.0.0.0+0.0.0.0.0.0.0+0.0.0.0.0.0 45-46|0.1 43-44|0.0.1.0.0.0 42-43|0.0.1.0.0 41-42|0.0.1.0 39-40|0.0.2.1.1 34-35|0.0.2.0.0.2.0+0.0.2.0.0.2 31-34|0.0.2.0.0.1.1.0.0.2+0.0.2.0.0.1.1.0.0.1+0.0.2.0.0.1.1.0.0.0+0.0.2.0.0.1.1.0.0+0.0.2.0.0.1.1.0 29-30|0.0.2.1.0 28-29|0.0.2.1.0.0 27-28|0.0.2.1.0.0.0 25-26|0.0.2.0.0.1.1.1.0 24-25|0.0.2.0.0.1.1.1.1.0+0.0.2.0.0.1.1.1.1+0.0.2.0.0.1.1.1 20-21|0.0.0.0.0.1 19-20|0.0.0.0.0 18-19|0.0.0.0.1.0+0.0.0.0.1+0.0.0.0 15-16|0.0.0.1+0.0.0+0.0 14-15|0.0.1 13-14|0.0.2 12-13|0.0.2.0 11-12|0.0.2.0.0 10-11|0.0.2.0.0.0 9-10|0.0.2.0.0.0.0 8-9|0.0.2.0.0.0.1 6-7|0.0.1.1 4-5|0.0.2.0.0.1 2-3|0.0.2.0.0.1.1 0-1|0.0.2.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:22.024
(a2 / and 
      :op1 (p2 / person 
            :ARG0-of (h4 / have-org-role-91 
                  :ARG1 (o / organization 
                        :ARG1-of (s / signal-01 
                              :ARG0 (t / thing 
                                    :name (n / name 
                                          :op1 (l / Leppavuori) 
                                          :op2 (e / et))) 
                              :manner (p / pathway) 
                              :op1-of (d / date-entity 
                                    :year 1996) 
                              :op1-of (w / wright)) 
                        :name (n4 / name 
                              :op1 "BMP")) 
                  :ARG2 (m / member)) 
            :ARG1-of (d5 / differ-02 
                  :ARG0 (h2 / human 
                        :mod-of (c2 / chromosome 
                              :mod-of 4q26)) 
                  :topic-of (s2 / several)) 
            :ARG1-of (e2 / encode-01 
                  :ARG0 (g3 / gene 
                        :ARG1-of (c5 / contain-01 
                              :ARG0 (r2 / region 
                                    :mod (c6 / chromosome) 
                                    :mod (t3 / this)) 
                              :ARG1-of (n5 / note-01 
                                    :ARG0 (i2 / it) 
                                    :ARG2-of (i / interest-01 
                                          :ARG0 (t2 / thing 
                                                :name (n2 / name 
                                                      :op1 "Loughlin" 
                                                      :op2 "et" 
                                                      :op3 "al.")) 
                                          :ARG1 (c4 / country 
                                                :mod-of (g2 / gene) 
                                                :name (n3 / name 
                                                      :op1 "BMP5")))) 
                              :ARG2 (d4 / date-entity 
                                    :year 2002))) 
                  :ARG2 (a / and 
                        :op1 (6 / 6p12 
                              :mod (c3 / chromosome 
                                    :mod (h3 / human))) 
                        :op2 (g / gene) 
                        :op3 (r / receptor 
                              :mod (b / BMPR2) 
                              :source (c / chromosome 
                                    :mod (h / human) 
                                    :mod-of 2q33))))) 
      :op2 4q31 
      :op3 (d3 / date-entity 
            :year 1999) 
      :op4 (k / ken) 
      :op5 (d2 / date-entity 
            :year 2002))

# ::snt The complex nature of human osteoarthritis suggests that interactions between multiple genes may be involved in modifying susceptibility to the disease .
# ::tok The complex nature of human osteoarthritis suggests that interactions between multiple genes may be involved in modifying susceptibility to the disease .
# ::alignments 20-21|0.1.0.1.2 17-18|0.1.0.1.1 16-17|0.1.0.1 14-15|0.1.0 12-13|0.1 11-12|0.1.0.1.0 10-11|0.1.0.1.0.0 8-9|0.1.0.0 6-7|0 5-6|0.0.1 4-5|0.0.1.0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:22.499
(s2 / suggest-01 
      :ARG0 (n / nature 
            :mod (c / complex) 
            :mod (o / osteoarthriti 
                  :mod (h / human))) 
      :ARG1 (p / possible-01 
            :ARG1 (i / involve-01 
                  :ARG1 (i2 / interaction) 
                  :ARG2 (m / modify-01 
                        :ARG0 (g / gene 
                              :quant (m2 / multiple)) 
                        :ARG1 (s / susceptibility) 
                        :ARG2 (d / disease)))))

# ::snt The inclusion of genetic markers near BMP signaling components may help identify additional osteoarthritis susceptibility loci and facilitate the search for causative mutations .
# ::tok The inclusion of genetic markers near BMP signaling components may help identify additional osteoarthritis susceptibility loci and facilitate the search for causative mutations .
# ::alignments 22-23|0.0.1.2.0.0.1 21-22|0.0.1.2.0.0.1.1 19-20|0.0.1.2.0.0 17-18|0.0.1.2.0 16-17|0.0.1.2 15-16|0.0.1.0 14-15|0.0.1.0.0.0 13-14|0.0.1.2.0.0.1.0 12-13|0.0.1.0.0 11-12|0.0.1 10-11|0.0 9-10|0 8-9|0.0.1.1.0.0 7-8|0.0.1.1.0 6-7|0.0.1.1.1.0+0.0.1.1.1+0.0.1.1 5-6|0.0.1.1.0.0.0 4-5|0.0.1.1.0.0.0.0 3-4|0.0.1.2.0.0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:23.163
(p / possible-01 
      :ARG1 (h / help-01 
            :ARG0 (i2 / inclusion) 
            :ARG1 (i / identify-01 
                  :ARG1 (l / locus 
                        :mod (a2 / additional 
                              :mod-of (s2 / susceptibility))) 
                  :ARG4 (o2 / organization 
                        :ARG0-of (s3 / signal-01 
                              :ARG1 (c2 / component 
                                    :ARG2-of (n2 / near-02 
                                          :ARG1 (m2 / marker)))) 
                        :name (n / name 
                              :op1 "BMP")) 
                  :op1-of (a / and 
                        :op2 (f / facilitate-01 
                              :ARG1 (s / search-01 
                                    :ARG1 (g / gene) 
                                    :ARG2 (m / mutate-01 
                                          :ARG1 (o / osteoarthriti) 
                                          :mod (c / causative))))))))

# ::snt Development and disease processes in synovial joints have been difficult to study genetically , because synovial joints are generated and function at relatively late stages of vertebrate development .
# ::tok Development and disease processes in synovial joints have been difficult to study genetically , because synovial joints are generated and function at relatively late stages of vertebrate development .
# ::alignments 27-28|0.0.0.1.1.0 26-27|0.0.0.1.1.0.0 24-25|0.0.0.1.1 23-24|0.0.0.1.1.1 22-23|0.0.0.1.1.1.0 20-21|0.0.0.1 19-20|0.0.0 18-19|0.0.0.0 16-17|0.0.0.1.0 15-16|0.0.0.1.0.0 14-15|0.0 12-13|0.1.1 11-12|0.1 9-10|0 6-7|0.1.0.0.1 5-6|0.1.0.0.1.0 3-4|0.1.0.0 2-3|0.1.0.0.0 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:23.633
(d2 / difficult 
      :ARG1-of (c / cause-01 
            :ARG0 (a / and 
                  :op1 (g / generate-01) 
                  :op2 (f / function-01 
                        :ARG1 (j / joint 
                              :mod (s2 / synovial)) 
                        :ARG2 (s / stage 
                              :mod-of (d / develop-02 
                                    :ARG1 (v / vertebrate)) 
                              :time (l / late 
                                    :degree (r / relative)))))) 
      :domain (s3 / study-01 
            :ARG0 (a2 / and 
                  :op1 (p / process-02 
                        :ARG1 (d3 / disease) 
                        :ARG2 (j2 / joint 
                              :mod (s4 / synovial)))) 
            :ARG1 (g2 / genetics)))

# ::snt The Gdf5-Cre system provides a new method for restricting gene expression or inactivation primarily to articular regions , thus avoiding the pleiotropic functions of many genes in other tissues .
# ::tok The Gdf5-Cre system provides a new method for restricting gene expression or inactivation primarily to articular regions , thus avoiding the pleiotropic functions of many genes in other tissues .
# ::alignments 28-29|0.1.0 27-28|0.1.0.0 25-26|0.0.3.0.0 24-25|0.0.3.0.0.0 22-23|0.0.3.0 19-20|0.0.3 18-19|0.0.3.1 16-17|0.0.1 15-16|0.0.1.0 13-14|0.0.2 12-13|0.2 11-12|0 10-11|0.1 9-10|0.1.1 8-9|0.0 6-7|0.0.0 5-6|0.0.0.1 3-4|0.0.0.0 2-3|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:24.173
(o2 / or 
      :ARG1-of (r2 / restrict-01 
            :ARG0 (m2 / method 
                  :ARG1-of (p2 / provide-01 
                        :ARG0 (s / system)) 
                  :mod (n / new)) 
            :ARG2 (r / region 
                  :mod (a2 / articular)) 
            :manner (p / primary) 
            :time (a / avoid-01 
                  :ARG1 (f / function-01 
                        :ARG1 (g / gene 
                              :quant (m / many))) 
                  :time (t2 / thus-far))) 
      :op1 (e / express-01 
            :ARG1 (t / tissue 
                  :mod (o / other)) 
            :mod (g2 / gene)) 
      :op2 (i / inactivation))

# ::snt Depending on the configuration of the floxed target gene , this system can be used to either activate the expression of a gene primarily in developing joints ( ssee Figure 1B -- 1D ) , or to inactivate gene function in articular regions ( see Figure 3 ) .
# ::tok Depending on the configuration of the floxed target gene , this system can be used to either activate the expression of a gene primarily in developing joints ( ssee Figure 1B -- 1D ) , or to inactivate gene function in articular regions ( see Figure 3 ) .
# ::alignments 46-47|0.0.0.2.0 45-46|0.0.2.0.0.1 44-45|0.0.2.0.0 42-43|0.0.0.3.0.0 41-42|0.0.0.3.0.0.0 39-40|0.0.0.3.0 38-39|0.0.0.3.0.1 35-36|0.0.0.3 29-30|0.0.0.1.0 26-27|0.0.0.2.1 25-26|0.0.0.2 23-24|0.0.2.0.0.0 22-23|0.0.0.1.1 19-20|0.0.0.1 17-18|0.0.0 16-17|0.0.0.0 14-15|0.0 12-13|0 11-12|0.0.1 10-11|0.0.1.0 8-9|0.0.2 7-8|0.0.2.0 6-7|0.0.2.1 3-4|0.1.0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:25.957
(p2 / possible-01 
      :ARG1 (u / use-01 
            :ARG0 (a2 / activate-01 
                  :ARG0 (e2 / either) 
                  :ARG1 (e / express-01 
                        :ARG0 (f3 / figure) 
                        :ARG1 (g2 / gene)) 
                  :ARG2 (d / develop-02 
                        :ARG0 3 
                        :ARG1 (j / joint)) 
                  :op1-of (o / or 
                        :op2 (f2 / function-01 
                              :ARG1 (r / region 
                                    :mod (a / articular)) 
                              :mod (g / gene)))) 
            :ARG1 (s2 / system 
                  :mod (t / this)) 
            :location (g3 / gene 
                  :ARG1-of (t2 / target-01 
                        :condition-of (s / see-01 
                              :ARG0 (p / primary) 
                              :ARG1 (f / figure))) 
                  :mod (f4 / flox))) 
      :condition (d2 / depend-01 
            :ARG1 (c / configuration)))

# ::snt Additional studies with this system should greatly enhance our knowledge of the development , function , and disease mechanisms of joints , and may bring us closer to better prevention and treatment of joint diseases .
# ::tok Additional studies with this system should greatly enhance our knowledge of the development , function , and disease mechanisms of joints , and may bring us closer to better prevention and treatment of joint diseases .
# ::alignments 34-35|0.1.0 33-34|0.0.0.3.0.0 31-32|0.1 30-31|0 29-30|0.1.0.0 28-29|0.1.0.0.0 26-27|0.0.1.1 24-25|0.0.1.0.0 23-24|0.0.1.0 22-23|0.0.1 20-21|0.0.0.3.1.0 18-19|0.0.0.3.2 17-18|0.0.0.3.2.0 16-17|0.0.0.3 14-15|0.0.0.3.1 12-13|0.0.0.3.0 9-10|0.0.0.1 8-9|0.0.0.1.0 7-8|0.0.0 6-7|0.0.0.2 5-6|0.0 4-5|0.0.0.0.1 3-4|0.0.0.0.1.0 1-2|0.0.0.0 0-1|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:27.068
(a / and 
      :op1 (r / recommend-01 
            :ARG1 (e / enhance-01 
                  :ARG0 (s2 / study-01 
                        :ARG1 (a4 / additional) 
                        :ARG2 (s / system 
                              :mod (t2 / this))) 
                  :ARG1 (k / knowledge 
                        :poss (w / we)) 
                  :degree (g2 / great) 
                  :op1-of (a3 / and 
                        :op2 (d3 / develop-02 
                              :ARG1 (j / joint)) 
                        :op3 (f / function-01 
                              :ARG1 (j2 / joint)) 
                        :op4 (m / mechanism 
                              :mod (d2 / disease)))) 
            :op1-of (a2 / and 
                  :op2 (p2 / possible-01 
                        :ARG1 (b / bring-01)) 
                  :op3 (c / close))) 
      :op2 (t / treat-03 
            :ARG2 (d / disease 
                  :ARG1-of (p / prevent-01 
                        :mod (g / good)))))

# ::snt Generation of Gdf5-Cre transgenic mice .
# ::tok Generation of Gdf5-Cre transgenic mice .
# ::alignments 4-5|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:27.075
(g / generation 
      :consist-of (m / mouse))

# ::snt A mouse 129x1/SvJ BAC library ( Invitrogen ) was screened to identify a 140-kb BAC from the Gdf5 locus .
# ::tok A mouse 129x1/SvJ BAC library ( Invitrogen ) was screened to identify a 140-kb BAC from the Gdf5 locus .
# ::alignments 18-19|0.0.2 17-18|0.0.2.0.0.0+0.0.2.0.0+0.0.2.0 11-12|0.0 9-10|0 6-7|0.0.1.0.0+0.0.1.0+0.0.1 4-5|0.0.0 3-4|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 1-2|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:27.176
(s / screen-01 
      :ARG1 (i / identify-01 
            :ARG0 (l2 / library 
                  :mod (o2 / organization 
                        :name (n3 / name 
                              :op1 "BAC")) 
                  :mod (m / mouse)) 
            :ARG1 (o / organization 
                  :name (n2 / name 
                        :op1 "Invitrogen")) 
            :ARG2 (l / locu 
                  :mod (t / thing 
                        :name (n / name 
                              :op1 "Gdf5")))))

# ::snt This BAC was modified using a homologous recombination system in E. coli ( Yang et al. 1997 ) to place nuclear-localized Cre recombinase ( from plasmid pML78 , gift of Gail Martin ) followed by IRES-hPLAP ( from plasmid 1726 , gift of Oliver Bogler ) directly behind the ATG start site of Gdf5 .
# ::tok This BAC was modified using a homologous recombination system in E. coli ( Yang et al. 1997 ) to place nuclear-localized Cre recombinase ( from plasmid pML78 , gift of Gail Martin ) followed by IRES-hPLAP ( from plasmid 1726 , gift of Oliver Bogler ) directly behind the ATG start site of Gdf5 .
# ::alignments 53-54|0.0.0.0.0.0.1.3.1.0.0 51-52|0.0.0.0.0.0.1.3.1.0 50-51|0.0.0.0.0.0.1.3.1.0.1 47-48|0.0.0.0.0.0.1.3.1 46-47|0.0.0.0.0.0.1.3 43-45|0+0.0.1+0.0+0.0.0 41-42|0.0.0.0+0.0.0.0.0 39-40|0.0.0.0.0.0.1.3.1.0.1.0.1+0.0.0.0.0.0.1.3.1.0.1.0 38-39|0.0.0.0.0.0.1.3.1.0.1.0.0 33-34|0.0.0.0.0.0.2 30-32|0.0.0.0.0.0.1.1.0.1.1+0.0.0.0.0.0.1.1.0.1.0+0.0.0.0.0.0.1.1.0.1+0.0.0.0.0.0.1.1.0 28-29|0.0.0.0.0.0.1.1.0.0+0.0.0.0.0.0.1.1.0.0.0 26-27|0.0.0.0.0.0.1.3.0.0 25-26|0.0.0.0.0.0.1.3.0 22-23|0.0.0.0.0.0.0 21-22|0.0.0.0.0.0.0.0 20-21|0.0.0.0.0.0.0.1 19-20|0.0.0.0.0.0 16-17|0.0.0.0.0.0.1.3.1.0.1.1.0+0.0.0.0.0.0.1.3.1.0.1.1 13-16|0.0.0.0.0.0.2.0.0.2+0.0.0.0.0.0.2.0.0.1+0.0.0.0.0.0.2.0.0.0+0.0.0.0.0.0.2.0.0+0.0.0.0.0.0.2.0 10-12|0.0.0.0.0.0.1.1.2.1+0.0.0.0.0.0.1.1.2.0.1+0.0.0.0.0.0.1.1.2.0.0+0.0.0.0.0.0.1.1.2.0+0.0.0.0.0.0.1.1.2 8-9|0.0.0.0.0.0.1.1 7-8|0.0.0.0.0.0.1.1.1 6-7|0.0.0.0.0.0.1.1.3 4-5|0.0.0.0.0.0.1 3-4|0.0.0.0.0.0.1.2 1-2|0.0.0.0.0.0.1.0.1.0+0.0.0.0.0.0.1.0.1+0.0.0.0.0.0.1.0 0-1|0.0.0.0.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:33.454
(b2 / Bogler 
      :op2-of (n / name 
            :name-of (t / thing 
                  :ARG0-of (g2 / gift-01 
                        :ARG1 (t2 / thing 
                              :ARG0-of (p4 / place-01 
                                    :ARG1 (r / recombinase 
                                          :mod (c / Cre) 
                                          :mod (n3 / nuclear-localiz)) 
                                    :ARG2-of (u / use-01 
                                          :ARG0 (t6 / thing 
                                                :mod (t7 / this) 
                                                :name (n6 / name 
                                                      :op1 "BAC")) 
                                          :ARG1 (s3 / system 
                                                :domain (t3 / thing 
                                                      :ARG0-of (g4 / gift-01 
                                                            :ARG1 (t4 / thing)) 
                                                      :name (n2 / name 
                                                            :op1 (g3 / Gail) 
                                                            :op2 (m / Martin))) 
                                                :mod (r2 / recombination) 
                                                :mod (d4 / disease 
                                                      :name (n5 / name 
                                                            :op1 "E." 
                                                            :op2 "coli") 
                                                      :wiki "Escherichia_coli") 
                                                :mod (h / homologou)) 
                                          :ARG1-of (m2 / modify-01) 
                                          :ARG1-of (d / direct-02 
                                                :ARG0 (p3 / plasmid 
                                                      :mod-of (p2 / pML78)) 
                                                :mod-of (b / behind 
                                                      :op1 (s / site 
                                                            :consist-of (g / Gdf5) 
                                                            :mod (s2 / start-01 
                                                                  :time (d2 / date-entity 
                                                                        :mod (p / plasmid) 
                                                                        :year 1726) 
                                                                  :time (d3 / date-entity 
                                                                        :year 1997)))))) 
                                    :purpose (f / follow-01 
                                          :ARG1 (t5 / thing 
                                                :name (n4 / name 
                                                      :op1 "Yang" 
                                                      :op2 "et" 
                                                      :op3 "al."))))))) 
            :op1 (o / Oliver)))

# ::snt In the process , 583 bp of the first exon of Gdf5 was removed and no functional GDF5 protein is predicted to be produced .
# ::tok In the process , 583 bp of the first exon of Gdf5 was removed and no functional GDF5 protein is predicted to be produced .
# ::alignments 23-24|0.2.0 20-21|0.2 18-19|0.2.0.0 16-17|0.0.0 15-16|0.2.1 14-15|0 13-14|0.1 11-12|0.1.0.0.0+0.1.0.0+0.1.0 9-10|0.1.0.1 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:33.662
(a / and 
      :op1 (p4 / process-02 
            :ARG1 (f / functional)) 
      :op2 (r / remove-01 
            :ARG1 (t / thing 
                  :name (n / name 
                        :op1 "Gdf5") 
                  :poss-of (e / exon))) 
      :op3 (p2 / predict-01 
            :ARG1 (p / produce-01 
                  :ARG0 (p3 / protein)) 
            :polarity -))

# ::snt The 5  homology arm was subcloned from a PCR product tailed with XhoI and Bsp120I restriction sites that contains 781 bp of 5  genomic Gdf5 sequence ending at the ATG translation start site ( forward primer 5  - CTGTCTCGAGATGAGGTGGAGGTGAAGACCCC-3  ; reverse 5  - GTTTGGGCCCATCCTCTGGCCAGCCGCTG-3  ) .
# ::tok The 5  homology arm was subcloned from a PCR product tailed with XhoI and Bsp120I restriction sites that contains 781 bp of 5  genomic Gdf5 sequence ending at the ATG translation start site ( forward primer 5  - CTGTCTCGAGATGAGGTGGAGGTGAAGACCCC-3  ; reverse 5  - GTTTGGGCCCATCCTCTGGCCAGCCGCTG-3  ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:33.664
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Cre was subcloned from a 1.1-kb Bsp120I/EcoRI fragment of pML78 .
# ::tok Cre was subcloned from a 1.1-kb Bsp120I/EcoRI fragment of pML78 .
# ::alignments 9-10|0.1 7-8|0 6-7|0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:33.739
(f / fragment-01 
      :ARG0 (t / thing 
            :name (n / name 
                  :op1 "Bsp120I/EcoRI")) 
      :ARG1 (p / pML78))

# ::snt IRES hPLAP was subcloned from a 2.1-kb PCR product tailed with EcoRI and SpeI sites that contains the hPLAP translation stop site ( forward primer 5  - ATCTCTCGAGGAATTCTCCACCATATTGCCGTCTTTTG-3  ; reverse 5  - AGAACTCGAGACTAGTCGGGACACTCAGGGAGTAGTGG-3  ) .
# ::tok IRES hPLAP was subcloned from a 2.1-kb PCR product tailed with EcoRI and SpeI sites that contains the hPLAP translation stop site ( forward primer 5  - ATCTCTCGAGGAATTCTCCACCATATTGCCGTCTTTTG-3  ; reverse 5  - AGAACTCGAGACTAGTCGGGACACTCAGGGAGTAGTGG-3  ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:33.742
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt The 3  homology arm was subcloned from a 0.8-kb PCR product amplified from a 0.9-kb XhoI Gdf5 genomic subclone containing part of the first exon and downstream intron .
# ::tok The 3  homology arm was subcloned from a 0.8-kb PCR product amplified from a 0.9-kb XhoI Gdf5 genomic subclone containing part of the first exon and downstream intron .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:33.745
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt The forward primer contains the 3  end of the first exon and is tailed with a SpeI site ; the reverse primer is from the T7 promoter of the vector containing the 0.9-kb subclone and flanks the intronic XhoI site ( forward primer 5  - CTAAACTAGTCACCAGCTTTATTGACAAAGG-3  ; reverse 5  - GATTTCTAGAGTAATACGACTCACTATAGGGC-3  ) .
# ::tok The forward primer contains the 3  end of the first exon and is tailed with a SpeI site ; the reverse primer is from the T7 promoter of the vector containing the 0.9-kb subclone and flanks the intronic XhoI site ( forward primer 5  - CTAAACTAGTCACCAGCTTTATTGACAAAGG-3  ; reverse 5  - GATTTCTAGAGTAATACGACTCACTATAGGGC-3  ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:33.748
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt The targeting construct was built and verified in pBSSK ( Stratagene , La Jolla , California , United States ) , then digested with XhoI and subcloned into pSV1 , the vector used for homologous recombination ( Yang et al. 1997 ) .
# ::tok The targeting construct was built and verified in pBSSK ( Stratagene , La Jolla , California , United States ) , then digested with XhoI and subcloned into pSV1 , the vector used for homologous recombination ( Yang et al. 1997 ) .
# ::alignments 40-41|0.1.0.0+0.1.0 37-40|0.3.0.2+0.3.0.1+0.3.0.0+0.3.0+0.3 35-36|0.2.2 34-35|0.0.0.0 32-33|0.2 31-32|0.2.1 28-29|0.0.1.0 25-26|0.0.1 24-25|0.1.1.0.0+0.1.1.0+0.1.1 22-23|0.1 21-22|0.1.2 17-19|0.2.0.1+0.2.0.0.1+0.2.0.0.0+0.2.0.0+0.2.0 15-16|0.0.0.1.1+0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 12-14|0.0.0.2.0.0.1+0.0.0.2.0.0.0+0.0.0.2.0.0+0.0.0.2.0 8-9|0.0.0.2.1 6-7|0.0 5-6|0 4-5|0.0.0.2 2-3|0.0.0 1-2|0.0.0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:34.989
(a2 / and 
      :op1 (v2 / verify-01 
            :ARG1 (c3 / construct-01 
                  :ARG0 (h / homologou) 
                  :ARG1 (s / state 
                        :name (n4 / name 
                              :op1 "California") 
                        :wiki "California") 
                  :ARG1-of (b / build-01 
                        :ARG0 (c2 / country 
                              :name (n5 / name 
                                    :op1 "La" 
                                    :op2 "Jolla")) 
                        :location (p2 / pBSSK)) 
                  :ARG1-of (t4 / target-01)) 
            :op1-of (a / and 
                  :time (p / pSV1))) 
      :op2 (d2 / digest-01 
            :ARG0 (d / date-entity 
                  :year 1997) 
            :ARG1 (t2 / thing 
                  :name (n2 / name 
                        :op1 "XhoI")) 
            :time (t3 / then)) 
      :op3 (u / use-01 
            :ARG0 (c / country 
                  :name (n3 / name 
                        :op1 "United" 
                        :op2 "States") 
                  :wiki "United_States") 
            :ARG1 (v / vector) 
            :ARG2 (r / recombination)) 
      :op4 (t / thing 
            :name (n / name 
                  :op1 "Yang" 
                  :op2 "et" 
                  :op3 "al.")))

# ::snt Southern blotting , PCR , and DNA sequence analysis confirmed the appropriate targeting construct and BAC modifications were made ( unpublished data ) .
# ::tok Southern blotting , PCR , and DNA sequence analysis confirmed the appropriate targeting construct and BAC modifications were made ( unpublished data ) .
# ::alignments 21-22|0.0.0.2 20-21|0.0.0.2.0 16-17|0.0.1.1.0 15-16|0.0.1.1.0.1.0.0+0.0.1.1.0.1.0+0.0.1.1.0.1 14-15|0 13-14|0.0.1 12-13|0.0.1.1 11-12|0.0.1.0 9-10|0.0 8-9|0.0.0.1 7-8|0.0.0.1.0 6-7|0.0.1.1.0.0 5-6|0.0.0 1-2|0.0.0.0 0-1|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:35.884
(a / and 
      :op1 (c2 / confirm-01 
            :ARG0 (a4 / and 
                  :op1 (b / blot-01 
                        :ARG1 (t2 / thing 
                              :name (n2 / name 
                                    :op1 "Southern"))) 
                  :op2 (a3 / analyze-01 
                        :ARG1 (s / sequence)) 
                  :op3 (d / data 
                        :mod (u / unpublish))) 
            :ARG1 (c / construct-01 
                  :ARG1-of (a2 / appropriate-02) 
                  :ARG1-of (t / target-01 
                        :ARG0 (m / modify-01 
                              :ARG0 (d2 / DNA) 
                              :ARG1 (o / organization 
                                    :name (n / name 
                                          :op1 "BAC")))))))

# ::snt Before the modified BAC was injected to produce transgenic animals , a loxP site present in the BAC vector , pBeloBAC11 , was removed to prevent the addition of undesired Cre target sites into the genome .
# ::tok Before the modified BAC was injected to produce transgenic animals , a loxP site present in the BAC vector , pBeloBAC11 , was removed to prevent the addition of undesired Cre target sites into the genome .
# ::alignments 35-36|0.0.3.1.1 32-33|0.0.3.1.0.0 31-32|0.0.3.1.0.0.0 29-30|0.0.0 27-28|0.0.3.1.0 25-26|0.0.3.1 23-24|0.0.3 20-21|0.0.3.1.2 18-19|0 14-15|0.0.3.0.0 13-14|0.0.3.0 12-13|0.0.3.0.1 9-10|0.0.1.0.0 7-8|0.0.1.0 5-6|0.0 3-4|0.0.1.2.0+0.0.1.2+0.0.1 2-3|0.0.1.1 0-1|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:36.835
(v / vector 
      :ARG1-of (i / inject-01 
            :ARG0 (u / undesir) 
            :ARG2 (o / organization 
                  :ARG0-of (p4 / produce-01 
                        :ARG1 (a2 / animal)) 
                  :ARG1-of (m / modify-01) 
                  :name (n / name 
                        :op1 "BAC")) 
            :op1-of (b / before) 
            :time-of (r / remove-01 
                  :ARG1 (s2 / site 
                        :location (p3 / present) 
                        :mod (l / loxP)) 
                  :purpose (p / prevent-01 
                        :ARG1 (a / addition 
                              :quant-of (s / site 
                                    :ARG1-of (t / target-01))) 
                        :ARG2 (g / genome) 
                        :manner (p2 / pBeloBAC11)))))

# ::snt To do this , BAC DNA was prepared by CsCl separation , digested with NotI to free the insert from the vector , and size-fractionated over a sucrose gradient .
# ::tok To do this , BAC DNA was prepared by CsCl separation , digested with NotI to free the insert from the vector , and size-fractionated over a sucrose gradient .
# ::alignments 28-29|0.1.0.1 27-28|0.1.0.1.0 24-25|0.2 23-24|0 21-22|0.1.0.0 18-19|0.1.0 16-17|0.1 14-15|0.0.1.0.0+0.0.1.0+0.0.1 12-13|0.0 10-11|0.0.0.0.0 9-10|0.0.0.0.0.0 7-8|0.0.0.0 5-6|0.0.0 4-5|0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 2-3|0.0.0.0.1.0 1-2|0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:38.315
(a / and 
      :op1 (d / digest-01 
            :ARG1 (d2 / DNA 
                  :ARG1-of (p / prepare-02 
                        :ARG0 (s3 / separation 
                              :mod (c / CsCl)) 
                        :ARG2 (d3 / do-02 
                              :ARG1 (t2 / this))) 
                  :mod (o / organization 
                        :name (n2 / name 
                              :op1 "BAC"))) 
            :ARG2 (t / thing 
                  :name (n / name 
                        :op1 "NotI"))) 
      :op2 (f / free-04 
            :ARG1 (i / insert-01 
                  :ARG0 (v / vector) 
                  :ARG1 (g / gradient 
                        :mod (s / sucrose)))) 
      :op3 (s2 / size-fractionat))

# ::snt Aliquots of fractions were run on a pulse-field gel and Southern blotted using vector-specific DNA as a probe .
# ::tok Aliquots of fractions were run on a pulse-field gel and Southern blotted using vector-specific DNA as a probe .
# ::alignments 17-18|0.2.2 14-15|0.2.0 12-13|0.2 11-12|0.2.1 10-11|0.2.1.0.0.0+0.2.1.0.0+0.2.1.0 9-10|0 8-9|0.1 4-5|0.0 2-3|0.2.2.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:38.577
(a / and 
      :op1 (r / run-01 
            :ARG1 (a2 / aliquot)) 
      :op2 (g / gel) 
      :op3 (u / use-01 
            :ARG1 (d / DNA) 
            :ARG1-of (b / blot-01 
                  :ARG0 (t / thing 
                        :name (n / name 
                              :op1 "Southern"))) 
            :ARG2 (p / probe-01 
                  :ARG1 (f / fraction-01))))

# ::snt Fractions containing unsheared insert and almost no detectable vector DNA were dialyzed in microinjection buffer ( 10 mM Tris [ pH 7.4 ] with 0.15 mM EDTA [ pH 8.0 ] ) using Centriprep-30 concentrators ( Millipore , Billerica , Massachusetts , United States ) .
# ::tok Fractions containing unsheared insert and almost no detectable vector DNA were dialyzed in microinjection buffer ( 10 mM Tris [ pH 7.4 ] with 0.15 mM EDTA [ pH 8.0 ] ) using Centriprep-30 concentrators ( Millipore , Billerica , Massachusetts , United States ) .
# ::alignments 42-44|0.3.2.0.1+0.3.2.0.0.1+0.3.2.0.0.0+0.3.2.0.0+0.3.2.0 40-41|0.0.1.0.1+0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 38-39|0.3.2.1.0.0+0.3.2.1.0+0.3.2.1 36-37|0.3.4.0.0+0.3.4.0+0.3.4 34-35|0.0.1.1 32-33|0.0.1 29-30|0.3.0.1.3 28-29|0.3.0.1.4 25-27|0.3.3.0.1+0.3.3.0.0+0.3.3.0+0.3.3 24-25|0.3.0.1.2 21-22|0.3.0.0.0 20-21|0.3.0.0.1 18-19|0.3.2.2.0+0.3.2.2+0.3.2 17-18|0.3.0.1.1 16-17|0.3.0.0.2 14-15|0.0 13-14|0.0.0 9-10|0 8-9|0.1 7-8|0.2 6-7|0.4 5-6|0.3.1 4-5|0.3 3-4|0.3.0.1 2-3|0.3.0.1.0 1-2|0.3.0 0-1|0.3.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:43.313
(d / DNA 
      :ARG0-of (b / buffer-01 
            :ARG1 (m3 / microinjection) 
            :ARG2 (u / use-01 
                  :ARG0 (s / state 
                        :name (n2 / name 
                              :op1 "Massachusetts") 
                        :wiki "Massachusetts") 
                  :ARG1 (c3 / concentrator))) 
      :mod (v / vector) 
      :mod (d2 / detectable) 
      :op1-of (a2 / and 
            :ARG1-of (c4 / contain-01 
                  :ARG0 (f / fraction-01 
                        :ARG2 7.4 
                        :op1-of (p2 / ph) 
                        :op1-of 10) 
                  :ARG2 (i / insert-01 
                        :mod (u2 / unshear) 
                        :op1-of (m2 / mm) 
                        :op1-of 0.15 
                        :op1-of 8.0 
                        :op1-of (p / ph))) 
            :mod (a / almost) 
            :op2 (p3 / person 
                  :mod (c / country 
                        :name (n / name 
                              :op1 "United" 
                              :op2 "States") 
                        :wiki "United_States") 
                  :mod (c2 / country 
                        :name (n3 / name 
                              :op1 "Billerica")) 
                  :name (n6 / name 
                        :op1 "Tris")) 
            :op3 (t / thing 
                  :name (n5 / name 
                        :op1 (m / mM) 
                        :op2 (e / EDTA))) 
            :op4 (o / organization 
                  :name (n4 / name 
                        :op1 "Millipore"))) 
      :polarity -)

# ::snt This purified insert DNA was adjusted to 1 ng/l and injected into the pronucleus of fertilized eggs from FVB/N mice by the Stanford Transgenic Facility .
# ::tok This purified insert DNA was adjusted to 1 ng/l and injected into the pronucleus of fertilized eggs from FVB/N mice by the Stanford Transgenic Facility .
# ::alignments 22-25|0.1.0.0.2+0.1.0.0.1+0.1.0.0.0+0.1.0.0+0.1.0 19-20|0.1.1.2.0 16-17|0.0.1 15-16|0.0 13-14|0.1.2 10-11|0.1 9-10|0 7-8|0.0.0 5-6|0.1.1.2 3-4|0.1.1 2-3|0.1.1.0 1-2|0.1.1.1 0-1|0.1.1.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:43.522
(a / and 
      :manner (f / fertilize-01 
            :ARG0 1 
            :ARG1 (e / egg)) 
      :op1 (i / inject-01 
            :ARG0 (o / organization 
                  :name (n / name 
                        :op1 "Stanford" 
                        :op2 "Transgenic" 
                        :op3 "Facility")) 
            :ARG1 (d / DNA 
                  :ARG1-of (i2 / insert-01) 
                  :ARG1-of (p2 / purify-01) 
                  :ARG1-of (a2 / adjust-01 
                        :ARG0 (m / mouse)) 
                  :mod (t / this)) 
            :ARG2 (p / pronucleu)))

# ::snt Transgenic founder mice were identified by PCR using Cre-specific primers 5  - GCCTGCATTACCGGTCGATGCAACGA-3  and 5  - GTGGCAGATGGCGCGGCAACACCATT-3  , which amplify a 725-bp product , and were assessed for absence of BAC vector using vector-specific primers 5  - CGGAGTCTGATGCGGTTGCGATG-3  and 5  - AGTGCTGTTCCCTGGTGCTTCCTC-3  , which amplify a 465-bp product .
# ::tok Transgenic founder mice were identified by PCR using Cre-specific primers 5  - GCCTGCATTACCGGTCGATGCAACGA-3  and 5  - GTGGCAGATGGCGCGGCAACACCATT-3  , which amplify a 725-bp product , and were assessed for absence of BAC vector using vector-specific primers 5  - CGGAGTCTGATGCGGTTGCGATG-3  and 5  - AGTGCTGTTCCCTGGTGCTTCCTC-3  , which amplify a 465-bp product .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:43.524
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Three lines of Gdf5-Cre mice were established and maintained on the FVB background .
# ::tok Three lines of Gdf5-Cre mice were established and maintained on the FVB background .
# ::alignments 12-13|0.0.0.0 11-12|0.0.0.1.0+0.0.0.1+0.0.0 8-9|0.1 7-8|0 6-7|0.0 4-5|0.1.0.0 1-2|0.1.0 0-1|0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:43.579
(a / and 
      :op1 (e / establish-01 
            :ARG1 (t / thing 
                  :mod-of (b / background) 
                  :name (n / name 
                        :op1 "FVB"))) 
      :op2 (m / maintain-01 
            :ARG1 (l / line 
                  :consist-of (m2 / mouse) 
                  :quant 3)))

# ::snt Matings with R26R Cre-inducible LACZ reporter mice ( Soriano 1999 ) were used to test for Cre activity .
# ::tok Matings with R26R Cre-inducible LACZ reporter mice ( Soriano 1999 ) were used to test for Cre activity .
# ::alignments 17-18|0.1 16-17|0.1.1 14-15|0.1.2 12-13|0.1.2.0 9-10|0.1.2.1.0+0.1.2.1 8-9|0.1.2.0.0.0.0+0.1.2.0.0.0+0.1.2.0.0 6-7|0.0.0 5-6|0 4-5|0.0.1.0+0.0.1+0.0 2-4|0.1.0.0.1+0.1.0.0.0+0.1.0.0+0.1.0 0-1|0.1.2.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:43.826
(r / report-01 
      :ARG0 (o / organization 
            :mod-of (m / mouse) 
            :name (n2 / name 
                  :op1 "LACZ")) 
      :ARG1 (a / activity-06 
            :ARG0 (p2 / person 
                  :name (n3 / name 
                        :op1 "R26R" 
                        :op2 "Cre-inducible")) 
            :ARG1 (c / Cre) 
            :ARG2-of (t / test-01 
                  :ARG2-of (u / use-01 
                        :ARG0 (p / person 
                              :name (n / name 
                                    :op1 "Soriano")) 
                        :ARG1 (m2 / mating)) 
                  :time (d / date-entity 
                        :year 1999))))

# ::snt Staining for LACZ and HPLAP on whole embryos or sections of embryos was accomplished following established protocols ( Lobe et al. 1999 ) .
# ::tok Staining for LACZ and HPLAP on whole embryos or sections of embryos was accomplished following established protocols ( Lobe et al. 1999 ) .
# ::alignments 21-22|0.0.1.2.0.0.0+0.0.1.2.0.0 18-21|0.0.1.2.0.1.1.0.2+0.0.1.2.0.1.1.0.1+0.0.1.2.0.1.1.0.0+0.0.1.2.0.1.1.0+0.0.1.2.0.1.1 16-17|0.0.1.2.0.1.0 15-16|0.0.1.2.0.1.0.0 14-15|0.0.1.2.0.1 13-14|0.0.1.2.0 11-12|0.0.1.2 9-10|0.0.1.1 8-9|0.0.1 7-8|0.0.1.0 6-7|0.0.1.0.0 4-5|0.1.0.0+0.1.0+0.1 3-4|0 2-3|0.0.0.0.0+0.0.0.0+0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:44.433
(a2 / and 
      :ARG2-of (s2 / stain-01 
            :ARG0 (o3 / organization 
                  :name (n3 / name 
                        :op1 "LACZ")) 
            :ARG1 (o / or 
                  :op1 (e3 / embryo 
                        :mod (w / whole)) 
                  :op2 (s / section) 
                  :op3 (e2 / embryo 
                        :ARG1-of (a / accomplish-01 
                              :ARG0 (d / date-entity 
                                    :year 1999) 
                              :ARG1-of (f / follow-01 
                                    :ARG2 (p / protocol 
                                          :ARG1-of (e / establish-01)) 
                                    :time (t / thing 
                                          :name (n / name 
                                                :op1 "Lobe" 
                                                :op2 "et" 
                                                :op3 "al."))))))) 
      :op1 (o2 / organization 
            :name (n2 / name 
                  :op1 "HPLAP")))

# ::snt The red LACZ substrate ( see Figure 1E ) is 6-chloro-3-indoxyl-beta-D-galactopyranoside ( Biosynth International , Naperville , Illinois , United States ) .
# ::tok The red LACZ substrate ( see Figure 1E ) is 6-chloro-3-indoxyl-beta-D-galactopyranoside ( Biosynth International , Naperville , Illinois , United States ) .
# ::alignments 19-21|0.0.0.1+0.0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 17-18|0.0.2.1+0.0.2.0.0+0.0.2.0+0.0.2 15-16|0.0.1.0.0+0.0.1.0+0.0.1 12-14|0.1.0.1+0.1.0.0+0.1.0+0.1 6-7|0.0 5-6|0 3-4|0.1.1.0 2-3|0.1.1.1.0+0.1.1.1+0.1.1 1-2|0.1.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:44.839
(s2 / see-01 
      :ARG1 (f / figure 
            :mod (c / country 
                  :name (n / name 
                        :op1 "United" 
                        :op2 "States") 
                  :wiki "United_States") 
            :mod (c2 / country 
                  :name (n3 / name 
                        :op1 "Naperville")) 
            :poss-of (s / state 
                  :name (n2 / name 
                        :op1 "Illinois") 
                  :wiki "Illinois")) 
      :ARG2 (o / organization 
            :name (n4 / name 
                  :op1 "Biosynth" 
                  :op2 "International") 
            :part-of (o2 / organization 
                  :mod-of (s3 / substrate 
                        :mod (r / red)) 
                  :name (n5 / name 
                        :op1 "LACZ"))))

# ::snt General characterization of Bmpr1a mutant mice .
# ::tok General characterization of Bmpr1a mutant mice .
# ::alignments 5-6|0.1 4-5|0.1.0 3-4|0.1.1.0.0+0.1.1.0+0.1.1 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:44.860
(c / characterization 
      :mod (g / general) 
      :mod (m / mouse 
            :mod (m2 / mutant) 
            :mod (p / person 
                  :name (n / name 
                        :op1 "Bmpr1a"))))

# ::snt Bmpr1a null and floxed alleles ( Ahn et al. 2001 ; Mishina et al. 2002 ) were obtained on a mixed 129 and C57BL/6 background and maintained by random breeding .
# ::tok Bmpr1a null and floxed alleles ( Ahn et al. 2001 ; Mishina et al. 2002 ) were obtained on a mixed 129 and C57BL/6 background and maintained by random breeding .
# ::alignments 29-30|0.1.0 28-29|0.1.1.0.1.0.0.0 26-27|0.1 25-26|0.1.1 24-25|0.1.1.1 22-23|0 20-21|0.0 17-18|0.1.1.0 14-15|0.1.0.0.0+0.1.0.0 11-13|0.1.1.0.0.0.0.1+0.1.1.0.0.0.0.0+0.1.1.0.0.0.0+0.1.1.0.0.0 10-11|0.1.1.0.0 9-10|0.0.0.0+0.0.0 6-9|0.1.1.0.1.0.2.0.2+0.1.1.0.1.0.2.0.1+0.1.1.0.1.0.2.0.0+0.1.1.0.1.0.2.0+0.1.1.0.1.0.2 4-5|0.1.1.0.1 3-4|0.1.1.0.1.0.1 2-3|0.1.1.0.1.0 1-2|0.1.1.0.1.0.0 0-1|0.1.1.0.1.0.0.1.0.0+0.1.1.0.1.0.0.1.0+0.1.1.0.1.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:46.374
(a2 / and 
      :ARG1-of (m2 / mix-01 
            :ARG0 (d2 / date-entity 
                  :year 2001)) 
      :ARG1-of (m / maintain-01 
            :ARG0 (b / breed-01 
                  :ARG0 (d / date-entity 
                        :year 2002)) 
            :op3-of (a / and 
                  :op1 (o / obtain-01 
                        :ARG0 (a3 / and 
                              :op1 (t / thing 
                                    :name (n / name 
                                          :op1 (m3 / Mishina) 
                                          :op2 (e / et)))) 
                        :ARG1 (a4 / allel 
                              :op3-of (a5 / and 
                                    :op1 (n3 / null-02 
                                          :ARG0 (r / random) 
                                          :ARG1 (p / person 
                                                :name (n4 / name 
                                                      :op1 "Bmpr1a"))) 
                                    :op2 (f / flox) 
                                    :op4 (t2 / thing 
                                          :name (n2 / name 
                                                :op1 "Ahn" 
                                                :op2 "et" 
                                                :op3 "al."))))) 
                  :op2 (b2 / background))))

# ::snt Mice carrying the null and floxed alleles were typically mated to Gdf5-Cre mice as shown in Figure 3 .
# ::tok Mice carrying the null and floxed alleles were typically mated to Gdf5-Cre mice as shown in Figure 3 .
# ::alignments 17-18|0.0.0 16-17|0.2.0.0.0.1.0 14-15|0.2.0.0.0.1 12-13|0.2.0.0.0.2 9-10|0.2.0.0.0 8-9|0.2.0.0.0.0 6-7|0.2 5-6|0.1 4-5|0 3-4|0.0 1-2|0.2.0 0-1|0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:46.789
(a2 / and 
      :op1 (n / null-02 
            :ARG1 3) 
      :op2 (f2 / flox) 
      :op3 (a / allel 
            :ARG1-of (c / carry-01 
                  :ARG0 (m3 / mouse 
                        :ARG1-of (m2 / mate-01 
                              :ARG1-of (t / typical-02) 
                              :ARG1-of (s / show-01 
                                    :ARG0 (f / figure)) 
                              :ARG2 (m / mouse))))))

# ::snt The resulting mice are on a mixed 129 ; C57Bl/6 ; FVB/N background , with both controls and mutant animals generated as littermates from the same matings .
# ::tok The resulting mice are on a mixed 129 ; C57Bl/6 ; FVB/N background , with both controls and mutant animals generated as littermates from the same matings .
# ::alignments 26-27|0.1.1.0.0.2 25-26|0.1.1.0.0.2.0 22-23|0.1.1.0.0.1 20-21|0.1.1.0.0 19-20|0.1.1.0.0.0 18-19|0.1.1.0.0.0.0 17-18|0.1.1.0 16-17|0.1.1 15-16|0.1.1.0.1 12-13|0.2 8-9|0 6-7|0.0 2-3|0.1.0 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:47.064
(a3 / and 
      :ARG1-of (m3 / mix-01) 
      :ARG2-of (r / result-01 
            :ARG1 (m4 / mouse) 
            :ARG1-of (c / control-01 
                  :op1-of (a2 / and 
                        :ARG1-of (g / generate-01 
                              :ARG0 (a / animal 
                                    :mod (m2 / mutant)) 
                              :ARG2 (l / littermat) 
                              :prep-in (m / mating 
                                    :ARG1-of (s / same-01))) 
                        :mod (b / both)))) 
      :op1 (b2 / background))

# ::snt Whole-mount skeletal preparations were made from 34 - to 36-d-old mice ( Lufkin et al. 1992 ) .
# ::tok Whole-mount skeletal preparations were made from 34 - to 36-d-old mice ( Lufkin et al. 1992 ) .
# ::alignments 15-16|0.1.2+0.1 12-15|0.0.2+0.0.1+0.0.0+0.0+0 10-11|0.1.0.0 6-7|0.1.1 2-3|0.1.0 1-2|0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:47.174
(t / thing 
      :name (n / name 
            :op1 "Lufkin" 
            :op2 "et" 
            :op3 "al.") 
      :time (d / date-entity 
            :ARG1-of (p / prepare-02 
                  :ARG0 (m / mouse) 
                  :manner (s / skeletal)) 
            :mod-of 34 
            :year 1992))

# ::snt Pairs of ears from euthanized 6-mo-old animals were removed , pinned , photographed , projected , and measured from the base of the curve formed between the tragus and antitragus to the farthest point at the edge of the pinnae .
# ::tok Pairs of ears from euthanized 6-mo-old animals were removed , pinned , photographed , projected , and measured from the base of the curve formed between the tragus and antitragus to the farthest point at the edge of the pinnae .
# ::alignments 39-40|0.1.0.0.2.0.0 36-37|0.1.0.0.2.0 33-34|0.0.0.0 32-33|0.0.0.0.0 29-30|0.1.0.0.0.0 28-29|0 27-28|0.1 24-25|0.0.0 23-24|0.0 20-21|0.1.0.0.3.0 17-18|0.1.0.0.3 16-17|0.1.0.0 14-15|0.1.0.0.2 12-13|0.1.0.0.1 10-11|0.1.0 8-9|0.1.0.0.0 6-7|0.1.0.0.0.1.0 4-5|0.1.0.0.0.1.0.0 2-3|0.1.0.0.0.1.1 0-1|0.1.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:47.408
(a2 / and 
      :ARG0-of (c / curve-01 
            :ARG1-of (f2 / form-01 
                  :purpose (p2 / point 
                        :mod (f / farthest)))) 
      :op1 (t / tragu 
            :ARG0-of (p5 / pin-01 
                  :op2-of (a3 / and 
                        :op1 (r / remove-01 
                              :ARG0 (a / antitragu) 
                              :ARG1 (p6 / pair-01 
                                    :ARG0 (a4 / animal 
                                          :mod (e2 / euthaniz)) 
                                    :ARG1 (e3 / ear))) 
                        :op3 (p4 / photograph-01) 
                        :op4 (p3 / project-02 
                              :ARG1 (e / edge-01 
                                    :ARG1 (p / pinna))) 
                        :op5 (m / measure-01 
                              :ARG1 (b / base))))))

# ::snt Grasping ability in 6-mo-old mice was measured by placing animals on a slender rod and timing how long they could remain suspended on the rod , to a maximum time allowed of 2 min .
# ::tok Grasping ability in 6-mo-old mice was measured by placing animals on a slender rod and timing how long they could remain suspended on the rod , to a maximum time allowed of 2 min .
# ::alignments 33-34|0.1.1.1.0 32-33|0.1.1.0.0.1.0 30-31|0.1.1.0.0.0 29-30|0.1.1.0.0.0.0 28-29|0.1.1.0.0.0.0.0 24-25|0.0 21-22|0 20-21|0.1 19-20|0.1.1 18-19|0.1.0 17-18|0.1.1.1 15-16|0.1.1.0 14-15|0.1.1.0.0 13-14|0.1.1.0.0.2.2 12-13|0.1.1.0.0.2.2.0 9-10|0.1.1.0.0.2.1 8-9|0.1.1.0.0.2 6-7|0.1.1.0.0.1 4-5|0.1.1.0.0.2.0 1-2|0.1.1.0.0.1.1.0 0-1|0.1.1.0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:48.027
(s / suspend-01 
      :ARG1 (r / rod) 
      :ARG3-of (r2 / remain-01 
            :ARG1 (t2 / they) 
            :ARG1-of (p / possible-01 
                  :ARG1-of (t3 / time-02 
                        :op2-of (a2 / and 
                              :ARG1-of (a / allow-01 
                                    :time (t / time 
                                          :mod (m2 / maximum))) 
                              :manner-of (m3 / measure-01 
                                    :ARG0 2 
                                    :ARG1 (g / grasp-01 
                                          :ARG1 (a4 / ability))) 
                              :op1 (p2 / place-01 
                                    :ARG0 (m4 / mouse) 
                                    :ARG1 (a3 / animal) 
                                    :ARG2 (r3 / rod 
                                          :mod (s2 / slender))))) 
                  :concession-of (l / long-03 
                        :ARG1 (m / min)))))

# ::snt Data from five consecutive trials for each mouse were averaged .
# ::tok Data from five consecutive trials for each mouse were averaged .
# ::alignments 9-10|0 7-8|0.0.0.0 6-7|0.0.0.0.0 4-5|0.0.0 3-4|0.0.0.1 2-3|0.0.0.2 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:48.105
(a / average-01 
      :ARG1 (d / data 
            :source (t / trial-06 
                  :ARG1 (m / mouse 
                        :mod (e / each)) 
                  :mod (c / consecutive) 
                  :quant 5)))

# ::snt Range of motion assays were conducted on the MT/P1 and P1/P2 joints of the second hindlimb digit from euthanized 18-wk-old animals .
# ::tok Range of motion assays were conducted on the MT/P1 and P1/P2 joints of the second hindlimb digit from euthanized 18-wk-old animals .
# ::alignments 20-21|0.3.0.1 18-19|0.3.0.1.0 16-17|0.3.0 15-16|0.3.0.0 11-12|0.3 10-11|0.2.0.0+0.2.0+0.2 9-10|0 8-9|0.1.0.0+0.1.0+0.1 5-6|0.0 3-4|0.0.0.0 2-3|0.0.0.0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:48.463
(a2 / and 
      :op1 (c / conduct-01 
            :ARG1 (r / range-01 
                  :ARG1 (a3 / assay 
                        :mod (m / motion)))) 
      :op2 (t2 / thing 
            :name (n2 / name 
                  :op1 "MT/P1")) 
      :op3 (t / thing 
            :name (n / name 
                  :op1 "P1/P2")) 
      :op4 (j / joint 
            :poss (d / digit 
                  :mod (h / hindlimb) 
                  :source (a / animal 
                        :mod (e / euthaniz)))))

# ::snt Forceps were used to bend the joint to its natural stopping position , and the resulting angle was measured to the nearest 10  under 12.5  magnification using a 360  reticule .
# ::tok Forceps were used to bend the joint to its natural stopping position , and the resulting angle was measured to the nearest 10  under 12.5  magnification using a 360  reticule .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:48.466
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Analysis described in this section occurred on animals lacking R26R .
# ::tok Analysis described in this section occurred on animals lacking R26R .
# ::alignments 9-10|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 8-9|0.1.0 7-8|0.1 5-6|0 4-5|0.0.0.0 3-4|0.0.0.0.0 1-2|0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:48.680
(o / occur-01 
      :ARG0 (a2 / analysi 
            :ARG1-of (d / describe-01 
                  :ARG2 (s / section 
                        :mod (t / this)))) 
      :ARG2 (a / animal 
            :ARG0-of (l / lack-01 
                  :ARG1 (p / person 
                        :name (n / name 
                              :op1 "R26R")))))

# ::snt Control mice included all nonmutant genotypes generated by Parent 1 being heterozygous for Gdf5-Cre and Bmpr1anull and Parent 2 being heterozygous for Bmpr1afloxP ( see Figure 3 ) .
# ::tok Control mice included all nonmutant genotypes generated by Parent 1 being heterozygous for Gdf5-Cre and Bmpr1anull and Parent 2 being heterozygous for Bmpr1afloxP ( see Figure 3 ) .
# ::alignments 26-27|0.0.0.0.0.0.1.0.1 25-26|0.0.0.0.0.0.2.0 24-25|0.0.0.0.0.0.2 22-23|0.0.0.0.1 20-21|0.0 18-19|0.0.0.0.0.0.0 16-17|0 15-16|0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 14-15|0.0.0 9-10|0.0.0.0.0.0.2.1 8-9|0.0.0.0.0.0.1.0.0 6-7|0.0.0.0.0.0.1.0 5-6|0.0.0.0.0.0.1 3-4|0.0.0.0.0.0.1.1 2-3|0.0.0.0.0.0 1-2|0.0.0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:49.556
(a / and 
      :domain-of (h / heterozygou 
            :domain (a2 / and 
                  :op1 (c / control-01 
                        :mod-of (m / mouse 
                              :ARG2-of (i / include-01 
                                    :ARG0 2 
                                    :ARG1 (g2 / genotyp 
                                          :ARG1-of (g / generate-01 
                                                :ARG0 (p / parent) 
                                                :op1-of 3) 
                                          :quant (a3 / all)) 
                                    :ARG2-of (s / see-01 
                                          :ARG1 (f / figure) 
                                          :op1-of 1))) 
                        :op1-of (b / Bmpr1afloxP)) 
                  :op2 (t / thing 
                        :name (n / name 
                              :op1 "Bmpr1anull")))))

# ::snt All statistical analysis used the Student 's t-test or Welch 's t-test , and values listed are mean  standard error of the mean .
# ::tok All statistical analysis used the Student 's t-test or Welch 's t-test , and values listed are mean  standard error of the mean .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:49.558
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Cell death and proliferation assays .
# ::tok Cell death and proliferation assays .
# ::alignments 4-5|0.0.1 3-4|0.0 2-3|0 1-2|0.0.0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:49.577
(a2 / and 
      :op1 (p / proliferate-01 
            :ARG1 (c / cell 
                  :ARG1-of (d / die-01)) 
            :location (a / assay)))

# ::snt Limbs from mutant and control animals at E13 .5 and E14 .5 were dissected and frozen in OCT ( Sakura Finetek , Torrence , CA , United States ) .
# ::tok Limbs from mutant and control animals at E13 .5 and E14 .5 were dissected and frozen in OCT ( Sakura Finetek , Torrence , CA , United States ) .
# ::alignments 26-28|0.1.2.1+0.1.2.0.1+0.1.2.0.0+0.1.2.0+0.1.2 24-25|0.1.0.1+0.1.0.0.0+0.1.0.0+0.1.0 22-23|0.4.0.0+0.4.0+0.4 19-21|0.3.0.1+0.3.0.0+0.3.0+0.3 17-18|0.5.0.0.0.0 15-16|0.5.0 14-15|0.5.0.0 13-14|0.5.0.0.0 9-10|0.1.1 5-6|0.2 4-5|0.1 3-4|0 2-3|0.0 0-1|0.5 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:50.391
(a4 / and 
      :op1 (m / mutant) 
      :op2 (c2 / control-01 
            :ARG0 (s / state 
                  :name (n2 / name 
                        :op1 "CA") 
                  :wiki "California") 
            :ARG1 (a2 / and) 
            :location (c / country 
                  :name (n / name 
                        :op1 "United" 
                        :op2 "States") 
                  :wiki "United_States")) 
      :op3 (a3 / animal) 
      :op4 (p2 / person 
            :name (n4 / name 
                  :op1 "Sakura" 
                  :op2 "Finetek")) 
      :op5 (p / person 
            :name (n3 / name 
                  :op1 "Torrence")) 
      :quant (l / limb 
            :ARG1-of (f / freeze-02 
                  :op2-of (a / and 
                        :op1 (d / dissect-01 
                              :location (o / oct))))))

# ::snt Cryosections of tissue were assayed by TUNEL using the In Situ Cell Death Detection Kit , Fluorescein ( Roche , Basel , Switzerland ) .
# ::tok Cryosections of tissue were assayed by TUNEL using the In Situ Cell Death Detection Kit , Fluorescein ( Roche , Basel , Switzerland ) .
# ::alignments 22-23|0.0.3.1+0.0.3.0.0+0.0.3.0+0.0.3 20-21|0.0.2.0.0+0.0.2.0+0.0.2 18-19|0.0.0.0.0+0.0.0.0+0.0.0 16-17|0.1.0.0.0+0.1.0.0+0.1.0 11-15|0.0.1.1.3+0.0.1.1.2+0.0.1.1.1+0.0.1.1.0+0.0.1.1+0.0.1 10-11|0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 7-8|0.0 2-3|0.1 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:50.825
(c4 / cryosection 
      :ARG1-of (u / use-01 
            :ARG0 (o / organization 
                  :name (n3 / name 
                        :op1 "Roche")) 
            :ARG2 (o2 / organization 
                  :mod (c3 / country 
                        :name (n6 / name 
                              :op1 "Situ")) 
                  :name (n5 / name 
                        :op1 "Cell" 
                        :op2 "Death" 
                        :op3 "Detection" 
                        :op4 "Kit")) 
            :location (c2 / country 
                  :name (n2 / name 
                        :op1 "Basel")) 
            :location (c / country 
                  :name (n / name 
                        :op1 "Switzerland") 
                  :wiki "Switzerland")) 
      :mod (t / tissue 
            :mod (p / person 
                  :name (n4 / name 
                        :op1 "Fluorescein"))))

# ::snt Following TUNEL , slides were washed in PBS , blocked with PBS + 0.05 % Tween-20 + 5 % goat serum , washed again , and incubated with a 1:200 dilution of a rabbit anti-phospho-histone-H3 antibody called Mitosis Marker ( Upstate Biotechnology , Lake Placid , New York , United States ) to identify cells in mitosis .
# ::tok Following TUNEL , slides were washed in PBS , blocked with PBS + 0.05 % Tween-20 + 5 % goat serum , washed again , and incubated with a 1:200 dilution of a rabbit anti-phospho-histone-H3 antibody called Mitosis Marker ( Upstate Biotechnology , Lake Placid , New York , United States ) to identify cells in mitosis .
# ::alignments 56-57|0.2.2.0.1.0 54-55|0.2.2.0.0.1.0.0 53-54|0.2.2.0.0.1.0 49-51|0.3.1+0.3.0.1+0.3.0.0+0.3.0+0.3 46-48|0.2.1.1+0.2.1.0.1+0.2.1.0.0+0.2.1.0+0.2.1 43-45|0.1.0.0.1+0.1.0.0.0+0.1.0.0+0.1.0 40-42|0.0.1.1.0.1+0.0.1.1.0.0+0.0.1.1.0+0.0.1.1 37-39|0.2.2.0.0.1.1.1+0.2.2.0.0.1.1.0+0.2.2.0.0.1.1+0.2.2.0.0.1 36-37|0.2.2.0.0 35-36|0.2.2.0 33-34|0.2.2.0.1 30-31|0.2.2 26-27|0.2 25-26|0 23-24|0.1.1 22-23|0.1 20-21|0.2.0 19-20|0.2.0.0 18-19|0.2.0.0.0 17-18|0.0.1.0 14-15|0.2.2.0.0.0 9-10|0.0 7-8|0.0.0.0.0+0.0.0.0+0.0.0 5-6|0.0.1.2 3-4|0.0.1 0-1|0.0.1.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:53.586
(a2 / and 
      :op1 (b / block-01 
            :ARG0 (c7 / country 
                  :name (n6 / name 
                        :op1 "PBS")) 
            :ARG1 (s2 / slide-01 
                  :ARG0 5 
                  :ARG1 (c5 / country 
                        :name (n4 / name 
                              :op1 "Upstate" 
                              :op2 "Biotechnology")) 
                  :ARG1-of (w2 / wash-01 
                        :ARG1-of (f / follow-01)))) 
      :op2 (w / wash-01 
            :ARG0 (c4 / country 
                  :name (n3 / name 
                        :op1 "Lake" 
                        :op2 "Placid")) 
            :mod (a3 / again)) 
      :op3 (i2 / incubate-01 
            :ARG0 (s / serum 
                  :mod (g / goat 
                        :mod (p / percentage-entity))) 
            :ARG1 (c3 / city 
                  :name (n2 / name 
                        :op1 "New" 
                        :op2 "York") 
                  :wiki "New_York_City") 
            :ARG2 (d / dilution 
                  :mod (a / antibody 
                        :ARG1-of (c6 / call-01 
                              :ARG0 (p2 / percentage-entity) 
                              :ARG2 (t / thing 
                                    :ARG0-of (i / identify-01 
                                          :ARG1 (c / cell)) 
                                    :name (n5 / name 
                                          :op1 "Mitosis" 
                                          :op2 "Marker"))) 
                        :ARG1-of (r / rabbit-01 
                              :ARG0 (m / mitosi))))) 
      :op4 (c2 / country 
            :name (n / name 
                  :op1 "United" 
                  :op2 "States") 
            :wiki "United_States"))

# ::snt Cy3-labeled anti-rabbit secondary antibody was used to detect the antibody .
# ::tok Cy3-labeled anti-rabbit secondary antibody was used to detect the antibody .
# ::alignments 9-10|0.1.0 7-8|0.1 5-6|0 3-4|0.0 2-3|0.0.0 0-1|0.0.1.0.0+0.0.1.0+0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:53.640
(u / use-01 
      :ARG1 (a2 / antibody 
            :mod (s / secondary) 
            :quant (t / thing 
                  :name (n / name 
                        :op1 "Cy3-labeled"))) 
      :ARG2 (d / detect-01 
            :ARG1 (a / antibody)))

# ::snt Cell nuclei were labeled with DAPI , and slides were mounted in Vectamount ( Vector Laboratories , Burlingame , California , United States ) and visualized at 100  magnification .
# ::tok Cell nuclei were labeled with DAPI , and slides were mounted in Vectamount ( Vector Laboratories , Burlingame , California , United States ) and visualized at 100  magnification .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:53.643
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt The area of selected anatomical sites were measured , and the number of TUNEL-labeled nuclear fragments and the number of Cy3-labeled nuclei were counted from three 10-m sections spanning 50 m , from three control and three mutant animals .
# ::tok The area of selected anatomical sites were measured , and the number of TUNEL-labeled nuclear fragments and the number of Cy3-labeled nuclei were counted from three 10-m sections spanning 50 m , from three control and three mutant animals .
# ::alignments 38-39|0.0.3.0.1.1 37-38|0.0.3.0.1.1.0 36-37|0.0.0 35-36|0.0.3.0.1 34-35|0.0.3.0 33-34|0.0.3.0.2 30-31|0.0.3.0.1.0.1 29-30|0.0.3.0.1.0.1.0 28-29|0.0.3.0.1.0 27-28|0.0.3.0.1.0.0 25-26|0.0.3.0.1.0.0.0 23-24|0.0.3.0.0 21-22|0.1.0 20-21|0.2.0.0+0.2.0+0.2 18-19|0.1 16-17|0 15-16|0.0 14-15|0.0.2 13-14|0.0.1.0.0+0.0.1.0+0.0.1 11-12|0.0.3 9-10|0.0.3.0.0.1 7-8|0.0.3.0.0.1.0 5-6|0.0.3.0.0.1.0.0 4-5|0.0.3.0.0.1.0.0.1 3-4|0.0.3.0.0.1.0.0.0 1-2|0.0.3.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:56.549
(a3 / and 
      :op1 (f / fragment-01 
            :ARG0 3 
            :ARG1 (t2 / thing 
                  :name (n5 / name 
                        :op1 "TUNEL-labeled")) 
            :mod (n4 / nucleus) 
            :quant (n6 / number 
                  :ARG1-of (c / control-01 
                        :ARG2-of (c2 / count-02 
                              :ARG1 (a6 / area) 
                              :op2-of (a4 / and 
                                    :op1 (m3 / measure-01 
                                          :ARG1 (s3 / site 
                                                :ARG1-of (s4 / select-01) 
                                                :mod (a5 / anatomy))))) 
                        :op2-of (a2 / and 
                              :op1 (s / span-01 
                                    :ARG0 (s2 / section 
                                          :quant 3) 
                                    :ARG1 (m2 / m 
                                          :quant 50)) 
                              :op3 (a / animal 
                                    :mod (m / mutant))) 
                        :quant 3))) 
      :op2 (n3 / number 
            :quant-of (n / nucleus)) 
      :op3 (t / thing 
            :name (n2 / name 
                  :op1 "Cy3-labeled")))

# ::snt The number of labeled cells in the metacarpal-phalangeal and metatarsal-phalangeal joints was counted in a 290 m  365 m rectangle placed around the center of the joint .
# ::tok The number of labeled cells in the metacarpal-phalangeal and metatarsal-phalangeal joints was counted in a 290 m  365 m rectangle placed around the center of the joint .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:56.551
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt The posterior region of the fifth digit was defined by drawing a line from the tip of the digit down 2.15 mm and across to the lateral edge of the tissue .
# ::tok The posterior region of the fifth digit was defined by drawing a line from the tip of the digit down 2.15 mm and across to the lateral edge of the tissue .
# ::alignments 30-31|0.0.2.1 27-28|0.0.2 26-27|0.0.2.2 23-24|0.2 22-23|0 21-22|0.1 19-20|0.0.2.0 18-19|0.0.3.1.0 15-16|0.0.3.1 12-13|0.0.1 10-11|0.0 8-9|0.0.3 6-7|0.0.0 5-6|0.0.0.0 2-3|0.0.3.0 1-2|0.0.3.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:56.927
(a2 / and 
      :ARG2-of (d3 / draw-01 
            :ARG0 (d5 / digit 
                  :mod (f / fifth)) 
            :ARG1 (l2 / line) 
            :ARG2-of (e / edge-01 
                  :ARG0 (d / down) 
                  :ARG1 (t / tissue) 
                  :mod (l / lateral)) 
            :manner-of (d4 / define-01 
                  :ARG1 (r / region 
                        :mod (p / posterior)) 
                  :ARG2 (t2 / tip 
                        :part-of (d2 / digit)))) 
      :op1 (m / mm) 
      :op2 (a / across))

# ::snt For this analysis , the R26R Cre reporter was not present .
# ::tok For this analysis , the R26R Cre reporter was not present .
# ::alignments 10-11|0.2 9-10|0.2.0 7-8|0 5-7|0.0.0.1+0.0.0.0+0.0.0+0.0 2-3|0.1 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:56.965
(r / report-01 
      :ARG0 (t / thing 
            :name (n / name 
                  :op1 (r2 / R26R) 
                  :op2 (c / Cre))) 
      :ARG1-of (a / analyze-01 
            :mod (t2 / this)) 
      :domain-of (p / present 
            :polarity -))

# ::snt Tissue from animals ranging from stages E14 .5 to P14 was prepared for analysis by fixing in 4 % paraformaldehyde ( PFA ) in PBS for 45 min to 4 h depending on the stage ; washing three times in PBS , once in PBS + 15 % sucrose for 1 h , and once in PBS + 30 % sucrose for 2 h to overnight depending on the stage ; and then freezing in OCT. .
# ::tok Tissue from animals ranging from stages E14 .5 to P14 was prepared for analysis by fixing in 4 % paraformaldehyde ( PFA ) in PBS for 45 min to 4 h depending on the stage ; washing three times in PBS , once in PBS + 15 % sucrose for 1 h , and once in PBS + 30 % sucrose for 2 h to overnight depending on the stage ; and then freezing in OCT. .
# ::alignments 73-74|0.0.0.1.1.2 72-73|0.0.0.1.1.1.0.0 71-72|0.0.0.1.1.2.2 69-70|0.0.0.1.1.1.0.1 66-67|0.0.0.1.1.1.0 65-66|0.0.0.1.1.1 62-63|0.0.0.1.1.2.1 59-60|0.1.1.0 58-59|0.1.1 53-54|0.0.0.1.1 50-51|0.0.0.1.1.2.0 48-49|0.0.0.1.1.0 47-48|0.0.0.1.1.0.0 46-47|0.0.0.1.1.0.0.0 42-43|0.0.0.1.1.1.0.2 37-38|0.1.1.0.0 36-37|0.1 35-36|0 34-35|0.1.0 31-32|0.0 29-30|0.0.0.1.0.0.0.3 27-28|0.0.0.1.0.0.0.4 26-27|0.0.0.1.0.0.0.2 24-25|0.0.0.1.0.0.0.0 21-22|0.0.0.1.2.0.0.0+0.0.0.1.2.0.0+0.0.0.1.2.0 19-20|0.0.0.0 18-19|0.0.0.0.0 17-18|0.0.0.0.0.0 15-16|0.0.0 13-14|0.0.0.1.2 11-12|0.0.0.1 5-6|0.0.0.1.0.0.0.1 3-4|0.0.0.1.0.0.0 2-3|0.0.0.1.0.0 0-1|0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:59.021
(a3 / and 
      :ARG1-of (d2 / depend-01 
            :ARG0 (f2 / fix-02 
                  :ARG2 (p4 / paraformaldehyde 
                        :mod (p5 / percentage-entity 
                              :value 4)) 
                  :manner-of (p6 / prepare-02 
                        :ARG0 (t2 / tissue 
                              :source (a5 / animal 
                                    :ARG1-of (r / range-01 
                                          :ARG2 (p3 / pb) 
                                          :ARG3 (s4 / stage) 
                                          :op1-of 45 
                                          :op1-of 4 
                                          :op1-of (m / min)))) 
                        :ARG1 (a2 / and 
                              :op1 (s2 / sucrose 
                                    :mod (p2 / percentage-entity 
                                          :value 15)) 
                              :op2 (o / overnight 
                                    :ARG0-of (d / depend-01 
                                          :ARG1 (t / then) 
                                          :ARG2 (s / stage) 
                                          :op1-of (o2 / once))) 
                              :op3 (f / freeze-02 
                                    :ARG0 1 
                                    :ARG1 2 
                                    :op1-of (a / and))) 
                        :purpose (a4 / analyze-01 
                              :ARG0 (o3 / organization 
                                    :name (n / name 
                                          :op1 "PFA")))))) 
      :op1 (w / wash-01 
            :ARG1 (s3 / stage) 
            :ARG2 (3 / 30 
                  :quant-of (p / percentage-entity 
                        :value 3))))

# ::snt Tissue from animals aged 7 wk to 9 mo was processed similarly to earlier stages except that it was decalcified in 0.5 M EDTA ( pH 7.4 ) for 4 d prior to incubating in sucrose .
# ::tok Tissue from animals aged 7 wk to 9 mo was processed similarly to earlier stages except that it was decalcified in 0.5 M EDTA ( pH 7.4 ) for 4 d prior to incubating in sucrose .
# ::alignments 35-36|0.0.0.0.0.1.0.1.2 33-34|0.0.0.0.0.1.0.1 31-32|0.0.0.0.0.1.0.1.1 30-31|0.0.0.0.0.1.0.1.1.0 29-30|0.0.1 26-27|0.0.3 25-26|0.0.0.0.0.0 23-24|0.0.2 22-23|0.0.2.0.1+0.0.2.0.0.0+0.0.2.0.0+0.0.2.0 21-22|0.0.0.0.0.1.0.1.0 15-16|0.0.0.0.0.1.0 14-15|0.0.0.0.0.1 13-14|0.0.0.0.0.1.1 11-12|0.0.0.0.0.2 10-11|0.0.0.0.0 8-9|0 7-8|0.0.0.0.0.1.0.1.3 4-5|0.0.0.0.0.1.0.0 3-4|0.0 2-3|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:16:59.704
(m / mo 
      :ARG2-of (a / age-01 
            :ARG1 (a2 / animal 
                  :source-of (t / tissue 
                        :ARG1-of (p3 / process-01 
                              :ARG0 (p2 / ph) 
                              :ARG2 (s2 / stage 
                                    :ARG1-of (e2 / except-01 
                                          :ARG0 7 
                                          :purpose-of (i / incubate-01 
                                                :ARG0 0.5 
                                                :ARG1 (p / prior 
                                                      :location-of (d / d)) 
                                                :location (s / sucrose) 
                                                :op1-of 9)) 
                                    :time (e3 / early)) 
                              :manner (s3 / similarly)))) 
            :op1-of 4 
            :op1-of (e / edta 
                  :mod (v / vehicle 
                        :name (n / name 
                              :op1 "M1") 
                        :wiki "M1_Abrams")) 
            :op1-of 7.4))

# ::snt All solutions were prechilled and used at 4 C with agitation , and skin from tissues of P0 or older mice was lacerated or removed prior to processing .
# ::tok All solutions were prechilled and used at 4 C with agitation , and skin from tissues of P0 or older mice was lacerated or removed prior to processing .
# ::alignments 27-28|0.2.1.0.1 25-26|0.2.1.0.1.1 24-25|0.2 23-24|0.2.1 22-23|0.2.1.0 20-21|0.2.1.0.0 19-20|0.2.1.0.0.0 18-19|0.2.1.0.0.1 15-16|0.2.1.0.0.1.0 13-14|0.2.0 12-13|0.2.1.0.2 10-11|0.2.1.0.2.0 8-9|0.1 7-8|0.2.1.0.1.0 5-6|0.0 4-5|0 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:00.165
(a3 / and 
      :op1 (u / use-01 
            :ARG1 (s2 / solution 
                  :quant (a4 / all))) 
      :op2 (c / C) 
      :op3 (r / remove-01 
            :ARG1 (s / skin) 
            :op2-of (o / or 
                  :op1 (l / lacerate-01 
                        :ARG1 (m / mouse 
                              :mod (o2 / old) 
                              :op1-of (o3 / or 
                                    :poss-of (t / tissue))) 
                        :ARG2 (p / process-01 
                              :ARG1 4 
                              :op1-of (p2 / prior)) 
                        :op2-of (a / and 
                              :op1 (a2 / agitation))))))

# ::snt Tissue was then cryosectioned at 12 m and processed .
# ::tok Tissue was then cryosectioned at 12 m and processed .
# ::alignments 8-9|0.0 7-8|0 6-7|0.0.1 5-6|0.0.1.0 2-3|0.1 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:00.206
(a / and 
      :op1 (p / process-01 
            :ARG0 (t2 / tissue) 
            :ARG1 (m / m 
                  :quant 12)) 
      :time (t / then))

# ::snt Staining of sections with Safranin O , Fast Green , and Harris ' hematoxylin was carried out using standard histological procedures .
# ::tok Staining of sections with Safranin O , Fast Green , and Harris ' hematoxylin was carried out using standard histological procedures .
# ::alignments 20-21|0.1.0 19-20|0.1.0.1 18-19|0.1.0.0 17-18|0.1 15-16|0 13-14|0.2.2.1 11-12|0.2.2.0.0+0.2.2.0+0.2.2 10-11|0.2 8-9|0.2.1.0.0+0.2.1.0+0.2.1 7-8|0.2.1.1 4-6|0.2.0.0.1+0.2.0.0.0+0.2.0.0+0.2.0 2-3|0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:00.754
(c / carry-out-03 
      :ARG1 (s3 / stain-01 
            :ARG1 (s2 / section)) 
      :ARG2 (u / use-01 
            :ARG1 (p / procedure 
                  :ARG1-of (s / standard-02) 
                  :instrument-of (h / histological))) 
      :op4-of (a / and 
            :op1 (o / organization 
                  :name (n3 / name 
                        :op1 "Safranin" 
                        :op2 "O")) 
            :op2 (p3 / political-party 
                  :name (n2 / name 
                        :op1 "Green") 
                  :poss (f / fast)) 
            :op3 (p2 / person 
                  :name (n / name 
                        :op1 "Harris") 
                  :poss-of (h2 / hematoxylin))))

# ::snt Detection of LACZ activity with X-Gal was performed as described ( Lobe et al. 1999 ) and was followed by refixing in 4 % PFA , rinsing with deionized water , counterstaining with Nuclear Fast Red ( Vector Labs ) , rinsing with water again , and then mounting in Aquamount ( Lerner Labs , Pittsburgh , Pennsylvania , United States ) .
# ::tok Detection of LACZ activity with X-Gal was performed as described ( Lobe et al. 1999 ) and was followed by refixing in 4 % PFA , rinsing with deionized water , counterstaining with Nuclear Fast Red ( Vector Labs ) , rinsing with water again , and then mounting in Aquamount ( Lerner Labs , Pittsburgh , Pennsylvania , United States ) .
# ::alignments 59-61|0.1.1.0.1+0.1.1.0.0.1+0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 57-58|0.2.0 55-56|0.1.0.0.1.1+0.1.0.0.1.0.0+0.1.0.0.1.0+0.1.0.0.1 52-53|0.0.0 48-49|0.3 47-48|0.3.2 46-47|0 44-45|0.2.1 43-44|0.3.1 41-42|0.2 37-38|0.3.0 35-36|0.1.0 33-35|0.1.0.0.0.1+0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 29-30|0.1.1 28-29|0.0.1.0.0 26-27|0.1 23-24|0.0.1.1.0 22-23|0.0.1.1.0.0 18-19|0.0 16-17|0.0.1 14-15|0.0.1.1.1.0.1.0+0.0.1.1.1.0.1 11-14|0.0.1.2.0.2+0.0.1.2.0.1+0.0.1.2.0.0+0.0.1.2.0+0.0.1.2 9-10|0.0.1.1 7-8|0.0.1.0 5-6|0.0.1.1.1.0.2.0.0+0.0.1.1.1.0.2.0+0.0.1.1.1.0.2 3-4|0.0.1.1.1.0 2-3|0.0.1.1.1.0.0.0.0+0.0.1.1.1.0.0.0+0.0.1.1.1.0.0 0-1|0.0.1.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:02.637
(a / and 
      :manner-of (f2 / follow-01 
            :ARG1 (l / lern) 
            :op3-of (a3 / and 
                  :ARG1-of (p3 / perform-02 
                        :ARG0 (d / deionize)) 
                  :op1 (d3 / describe-01 
                        :ARG0 (p2 / percentage-entity 
                              :value 4) 
                        :ARG1 (d4 / detection 
                              :mod (a4 / activity-06 
                                    :ARG0 (o / organization 
                                          :name (n7 / name 
                                                :op1 "LACZ")) 
                                    :ARG1 (d2 / date-entity 
                                          :year 1999) 
                                    :ARG2 (t4 / thing 
                                          :name (n6 / name 
                                                :op1 "X-Gal"))))) 
                  :op2 (t3 / thing 
                        :name (n5 / name 
                              :op1 "Lobe" 
                              :op2 "et" 
                              :op3 "al.")))) 
      :op1 (r3 / rinse-01 
            :ARG1 (r2 / red 
                  :mod (t2 / thing 
                        :name (n3 / name 
                              :op1 (n4 / Nuclear) 
                              :op2 (f / Fast)) 
                        :poss (c2 / city 
                              :name (n2 / name 
                                    :op1 "Pittsburgh") 
                              :wiki "Pittsburgh"))) 
            :ARG2 (w2 / water 
                  :poss (c / country 
                        :name (n / name 
                              :op1 "United" 
                              :op2 "States") 
                        :wiki "United_States"))) 
      :op2 (r / rinse-01 
            :ARG0 (p / pennsylvania) 
            :mod (a2 / again)) 
      :op3 (m / mount-02 
            :ARG0 (v / vector) 
            :ARG1 (w / water) 
            :time (t / then)))

# ::snt RNA in situ hybridization was performed as described ( Storm and Kingsley 1996 ) , with the following modifications : ( 1 ) Prior to the acetylation step , sections were incubated with 10 -- 20 g/ml proteinase K for 30 s to 7 min at room temperature ( depending on the developmental stage ) , followed by refixing in 4 % PFA and washing three times in PBS ; ( 2 ) prehybridization step was skipped , and ( 3 ) embryonic tissue sections used a different color development mix ( Thut et al. 2001 ) .
# ::tok RNA in situ hybridization was performed as described ( Storm and Kingsley 1996 ) , with the following modifications : ( 1 ) Prior to the acetylation step , sections were incubated with 10 -- 20 g/ml proteinase K for 30 s to 7 min at room temperature ( depending on the developmental stage ) , followed by refixing in 4 % PFA and washing three times in PBS ; ( 2 ) prehybridization step was skipped , and ( 3 ) embryonic tissue sections used a different color development mix ( Thut et al. 2001 ) .
# ::alignments 95-96|0.0.0.1.0+0.0.0.1 92-95|0.0.0.0.2+0.0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 90-91|0.4.2 89-90|0.4 88-89|0.4.1 87-88|0.4.2.0 85-86|0.4.2.1 84-85|0.4.2.1.0 83-84|0.4.2.1.0.0 82-83|0.4.2.1.0.1 80-81|0.4.2.1.1 78-79|0.4.2.1.2 76-77|0.4.2.1.2.5 74-75|0.4.2.1.2.5.0 73-74|0.4.2.1.2.5.0.0 71-72|0.4.2.0.0 69-70|0.4.2.1.2.1 68-69|0.3.1 65-66|0.4.0 64-65|0.3 63-64|0 62-63|0.2.1.0+0.2.1+0.2 61-62|0.2.0 60-61|0.2.0.0 56-57|0.1 53-54|0.0.1 52-53|0.0.1.0 49-50|0.0 47-48|0.4.2.1.2.3.2.0 46-47|0.4.2.1.2.3.2.0.0 44-45|0.4.2.1.2.3.2 43-44|0.3.0 40-41|0.4.2.1.2.2.0 38-39|0.4.2.1.2.4 37-38|0.4.2.1.2.4.0 35-36|0.1.0 33-34|0.2.0.1 31-32|0.4.2.1.2.3 29-30|0.4.2.1.2.3.1 27-28|0.4.2.1.2.3.3.0 26-27|0.4.2.1.2.3.3.0.0 23-24|0.4.2.1.2.3.3 21-22|0.4.2.1.2.0.1.0 18-19|0.4.2.1.2.2 17-18|0.4.2.1.2.2.1 12-13|0.4.2.1.2.0.2.0+0.4.2.1.2.0.2 11-12|0.4.2.1.2.0.0.1.0.0+0.4.2.1.2.0.0.1.0+0.4.2.1.2.0.0.1 10-11|0.4.2.1.2.0.0 9-10|0.4.2.1.2.0.0.0.0.0+0.4.2.1.2.0.0.0.0+0.4.2.1.2.0.0.0 7-8|0.4.2.1.2.0.1 5-6|0.4.2.1.2.0 3-4|0.4.2.1.2.0.1.1 0-1|0.4.2.1.2.3.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:13.790
(a3 / and 
      :ARG0-of (d5 / depend-01 
            :ARG1 (t / thing 
                  :name (n / name 
                        :op1 "Thut" 
                        :op2 "et" 
                        :op3 "al.") 
                  :time (d / date-entity 
                        :year 2001)) 
            :ARG2 (s4 / stage 
                  :mod (d4 / developmental))) 
      :manner-of (f / follow-01 
            :ARG1 20) 
      :op1 (o / organization 
            :mod (p3 / percentage-entity 
                  :value 4 
                  :value 10) 
            :name (n2 / name 
                  :op1 "PFA")) 
      :op2 (w / wash-01 
            :ARG0 7 
            :ARG1 (p2 / pb)) 
      :op3 (d2 / develop-02 
            :ARG0 3 
            :ARG1 (c / color) 
            :ARG1-of (m / mix-01 
                  :ARG1-of (d3 / differ-02 
                        :ARG0 2) 
                  :ARG1-of (u / use-01 
                        :ARG0 (s / section 
                              :mod (t2 / tissue) 
                              :mod (e / embryonic)) 
                        :li 3 
                        :op6-of (a / and 
                              :op1 (p7 / perform-02 
                                    :ARG0 (a5 / and 
                                          :op1 (o2 / organization 
                                                :name (n4 / name 
                                                      :op1 "Storm")) 
                                          :op2 (p6 / person 
                                                :name (n3 / name 
                                                      :op1 "Kingsley"))) 
                                    :ARG1 (d7 / describe-01 
                                          :ARG0 1 
                                          :ARG1 (h / hybridization)) 
                                    :time (d6 / date-entity 
                                          :year 1996)) 
                              :op1-of (a2 / and) 
                              :op2 (m3 / modify-01 
                                    :ARG0 30 
                                    :ARG1-of (f2 / follow-01)) 
                              :op3 (i / incubate-01 
                                    :ARG0 (r2 / rna) 
                                    :ARG1 (s5 / section) 
                                    :ARG2 (m2 / min 
                                          :location (t3 / temperature 
                                                :consist-of (r / room))) 
                                    :ARG4 (p5 / prior 
                                          :op1 (s6 / step 
                                                :consist-of (a4 / acetylation)))) 
                              :op4 (k / k 
                                    :mod (p4 / proteinase)) 
                              :op5 (s2 / skip-01 
                                    :ARG1 (s3 / step 
                                          :consist-of (p / prehybridization))))))))

# ::snt Probes for the following genes have been published previously : Bmpr1a ( Mishina et al. 1995 ) , Col2a1 ( Metsaranta et al. 1991 ) , Col10a1 ( Apte et al. 1992 ) , Gdf5 ( Storm and Kingsley 1996 ) , Osteocalcin ( Celeste et al. 1986 ) , and Sox5 and Sox6 ( Lefebvre et al. 1998 ) .
# ::tok Probes for the following genes have been published previously : Bmpr1a ( Mishina et al. 1995 ) , Col2a1 ( Metsaranta et al. 1991 ) , Col10a1 ( Apte et al. 1992 ) , Gdf5 ( Storm and Kingsley 1996 ) , Osteocalcin ( Celeste et al. 1986 ) , and Sox5 and Sox6 ( Lefebvre et al. 1998 ) .
# ::alignments 58-59|0.0.2.0+0.0.2 53-54|0.0.0.0.2.1 52-53|0.0.0.0.2 51-52|0.0.0.0.2.0 50-51|0.0.0 47-48|0.0.1.0+0.0.1 39-40|0.0.0.0.0.3.0+0.0.0.0.0.3 37-38|0 36-37|0.0 34-35|0.0.0.3 31-32|0.0.0.0.0.2.0+0.0.0.0.0.2 26-27|0.0.0.2 23-24|0.0.0.0.0.0.0.0+0.0.0.0.0.0.0 18-19|0.0.0.1 15-16|0.0.0.0.0.0.1.0.0.0+0.0.0.0.0.0.1.0.0 12-15|0.0.0.0.0.0.1.0.1.0.2+0.0.0.0.0.0.1.0.1.0.1+0.0.0.0.0.0.1.0.1.0.0+0.0.0.0.0.0.1.0.1.0+0.0.0.0.0.0.1.0.1 10-11|0.0.0.0.1.0+0.0.0.0.1+0.0.0.0 8-9|0.0.0.0.0.1 7-8|0.0.0.0.0 4-5|0.0.0.0.0.0.1 3-4|0.0.0.0.0.0.1.0 0-1|0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:14.979
(a3 / and 
      :op1 (s3 / storm-01 
            :ARG0 (a2 / and 
                  :op1 (p / person 
                        :ARG2-of (p3 / publish-01 
                              :ARG1 (p4 / probe-01 
                                    :ARG0 (d5 / date-entity 
                                          :year 1991) 
                                    :ARG1 (g2 / gene 
                                          :ARG1-of (f / follow-01 
                                                :ARG0 (d6 / date-entity 
                                                      :year 1995) 
                                                :ARG2 (t / thing 
                                                      :name (n / name 
                                                            :op1 "Mishina" 
                                                            :op2 "et" 
                                                            :op3 "al."))))) 
                              :time (p2 / previous) 
                              :time (d4 / date-entity 
                                    :year 1992) 
                              :time (d3 / date-entity 
                                    :year 1996)) 
                        :name (n2 / name 
                              :op1 "Bmpr1a") 
                        :op1-of (a / and 
                              :op2 (s2 / Sox5) 
                              :op3 (s / Sox6))) 
                  :op2 (c2 / Col2a1) 
                  :op3 (c / Col10a1) 
                  :op4 (g / Gdf5)) 
            :ARG1 (d2 / date-entity 
                  :year 1986) 
            :op1-of (d / date-entity 
                  :year 1998)))

# ::snt The following probe templates were gifts : Agg , Dr. Vicki Rosen , Genetics Institute ; Bmp2 and Bmp4 , Arend Sidow , Stanford University ; Col1a1 , Bjorn Olsen , Harvard Medical School ; Bmpr1b , Col3a1 , and Mat4 probes were made from ESTs with IMAGE clone numbers 5056341 , 478480 , and 406027 , respectively ( Invitrogen , Carlsbad , California , United States ) .
# ::tok The following probe templates were gifts : Agg , Dr. Vicki Rosen , Genetics Institute ; Bmp2 and Bmp4 , Arend Sidow , Stanford University ; Col1a1 , Bjorn Olsen , Harvard Medical School ; Bmpr1b , Col3a1 , and Mat4 probes were made from ESTs with IMAGE clone numbers 5056341 , 478480 , and 406027 , respectively ( Invitrogen , Carlsbad , California , United States ) .
# ::alignments 65-67|0.4.1.2.1+0.4.1.2.0.1+0.4.1.2.0.0+0.4.1.2.0+0.4.1.2 63-64|0.4.1.1.1+0.4.1.1.0.0+0.4.1.1.0+0.4.1.1 61-62|0.4.1.9.0.0+0.4.1.9.0+0.4.1.9 59-60|0.4.1.5.1.0.0+0.4.1.5.1.0+0.4.1.5.1 57-58|0.0 55-56|0.4.1.4.2.1.2+0.4.1.4.2.1.1+0.4.1.4.2.1.0+0.4.1.4.2.1 54-55|0.4.1.4.2 52-53|0.4.1.4.0.0.0.0.2+0.4.1.4.0.0.0.0.1+0.4.1.4.0.0.0.0.0+0.4.1.4.0.0.0.0 50-51|0.4.1.4.2.0.2+0.4.1.4.2.0.1+0.4.1.4.2.0.0+0.4.1.4.2.0 49-50|0.4.1.4.3 48-49|0.4.1.4.3.1 47-48|0.4.1.4.3.0 45-46|0.4.1.4.3.1.0 41-42|0.4.1.8 39-40|0.4.1 37-38|0.4.1.7 35-36|0.4.1.6 31-34|0.4.1.5.0.2+0.4.1.5.0.1+0.4.1.5.0.0+0.4.1.5.0+0.4.1.5 28-30|0.4.1.4.1.1+0.4.1.4.1.0+0.4.1.4.1+0.4.1.4 26-27|0.3.1 23-25|0.4.1.3.0.1+0.4.1.3.0.0+0.4.1.3.0+0.4.1.3 20-22|0.4.0.1+0.4.0.0+0.4.0+0.4 18-19|0.2 17-18|0 16-17|0.1 15-16|0.3 13-15|0.3.0.0.1+0.3.0.0.0+0.3.0.0+0.3.0 10-12|0.4.1.0.1.1+0.4.1.0.1.0+0.4.1.0.1+0.4.1.0 9-10|0.4.1.0.0 5-6|0.4.1.4.0.0.0 3-4|0.4.1.4.0.0 2-3|0.4.1.4.0 1-2|0.4.1.4.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:18.867
(a3 / and 
      :mod (r / respective) 
      :op1 (b3 / Bmp2) 
      :op2 (b2 / Bmp4) 
      :op2-of (a4 / and 
            :op1 (o4 / organization 
                  :name (n10 / name 
                        :op1 "Genetics" 
                        :op2 "Institute")) 
            :op3 (c5 / Col1a1)) 
      :op3 (p3 / person 
            :name (n9 / name 
                  :op1 "Arend" 
                  :op2 "Sidow") 
            :op2-of (a2 / and 
                  :op1 (p4 / person 
                        :mod (d4 / dr.) 
                        :name (n11 / name 
                              :op1 "Vicki" 
                              :op2 "Rosen")) 
                  :op10 (s / state 
                        :name (n2 / name 
                              :op1 "California") 
                        :wiki "California") 
                  :op11 (c / country 
                        :name (n / name 
                              :op1 "United" 
                              :op2 "States") 
                        :wiki "United_States") 
                  :op3 (o3 / organization 
                        :name (n8 / name 
                              :op1 "Stanford" 
                              :op2 "University")) 
                  :op4 (p2 / person 
                        :ARG0-of (p5 / probe-01 
                              :ARG1 (t / templat 
                                    :ARG1-of (g / gift-01 
                                          :ARG0 (d2 / date-entity 
                                                :day 80 
                                                :month 84 
                                                :year 1947)) 
                                    :ARG1-of (f / follow-01))) 
                        :name (n7 / name 
                              :op1 "Bjorn" 
                              :op2 "Olsen") 
                        :op1-of (a / and 
                              :op2 (d3 / date-entity 
                                    :day 41 
                                    :month 63 
                                    :year 505) 
                              :op3 (d / date-entity 
                                    :day 27 
                                    :month 60 
                                    :year 40)) 
                        :quant (n5 / number 
                              :mod (i / image) 
                              :mod (c3 / clone 
                                    :source-of (e / est)))) 
                  :op5 (o2 / organization 
                        :name (n6 / name 
                              :op1 "Harvard" 
                              :op2 "Medical" 
                              :op3 "School") 
                        :part (o / organization 
                              :name (n4 / name 
                                    :op1 "Invitrogen"))) 
                  :op6 (b / Bmpr1b) 
                  :op7 (c4 / Col3a1) 
                  :op8 (p / probe) 
                  :op9 (c2 / country 
                        :name (n3 / name 
                              :op1 "Carlsbad")))))

# ::snt Sections for immunohistochemistry were fixed in 4 % PFA , then digested with 942 -- 2,000 U/ml type IV-S bovine hyaluronindase ( Sigma , St. Louis , Missouri , United States ) in PBS ( pH 5 ) at 37 C for 30 min to 2 h depending on the stage .
# ::tok Sections for immunohistochemistry were fixed in 4 % PFA , then digested with 942 -- 2,000 U/ml type IV-S bovine hyaluronindase ( Sigma , St. Louis , Missouri , United States ) in PBS ( pH 5 ) at 37 C for 30 min to 2 h depending on the stage .
# ::alignments 50-51|0.0.5.2 47-48|0.0.5 46-47|0.0.5.0 45-46|0.0.5.0.0 43-44|0.0.4.0 42-43|0.0.4 40-41|0.0.5.1 39-40|0.0.5.0.1 36-37|0.0.3 35-36|0 33-34|0.0.5.1.0 29-31|0.0.0.0.0.1+0.0.0.0.0.0.1+0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 27-28|0.0.0.0.1.3.1+0.0.0.0.1.3.0.0+0.0.0.0.1.3.0+0.0.0.0.1.3 24-26|0.0.0.0.1.2.0.1+0.0.0.0.1.2.0.0+0.0.0.0.1.2.0+0.0.0.0.1.2 22-23|0.0.0.0.1.0 20-21|0.0.2 19-20|0.0.2.0 17-18|0.0.2.1 13-14|0.0.1 11-12|0.0 10-11|0.0.6 8-9|0.0.0.2.0+0.0.0.2+0.0.0 7-8|0.0.0.1 6-7|0.0.0.1.0 4-5|0.0.0.0 2-3|0.0.0.0.1.1 0-1|0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:19.869
(p / ph 
      :op1 (d2 / digest-01 
            :ARG1 (o / organization 
                  :ARG2-of (f / fix-03 
                        :ARG0 (c2 / country 
                              :name (n / name 
                                    :op1 "United" 
                                    :op2 "States") 
                              :wiki "United_States") 
                        :ARG1 (s4 / section-01 
                              :ARG0 (s3 / sigma) 
                              :ARG1 (i / immunohistochemistry) 
                              :ARG2 (c3 / country 
                                    :name (n3 / name 
                                          :op1 "St." 
                                          :op2 "Louis")) 
                              :op1-of (s2 / state 
                                    :name (n2 / name 
                                          :op1 "Missouri") 
                                    :wiki "Missouri"))) 
                  :mod (p3 / percentage-entity 
                        :value 4) 
                  :name (n4 / name 
                        :op1 "PFA")) 
            :ARG2 942 
            :op1-of (h2 / hyaluronindase 
                  :mod (b / bovine) 
                  :poss (t / type)) 
            :op1-of 5 
            :op1-of (3 / 30 
                  :quant-of (m / min)) 
            :purpose (d / depend-01 
                  :ARG0 (h / h 
                        :quant 2 
                        :value 37) 
                  :ARG1 (c / C 
                        :mod-of (p2 / pb)) 
                  :ARG2 (s / stage)) 
            :time (t2 / then)))

# ::snt Slides were then washed in PBS , treated with 0.3 % hydrogen peroxide in 100 % methanol for 30 min , washed , blocked with PBS + 0.05 % Tween20 + 5 % goat or fetal bovine serum , washed again , and incubated with primary antibodies in PBS + 0.05 % Tween 20 + 1 % goat or fetal bovine serum overnight at 4 C .
# ::tok Slides were then washed in PBS , treated with 0.3 % hydrogen peroxide in 100 % methanol for 30 min , washed , blocked with PBS + 0.05 % Tween20 + 5 % goat or fetal bovine serum , washed again , and incubated with primary antibodies in PBS + 0.05 % Tween 20 + 1 % goat or fetal bovine serum overnight at 4 C .
# ::alignments 65-66|0.4.1 64-65|0.5.2 62-63|0.4.0 61-62|0.1.1 60-61|0.1.1.0 59-60|0.1.1.1 58-59|0.1 57-58|0.1.0 56-57|0.1.0.0 55-56|0.1.0.0.0 53-54|0.5.0.2.1.0.0 51-52|0.2.0 46-47|0.5.1 45-46|0.5.1.0 43-44|0.5 42-43|0 40-41|0.4.2 39-40|0.4 37-38|0.5.0 36-37|0.5.0.0 35-36|0.5.0.1 34-35|0.5.0.2 33-34|0.5.0.2.1 32-33|0.5.0.2.1.0 31-32|0.0.0.1.0 29-30|0.0.0.0 28-29|0.5.0.2.0 23-24|0.3 21-22|0.2 19-20|0.0.2 18-19|0.0.2.0 16-17|0.2.1.0 15-16|0.2.1 14-15|0.2.1.1 12-13|0.0.1 11-12|0.0.1.0 10-11|0.0.1.0.0 7-8|0.0 5-6|0.3.0 3-4|0.0.0.1 2-3|0.0.0.1.1 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:21.921
(a2 / and 
      :op1 (t2 / treat-01 
            :ARG1 (s3 / slide-01 
                  :ARG1 (t / Tween20) 
                  :ARG1-of (w3 / wash-01 
                        :ARG0 5 
                        :time (t3 / then))) 
            :ARG2 (p7 / peroxide 
                  :mod (h / hydrogen 
                        :mod (p8 / percentage-entity))) 
            :purpose (m / min 
                  :quant 30)) 
      :op1-of (o2 / or 
            :op2 (g / goat 
                  :mod (p / percentage-entity 
                        :value 1)) 
            :op3 (s / serum 
                  :mod (b / bovine) 
                  :mod (f / fetal))) 
      :op2 (w2 / wash-01 
            :ARG0 (p2 / percentage-entity) 
            :ARG1 (p6 / percentage-entity 
                  :mod-of (m2 / methanol) 
                  :value 100)) 
      :op3 (b3 / block-01 
            :ARG0 (p9 / pb)) 
      :op4 (w / wash-01 
            :ARG1 (o / overnight) 
            :ARG2 (c / C) 
            :mod (a3 / again)) 
      :op5 (i / incubate-01 
            :ARG0 (s2 / serum 
                  :mod (b2 / bovine) 
                  :mod (f2 / fetal) 
                  :op2-of (o3 / or 
                        :mod-of (p5 / percentage-entity) 
                        :op1 (g2 / goat 
                              :mod (p4 / percentage-entity 
                                    :value 20)))) 
            :ARG1 (a / antibodi 
                  :mod (p3 / primary)) 
            :ARG2 4))

# ::snt Biotin-labeled secondary antibodies ( Vector Labs ) were tagged with HRP using the Vectastain Elite ABC kit ( Vector Labs ) followed by detection with DAB ( Vector Labs ) .
# ::tok Biotin-labeled secondary antibodies ( Vector Labs ) were tagged with HRP using the Vectastain Elite ABC kit ( Vector Labs ) followed by detection with DAB ( Vector Labs ) .
# ::alignments 27-29|0.1.1.1.0.1+0.1.1.1.0.0+0.1.1.1.0+0.1.1.1 25-26|0.1.0.0.0.1.0.0+0.1.0.0.0.1.0+0.1.0.0.0.1 23-24|0.1.0.0.0 21-22|0.1.0.0 18-20|0.1.1.1.1.1.0.1+0.1.1.1.1.1.0.0+0.1.1.1.1.1.0+0.1.1.1.1.1 16-17|0.1.1 13-16|0.1.1.0.0.2+0.1.1.0.0.1+0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 11-12|0.1 10-11|0.1.0.1.0+0.1.0.1+0.1.0 8-9|0 4-6|0.1.1.1.1.0.1+0.1.1.1.1.0.0+0.1.1.1.1.0+0.1.1.1.1 2-3|0.0 1-2|0.1.0.0.0.0 0-1|0.1.0.0.1.0.0+0.1.0.0.1.0+0.1.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:22.997
(t2 / tag-01 
      :ARG1 (a / antibodi) 
      :ARG2 (u / use-01 
            :ARG0 (o4 / organization 
                  :ARG0-of (f / follow-01 
                        :ARG1 (d / detect-01 
                              :ARG0 (s / secondary) 
                              :ARG1 (o2 / organization 
                                    :name (n2 / name 
                                          :op1 "DAB"))) 
                        :ARG2 (t3 / thing 
                              :name (n7 / name 
                                    :op1 "Biotin-labeled"))) 
                  :name (n5 / name 
                        :op1 "HRP")) 
            :ARG1 (k / kit 
                  :mod (t / thing 
                        :name (n4 / name 
                              :op1 "Vectastain" 
                              :op2 "Elite" 
                              :op3 "ABC")) 
                  :poss (o / organization 
                        :name (n / name 
                              :op1 "Vector" 
                              :op2 "Labs") 
                        :part (o5 / organization 
                              :name (n6 / name 
                                    :op1 "Vector" 
                                    :op2 "Labs") 
                              :part-of (o3 / organization 
                                    :name (n3 / name 
                                          :op1 "Vector" 
                                          :op2 "Labs")))))))

# ::snt Primary antibodies and dilutions used were : goat anti-mouse MMP13 , 1:100 ( Chemicon International , Temecula , California , United States ) ; rabbit anti-human SOX9 , 1:500 ( Morais da Silva et al. 1996 ) ; rabbit anti-phosphorylated-SOX9 ( SOX9.P ) , 1:10 -- 1:250 ( Huang et al. 2000 ) .
# ::tok Primary antibodies and dilutions used were : goat anti-mouse MMP13 , 1:100 ( Chemicon International , Temecula , California , United States ) ; rabbit anti-human SOX9 , 1:500 ( Morais da Silva et al. 1996 ) ; rabbit anti-phosphorylated-SOX9 ( SOX9.P ) , 1:10 -- 1:250 ( Huang et al. 2000 ) .
# ::alignments 51-52|0.2.0.0.0+0.2.0.0 38-39|0.0.1.3 35-36|0.0.1.2.0+0.0.1.2 32-35|0.0.4.1.3+0.0.4.1.2+0.0.4.1.1+0.0.4.1+0.0.4.1.0 30-32|0.0.4.0.1+0.0.4.0.0+0.0.4.0+0.0.4 26-27|0.2 24-25|0.2.0 23-24|0 20-22|0.0.3.1+0.0.3.0.1+0.0.3.0.0+0.0.3.0+0.0.3 18-19|0.0.1.0.1+0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 16-17|0.0.2.0.0+0.0.2.0+0.0.2 13-15|0.1.0.1+0.1.0.0+0.1.0+0.1 9-10|0.0.1.3.0 7-8|0.0.1.3.0.0 4-5|0.0.1 3-4|0.0.1.1 2-3|0.0 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:24.180
(a / and 
      :op1 (a2 / and 
            :op1 (a3 / antibodi 
                  :mod (p2 / primary)) 
            :op2 (u / use-01 
                  :ARG0 (s2 / state 
                        :name (n4 / name 
                              :op1 "California") 
                        :wiki "California") 
                  :ARG1 (d3 / dilution) 
                  :ARG2 (d2 / date-entity 
                        :year 1996) 
                  :ARG2-of (r / rabbit-01 
                        :ARG0 (m / MMP13 
                              :mod (g / goat)))) 
            :op3 (c2 / country 
                  :name (n5 / name 
                        :op1 "Temecula")) 
            :op4 (c / country 
                  :name (n3 / name 
                        :op1 "United" 
                        :op2 "States") 
                  :wiki "United_States") 
            :op5 (p / person 
                  :name (n2 / name 
                        :op1 "Morais" 
                        :op2 "da") 
                  :name (n / name 
                        :name-of (t / thing) 
                        :op1 "Silva" 
                        :op2 "et" 
                        :op3 "al."))) 
      :op2 (o / organization 
            :name (n6 / name 
                  :op1 "Chemicon" 
                  :op2 "International")) 
      :op3 (s / SOX9 
            :ARG1-of (r2 / rabbit-01 
                  :op1-of (d / date-entity 
                        :year 2000))))

# ::snt GenBank ( http://www.ncbi.nih.gov/Genbank/ ) accession numbers for the genes discussed in this paper are Gdf5 ( AC084323 ) and Bmpr1a ( NM_009758 ) .
# ::tok GenBank ( http://www.ncbi.nih.gov/Genbank/ ) accession numbers for the genes discussed in this paper are Gdf5 ( AC084323 ) and Bmpr1a ( NM_009758 ) .
# ::alignments 21-22|0.1.0.1 19-20|0.2.0.0+0.2.0+0.2 18-19|0 14-15|0.1.2.0+0.1.2+0.1 12-13|0.1.0.2 11-12|0.1.0.2.0 9-10|0.1.0 8-9|0.1.0.0 5-6|0.0 4-5|0.0.0 0-1|0.1.1.0.0+0.1.1.0+0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:24.412
(a / and 
      :op1 (n4 / number 
            :mod (a2 / accession)) 
      :op2 (p2 / person 
            :ARG0-of (d / discuss-01 
                  :ARG1 (g / gene) 
                  :ARG2 (n / nm_009758) 
                  :medium (p3 / paper 
                        :mod (t / this))) 
            :domain (p4 / person 
                  :name (n5 / name 
                        :op1 "GenBank")) 
            :name (n3 / name 
                  :op1 "Gdf5")) 
      :op3 (p / person 
            :name (n2 / name 
                  :op1 "Bmpr1a")))

# ::snt We thank Gail Martin for the Cre construct ( plasmid pML78 ) and Oliver Bogler for the IRES-hPLAP construct ( plasmid 1726 ) ; Bjorn Olsen and Benoit de Crombrugghe for antibodies ; the following individuals for in situ probe templates : Sophie Candille , Arend Sidow ( Bmp2 and Bmp4 ) , Vicki Rosen ( Agg ) , and Bjorn Olsen ( Col1a1 ) ; Vronique Lefebvre for Sox5 and Sox6 probe templates and useful discussions ; Michelle Johnson for help with phenotypic assays on mice ; Dr. Corrine Davis for help in evaluating synovial sections ; Rebecca Rountree for Adobe Photoshop and Illustrator tips ; and members of the Kingsley lab for helpful comments on the manuscript .
# ::tok We thank Gail Martin for the Cre construct ( plasmid pML78 ) and Oliver Bogler for the IRES-hPLAP construct ( plasmid 1726 ) ; Bjorn Olsen and Benoit de Crombrugghe for antibodies ; the following individuals for in situ probe templates : Sophie Candille , Arend Sidow ( Bmp2 and Bmp4 ) , Vicki Rosen ( Agg ) , and Bjorn Olsen ( Col1a1 ) ; Vronique Lefebvre for Sox5 and Sox6 probe templates and useful discussions ; Michelle Johnson for help with phenotypic assays on mice ; Dr. Corrine Davis for help in evaluating synovial sections ; Rebecca Rountree for Adobe Photoshop and Illustrator tips ; and members of the Kingsley lab for helpful comments on the manuscript .
# ::alignments 118-119|0.0.1.0.1 115-116|0.0.1.0 114-115|0.0.1.0.0 112-113|0.0.1.6.0.0 111-112|0.0.1.6.0.0.0.0.0+0.0.1.6.0.0.0.0+0.0.1.6.0.0.0 108-109|0.0.1.6.0.1+0.0.1.6.0+0.0.1.6 107-108|0.0.1 105-106|0.0.1.5.1.1 104-105|0.0.1.5.1.1.0 103-104|0.0.1.5.1 101-103|0.0.1.5.1.0.0.1+0.0.1.5.1.0.0.0+0.0.1.5.1.0.0+0.0.1.5.1.0 98-100|0.0.1.5.0.1+0.0.1.5.0.0+0.0.1.5.0+0.0.1.5 96-97|0.0.1.1.1.0.2.2.1.1 95-96|0.0.1.1.1.0.2.2.1.1.0 94-95|0.0.1.4.2.0 92-93|0.0.1.4.2 89-91|0.0.1.4.1.1+0.0.1.4.1.0+0.0.1.4.1+0.0.1.4 88-89|0.0.1.4.0 86-87|0.0.1.1.1.0.2.2.1.0 84-85|0.0.1.1.1.0.2.2.1.2 83-84|0.0.1.1.1.0.2.2.1.2.0 81-82|0.0.1.1.1.0.2.2.1 78-80|0.0.1.1.1.0.2.2.0.1+0.0.1.1.1.0.2.2.0.0+0.0.1.1.1.0.2.2.0+0.0.1.1.1.0.2.2 76-77|0.3.0 75-76|0.3.0.1 74-75|0.3 73-74|0.3.1 72-73|0.3.1.0 71-72|0.2.0.0+0.2.0+0.2 70-71|0 69-70|0.1.0.0+0.1.0+0.1 66-68|0.0.0.1+0.0.0.0+0.0.0+0.0 60-62|0.0.1.1.1.0.2.1.0.1+0.0.1.1.1.0.2.1.0.0+0.0.1.1.1.0.2.1.0+0.0.1.1.1.0.2.1 59-60|0.0.1.1.1.0.2 53-55|0.0.1.1.1.0.2.1.1.2.0.1+0.0.1.1.1.0.2.1.1.2.0.0+0.0.1.1.1.0.2.1.1.2.0+0.0.1.1.1.0.2.1.1.2 49-50|0.3.0.0 45-47|0.0.1.1.1.0.2.1.1.1.0.1+0.0.1.1.1.0.2.1.1.1.0.0+0.0.1.1.1.0.2.1.1.1.0+0.0.1.1.1.0.2.1.1.1 42-44|0.0.1.3.1.1+0.0.1.3.1.0+0.0.1.3.1+0.0.1.3 40-41|0.0.1.3.0.0 39-40|0.0.1.3.0 35-36|0.0.1.2 34-35|0.0.1.2.0 31-32|0.0.1.1.1.0.2.1.1.0.0 27-30|0.0.1.1.1.0.2.1.1.0.1.2+0.0.1.1.1.0.2.1.1.0.1.1+0.0.1.1.1.0.2.1.1.0.1.0+0.0.1.1.1.0.2.1.1.0.1+0.0.1.1.1.0.2.1.1.0 26-27|0.0.1.1.1 24-26|0.0.1.1.0.1+0.0.1.1.0.0+0.0.1.1.0+0.0.1.1 23-24|0.0.1.1.1.0.2.1.1 21-22|0.0.1.3.0.2.0+0.0.1.3.0.2 20-21|0.0.1.3.0.1 18-19|0.0.1.1.1.0.2.0 17-18|0.0.1.1.1.0.2.0.1.0.0+0.0.1.1.1.0.2.0.1.0+0.0.1.1.1.0.2.0.1 13-15|0.0.1.1.1.0.0.1.1.0.1+0.0.1.1.1.0.0.1.1.0.0+0.0.1.1.1.0.0.1.1.0+0.0.1.1.1.0.0.1.1 12-13|0.0.1.1.1.0.0.1 10-11|0.0.1.1.1.0.2.0.0 9-10|0.0.1.1.1.0.2.0.0.0 7-8|0.0.1.1.1.0.0.1.0 2-4|0.0.1.1.1.0.1.1+0.0.1.1.1.0.1.0+0.0.1.1.1.0.1+0.0.1.1.1.0 1-2|0.0.1.1.1.0.0 0-1|0.0.1.1.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:36.043
(a5 / and 
      :op1 (p8 / person 
            :name (n8 / name 
                  :op1 "Vronique" 
                  :op2 "Lefebvre") 
            :op4-of (a / and 
                  :ARG1-of (c / comment-01 
                        :ARG1-of (h / helpful-04) 
                        :ARG3 (m / manuscript)) 
                  :op1 (p15 / person 
                        :name (n14 / name 
                              :op1 "Bjorn" 
                              :op2 "Olsen") 
                        :op2-of (a9 / and 
                              :op1 (p20 / person 
                                    :ARG1-of (t7 / thank-01 
                                          :ARG0 (w / we) 
                                          :ARG3 (a11 / and 
                                                :op1 (c3 / construct-01) 
                                                :op2 (p17 / person 
                                                      :name (n16 / name 
                                                            :op1 "Oliver" 
                                                            :op2 "Bogler")))) 
                                    :name (n17 / name 
                                          :op1 "Gail" 
                                          :op2 "Martin") 
                                    :op1-of (a6 / and 
                                          :op2 (c2 / construct-01 
                                                :ARG0 (p18 / pML78 
                                                      :mod (p19 / plasmid)) 
                                                :ARG1 (t6 / thing 
                                                      :name (n15 / name 
                                                            :op1 "IRES-hPLAP"))) 
                                          :op3 (p9 / person 
                                                :name (n9 / name 
                                                      :op1 "Bjorn" 
                                                      :op2 "Olsen") 
                                                :op4-of (a10 / and 
                                                      :op1 (p14 / person 
                                                            :location (a8 / antibodi) 
                                                            :name (n13 / name 
                                                                  :op1 "Benoit" 
                                                                  :op2 "de" 
                                                                  :op3 "Crombrugghe")) 
                                                      :op2 (p11 / person 
                                                            :name (n11 / name 
                                                                  :op1 "Arend" 
                                                                  :op2 "Sidow")) 
                                                      :op3 (p10 / person 
                                                            :name (n10 / name 
                                                                  :op1 "Vicki" 
                                                                  :op2 "Rosen")))) 
                                          :op4 (p6 / person 
                                                :name (n5 / name 
                                                      :op1 "Michelle" 
                                                      :op2 "Johnson") 
                                                :purpose (h4 / help-01 
                                                      :ARG0 (m3 / mouse) 
                                                      :ARG1 (s / section 
                                                            :mod (s2 / synovial)) 
                                                      :ARG2 (a3 / assay 
                                                            :mod (p5 / phenotypic)))))))) 
                  :op2 (i2 / individual 
                        :ARG1-of (f / follow-01)) 
                  :op3 (p12 / person 
                        :ARG2-of (p13 / probe-01 
                              :ARG1 (t5 / templat) 
                              :op1-of (p16 / plasmid) 
                              :op1-of (d3 / date-entity 
                                    :year 1726)) 
                        :name (n12 / name 
                              :op1 "Sophie" 
                              :op2 "Candille")) 
                  :op5 (p4 / person 
                        :mod (d / dr.) 
                        :name (n4 / name 
                              :op1 "Corrine" 
                              :op2 "Davis") 
                        :purpose (h3 / help-01 
                              :ARG1 (e / evaluate-101))) 
                  :op6 (p3 / person 
                        :name (n3 / name 
                              :op1 "Rebecca" 
                              :op2 "Rountree") 
                        :op1-of (a2 / and 
                              :op2 (o / organization 
                                    :name (n2 / name 
                                          :op1 "Adobe" 
                                          :op2 "Photoshop")) 
                              :op3 (t / tip-05 
                                    :ARG1 (i / illustrator)))) 
                  :op7 (p2 / person 
                        :ARG0-of (h2 / have-org-role-91 
                              :ARG1 (l / lab 
                                    :mod (p / person 
                                          :name (n / name 
                                                :op1 "Kingsley"))) 
                              :ARG2 (m2 / member))))) 
      :op2 (t4 / thing 
            :name (n7 / name 
                  :op1 "Sox5")) 
      :op3 (t3 / thing 
            :name (n6 / name 
                  :op1 "Sox6")) 
      :op4 (a4 / and 
            :ARG0-of (d2 / discuss-01 
                  :ARG1 (a7 / and) 
                  :ARG1-of (u / useful-05)) 
            :op1 (t2 / templat 
                  :ARG1-of (p7 / probe-01))))

# ::snt This work was supported by an NIH predoctoral training grant ( RR ) , a postdoctoral fellowship from the Arthritis Foundation ( MS ) , and grants from the National Institutes of Health ( DK ) .
# ::tok This work was supported by an NIH predoctoral training grant ( RR ) , a postdoctoral fellowship from the Arthritis Foundation ( MS ) , and grants from the National Institutes of Health ( DK ) .
# ::alignments 34-35|0.1.1.0.0+0.1.1.0+0.1.1 29-33|0.0.2.0.0.3+0.0.2.0.0.2+0.0.2.0.0.1+0.0.2.0.0.0+0.0.2.0.0+0.0.2.0 26-27|0.0.2 25-26|0.0 22-23|0.1.0.0.0+0.1.0.0+0.1.0 19-21|0.0.1.1.0.1+0.0.1.1.0.0+0.0.1.1.0+0.0.1.1 16-17|0.0.1 15-16|0.0.1.0 9-10|0.0.0 8-9|0.0.0.1 6-7|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 3-4|0 1-2|0.1 0-1|0.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:36.655
(s / support-01 
      :ARG0 (a / and 
            :op1 (g2 / grant-01 
                  :ARG1 (t2 / thing 
                        :name (n5 / name 
                              :op1 "NIH")) 
                  :purpose (t / train-01)) 
            :op2 (f / fellowship 
                  :mod (p / postdoctoral) 
                  :source (o3 / organization 
                        :name (n4 / name 
                              :op1 "Arthritis" 
                              :op2 "Foundation"))) 
            :op3 (g / grant-01 
                  :ARG1 (o2 / organization 
                        :name (n2 / name 
                              :op1 "National" 
                              :op2 "Institutes" 
                              :op3 "of" 
                              :op4 "Health")))) 
      :ARG1 (w / work-01 
            :ARG0 (c / country 
                  :name (n3 / name 
                        :op1 "MS")) 
            :ARG3 (o / organization 
                  :name (n / name 
                        :op1 "DK")) 
            :mod (t3 / this)))

# ::snt Dr. Kingsley is an associate investigator of the Howard Hughes Medical Institute .
# ::tok Dr. Kingsley is an associate investigator of the Howard Hughes Medical Institute .
# ::alignments 11-12|0.2 10-11|0.2.0 8-10|0.2.1.1+0.2.1.0+0.2.1 5-6|0 4-5|0.0 0-2|0.1.0.1+0.1.0.0+0.1.0+0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:36.695
(i2 / investigator 
      :ARG1-of (a / associate-01) 
      :domain (t / thing 
            :name (n2 / name 
                  :op1 (d / Dr.) 
                  :op2 (k / Kingsley))) 
      :poss (i / institute-01 
            :ARG1 (m / medical) 
            :name (n / name 
                  :op1 "Howard" 
                  :op2 "Hughes")))

# ::snt BAC - bacterial artificial chromosome .
# ::tok BAC - bacterial artificial chromosome .
# ::alignments 4-5|0 3-4|0.0 2-3|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:36.704
(c / chromosome 
      :mod (a / artificial) 
      :mod (b / bacterial))

# ::snt Bmpr1a - bone morphogenetic protein receptor 1a .
# ::tok Bmpr1a - bone morphogenetic protein receptor 1a .
# ::alignments 6-7|0.0.0.0.0.0 5-6|0.0.0.0.0 4-5|0.0.0.0 3-4|0.0.0 2-3|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:36.727
(b2 / Bmpr1a 
      :mod-of (b / bone 
            :mod-of (m / morphogenetic 
                  :mod-of (p / protein 
                        :mod-of (r / receptor 
                              :mod-of 1a)))))

# ::snt E [ number ] - embyonic day [ number ] .
# ::tok E [ number ] - embyonic day [ number ] .
# ::alignments 8-9|0.1.0 6-7|0.1 2-3|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:36.741
(e / E 
      :mod-of (n2 / number) 
      :op1-of (d / day 
            :time (n / number)))

# ::snt ECM - extracellular matrix .
# ::tok ECM - extracellular matrix .
# ::alignments 3-4|0.0.0 2-3|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:36.749
(e2 / ecm 
      :degree-of (e / extracellular 
            :mod-of (m / matrix)))

# ::snt GAC - transgenic line carrying Gdf5-alkaline phosphatase-Cre construct .
# ::tok GAC - transgenic line carrying Gdf5-alkaline phosphatase-Cre construct .
# ::alignments 7-8|0.0.0.0 5-6|0.1.0+0.1+0 4-5|0.0 3-4|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:36.805
(t / thing 
      :ARG1-of (c2 / carry-01 
            :ARG0 (l / line 
                  :ARG1-of (c / construct-01))) 
      :name (n / name 
            :op1 "Gdf5-alkaline"))

# ::snt Gdf5 - growth differentiation factor 5 .
# ::tok Gdf5 - growth differentiation factor 5 .
# ::alignments 5-6|0.0.0 4-5|0.0.1.0 3-4|0.0.1 2-3|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:36.819
(g2 / Gdf5 
      :mod-of (g / grow-01 
            :ARG1 5 
            :mod-of (d / differentiation 
                  :mod-of (f / factor))))

# ::snt hPLAP - human placental alkaline phosphatase .
# ::tok hPLAP - human placental alkaline phosphatase .
# ::alignments 5-6|0.0.0.0 4-5|0.0.0 3-4|0.0.1 2-3|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:36.836
(h2 / hPLAP 
      :degree-of (h / human 
            :mod-of (a / alkaline 
                  :mod-of (p / phosphatase)) 
            :mod-of (p2 / placental)))

# ::snt IRES - internal ribosome entry site .
# ::tok IRES - internal ribosome entry site .
# ::alignments 5-6|0.0.0 4-5|0.0.0.0 3-4|0.0.0.1 2-3|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:36.869
(i2 / ir 
      :ARG1-of (i / internal-02 
            :mod-of (s / site 
                  :mod (e / entry) 
                  :mod (r / ribosome))))

# ::snt R26R - lacZ ROSA26 Cre reporter strain .
# ::tok R26R - lacZ ROSA26 Cre reporter strain .
# ::alignments 6-7|0.1.0.1+0.1.0 5-6|0.1.0.0 3-5|0.1.1.1+0.1.1.0+0.1.1+0.1 0-1|0.0.0+0.0+0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:36.910
(t2 / thing 
      :name (n2 / name 
            :op1 "R26R") 
      :quant-of (t / thing 
            :mod-of (s / strain 
                  :mod (r / report-01) 
                  :wiki "Influenza_A_virus_subtype_H5N1") 
            :name (n / name 
                  :op1 (r2 / ROSA26) 
                  :op2 (c / Cre))))

# ::snt TGF- - transforming growth factor  .
# ::tok TGF- - transforming growth factor  .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:36.911
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt TUNEL - terminal deoxynucleotidyl transferase -- mediated deoxyuridine triphosphate nick end labeling .
# ::tok TUNEL - terminal deoxynucleotidyl transferase -- mediated deoxyuridine triphosphate nick end labeling .
# ::alignments 11-12|0.1 10-11|0.1.0 9-10|0.1.1 6-7|0 4-5|0.0 2-3|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:36.967
(m / mediate-01 
      :ARG0 (t / transferase 
            :mod (t2 / terminal)) 
      :ARG1 (l / label-01 
            :ARG1-of (e / end-01) 
            :ARG1-of (n / nick-01)))

# ::snt A Genetic System to Drive Gene Recombination in Developing Joints .
# ::tok A Genetic System to Drive Gene Recombination in Developing Joints .
# ::alignments 9-10|0.0.0.0 8-9|0.0.0 4-7|0.1.2+0.1.1+0.1.0+0.1+0 1-3|0.0.1.1+0.0.1.0+0.0.1+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:37.012
(o / organization 
      :mod (o2 / organization 
            :ARG1-of (d / develop-02 
                  :ARG0 (j / joint)) 
            :name (n2 / name 
                  :op1 "Genetic" 
                  :op2 "System")) 
      :name (n / name 
            :op1 "Drive" 
            :op2 "Gene" 
            :op3 "Recombination"))

# ::snt ( A ) A 140-kb BAC from the Gdf5 locus was modified by inserting Cre-IRES-hPLAP into the translation start site of Gdf5 and used to make transgenic mice .
# ::tok ( A ) A 140-kb BAC from the Gdf5 locus was modified by inserting Cre-IRES-hPLAP into the translation start site of Gdf5 and used to make transgenic mice .
# ::alignments 27-28|0 23-24|0.0 22-23|0.0.0 19-20|0.0.0.1.2 18-19|0.0.0.1.2.0 17-18|0.0.0.1.2.1.0+0.0.0.1.2.1 14-15|0.0.0.1.1.0.0+0.0.0.1.1.0+0.0.0.1.1 13-14|0.0.0.1 11-12|0.0.0.0 9-10|0.0.0.1.0 8-9|0.0.0.1.0.0.0.0+0.0.0.1.0.0.0+0.0.0.1.0.0 5-6|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:37.314
(m / mouse 
      :ARG1-of (u / use-01 
            :op2-of (a / and 
                  :manner-of (m2 / modify-01 
                        :ARG1 (b / BAC)) 
                  :op1 (i / insert-01 
                        :ARG0 (l / locu 
                              :mod (p / person 
                                    :name (n2 / name 
                                          :op1 "Gdf5"))) 
                        :ARG1 (t3 / thing 
                              :name (n / name 
                                    :op1 "Cre-IRES-hPLAP")) 
                        :location (s / site 
                              :mod (s2 / start-01) 
                              :mod (t / thing 
                                    :ARG2-of (t2 / translate-01)))))))

# ::snt Not to scale .
# ::tok Not to scale .
# ::alignments 2-3|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:37.320
(s / scale 
      :time -)

# ::snt See Materials and Methods for details .
# ::tok See Materials and Methods for details .
# ::alignments 5-6|0.1.0 3-4|0.1.1 2-3|0.1 1-2|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:37.430
(s / see-01 
      :ARG0 (m2 / material) 
      :ARG1 (a / and 
            :ARG1-of (d / detail-01) 
            :op1 (m / method)))

# ::snt ( B -- E ) Visualization of Gdf5-Cre driven recombination patterns based on activation of lacZ expression from the R26R Cre reporter allele .
# ::tok ( B -- E ) Visualization of Gdf5-Cre driven recombination patterns based on activation of lacZ expression from the R26R Cre reporter allele .
# ::alignments 22-23|0.0.1.2 21-22|0.0 19-21|0.0.1.1.0.1+0.0.1.1.0.0+0.0.1.1.0+0.0.1.1 16-17|0.0.1 15-16|0.0.1.0 13-14|0.0.1.2.0.0.1 11-12|0.0.1.2.0.0 10-11|0.0.1.2.0 9-10|0.0.1.2.0.2 8-9|0.0.1.2.0.1 7-8|0.0.1.2.0.1.0.0.0+0.0.1.2.0.1.0.0+0.0.1.2.0.1.0 5-6|0.0.1.2.0.0.0 3-4|0 1-2|0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:38.311
(e2 / E 
      :ARG1-of (r / report-01 
            :ARG0 (l2 / location 
                  :name (n3 / name 
                        :op1 "B") 
                  :wiki -) 
            :time-of (e / express-01 
                  :ARG0 (l / lacZ) 
                  :ARG1 (t / thing 
                        :name (n / name 
                              :op1 (r2 / R26R) 
                              :op2 (c / Cre))) 
                  :location (a / allele 
                        :ARG1-of (p / pattern-01 
                              :ARG1-of (b / base-02 
                                    :ARG0 (v / visualization) 
                                    :ARG2 (a2 / activation)) 
                              :ARG1-of (d / drive-02 
                                    :ARG0 (t2 / thing 
                                          :name (n2 / name 
                                                :op1 "Gdf5-Cre"))) 
                              :mod (r3 / recombination))))))

# ::snt ( B ) LACZ activity is visible as blue staining in the ear ( ea ) and the joints of the shoulder ( s ) , elbow ( eb ) , wrist ( w ) , knee ( k ) , ankle ( a ) , vertebra ( vj ) , and phalanges ( black arrowheads ) of an E14 .5 mouse embryo .
# ::tok ( B ) LACZ activity is visible as blue staining in the ear ( ea ) and the joints of the shoulder ( s ) , elbow ( eb ) , wrist ( w ) , knee ( k ) , ankle ( a ) , vertebra ( vj ) , and phalanges ( black arrowheads ) of an E14 .5 mouse embryo .
# ::alignments 62-63|0.1.2.1.0 61-62|0.1.2.1 55-56|0.1.2.2.1 54-55|0.1.2.2 52-53|0.1.5 51-52|0.1 46-47|0.1.4 41-42|0.1.3 38-39|0.0.0.0 36-37|0.1.2 33-34|0.1.2.2.0 31-32|0.1.1 28-29|0.1.0 26-27|0.0.0.1.0.1 21-22|0.2.0 18-19|0.2 16-17|0 14-15|0.1.2.0 12-13|0.0 9-10|0.0.0 8-9|0.0.0.2 6-7|0.0.0.1 4-5|0.0.0.1.0 1-2|0.0.0.1.0.0.1+0.0.0.1.0.0.0.0+0.0.0.1.0.0.0+0.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:39.217
(a4 / and 
      :op1 (e5 / ear 
            :ARG1-of (s2 / stain-01 
                  :ARG0 (k / k) 
                  :compared-to-of (v2 / visible 
                        :domain (a5 / activity-06 
                              :ARG0 (l / location 
                                    :name (n / name 
                                          :op1 "B") 
                                    :wiki -) 
                              :ARG1 (e3 / elbow))) 
                  :mod (b2 / blue))) 
      :op1-of (a2 / and 
            :op2 (e2 / eb) 
            :op3 (w2 / wrist) 
            :op4 (k2 / knee-01 
                  :ARG1 (e4 / ea) 
                  :op1-of (m / mouse 
                        :mod-of (e / embryo)) 
                  :purpose-of (b / black-04 
                        :ARG0 (w / w) 
                        :ARG1 (a / arrowhead))) 
            :op5 (a3 / ankle) 
            :op6 (v / vertebra) 
            :op7 (p / phalanx)) 
      :op2 (j / joint 
            :part-of (s / shoulder)))

# ::snt ( C ) E14 .5 hindlimb double-stained to show both HPLAP expression from the transgene ( grey/purple staining ) and LACZ expression from the rearranged R26R allele ( blue staining ) .
# ::tok ( C ) E14 .5 hindlimb double-stained to show both HPLAP expression from the transgene ( grey/purple staining ) and LACZ expression from the rearranged R26R allele ( blue staining ) .
# ::alignments 29-30|0.0 28-29|0 26-27|0.0.0.3.0.0 25-26|0.0.0.3.0.0.1.0.0+0.0.0.3.0.0.1.0+0.0.0.3.0.0.1 24-25|0.0.0.3.0.0.0 21-22|0.0.0.3.0 19-20|0.0.0.3 17-18|0.0.0.1.0 14-15|0.0.0.2 11-12|0.0.0.1 9-10|0.0.0.1.1 8-9|0.0.0 5-6|0.0.0.3.0.1 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:39.896
(b / blue 
      :mod-of (s / stain-01 
            :ARG1 (s3 / show-01 
                  :ARG0 (c / C) 
                  :ARG1 (e2 / express-01 
                        :ARG1 (s2 / stain-01) 
                        :mod (b2 / both)) 
                  :ARG2 (t2 / transgene) 
                  :op1-of (a2 / and 
                        :op2 (e / express-01 
                              :ARG0 (a / allele 
                                    :ARG1-of (r / rearrange-01) 
                                    :mod (t / thing 
                                          :name (n / name 
                                                :op1 "R26R"))) 
                              :ARG1 (h / hindlimb))))))

# ::snt Note that both markers are visible in the oldest , proximal interphalangeal joint ( black arrowhead ) , only HPLAP activity is visible in the more recently formed medial interphalangeal joint ( black arrow ) , and neither HPLAP nor LACZ expression is visible in the youngest , most distal joint of the digit ( white arrowhead ) .
# ::tok Note that both markers are visible in the oldest , proximal interphalangeal joint ( black arrowhead ) , only HPLAP activity is visible in the more recently formed medial interphalangeal joint ( black arrow ) , and neither HPLAP nor LACZ expression is visible in the youngest , most distal joint of the digit ( white arrowhead ) .
# ::alignments 56-57|0.1.2.0.0 55-56|0.1.2.0 53-54|0.1.2.1.1.1.1 50-51|0.1.2.1.1.1 49-50|0.1.2.1.1.1.0 48-49|0.1.2.1.1.1.0.0 46-47|0.1.2.1.0.1 43-44|0.1.2.1 41-42|0.1.2 36-37|0.1.2.1.1 33-34|0.1.0 30-31|0.1.2.2.0 28-29|0.1.2.2.0.0 27-28|0.1.2.2 26-27|0.1.2.2.1 25-26|0.1.2.2.1.0 22-23|0.1.2.1.0.2 20-21|0.1.2.1.0 18-19|0.1.2.1.0.3 15-16|0.1.1 14-15|0.1 12-13|0.1.2.1.1.0.0.1 10-11|0.0 8-9|0.1.2.1.0.0.0+0.1.2.1.0.0 5-6|0.1.2.1.1.0.0.0 3-4|0.1.2.1.1.0.0 2-3|0.1.2.1.1.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:40.800
(n / note-01 
      :ARG0 (p / proximal) 
      :ARG1 (b / black-04 
            :ARG0 (a3 / arrow) 
            :ARG1 (a5 / arrowhead) 
            :ARG2-of (e / express-01 
                  :ARG0 (w / white 
                        :mod-of (a / arrowhead)) 
                  :domain-of (v / visible 
                        :domain (a4 / activity-06 
                              :ARG1 (o2 / old 
                                    :degree (m4 / most)) 
                              :ARG2 (y / young) 
                              :domain-of (v2 / visible) 
                              :mod (o / only)) 
                        :op1-of (a2 / and 
                              :mod (b2 / both 
                                    :mod-of (m5 / marker 
                                          :domain-of (v3 / visible) 
                                          :poss-of (j3 / joint))) 
                              :op1-of (j / joint 
                                    :mod (d2 / distal 
                                          :degree (m / most)) 
                                    :poss (d / digit)))) 
                  :purpose (f / form-01 
                        :ARG1 (j2 / joint 
                              :mod (m2 / medial)) 
                        :time (r / recent 
                              :degree (m3 / more))))))

# ::snt ( D ) Newborn ( P0 ) forelimb with skin partially removed showing LACZ activity expressed in all phalangeal joints ( red Salmon gal staining , black arrowheads ) and regions of some tendons ( asterisk ) .
# ::tok ( D ) Newborn ( P0 ) forelimb with skin partially removed showing LACZ activity expressed in all phalangeal joints ( red Salmon gal staining , black arrowheads ) and regions of some tendons ( asterisk ) .
# ::alignments 35-36|0.0.0.1 33-34|0.0.0.2.0.0 32-33|0.0.0.2.0 30-31|0.2 29-30|0 27-28|0.0.2.1 26-27|0.0.2 24-25|0.1 23-24|0.1.0 22-23|0.1.0.0 21-22|0.1.1 19-20|0.0.1 18-19|0.0.1.0 17-18|0.0.1.1 15-16|0.0 14-15|0.0.0 12-13|0.0.0.2 11-12|0.0.0.2.1 10-11|0.0.0.2.1.1 9-10|0.0.0.2.1.0 7-8|0.0.0.0.0 3-4|0.0.0.0 1-2|0.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:41.660
(a2 / and 
      :ARG0-of (e / express-01 
            :ARG1 (a5 / activity-06 
                  :ARG0 (n / newborn 
                        :mod (f / forelimb)) 
                  :ARG1 (a / asterisk) 
                  :ARG1-of (s4 / show-01 
                        :ARG0 (s / some 
                              :quant-of (t / tendon)) 
                        :ARG1-of (r3 / remove-01 
                              :ARG0 (s5 / skin) 
                              :mod (p2 / partial)))) 
            :ARG2 (j / joint 
                  :mod (p / phalangeal) 
                  :quant (a4 / all)) 
            :purpose (b / black-04 
                  :ARG0 (d / D) 
                  :ARG1 (a3 / arrowhead))) 
      :ARG2-of (s2 / stain-01 
            :ARG1 (g / gal 
                  :mod (s3 / salmon)) 
            :mod (r2 / red)) 
      :op1 (r / region))

# ::snt ( E ) Section through the most distal phalangeal joint of a P0 hindlimb stained with Alcian blue to mark cartilage showing LACZ expression ( stained red ) in all tissues of developing joints : articular cartilage ( black arrowhead ) , precursors of ligaments and synovial membranes ( black arrow ) , and cells where cavitation is occurring ( asterisk ) .
# ::tok ( E ) Section through the most distal phalangeal joint of a P0 hindlimb stained with Alcian blue to mark cartilage showing LACZ expression ( stained red ) in all tissues of developing joints : articular cartilage ( black arrowhead ) , precursors of ligaments and synovial membranes ( black arrow ) , and cells where cavitation is occurring ( asterisk ) .
# ::alignments 60-61|0.0.1.0.0.1.2.0 58-59|0.1.0.2.0 56-57|0.1.0.2.0.0 54-55|0.1.0.2 53-54|0.1.0 50-51|0.1.0.0.1.0 47-48|0.3 46-47|0.3.0 45-46|0 44-45|0.2 42-43|0.1 39-40|0.0.1.0.0.1.2.1 38-39|0.0.1.0.0.1.2 36-37|0.1.0.1 35-36|0.1.0.1.0 33-34|0.1.0.0.0 32-33|0.1.0.0 30-31|0.1.0.0.0.0 29-30|0.1.0.0.0.0.0 26-27|0.1.0.0.1.1 25-26|0.1.0.0.1 23-24|0.0 21-22|0.0.1 20-21|0.0.1.0 19-20|0.0.1.0.0 17-18|0.0.1.0.0.1.1 16-17|0.0.1.0.0.1.1.0.0.0+0.0.1.0.0.1.1.0.0+0.0.1.0.0.1.1.0 14-15|0.0.1.0.0.1 13-14|0.0.1.0.0.1.0 9-10|0.0.1.0.0.1.0.0 8-9|0.0.1.0.0.1.0.0.0 7-8|0.0.1.0.0.1.0.0.1 6-7|0.0.1.0.0.1.0.0.1.0 3-4|0.0.1.0.0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:43.398
(a4 / and 
      :ARG1-of (e / express-01 
            :ARG0 (e2 / E) 
            :ARG1-of (s3 / show-01 
                  :ARG0 (c4 / cartilage 
                        :ARG1-of (m2 / mark-01 
                              :ARG0 (s5 / section) 
                              :purpose-of (s4 / stain-01 
                                    :ARG0 (h / hindlimb 
                                          :poss-of (j2 / joint 
                                                :mod (p2 / phalangeal) 
                                                :mod (d2 / distal 
                                                      :degree (m3 / most)))) 
                                    :ARG1 (b2 / blue 
                                          :mod (t2 / thing 
                                                :name (n / name 
                                                      :op1 "Alcian"))) 
                                    :ARG2-of (b / black-04 
                                          :ARG0 (a / asterisk) 
                                          :ARG1 (a5 / arrowhead))))))) 
      :op1 (p / precursor 
            :op3-of (a2 / and 
                  :op1 (d / develop-02 
                        :ARG1 (j / joint 
                              :poss-of (t / tissue 
                                    :quant (a7 / all))) 
                        :ARG2 (s2 / stain-01 
                              :ARG0 (a3 / arrow) 
                              :ARG1 (r / red))) 
                  :op2 (c3 / cartilage 
                        :mod (a6 / articular)) 
                  :op4 (c2 / cell 
                        :ARG1-of (o / occur-01 
                              :ARG0 (c / cavitation))))) 
      :op2 (l / ligament) 
      :op3 (m / membran 
            :mod (s / synovial)))

# ::snt Bmpr1a Is Required for Webbing Regression and Apoptosis in Specific Regions of the Limb .
# ::tok Bmpr1a Is Required for Webbing Regression and Apoptosis in Specific Regions of the Limb .
# ::alignments 13-14|0.0.0.0 10-11|0.0.0.0.0 9-10|0.0.0.0.0.0 7-8|0.0.2 6-7|0.0 4-6|0.0.1.0.1+0.0.1.0.0+0.0.1.0+0.0.1 2-3|0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:43.491
(r3 / require-01 
      :ARG1 (a2 / and 
            :ARG0-of (b / be-01 
                  :ARG1 (l / limb 
                        :poss-of (r / region 
                              :mod (s / specific)))) 
            :op1 (t / thing 
                  :name (n / name 
                        :op1 (w / Webbing) 
                        :op2 (r2 / Regression))) 
            :op2 (a / apoptosi)))

# ::snt ( A and B ) Control E14 .5 forelimb ( A ) compared to a , E14 .5 mutant forelimb ( B ) showing webbing between digits 1 and 2 ( arrowheads ) and extra tissue at the posterior of digit 5 ( arrows ) .
# ::tok ( A and B ) Control E14 .5 forelimb ( A ) compared to a , E14 .5 mutant forelimb ( B ) showing webbing between digits 1 and 2 ( arrowheads ) and extra tissue at the posterior of digit 5 ( arrows ) .
# ::alignments 43-44|0.2 41-42|0.3.1.2.0.2 40-41|0.3.1.2.0.4 38-39|0.3.1.2.0.0 35-36|0.3.1.2.0.0.0 34-35|0.3.1.2.0.0.0.0 33-34|0.3.1.3 31-32|0.3.0 29-30|0.3.1.2.0.3 28-29|0.3 27-28|0.3.1.1.1 26-27|0.3.1.2.0.1 23-24|0 21-22|0.1.1+0.1.0.0+0.1.0+0.1 19-20|0.0 18-19|0.0.0 12-13|0.3.1.2.0 8-9|0.3.1.2 5-7|0.3.1.1.0.1+0.3.1.1.0.0+0.3.1.1.0+0.3.1.1 3-4|0.3.1.0.1+0.3.1.0.0.0+0.3.1.0.0+0.3.1.0 2-3|0.3.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:44.093
(s / show-01 
      :ARG0 (f / forelimb 
            :mod (m / mutant)) 
      :ARG1 (l / location 
            :name (n / name 
                  :op1 "B") 
            :wiki -) 
      :op1-of (a / arrow) 
      :op1-of (a4 / and 
            :op2 (a3 / arrowhead) 
            :op4-of (a5 / and 
                  :op1 (l2 / location 
                        :name (n3 / name 
                              :op1 "B") 
                        :wiki -) 
                  :op2 (t2 / thing 
                        :name (n2 / name 
                              :op1 (c2 / Control) 
                              :op2 (e2 / E14)) 
                        :quant 1) 
                  :op3 (f2 / forelimb 
                        :ARG0-of (c / compare-01 
                              :op1-of (p / posterior 
                                    :location-of (t / tissue 
                                          :mod (e / extra))) 
                              :op1-of (d2 / digit) 
                              :op1-of 5 
                              :op1-of 2 
                              :op1-of (d / digit))) 
                  :op5 (a2 / and))))

# ::snt ( C ) Gdf5-Cre induced lacZ expression from R26R in an E13 .5 forelimb showing LACZ staining ( blue ) in metacarpal-phalangeal joints , between digits 1 and 2 ( arrowhead ) , and in a region posterior to digit 5 ( arrow ) .
# ::tok ( C ) Gdf5-Cre induced lacZ expression from R26R in an E13 .5 forelimb showing LACZ staining ( blue ) in metacarpal-phalangeal joints , between digits 1 and 2 ( arrowhead ) , and in a region posterior to digit 5 ( arrow ) .
# ::alignments 42-43|0.0.2 40-41|0.0.1.2.1.1 39-40|0.0.1.2.1.2 37-38|0.0.1.2.2.0 36-37|0.0.1.2.2 33-34|0 28-29|0.0.4 27-28|0.0.5 26-27|0.0.6 25-26|0.0.1.1 22-23|0.0.1.2.1.0 18-19|0.0.1.3 16-17|0.0.1.2.1 14-15|0.0.1.2 13-14|0.0.1.2.0 11-12|0.0.1.2.0.0.0.0+0.0.1.2.0.0.0+0.0.1.2.0.0 8-9|0.0.0.0.0+0.0.0.0+0.0.0 6-7|0.0 5-6|0.0.3 4-5|0.0.1 1-2|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:44.859
(a2 / and 
      :ARG2-of (e / express-01 
            :ARG1 (t2 / thing 
                  :name (n2 / name 
                        :op1 "R26R")) 
            :ARG1-of (i / induce-01 
                  :ARG0 (c / C) 
                  :ARG2 (d2 / digit) 
                  :manner (s2 / show-01 
                        :ARG0 (f / forelimb 
                              :mod (t / thing 
                                    :name (n / name 
                                          :op1 "E13"))) 
                        :ARG1 (s / stain-01 
                              :ARG1 (j / joint) 
                              :op1-of 5 
                              :op1-of (d / digit)) 
                        :ARG2 (r / region 
                              :mod-of (p / posterior))) 
                  :op1-of (b / blue)) 
            :ARG3 (a / arrow) 
            :mod (l / lacZ) 
            :op1-of 2 
            :op1-of (a3 / and) 
            :op1-of 1))

# ::snt ( D and E ) Sections of E14 .5 hindlimbs showing apoptosis visualized by TUNEL staining ( green ) and proliferation visualized by staining for histone H3 phosphorylation ( red ) .
# ::tok ( D and E ) Sections of E14 .5 hindlimbs showing apoptosis visualized by TUNEL staining ( green ) and proliferation visualized by staining for histone H3 phosphorylation ( red ) .
# ::alignments 29-30|0.1.0 27-28|0.0.0.0.0.0.0.0 26-27|0.0.0.0.0.0.0.0.0 25-26|0.0.0.0.0.0.0.0.1 23-24|0.0.0.0.0.0.0 21-22|0.0.0.0.0.0.0.1 20-21|0.2 19-20|0 17-18|0.2.0 15-16|0.1 12-13|0.0 11-12|0.0.0 10-11|0.0.0.0 9-10|0.0.0.0.0 5-6|0.0.0.0.0.0 3-4|0.0.0.0.0.0.0.1.0.1 2-3|0.0.0.0.0.0.0.1.0 1-2|0.0.0.0.0.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:45.506
(a / and 
      :ARG0-of (v2 / visualize-01 
            :ARG1 (a2 / apoptosi 
                  :ARG1-of (s3 / show-01 
                        :ARG0 (h3 / hindlimb 
                              :ARG1-of (s4 / section-01 
                                    :ARG0-of (s / stain-01 
                                          :ARG1 (p / phosphorylate-01 
                                                :ARG1 (h / H3) 
                                                :mod (h2 / histone)) 
                                          :ARG2-of (v / visualize-01 
                                                :ARG1 (a3 / and 
                                                      :op1 (d / D) 
                                                      :op2 (e / E))))))))) 
      :op1 (s2 / stain-01 
            :ARG1 (r / red)) 
      :op2 (p2 / proliferate-01 
            :ARG1-of (g / green-02)))

# ::snt Controls show strong , uniform TUNEL staining between digits 1 and 2 ( D , arrowhead ) while mutants show patchy TUNEL staining interspersed with mitotic cells in similar regions ( E ) .
# ::tok Controls show strong , uniform TUNEL staining between digits 1 and 2 ( D , arrowhead ) while mutants show patchy TUNEL staining interspersed with mitotic cells in similar regions ( E ) .
# ::alignments 31-32|0.1.2.0 29-30|0.2.1.3.1 28-29|0.2.1.3 26-27|0.2.1.1.1 25-26|0.2.1.1.1.0 23-24|0.2.1.1 22-23|0.2.1 20-21|0.2.1.2 19-20|0.2 18-19|0.2.0 15-16|0.2.1.0 13-14|0.2.1.3.0 11-12|0.0.0 10-11|0.0.1 9-10|0.2.1.1.0 8-9|0.1.0 6-7|0.1 4-5|0.1.1.0+0.1.1 2-3|0.1.2 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:46.522
(s5 / show-01 
      :ARG0 (c2 / control-01 
            :ARG0 2 
            :ARG1 (a2 / and)) 
      :ARG1 (s3 / stain-01 
            :ARG0 (d2 / digit) 
            :ARG1 (t / thing 
                  :ARG1-of (u / uniform-01)) 
            :ARG1-of (s4 / strong-02 
                  :ARG0 (e / E))) 
      :condition (s2 / show-01 
            :ARG0 (m2 / mutant) 
            :ARG1 (s / stain-01 
                  :ARG0 (a / arrowhead) 
                  :ARG1-of (i / intersperse-01 
                        :ARG0 1 
                        :ARG2 (c / cell 
                              :mod (m / mitotic))) 
                  :mod (p / patchy) 
                  :purpose (r2 / resemble-01 
                        :ARG0 (d / D) 
                        :ARG1 (r / region)))))

# ::snt Scale bar = 200 m .
# ::tok Scale bar = 200 m .
# ::alignments 4-5|0 3-4|0.0.0 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:46.547
(m / m 
      :domain (b / bar-01 
            :ARG0 200 
            :ARG1 (s / scale)))

# ::snt ( F ) Quantitation of TUNEL staining and mitotic cells in the posterior region of the fifth digit shows apoptosis is reduced 30 % while proliferation is increased 20 % ( asterisks indicate statistically significant difference ) .
# ::tok ( F ) Quantitation of TUNEL staining and mitotic cells in the posterior region of the fifth digit shows apoptosis is reduced 30 % while proliferation is increased 20 % ( asterisks indicate statistically significant difference ) .
# ::alignments 35-36|0.0.0 34-35|0.0.0.0 33-34|0.0.0.0.0 32-33|0 31-32|0.0 29-30|0.2.2.2.2 28-29|0.2.2.2.2.0 27-28|0.2.2.2 25-26|0.2.2.2.1 23-24|0.2.2.2.0 22-23|0.1 21-22|0.2.2 19-20|0.2.2.0 18-19|0.2.2.1 17-18|0.2.2.1.0 16-17|0.2.2.1.0.0 13-14|0.2.2.0.0 12-13|0.2.2.0.0.0 9-10|0.2.0.0 8-9|0.2.1 7-8|0.2 6-7|0.2.0 1-2|0.2.2.2.1.0.1+0.2.2.2.1.0.0.0+0.2.2.2.1.0.0+0.2.2.2.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:47.455
(i / indicate-01 
      :ARG0 (a / asterisk 
            :ARG1-of (d / differ-02 
                  :ARG1-of (s / significant-02 
                        :mod (s2 / statistics)))) 
      :ARG1 30 
      :op4-of (a3 / and 
            :op1 (s4 / stain-01 
                  :ARG1 (c / cell)) 
            :op2 (m / mitotic) 
            :op3 (r / reduce-01 
                  :ARG1 (a2 / apoptosi 
                        :mod-of (r2 / region 
                              :mod (p4 / posterior))) 
                  :ARG1-of (s3 / show-01 
                        :ARG0 (d2 / digit 
                              :mod (f / fifth))) 
                  :condition (i2 / increase-01 
                        :ARG0 (p3 / percentage-entity) 
                        :ARG1 (p2 / proliferate-01 
                              :ARG1 (a4 / aircraft-type 
                                    :name (n / name 
                                          :op1 "F22") 
                                    :wiki "Lockheed_Martin_F-22_Raptor")) 
                        :ARG2 (p / percentage-entity 
                              :value 20)))))

# ::snt ( G and H ) By E15 .5 , interdigital tissue has regressed in controls ( G , arrowhead ) .
# ::tok ( G and H ) By E15 .5 , interdigital tissue has regressed in controls ( G , arrowhead ) .
# ::alignments 18-19|0.0.0.0.0.1 16-17|0.0.0.1.1+0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 14-15|0.0.0.0.0 12-13|0.0.0 10-11|0.0.0.0 6-7|0.0.0.0.0.0.0.0+0.0.0.0.0.0.0+0.0.0.0.0.0 3-4|0 2-3|0.0 1-2|0.0.1.1+0.0.1.0.0+0.0.1.0+0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:48.047
(h / h 
      :op2-of (a2 / and 
            :ARG1-of (r / regress-01 
                  :ARG0 (t / tissue 
                        :ARG1-of (c / control-01 
                              :ARG0 (c2 / country 
                                    :name (n2 / name 
                                          :op1 "E15")) 
                              :ARG2 (a / arrowhead))) 
                  :ARG2 (o / organization 
                        :name (n / name 
                              :op1 "G-8") 
                        :wiki "G8")) 
            :op1 (o2 / organization 
                  :name (n3 / name 
                        :op1 "G-8") 
                  :wiki "G8")))

# ::snt In contrast , tissue remains in mutants at this location , primarily derived from cells that have undergone Gdf5-Cre-mediated recombination that inactivates Bmpr1a function and activates expression of LACZ ( H ) .
# ::tok In contrast , tissue remains in mutants at this location , primarily derived from cells that have undergone Gdf5-Cre-mediated recombination that inactivates Bmpr1a function and activates expression of LACZ ( H ) .
# ::alignments 30-31|0.0.1 26-27|0 25-26|0.0 24-25|0.0.2 23-24|0.0.2.0 19-20|0.0.0 18-19|0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 17-18|0.0.0.0 14-15|0.0.0.0.0 12-13|0.0.0.0.0.0 11-12|0.0.0.0.0.0.1 9-10|0.0.0.0.0.0.0 8-9|0.0.0.0.0.0.0.0 6-7|0.0.0.0.0.0.0.1.2 4-5|0.0.0.0.0.0.0.1 3-4|0.0.0.0.0.0.0.1.0 1-2|0.0.0.0.0.0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:48.496
(e / express-01 
      :ARG1-of (a / activate-01 
            :ARG0 (r / recombination 
                  :ARG1-of (u / undergo-28 
                        :ARG0 (c / cell 
                              :ARG2-of (d / derive-01 
                                    :ARG1 (l / location 
                                          :domain (t2 / this) 
                                          :location-of (r2 / remain-01 
                                                :ARG1 (t3 / tissue) 
                                                :ARG1-of (c2 / contrast-01) 
                                                :location (m / mutant))) 
                                    :mod (p / primary)))) 
                  :mod (t / thing 
                        :name (n / name 
                              :op1 "Gdf5-Cre-mediated"))) 
            :ARG2 (h / h) 
            :op2-of (a2 / and 
                  :op1 (f / function-01))))

# ::snt Scale bar = 75 m .
# ::tok Scale bar = 75 m .
# ::alignments 4-5|0 3-4|0.1 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:48.513
(m / m 
      :domain (b / bar-01 
            :ARG1 (s / scale)) 
      :quant 75)

# ::snt Gdf5-Cre-Mediated Deletion of Bmpr1a .
# ::tok Gdf5-Cre-Mediated Deletion of Bmpr1a .
# ::alignments 3-4|0.1.0.0+0.1.0+0.1 0-2|0.0.1+0.0.0+0.0+0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:48.530
(p2 / person 
      :name (n2 / name 
            :op1 "Gdf5-Cre-Mediated" 
            :op2 "Deletion") 
      :topic (p / person 
            :name (n / name 
                  :op1 "Bmpr1a")))

# ::snt ( A ) Breeding strategy simultaneously deletes Bmpr1afloxP and allows visualization of Gdf5-Cre-mediated recombination by lacZ expression from R26R .
# ::tok ( A ) Breeding strategy simultaneously deletes Bmpr1afloxP and allows visualization of Gdf5-Cre-mediated recombination by lacZ expression from R26R .
# ::alignments 18-19|0.2.1.0.0+0.2.1.0+0.2.1 16-17|0.2 15-16|0.2.0 13-14|0.3 12-13|0.3.0.0.0+0.3.0.0+0.3.0 10-11|0.1.0 9-10|0.1 8-9|0 7-8|0.0.1.0.0+0.0.1.0+0.0.1 6-7|0.0 5-6|0.2.2 4-5|0.0.0 3-4|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:48.749
(a2 / and 
      :op1 (d / delete-01 
            :ARG0 (s2 / strategy 
                  :ARG1-of (b / breed-01)) 
            :ARG1 (t3 / thing 
                  :name (n3 / name 
                        :op1 "Bmpr1afloxP"))) 
      :op2 (a / allow-01 
            :ARG1 (v / visualization)) 
      :op3 (e / express-01 
            :ARG1 (l / lacZ) 
            :ARG2 (t / thing 
                  :name (n / name 
                        :op1 "R26R")) 
            :op1-of (s / simultaneous)) 
      :poss (r / recombination 
            :mod (t2 / thing 
                  :name (n2 / name 
                        :op1 "Gdf5-Cre-mediated"))))

# ::snt ( B -- E ) 5-week-old mutant and control mice stained with Alcian blue to mark cartilage and alizarin red to mark bone .
# ::tok ( B -- E ) 5-week-old mutant and control mice stained with Alcian blue to mark cartilage and alizarin red to mark bone .
# ::alignments 22-23|0 21-22|0.0 19-20|0.0.1 18-19|0.0.1.0 17-18|0.0.1.0.0 16-17|0.0.1.0.0.0.2.0 15-16|0.0.1.0.0.0.2 13-14|0.0.1.0.0.0.1.0 12-13|0.0.1.0.0.0.1.1.0+0.0.1.0.0.0.1.1+0.0.1.0.0.0.1 10-11|0.0.1.0.0.0 9-10|0.0.1.0.0.0.0.1 8-9|0.0.1.0.0.0.0.0.0 7-8|0.0.1.0.0.0.0 6-7|0.0.1.0.0.0.0.0 3-4|0.0.0 1-2|0.0.1.0.0.0.0.0.0.0.1+0.0.1.0.0.0.0.0.0.0.0.0+0.0.1.0.0.0.0.0.0.0.0+0.0.1.0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:49.847
(b / bone 
      :ARG1-of (m / mark-01 
            :ARG0 (e / E) 
            :domain-of (r / red 
                  :location-of (a / alizarin 
                        :op1-of (a2 / and 
                              :ARG2-of (s / stain-01 
                                    :ARG0 (a3 / and 
                                          :op1 (m4 / mutant 
                                                :ARG0-of (c2 / control-01 
                                                      :ARG1 (l / location 
                                                            :name (n2 / name 
                                                                  :op1 "B") 
                                                            :wiki -))) 
                                          :op2 (m3 / mouse)) 
                                    :ARG1 (t / thing 
                                          :mod (b2 / blue) 
                                          :name (n / name 
                                                :op1 "Alcian")) 
                                    :purpose (m2 / mark-01 
                                          :ARG1 (c / cartilage))))))))

# ::snt ( B ) Ankle of control with strong blue staining lining each joint ( arrowheads ) .
# ::tok ( B ) Ankle of control with strong blue staining lining each joint ( arrowheads ) .
# ::alignments 14-15|0 12-13|0.0.0.2.0.0 11-12|0.0.0.2.0 10-11|0.0 9-10|0.0.0 8-9|0.0.0.3 7-8|0.0.0.1 5-6|0.0.0.2 3-4|0.0.0.2.1 1-2|0.0.0.0.1+0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:50.028
(a / arrowhead 
      :ARG0-of (l / line-01 
            :ARG1 (s / stain-01 
                  :ARG1 (l2 / location 
                        :name (n / name 
                              :op1 "B") 
                        :wiki -) 
                  :ARG1-of (s2 / strong-02) 
                  :ARG1-of (c / control-01 
                        :ARG0 (e / each 
                              :mod-of (j / joint)) 
                        :topic-of (a2 / ankle)) 
                  :mod (b / blue))))

# ::snt ( C ) Ankle of mutant showing an absence of blue staining in most regions ( arrowheads ) and a joint fusion between the central ( c ) and second ( 2 ) tarsals ( arrow ) .
# ::tok ( C ) Ankle of mutant showing an absence of blue staining in most regions ( arrowheads ) and a joint fusion between the central ( c ) and second ( 2 ) tarsals ( arrow ) .
# ::alignments 35-36|0.0.0.1.1.3 33-34|0.2 31-32|0.2.0 28-29|0 26-27|0.0.0.1.2 24-25|0.1 21-22|0.0.1 20-21|0.0.1.0 18-19|0.0 16-17|0.0.0.1.0 14-15|0.0.0.2 13-14|0.0.0.2.0 11-12|0.0.0.1.1 10-11|0.0.0.1.1.2 8-9|0.0.0.1 6-7|0.0.0 5-6|0.0.0.1.1.0 3-4|0.0.0.0 1-2|0.0.0.1.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:51.027
(a2 / and 
      :op1 (a3 / and 
            :location-of (s2 / show-01 
                  :ARG0 (a6 / ankle) 
                  :ARG1 (a5 / absent-01 
                        :ARG0 (a4 / arrowhead) 
                        :ARG1 (s / stain-01 
                              :ARG1 (m2 / mutant) 
                              :ARG2 (c3 / C) 
                              :mod (b / blue) 
                              :op1-of (a / arrow)) 
                        :ARG2 (c / c)) 
                  :ARG2 (r / region 
                        :quant (m / most))) 
            :op1 (f / fusion 
                  :mod (j / joint))) 
      :op2 (c2 / central) 
      :op3 (t / tarsal 
            :li 2))

# ::snt ( D ) Control and ( E ) mutant metatarsal/phalangeal joint which lacks blue staining in articular regions ( arrowheads ) but retains staining in the growth plate ( asterisks ) .
# ::tok ( D ) Control and ( E ) mutant metatarsal/phalangeal joint which lacks blue staining in articular regions ( arrowheads ) but retains staining in the growth plate ( asterisks ) .
# ::alignments 29-30|0.0.1.0 27-28|0.2.1 26-27|0.2 23-24|0.1.0 22-23|0.1 21-22|0 19-20|0.2.0 17-18|0.0.2 16-17|0.0.2.0 14-15|0.0.1 13-14|0.0.1.1 12-13|0.0 10-11|0.0.0 8-9|0.0.0.0 6-7|0.1.0.0 4-5|0.0.0.1 3-4|0.0.0.1.0 1-2|0.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:51.966
(c / contrast-01 
      :ARG1 (l / lack-01 
            :ARG0 (j / joint 
                  :mod (m / mutant) 
                  :op2-of (a4 / and 
                        :op1 (c2 / control-01 
                              :ARG1 (d / D)))) 
            :ARG1 (s2 / stain-01 
                  :ARG1 (a / asterisk) 
                  :mod (b / blue)) 
            :location (r2 / region 
                  :mod (a3 / articular))) 
      :ARG2 (r / retain-01 
            :ARG1 (s / stain-01 
                  :ARG1 (e / E))) 
      :manner (g / grow-01 
            :ARG1 (a2 / arrowhead) 
            :mod-of (p / plate)))

# ::snt ( F ) Control forelimb .
# ::tok ( F ) Control forelimb .
# ::alignments 4-5|0 3-4|0.0 1-2|0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:51.978
(f / forelimb 
      :mod (c / control-01 
            :purpose-of (a / aircraft-type 
                  :name (n / name 
                        :op1 "F22") 
                  :wiki "Lockheed_Martin_F-22_Raptor")))

# ::snt ( G ) Mutant forelimb with webbing between the first and second digit ( black arrowhead ) .
# ::tok ( G ) Mutant forelimb with webbing between the first and second digit ( black arrowhead ) .
# ::alignments 15-16|0.2 14-15|0.2.0 12-13|0.1 10-11|0 3-4|0.2.0.0 1-2|0.0.1+0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:52.070
(a2 / and 
      :op1 (o / organization 
            :name (n / name 
                  :op1 "G-8") 
            :wiki "G8") 
      :op2 (d / digit) 
      :op3 (a / arrowhead 
            :ARG1-of (b / black-04 
                  :ARG0 (m / mutant))))

# ::snt Bmpr1a Is Expressed in Joints and Is Required for Continued Joint Formation in the Ankle Region .
# ::tok Bmpr1a Is Expressed in Joints and Is Required for Continued Joint Formation in the Ankle Region .
# ::alignments 14-16|0.0.0.1.0.0.0.0.1+0.0.0.1.0.0.0.0.0+0.0.0.1.0.0.0.0+0.0.0.1.0.0.0 11-12|0.0.0.1.0.0 10-11|0.0.0.1.0.0.1 9-10|0.0.0.1.0 7-8|0.0.0 6-7|0.0.0.0 5-6|0.0.0.1 4-5|0.0.0.1.1.0 2-3|0.0.0.1.1 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:52.181
(b2 / be-01 
      :ARG1 (b3 / Bmpr1a 
            :ARG1-of (r / require-01 
                  :ARG2-of (b / be-01) 
                  :op1-of (a / and 
                        :ARG0-of (c / continue-01 
                              :ARG1 (f / formation 
                                    :location (o / organization 
                                          :name (n / name 
                                                :op1 "Ankle" 
                                                :op2 "Region")) 
                                    :mod (j / joint))) 
                        :ARG1-of (e / express-01 
                              :location (j2 / joint))))))

# ::snt ( A ) Diagram of ankle bones from a wild-type mouse ; bones fusing in mutant are colored red .
# ::tok ( A ) Diagram of ankle bones from a wild-type mouse ; bones fusing in mutant are colored red .
# ::alignments 18-19|0.0.0.0 17-18|0.0.0 15-16|0.0.2 13-14|0.0 12-13|0 11-12|0.0.3 10-11|0.1 6-7|0.1.0.0 5-6|0.0.1 3-4|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:52.310
(b / bone 
      :ARG1-of (f / fuse-01 
            :ARG1-of (c / color-01 
                  :ARG2 (r / red)) 
            :ARG2 (a2 / ankle) 
            :location (m / mutant) 
            :op1-of (a / and)) 
      :mod (m2 / mouse 
            :purpose-of (d / diagram-01 
                  :ARG1 (b2 / bone))))

# ::snt Roman numerals II -- IV , metatarsals ; 2 , 3 , and 4/5 , distal row of tarsal bones ; c , central tarsal bone ; ta , talus ; ca , calcaneus .
# ::tok Roman numerals II -- IV , metatarsals ; 2 , 3 , and 4/5 , distal row of tarsal bones ; c , central tarsal bone ; ta , talus ; ca , calcaneus .
# ::alignments 33-34|0.1 29-30|0.3.0.0.0 27-28|0.3.0.0.0.0.4 25-26|0.3.0.0.0.0.3.0 24-25|0.3.0.0.0.0.3 23-24|0.3.0.0.0.0.3.0.0 21-22|0.3.0.0.0.0.2 19-20|0 18-19|0.0 16-17|0.2 15-16|0.2.0 12-13|0.3.0.0.0.0.1 10-11|0.3.0.0.0.0.4.0 8-9|0.3.0.0.0.1 7-8|0.3.0.0.0.0 6-7|0.3.0.0.0.0.0 1-3|0.3.0.2+0.3.0.1+0.3.0+0.3 0-1|0.3.0.0.2+0.3.0.0.1.1+0.3.0.0.1.0+0.3.0.0.1+0.3.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:52.524
(b2 / bone 
      :mod (t4 / tarsal) 
      :mod (c / calcaneu) 
      :mod-of (r / row 
            :mod (d / distal)) 
      :poss (t5 / thing 
            :name (n / name 
                  :name-of (r2 / religious-group 
                        :mod (t / talu 
                              :mod (a2 / and 
                                    :op1 (m / metatarsal) 
                                    :op2 (a / and) 
                                    :op3 (c3 / c) 
                                    :poss (t3 / tarsal 
                                          :mod-of (b / bone 
                                                :mod (c2 / central))) 
                                    :poss-of (t2 / ta 
                                          :poss-of 3)) 
                              :mod-of 2) 
                        :name (n3 / name 
                              :op1 "Roman" 
                              :op2 "Catholic") 
                        :wiki "Catholic_Church") 
                  :op1 (n2 / numerals) 
                  :op2 (i / II))))

# ::snt ( B and C ) In situ hybridization at E15 .5 showing that Bmpr1a is expressed in ankle joint interzones ( B , arrowheads ) and in the forming articular regions of the phalangeal joints ( C , arrowheads ) .
# ::tok ( B and C ) In situ hybridization at E15 .5 showing that Bmpr1a is expressed in ankle joint interzones ( B , arrowheads ) and in the forming articular regions of the phalangeal joints ( C , arrowheads ) .
# ::alignments 38-39|0.4 36-37|0.5 34-35|0.2.1 33-34|0.2.1.0 30-31|0.2.0 29-30|0.2.0.1 28-29|0.2.0.0 25-26|0.2 23-24|0.1.1 21-22|0.2.0.0.1.1+0.2.0.0.1.0.0+0.2.0.0.1.0+0.2.0.0.1 19-20|0.3 18-19|0.3.0 17-18|0.2.0.0.0 15-16|0 13-14|0.0.0.0+0.0.0+0.0 11-12|0.1 9-10|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 7-8|0.1.0 3-4|0.2.2.1 2-3|0.2.2 1-2|0.2.2.0.1+0.2.2.0.0.0+0.2.2.0.0+0.2.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:53.415
(e / express-01 
      :ARG1 (p2 / person 
            :name (n2 / name 
                  :op1 "Bmpr1a")) 
      :ARG1-of (s / show-01 
            :ARG0 (h / hybridization 
                  :location (c2 / country 
                        :name (n3 / name 
                              :op1 "E15"))) 
            :ARG2 (a4 / arrowhead)) 
      :ARG2 (a3 / and 
            :op1 (r / region 
                  :ARG1-of (f / form-01 
                        :ARG0 (a5 / ankle) 
                        :ARG2 (l / location 
                              :name (n / name 
                                    :op1 "B") 
                              :wiki -)) 
                  :mod (a2 / articular)) 
            :op2 (j / joint 
                  :mod (p / phalangeal)) 
            :op3-of (a6 / and 
                  :op1 (l2 / location 
                        :name (n4 / name 
                              :op1 "B") 
                        :wiki -) 
                  :op2 (c3 / C))) 
      :manner (i / interzon 
            :mod (j2 / joint)) 
      :op1-of (a / arrowhead) 
      :op1-of (c / C))

# ::snt ( D ) Near adjacent section to ( C ) showing Gdf5-Cre induced LACZ expression from R26R in the forming joints of the digits ( arrowheads ) .
# ::tok ( D ) Near adjacent section to ( C ) showing Gdf5-Cre induced LACZ expression from R26R in the forming joints of the digits ( arrowheads ) .
# ::alignments 25-26|0 23-24|0.0.0.0.0 20-21|0.0.0.0 19-20|0.0.0 16-17|0.0.2.1.1.0.0+0.0.2.1.1.0+0.0.2.1.1 14-15|0.0.2.1 12-13|0.0.2 11-12|0.0.2.0.1.0+0.0.2.0.1+0.0.2.0 10-11|0.0.2.0.0 8-9|0.0.2.0.0.0 5-6|0.0.1 4-5|0.0.1.0 3-4|0.0 1-2|0.0.2.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:53.628
(a / arrowhead 
      :ARG0-of (n3 / near-02 
            :ARG1 (f / form-01 
                  :ARG1 (j / joint 
                        :poss (d / digit))) 
            :ARG2 (s2 / section 
                  :mod (a2 / adjacent)) 
            :time-of (i / induce-01 
                  :ARG0 (t2 / thing 
                        :ARG1-of (s / show-01 
                              :ARG0 (c / C)) 
                        :name (n2 / name 
                              :op1 "Gdf5-Cre")) 
                  :ARG1 (e / express-01 
                        :ARG0 (d2 / D) 
                        :ARG1 (t / thing 
                              :name (n / name 
                                    :op1 "R26R"))))))

# ::snt ( E -- J ) Marker gene expression and R26R LACZ staining patterns on near adjacent sections of control and mutant embryos .
# ::tok ( E -- J ) Marker gene expression and R26R LACZ staining patterns on near adjacent sections of control and mutant embryos .
# ::alignments 21-22|0.2 20-21|0.2.0 19-20|0 18-19|0.1 16-17|0.0.0.0.0.0 15-16|0.0.0.0.0.0.0 14-15|0.0.0.0.0.0.0.0 12-13|0.0.0.0.0 11-12|0.0.0.0.0.1 9-11|0.0.0.0.1.1+0.0.0.0.1.0+0.0.0.0.1+0.0.0.0 8-9|0.0.0 7-8|0.0 6-7|0.1.1.0 5-6|0.1.1 3-4|0.0.0.0.0.0.0.0.0.1+0.0.0.0.0.0.0.0.0.0.0+0.0.0.0.0.0.0.0.0.0+0.0.0.0.0.0.0.0.0 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:53.927
(a / and 
      :ARG1-of (e2 / express-01 
            :op1-of (a3 / and 
                  :op2 (t / thing 
                        :mod-of (p / pattern-01 
                              :ARG1 (s / section 
                                    :mod (a2 / adjacent 
                                          :ARG1-of (n / near-02 
                                                :ARG0 (a4 / aircraft-type 
                                                      :name (n3 / name 
                                                            :op1 "J-10") 
                                                      :wiki "Chengdu_J-10")))) 
                              :mod (s2 / stain-01)) 
                        :name (n2 / name 
                              :op1 (r / R26R) 
                              :op2 (l / LACZ))))) 
      :op1 (c / control-01 
            :ARG0 (e3 / E) 
            :ARG1 (m2 / mark-01 
                  :ARG1 (g / gene))) 
      :op2 (e / embryo 
            :mod (m / mutant)))

# ::snt In control mice at E15 .5 ankle joints are clearly delineated as regions that have down-regulated Col2 ( E ) , express Gdf5 throughout ( F ) , and express LACZ in most cells ( G ; white arrowheads and black arrows ) .
# ::tok In control mice at E15 .5 ankle joints are clearly delineated as regions that have down-regulated Col2 ( E ) , express Gdf5 throughout ( F ) , and express LACZ in most cells ( G ; white arrowheads and black arrows ) .
# ::alignments 41-42|0.1 40-41|0.1.0 39-40|0 38-39|0.2.1 37-38|0.2.1.0 36-37|0.2 35-36|0.2.0.1+0.2.0.0.0+0.2.0.0+0.2.0 33-34|0.0.1 32-33|0.0.1.0 29-30|0.0 28-29|0.0.2 25-26|0.0.2.0.2.1+0.0.2.0.2.0.0+0.0.2.0.2.0+0.0.2.0.2 23-24|0.0.2.0.1.0 22-23|0.0.2.0.1.1.0+0.0.2.0.1.1+0.0.2.0.1 21-22|0.0.2.0 18-19|0.0.0.0.2.1.0 16-17|0.0.2.0.0.1.0+0.0.2.0.0.1+0.0.2.0.0 15-16|0.0.2.0.0.0 12-13|0.0.0 10-11|0.0.0.0 9-10|0.0.0.0.1 7-8|0.0.0.0.0 6-7|0.0.0.0.0.0 4-5|0.0.0.0.2.0.0.0+0.0.0.0.2.0.0+0.0.0.0.2.0 2-3|0.0.0.0.2 1-2|0.0.0.0.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:55.180
(a2 / and 
      :ARG1-of (e / express-01 
            :ARG0 (r / region 
                  :ARG2-of (d2 / delineate-01 
                        :ARG1 (j / joint 
                              :mod (a7 / ankle)) 
                        :ARG1-of (c2 / clear-06) 
                        :manner (m2 / mouse 
                              :location (c3 / country 
                                    :name (n5 / name 
                                          :op1 "E15")) 
                              :mod (c4 / control-01 
                                    :ARG1 (e3 / E))))) 
            :manner (c / cell 
                  :quant (m / most)) 
            :op2-of (a5 / and 
                  :op1 (e2 / express-01 
                        :ARG0 (p2 / person 
                              :mod (d / down-regulat) 
                              :name (n4 / name 
                                    :op1 "Col2")) 
                        :ARG1 (p / person 
                              :location (t / throughout) 
                              :name (n3 / name 
                                    :op1 "Gdf5")) 
                        :ARG2 (a6 / aircraft-type 
                              :name (n2 / name 
                                    :op1 "F22") 
                              :wiki "Lockheed_Martin_F-22_Raptor")))) 
      :op1 (a / arrow 
            :ARG1-of (b / black-04)) 
      :op3-of (a4 / and 
            :op1 (o / organization 
                  :name (n / name 
                        :op1 "G-8") 
                  :wiki "G8") 
            :op2 (a3 / arrowhead 
                  :mod (w / white))))

# ::snt In mutant embryos at the same stage , joint formation is incomplete .
# ::tok In mutant embryos at the same stage , joint formation is incomplete .
# ::alignments 11-12|0.0.0.0+0.0.0 9-10|0.0 8-9|0.0.1 6-7|0.1 5-6|0 2-3|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:55.220
(s2 / same-01 
      :ARG0 (f / form-01 
            :ARG1-of (c / complete-02 
                  :polarity -) 
            :manner (j / joint)) 
      :ARG1 (s / stage 
            :location-of (e / embryo)))

# ::snt Faint Col2 expression can be seen connecting a medial region of tarsal 2 with metatarsal II ( H , white arrowhead ) , and Gdf5 expression does not extend all the way across the joint at this location ( I , white arrowhead ) .
# ::tok Faint Col2 expression can be seen connecting a medial region of tarsal 2 with metatarsal II ( H , white arrowhead ) , and Gdf5 expression does not extend all the way across the joint at this location ( I , white arrowhead ) .
# ::alignments 42-43|0.2.0.1.1.0.0.0 41-42|0.2.0.1.1.0.0 39-40|0.1.0 37-38|0.2.0.1.3 36-37|0.2.0.1.3.0 34-35|0.2.0.0 32-33|0.2.0 31-32|0.2.0.1.2 29-30|0.2.0.1.2.0 28-29|0.2.0.1 27-28|0.2.0.1.4 25-26|0.2.0.1.1 24-25|0.2.0.1.1.0.1.0+0.2.0.1.1.0.1+0.2.0.1.1.0 23-24|0.2 20-21|0.1.1.1.0 19-20|0.1.1.1.0.0 17-18|0.0 14-16|0.1.1.1.1.1.0.1+0.1.1.1.1.1.0.0+0.1.1.1.1.1.0+0.1.1.1.1.1 12-13|0.2.0.1.1.1 11-12|0.2.0.1.0 9-10|0.1.1.1.1 8-9|0.1.1.1.1.0 6-7|0.1.1.1 5-6|0.1 3-4|0 2-3|0.1.1 0-1|0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:57.402
(p2 / possible-01 
      :ARG0 (h / h) 
      :ARG1 (s / see-01 
            :ARG0 (i / i) 
            :ARG1 (e3 / express-01 
                  :ARG1-of (f / faint-01) 
                  :ARG3-of (c / connect-01 
                        :ARG0 (a5 / arrowhead 
                              :mod (w3 / white)) 
                        :ARG1 (r / region 
                              :mod (m2 / medial) 
                              :prep-with (t2 / thing 
                                    :name (n2 / name 
                                          :op1 (m / metatarsal) 
                                          :op2 (i2 / II))))))) 
      :op1-of (a4 / and 
            :location (a2 / across 
                  :op1 (j / joint) 
                  :path-of (e / extend-01 
                        :ARG0 (t3 / tarsal) 
                        :ARG1 (e2 / express-01 
                              :ARG0 (p / person 
                                    :mod (w / white 
                                          :mod-of (a / arrowhead)) 
                                    :name (n / name 
                                          :op1 "Gdf5")) 
                              :ARG1 2) 
                        :extent (w2 / way 
                              :mod (a3 / all)) 
                        :location (l / location 
                              :domain (t / this)) 
                        :polarity -))))

# ::snt Between tarsals c and 2 , mutants express Col2 across the normal joint-forming region ( H , black arrow ) and lack expression of Gdf5 at sites where skeletal fusions are observed ( I , black arrow and bracket ) .
# ::tok Between tarsals c and 2 , mutants express Col2 across the normal joint-forming region ( H , black arrow ) and lack expression of Gdf5 at sites where skeletal fusions are observed ( I , black arrow and bracket ) .
# ::alignments 38-39|0.1.1.1 37-38|0.1.1 36-37|0.1.1.0 33-34|0.2.0.2.0.0 31-32|0.2.0.2.0 29-30|0.2.0.2.0.1 28-29|0.2.0.2.0.1.0 26-27|0.2.0.2 24-25|0.2.0.1.0.0.0+0.2.0.1.0.0+0.2.0.1.0 22-23|0.2.0.1 21-22|0.2.0 20-21|0.2 18-19|0.1.1.1.0.1 17-18|0.1.1.1.0 15-16|0.3.1 13-14|0.3.0 12-13|0.3.0.1 11-12|0.3.0.0 9-10|0.3 8-9|0.1.0.0+0.1.0+0.1 7-8|0 6-7|0.2.0.0 4-5|0.2.0.1.1 3-4|0.2.0.3 2-3|0.1.1.1.0.0 1-2|0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:59.744
(e2 / express-01 
      :ARG0 (b3 / between 
            :op1 (t / tarsal)) 
      :ARG1 (p2 / person 
            :name (n3 / name 
                  :op1 "Col2") 
            :op1-of (a / and 
                  :op2 (a2 / arrow) 
                  :op3 (b / bracket-01 
                        :ARG1 (b2 / black-04 
                              :ARG0 (c / c) 
                              :ARG1 (a4 / arrow))))) 
      :op1-of (a3 / and 
            :op2 (l / lack-01 
                  :ARG0 (m / mutant) 
                  :ARG1 (e / express-01 
                        :ARG0 (p / person 
                              :name (n / name 
                                    :op1 "Gdf5")) 
                        :ARG1 2) 
                  :destination (s2 / site 
                        :ARG2-of (o / observe-01 
                              :ARG0 (i / i) 
                              :ARG1 (f / fusion 
                                    :mod (s / skeletal)))) 
                  :op1-of (a6 / and))) 
      :path (a5 / across 
            :op1 (r / region 
                  :ARG1-of (n2 / normal-02) 
                  :mod (j / joint-form)) 
            :op2 (h / h)))

# ::snt ( J ) Scale bar = 100 m .
# ::tok ( J ) Scale bar = 100 m .
# ::alignments 7-8|0.1 6-7|0.1.0 4-5|0 3-4|0.0 1-2|0.2.1+0.2.0.0+0.2.0+0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:59.810
(b / bar-01 
      :ARG0 (s / scale) 
      :ARG1 (m / m 
            :quant 100) 
      :ARG2 (a / aircraft-type 
            :name (n / name 
                  :op1 "J-10") 
            :wiki "Chengdu_J-10"))

# ::snt Bmpr1a Is Required to Maintain Expression of ECM Components in Articular Cartilage .
# ::tok Bmpr1a Is Required to Maintain Expression of ECM Components in Articular Cartilage .
# ::alignments 10-12|0.0.1.0.1+0.0.1.0.0+0.0.1.0+0.0.1 7-9|0.0.0.0.1.0.0.1+0.0.0.0.1.0.0.0+0.0.0.0.1.0.0+0.0.0.0.1.0 4-6|0.0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 2-3|0.0 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:17:59.933
(b / be-01 
      :ARG3-of (r / require-01 
            :ARG1 (t / thing 
                  :name (n3 / name 
                        :op1 (m / Maintain) 
                        :op2 (e / Expression 
                              :poss (o / organization 
                                    :name (n2 / name 
                                          :op1 "ECM" 
                                          :op2 "Components"))))) 
            :location (c / country 
                  :name (n / name 
                        :op1 "Articular" 
                        :op2 "Cartilage"))))

# ::snt In situ hybridization or LACZ staining on near adjacent sections of metacarpal-phalangeal joints ( A -- C and F -- H ) and the tarsal 2-metatarsal II joint ( D -- E and I -- J ) of P0 mice .
# ::tok In situ hybridization or LACZ staining on near adjacent sections of metacarpal-phalangeal joints ( A -- C and F -- H ) and the tarsal 2-metatarsal II joint ( D -- E and I -- J ) of P0 mice .
# ::alignments 39-40|0.0.0.0.1.0.1 35-36|0.1.2.1+0.1.2.0.0+0.1.2.0+0.1.2 33-34|0.1.1 32-33|0.1 31-32|0.1.0 29-30|0.0.0.0.1.0.0 27-28|0.0.0.1 26-27|0.0.0.1.0.1+0.0.0.1.0.0.2+0.0.0.1.0.0.1+0.0.0.1.0.0.0+0.0.0.1.0.0+0.0.0.1.0 24-25|0.0.0.1.1 22-23|0.0.0 20-21|0.3 18-19|0.2.1+0.2.0.0+0.2.0+0.2 17-18|0 16-17|0.0 12-13|0.0.0.0.2 9-10|0.0.0.0 8-9|0.0.0.0.1 7-8|0.0.0.0.1.0 5-6|0.0.0.0.0 3-4|0.0.0.0.0.0 2-3|0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:18:00.554
(a5 / and 
      :op1 (c / C 
            :op2-of (a3 / and 
                  :op1 (s / section 
                        :ARG1-of (s2 / stain-01 
                              :ARG0 (o / or 
                                    :op1 (h2 / hybridization))) 
                        :mod (a6 / adjacent 
                              :ARG1-of (n4 / near-02 
                                    :ARG2 (d / D) 
                                    :op1-of (m / mouse))) 
                        :quant-of (j2 / joint)) 
                  :op3 (j / joint 
                        :mod (w / war 
                              :name (n2 / name 
                                    :op1 "World" 
                                    :op2 "War" 
                                    :op3 "II") 
                              :wiki "World_War_II") 
                        :mod (t / tarsal)))) 
      :op1-of (a2 / and 
            :op2 (e / E) 
            :op3 (i / i) 
            :op4 (a / aircraft-type 
                  :name (n / name 
                        :op1 "J-10") 
                  :wiki "Chengdu_J-10")) 
      :op2 (a4 / aircraft-type 
            :name (n3 / name 
                  :op1 "F22") 
            :wiki "Lockheed_Martin_F-22_Raptor") 
      :op3 (h / h))

# ::snt At birth , articular cartilage of controls ( A -- E ) and mutants ( F -- J ) appears similar by Safranin O staining ( A and F ) , and Col2 expression ( B , G ) .
# ::tok At birth , articular cartilage of controls ( A -- E ) and mutants ( F -- J ) appears similar by Safranin O staining ( A and F ) , and Col2 expression ( B , G ) .
# ::alignments 37-38|0.1.0.0.1.0.1.1.1.1+0.1.0.0.1.0.1.1.1.0.0+0.1.0.0.1.0.1.1.1.0+0.1.0.0.1.0.1.1.1 35-36|0.1.0.0.0.1+0.1.0.0.0.0.0+0.1.0.0.0.0+0.1.0.0.0 33-34|0.1.0.0.1.0 31-32|0.1.0.0.1.0.1 28-29|0.1.0.0.1.0.1.1.0.1+0.1.0.0.1.0.1.1.0.0.0+0.1.0.0.1.0.1.1.0.0+0.1.0.0.1.0.1.1.0 27-28|0.1.0.0.1.0.1.1 24-25|0.1.0.0.1.0.1.0.1 23-24|0.1.0.0.1.0.1.0.3+0.1.0.0.1.0.1.0.2.0+0.1.0.0.1.0.1.0.2+0.1.0.0.1.0.1.0 22-23|0.1.0.0.1.0.1.0.1.0 20-21|0.1 19-20|0 17-18|0.1.0.0.1.0.1.0.0.0.1+0.1.0.0.1.0.1.0.0.0.0.0+0.1.0.0.1.0.1.0.0.0.0+0.1.0.0.1.0.1.0.0.0 15-16|0.0.1+0.0.0.0+0.0.0+0.0 13-14|0.1.0.0.1.1 12-13|0.1.0.0.1 10-11|0.1.0.0.1.0.0 6-7|0.1.0.0 4-5|0.1.0 3-4|0.1.0.1 1-2|0.1.0.0.1.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:18:01.777
(a4 / appear-02 
      :ARG0 (a6 / aircraft-type 
            :name (n6 / name 
                  :op1 "F22") 
            :wiki "Lockheed_Martin_F-22_Raptor") 
      :ARG1 (r / resemble-01 
            :ARG1 (c2 / cartilage 
                  :mod (c / control-01 
                        :ARG1 (l / location 
                              :name (n2 / name 
                                    :op1 "B") 
                              :wiki -) 
                        :op1-of (a7 / and 
                              :ARG1-of (e / express-01 
                                    :ARG0 (e2 / E) 
                                    :op3-of (a / and 
                                          :op1 (p / person 
                                                :ARG0-of (b / birth-01 
                                                      :ARG1 (a5 / aircraft-type 
                                                            :name (n5 / name 
                                                                  :op1 "J-10") 
                                                            :wiki "Chengdu_J-10")) 
                                                :ARG0-of (s / stain-01 
                                                      :ARG1 (s2 / safranin)) 
                                                :name (n4 / name 
                                                      :op1 "O'Reilly") 
                                                :wiki "Bill_O'Reilly_(political_commentator)") 
                                          :op2 (a3 / and 
                                                :op1 (a2 / aircraft-type 
                                                      :name (n3 / name 
                                                            :op1 "F22") 
                                                      :wiki "Lockheed_Martin_F-22_Raptor") 
                                                :op2 (o / organization 
                                                      :name (n / name 
                                                            :op1 "G-8") 
                                                      :wiki "G8")))) 
                              :op2 (m / mutant))) 
                  :mod (a8 / articular))))

# ::snt Mat4 expression confirms that articular cartilage is initially specified in mutants ( D andI , brackets ) .
# ::tok Mat4 expression confirms that articular cartilage is initially specified in mutants ( D andI , brackets ) .
# ::alignments 15-16|0.0.0.1 13-14|0.1 12-13|0 10-11|0.0.0.0.1 8-9|0.0.0.0 7-8|0.0.0.0.2 5-6|0.0.0.0.0 4-5|0.0.0.0.0.0 2-3|0.0.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:18:01.869
(d / D 
      :ARG1-of (e / express-01 
            :ARG0-of (c2 / confirm-01 
                  :ARG1 (s / specify-01 
                        :ARG1 (c / cartilage 
                              :mod (a2 / articular)) 
                        :location (m / mutant) 
                        :time (i / initial)) 
                  :ARG1-of (b / bracket-01))) 
      :mod-of (a / andI))

# ::snt LACZ expression confirms Cre-mediated recombination has occurred in articular cartilage ( C , H , E , and J ) .
# ::tok LACZ expression confirms Cre-mediated recombination has occurred in articular cartilage ( C , H , E , and J ) .
# ::alignments 18-19|0.3.1+0.3.0.0+0.3.0+0.3 17-18|0 15-16|0.2 13-14|0.1 11-12|0.0.0.0.1 9-10|0.0.0.0.2 8-9|0.0.0.0.2.0 6-7|0.0.0.0 4-5|0.0.0.0.0 3-4|0.0.0.0.0.0 2-3|0.0.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:18:02.081
(a2 / and 
      :ARG1-of (e2 / express-01 
            :ARG0-of (c4 / confirm-01 
                  :ARG1 (o / occur-01 
                        :ARG0 (r / recombination 
                              :mod (c3 / cre-mediat)) 
                        :ARG1 (c / C) 
                        :ARG2 (c2 / cartilage 
                              :mod (a3 / articular))))) 
      :op1 (h / h) 
      :op2 (e / E) 
      :op3 (a / aircraft-type 
            :name (n / name 
                  :op1 "J-10") 
            :wiki "Chengdu_J-10"))

# ::snt ( K -- T ) Near adjacent sections of the metacarpal-phalangeal joints of P14 mice .
# ::tok ( K -- T ) Near adjacent sections of the metacarpal-phalangeal joints of P14 mice .
# ::alignments 14-15|0 13-14|0.0 11-12|0.1 7-8|0.1.0 6-7|0.1.0.0 5-6|0.0.0 3-4|0.3.1+0.3.0.0+0.3.0+0.3 1-2|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:18:02.134
(m / mouse 
      :mod (p / P14 
            :ARG1-of (n / near-02)) 
      :mod-of (j / joint 
            :poss-of (s / section 
                  :mod (a / adjacent))) 
      :poss-of (k / k) 
      :poss-of (a2 / aircraft-type 
            :name (n2 / name 
                  :op1 "T50") 
            :wiki "Sukhoi_PAK_FA"))

# ::snt Two weeks after birth , articular cartilage of controls stains with pericellular Safranin O ( orange staining , K ) , and expresses Col2 ( L ) , Agg ( M ) , and SOX9 ( N ) .
# ::tok Two weeks after birth , articular cartilage of controls stains with pericellular Safranin O ( orange staining , K ) , and expresses Col2 ( L ) , Agg ( M ) , and SOX9 ( N ) .
# ::alignments 36-37|0.0.0.0.0.0.0 33-34|0.1.1 30-31|0.0.0.0.1.1+0.0.0.0.1.0.0+0.0.0.0.1.0+0.0.0.0.1 25-26|0.0.1.0.1 23-24|0.1.0.0.0+0.1.0.0+0.1.0 22-23|0.1 21-22|0 18-19|0.0.1.0.2 16-17|0.0.0.0.0.0 15-16|0.0.0.0.0.0.1 13-14|0.0.0.0.0.3+0.0.0.0.0.2.0+0.0.0.0.0.2+0.0.0.0.0 12-13|0.0.0.0.0.1 11-12|0.0.0.0.0.1.0 9-10|0.0.0.0 8-9|0.0 6-7|0.0.0 5-6|0.0.0.1 3-4|0.0.1.0 2-3|0.0.1 1-2|0.0.1.0.0.1+0.0.1.0.0 0-1|0.0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:18:04.322
(a2 / and 
      :ARG1-of (c / control-01 
            :ARG0 (c2 / cartilage 
                  :ARG0-of (s3 / stain-01 
                        :ARG1 (p2 / person 
                              :ARG0-of (s / stain-01 
                                    :ARG1 (n / N) 
                                    :mod (o / orange)) 
                              :mod (s2 / safranin 
                                    :mod (p3 / pericellular)) 
                              :name (n4 / name 
                                    :op1 "O'Reilly") 
                              :wiki "Bill_O'Reilly_(political_commentator)") 
                        :ARG2 (v / vehicle 
                              :name (n2 / name 
                                    :op1 "M1") 
                              :wiki "M1_Abrams")) 
                  :mod (a3 / articular)) 
            :time (a4 / after 
                  :op1 (b / birth-01 
                        :location-of (t / temporal-quantity 
                              :quant 2 
                              :unit (w / week)) 
                        :op1-of (l / L) 
                        :op1-of (k / k)))) 
      :op1 (e / express-01 
            :ARG0 (p / person 
                  :name (n3 / name 
                        :op1 "Col2")) 
            :ARG1 (a / and)))

# ::snt In contrast , mutant articular cells are smaller and more densely packed , lack pericellular Safranin O staining ( P ) , have reduced expression of Col2 ( Q ) and Agg ( R ) , but retain normal levels of SOX9 protein ( S , brackets ; dashed line marks faint edges of articular surfaces ) .
# ::tok In contrast , mutant articular cells are smaller and more densely packed , lack pericellular Safranin O staining ( P ) , have reduced expression of Col2 ( Q ) and Agg ( R ) , but retain normal levels of SOX9 protein ( S , brackets ; dashed line marks faint edges of articular surfaces ) .
# ::alignments 55-56|0.1.1.3.1.1.0.0 54-55|0.1.1.3.1.1.0.0.0 52-53|0.1.1.3.1.1.2 51-52|0.1.1.3.1.1.2.0 50-51|0.1.1.3.1.1.1.0+0.1.1.3.1.1.1 49-50|0.1.1.3.1.1.1.1 48-49|0.1.1.3.1.1.0.1 47-48|0.1.1.3.1.1 46-47|0.1.1.3.1.1.0 44-45|0.1.1.3.0.0+0.1.1.3.0 42-43|0.0 39-40|0.1.0 38-39|0.1.0.0 37-38|0.1 36-37|0 33-34|0.1.1.3.1.0.1.1 30-31|0.1.1.3.1.0.1 28-29|0.1.1.3.2 26-27|0.1.1.3.1.0.0.0+0.1.1.3.1.0.0+0.1.1.3.1.0 24-25|0.1.1.3.1 23-24|0.1.1.3 19-20|0.1.1.2.0.0.0 17-18|0.1.1.2.0.0 16-17|0.1.1.2.0.3+0.1.1.2.0.2.0+0.1.1.2.0.2+0.1.1.2.0 15-16|0.1.1.2.0.1 14-15|0.1.1.0.0 13-14|0.1.1.2 11-12|0.1.1.3.1.0.1.0 10-11|0.1.1.3.1.0.1.0.1 9-10|0.1.1.3.1.0.1.0.0 8-9|0.1.1 7-8|0.1.1.1 5-6|0.1.1.1.0 4-5|0.1.1.1.0.0 3-4|0.1.1.1.0.1 1-2|0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:18:06.135
(c / contrast-01 
      :ARG1 (p / protein) 
      :ARG2 (r / retain-01 
            :ARG1 (l2 / level 
                  :ARG1-of (n2 / normal-02)) 
            :op4-of (a4 / and 
                  :ARG2-of (c3 / contrast-01 
                        :ARG1 (p5 / pericellular)) 
                  :op1 (s4 / small 
                        :domain (c2 / cell 
                              :mod (a5 / articular) 
                              :mod (m3 / mutant))) 
                  :op2 (l3 / lack-01 
                        :ARG1 (p4 / person 
                              :ARG0-of (s2 / stain-01 
                                    :ARG1 (p3 / P60)) 
                              :mod (s3 / safranin) 
                              :name (n4 / name 
                                    :op1 "O'Reilly") 
                              :wiki "Bill_O'Reilly_(political_commentator)")) 
                  :op3 (r3 / reduce-01 
                        :ARG0 (n / name 
                              :op1 "S-400") 
                        :ARG1 (e2 / express-01 
                              :ARG0 (p2 / person 
                                    :name (n3 / name 
                                          :op1 "Col2") 
                                    :op1-of (a3 / and 
                                          :ARG2-of (p6 / pack-01 
                                                :ARG1 (m2 / more) 
                                                :manner (d2 / densely)) 
                                          :op2 (r2 / r))) 
                              :ARG1 (a2 / and 
                                    :op1 (b / bracket-01 
                                          :ARG1 (s / surface-01 
                                                :ARG1 (a / articular)) 
                                          :ARG1-of (d / dash-01)) 
                                    :op2 (t / thing 
                                          :ARG0-of (m / mark-01) 
                                          :mod (l / line)) 
                                    :op3 (e / edge 
                                          :ARG1-of (f / faint-01)))) 
                        :ARG2 (q / q)))))

# ::snt LACZ expression confirms Cre-mediated recombination has occurred in articular cells ( O ansd T , brackets ) .
# ::tok LACZ expression confirms Cre-mediated recombination has occurred in articular cells ( O ansd T , brackets ) .
# ::alignments 15-16|0.0.0.0.0.0.1 13-14|0.0.0.0.2+0.0.0.0.1.0+0.0.0.0.1+0.0.0.0 11-13|0+0.0.1+0.0+0.0.0 9-10|0.0.0.0.0.0.0.1 8-9|0.0.0.0.0.0.0.1.0 6-7|0.0.0.0.0.0.0 4-5|0.0.0.0.0.0.0.0 3-4|0.0.0.0.0.0.0.0.0 2-3|0.0.0.0.0.0 1-2|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:18:06.235
(a2 / ansd 
      :op2-of (n2 / name 
            :name-of (t / thing 
                  :mod-of (a / aircraft-type 
                        :ARG1-of (e / express-01 
                              :ARG0-of (c3 / confirm-01 
                                    :ARG1 (o2 / occur-01 
                                          :ARG0 (r / recombination 
                                                :mod (c2 / cre-mediat)) 
                                          :ARG1 (c / cell 
                                                :mod (a3 / articular))) 
                                    :ARG1-of (b / bracket-01))) 
                        :name (n / name 
                              :op1 "T50") 
                        :wiki "Sukhoi_PAK_FA")) 
            :op1 (o / O)))

# ::snt ( A and K ) Scale bar = 75 m .
# ::tok ( A and K ) Scale bar = 75 m .
# ::alignments 9-10|0.0 8-9|0.0.0 6-7|0 5-6|0.1 3-4|0.2.0 2-3|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:18:06.259
(b / bar-01 
      :ARG1 (m / m 
            :quant 75) 
      :mod (s / scale) 
      :op2-of (a / and 
            :op1 (k / k)))

# ::snt Synovial Membrane Expansion , Articular Surface Erosion , and Accelerated Maturation of Underlying Cartilage in Ankles of Bmpr1a Mutant Mice .
# ::tok Synovial Membrane Expansion , Articular Surface Erosion , and Accelerated Maturation of Underlying Cartilage in Ankles of Bmpr1a Mutant Mice .
# ::alignments 17-20|0.4.0.2+0.4.0.1+0.4.0.0+0.4.0+0.4 15-16|0.4.1 12-14|0.3.0.1+0.3.0.0+0.3.0+0.3 9-11|0.2.0.1+0.2.0.0+0.2.0+0.2 8-9|0 4-7|0.1.0.2+0.1.0.1+0.1.0.0+0.1.0+0.1 0-3|0.0.0.2+0.0.0.1+0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:18:06.371
(a3 / and 
      :op1 (o2 / organization 
            :name (n5 / name 
                  :op1 "Synovial" 
                  :op2 "Membrane" 
                  :op3 "Expansion")) 
      :op2 (o / organization 
            :name (n4 / name 
                  :op1 "Articular" 
                  :op2 "Surface" 
                  :op3 "Erosion")) 
      :op3 (t2 / thing 
            :name (n3 / name 
                  :op1 (a2 / Accelerated) 
                  :op2 (m / Maturation))) 
      :op4 (t / thing 
            :name (n2 / name 
                  :op1 (u / Underlying) 
                  :op2 (c / Cartilage))) 
      :op5 (p / person 
            :name (n / name 
                  :op1 "Bmpr1a" 
                  :op2 "Mutant" 
                  :op3 "Mice") 
            :poss-of (a / ankl)))

# ::snt Near adjacent sections from the tarsal 2-metatarsal II joint of 7-d-old mice .
# ::tok Near adjacent sections from the tarsal 2-metatarsal II joint of 7-d-old mice .
# ::alignments 11-12|0.0.0.0 8-9|0.0.0 7-8|0.0.2+0.0.1.2+0.0.1.1+0.0.1.0+0.0.1+0.0 5-6|0 2-3|0.0.0.1 1-2|0.0.0.1.1 0-1|0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:18:06.431
(t / tarsal 
      :mod-of (w / war 
            :mod-of (j / joint 
                  :mod (m / mouse) 
                  :source-of (s / section 
                        :ARG1-of (n2 / near-02) 
                        :mod (a / adjacent))) 
            :name (n / name 
                  :op1 "World" 
                  :op2 "War" 
                  :op3 "II") 
            :wiki "World_War_II"))

# ::snt ( A and B ) LACZ staining ( blue ) shows Cre-mediated recombination is largely restricted to articular ( arrowheads ) and synovial cells ( asterisks ) in both controls and mutants .
# ::tok ( A and B ) LACZ staining ( blue ) shows Cre-mediated recombination is largely restricted to articular ( arrowheads ) and synovial cells ( asterisks ) in both controls and mutants .
# ::alignments 31-32|0.1.1.2 30-31|0.1.1 29-30|0.1.1.1 28-29|0.1.1.0 25-26|0.0.0 23-24|0.2.1.1 21-22|0.2.1 19-20|0.2.1.0 15-16|0.2 14-15|0.2.2 12-13|0.2.0 11-12|0.2.0.0 10-11|0 8-9|0.1.1.1.0 6-7|0.0 3-4|0.1.0.1+0.1.0.0.0+0.1.0.0+0.1.0 2-3|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:18:07.710
(s / show-01 
      :ARG0 (s2 / stain-01 
            :ARG1 (a2 / asterisk)) 
      :ARG1 (a5 / and 
            :op1 (l2 / location 
                  :name (n / name 
                        :op1 "B") 
                  :wiki -) 
            :op2 (a / and 
                  :mod (b / both) 
                  :op1 (c / control-01 
                        :ARG1 (b2 / blue)) 
                  :op2 (m / mutant))) 
      :ARG2 (r / restrict-01 
            :ARG0 (r2 / recombination 
                  :mod (c3 / cre-mediat)) 
            :ARG1 (a3 / and 
                  :op1 (a4 / arrowhead) 
                  :op2 (c2 / cell)) 
            :degree (l / large)))

# ::snt ( C and D ) In situ hybridization shows Col10 expression expands in mutants toward regions of synovial membrane expansion and articular surface erosion ( brackets and arrows ) .
# ::tok ( C and D ) In situ hybridization shows Col10 expression expands in mutants toward regions of synovial membrane expansion and articular surface erosion ( brackets and arrows ) .
# ::alignments 27-28|0.0.0.2.0.0.0 26-27|0.0.0.2.0.0 25-26|0.0.0.2.0 23-24|0.0.0.2.3 22-23|0.0.0.2.3.0 21-22|0.0.0.2.3.0.0 20-21|0.0.0.2 19-20|0.0.0.2.2 18-19|0.0.0.2.2.0 17-18|0.0.0.2.2.1 15-16|0.0.0.2.3.1 13-14|0.0.0.2.1 11-12|0.0.0.0 10-11|0 9-10|0.1.0.0+0.1.0+0.1 8-9|0.0.0 7-8|0.0 3-4|0.0.0.1.1 2-3|0.0.0.1 1-2|0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:18:08.874
(e4 / express-01 
      :ARG0 (h / hybridization 
            :ARG0-of (s3 / show-01 
                  :ARG0-of (e3 / expand-01) 
                  :ARG1 (a5 / and 
                        :op1 (c / C) 
                        :op2 (d / D)) 
                  :op1-of (a4 / and 
                        :ARG0-of (b / bracket-01 
                              :op1-of (a2 / and 
                                    :op2 (a / arrow))) 
                        :op2 (m2 / mutant) 
                        :op3 (e2 / expand-01 
                              :manner (m / membrane) 
                              :manner (s2 / synovial)) 
                        :op4 (e / erosion 
                              :mod (s / surface 
                                    :mod (a3 / articular)) 
                              :mod-of (r / region))))) 
      :ARG1 (t / thing 
            :name (n / name 
                  :op1 "Col10")))

# ::snt This may be a cell nonautonomous effect of joint damage , since the LACZ expressing cells at the articular surface do not show upregulation of Col10 ( arrowheads ) and the region of expanded Col10 expression is largely made up of cells that have not undergone Cre-mediated recombination .
# ::tok This may be a cell nonautonomous effect of joint damage , since the LACZ expressing cells at the articular surface do not show upregulation of Col10 ( arrowheads ) and the region of expanded Col10 expression is largely made up of cells that have not undergone Cre-mediated recombination .
# ::alignments 47-48|0.0.0.1.1 46-47|0.0.0.1.1.0 45-46|0.0.0.1 44-45|0.0.0.1.2 41-42|0.0.0.1.0 37-38|0.0.0.0.1.0.0.0 35-36|0.0.0.2.0 33-34|0.0.0.2 31-32|0.0.0.2.0.0 29-30|0.0.0 27-28|0.0.0.0.1.0.0.1 25-26|0.0.0.0.0.0.0.0+0.0.0.0.0.0.0+0.0.0.0.0.0 23-24|0.0.0.0.0 22-23|0.0.0.0 21-22|0.0.0.0.2 19-20|0.1.0 18-19|0.1.0.0 15-16|0.1 14-15|0 13-14|0.0 11-12|0.0.0.0.1 9-10|0.0.0.0.1.0.0 8-9|0.0.0.0.1.0.0.2 6-7|0.0.0.0.1.0 5-6|0.0.0.0.1.0.3 4-5|0.0.0.0.1.0.3.0 1-2|0.0.0.0.1.0.2 0-1|0.0.0.0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:18:10.780
(e3 / express-01 
      :ARG0 (l2 / LACZ 
            :op1-of (a / and 
                  :ARG0-of (s / show-01 
                        :ARG1 (u2 / upregulation 
                              :poss (t / thing 
                                    :name (n / name 
                                          :op1 "Col10"))) 
                        :op1-of (s3 / since 
                              :time-of (e4 / effect-03 
                                    :ARG0 (d / damage-01 
                                          :ARG0 (l / large) 
                                          :ARG1 (a2 / arrowhead) 
                                          :mod (j / joint)) 
                                    :ARG1 (t2 / this) 
                                    :ARG1-of (p / possible-01) 
                                    :mod (n2 / nonautonomou 
                                          :mod (c4 / cell)))) 
                        :polarity -) 
                  :ARG2-of (u / undergo-28 
                        :ARG0 (c2 / cell) 
                        :ARG1 (r / recombination 
                              :mod (c / cre-mediat)) 
                        :polarity -) 
                  :op2 (e2 / expand-01 
                        :ARG1 (e / express-01 
                              :ARG1 (r2 / region))))) 
      :ARG1 (c3 / cell 
            :location (s2 / surface 
                  :mod (a3 / articular))))

# ::snt Note the formation of a cartilaginous bridge along the joint capsule of the mutant where joint formation is disrupted at earlier stages ( B , white arrowhead , and Figure 3 , white arrowheads ) .
# ::tok Note the formation of a cartilaginous bridge along the joint capsule of the mutant where joint formation is disrupted at earlier stages ( B , white arrowhead , and Figure 3 , white arrowheads ) .
# ::alignments 33-34|0.1.4 32-33|0.1.4.0 30-31|0.1.0.0.0.0 29-30|0.1.3 28-29|0.1 26-27|0.1.2 25-26|0.1.2.0 23-24|0.1.1.1+0.1.1.0.0+0.1.1.0+0.1.1 21-22|0.1.0 20-21|0.1.0.1 18-19|0.1.0.0 16-17|0.1.0.0.0 15-16|0.1.0.0.0.2 13-14|0.1.0.0.0.1 10-11|0.0.0.0.0 9-10|0.0.0.0.0.0 7-8|0.0.0.0 6-7|0.0.0 5-6|0.0.0.1 2-3|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:18:11.191
(n2 / note-01 
      :ARG1 (f3 / form-01 
            :ARG1 (b / bridge 
                  :location (a4 / along 
                        :op1 (c / capsule 
                              :mod (j2 / joint))) 
                  :mod (c2 / cartilaginou))) 
      :op1-of (a2 / and 
            :op2 (s / stage 
                  :ARG2-of (d / disrupt-01 
                        :ARG1 (f2 / form-01 
                              :ARG0 3 
                              :ARG1 (m / mutant) 
                              :manner (j / joint))) 
                  :time (e / early)) 
            :op3 (l / location 
                  :name (n / name 
                        :op1 "B") 
                  :wiki -) 
            :op4 (a3 / arrowhead 
                  :mod (w2 / white)) 
            :op5 (f / figure) 
            :op6 (a / arrowhead 
                  :mod (w / white))))

# ::snt ( A ) Scale bar = 75 m .
# ::tok ( A ) Scale bar = 75 m .
# ::alignments 7-8|0.1 6-7|0.1.0 4-5|0 3-4|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:18:11.215
(b / bar-01 
      :ARG0 (s / scale) 
      :ARG1 (m / m 
            :quant 75))

# ::snt Loss of Bmpr1a Signaling Leads to Articular Cartilage Fibrillation and Degeneration in Digits and Knees of Aging Mice .
# ::tok Loss of Bmpr1a Signaling Leads to Articular Cartilage Fibrillation and Degeneration in Digits and Knees of Aging Mice .
# ::alignments 16-18|0.1.1.0.0.1+0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 14-15|0.1.1 13-14|0.1 12-13|0.1.0 10-11|0.3.0.1.0+0.3.0.1+0.3.0 9-10|0.3 6-9|0.2.0.2+0.2.0.1+0.2.0.0+0.2.0+0.2 4-5|0 3-4|0.3.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:18:11.552
(l / lead-01 
      :ARG0 (l2 / los) 
      :ARG1 (a2 / and 
            :op1 (d / digit) 
            :op2 (k / knee-01 
                  :ARG1 (t / thing 
                        :name (n / name 
                              :op1 (a / Aging) 
                              :op2 (m / Mice))))) 
      :ARG2 (o2 / organization 
            :name (n3 / name 
                  :op1 "Articular" 
                  :op2 "Cartilage" 
                  :op3 "Fibrillation")) 
      :op1-of (a3 / and 
            :op2 (o / organization 
                  :ARG1-of (s / signal-01) 
                  :name (n2 / name 
                        :op1 "Degeneration"))))

# ::snt ( A -- D ) Near adjacent sections of metatarsal-phalangeal joints from 9 month old mice .
# ::tok ( A -- D ) Near adjacent sections of metatarsal-phalangeal joints from 9 month old mice .
# ::alignments 15-16|0.1.1.0 14-15|0.1.1.0.0 13-14|0.2+0.2.0 12-13|0.2.0.0 10-11|0.1.1 7-8|0.1 6-7|0.1.0 5-6|0 3-4|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:18:11.621
(n / near-02 
      :ARG0 (d / D) 
      :ARG1 (s / section 
            :mod (a / adjacent) 
            :quant-of (j / joint 
                  :mod (m / mouse 
                        :mod (o / old)))) 
      :ARG2 (m2 / month 
            :unit-of (t / temporal-quantity 
                  :quant 9)))

# ::snt Articular cartilage of controls is complete and stains strongly with Safranin O ( A , orange stain ) .
# ::tok Articular cartilage of controls is complete and stains strongly with Safranin O ( A , orange stain ) .
# ::alignments 16-17|0.0.0 15-16|0.0.0.0 11-12|0.1.1.2+0.1.1.1.0+0.1.1.1+0.1.1 10-11|0.1.1.0 8-9|0.1.2 7-8|0.1 6-7|0 5-6|0.1.0.0 3-4|0.0 1-2|0.1.0 0-1|0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:18:11.735
(a / and 
      :op1 (c2 / control-01 
            :ARG1-of (s / stain-01 
                  :mod (o / orange))) 
      :op2 (s4 / stain-01 
            :ARG0 (c3 / cartilage 
                  :ARG1-of (c / complete-02) 
                  :mod (a2 / articular)) 
            :ARG1 (p / person 
                  :mod (s2 / safranin) 
                  :name (n / name 
                        :op1 "O'Reilly") 
                  :wiki "Bill_O'Reilly_(political_commentator)") 
            :ARG1-of (s3 / strong-02)))

# ::snt In contrast , articular cells of mutants are severely fibrillated or absent with much reduced staining of Safranin O ( C , arrowheads ) .
# ::tok In contrast , articular cells of mutants are severely fibrillated or absent with much reduced staining of Safranin O ( C , arrowheads ) .
# ::alignments 22-23|0 20-21|0.0.0.0.0.1.0.0 18-19|0.0.0.0.0.0.2+0.0.0.0.0.0.1.0+0.0.0.0.0.0.1+0.0.0.0.0.0 17-18|0.0.0.0.0.0.0 15-16|0.0.0.0.0 14-15|0.0.0.0.0.1 13-14|0.0.0.0.0.2 11-12|0.0 10-11|0.0.1 9-10|0.0.1.0 8-9|0.0.1.0.0 6-7|0.0.0.0 4-5|0.0.0 3-4|0.0.0.1 1-2|0.0.0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:18:12.154
(a / arrowhead 
      :ARG0-of (a2 / absent-01 
            :ARG1 (c2 / cell 
                  :consist-of (m2 / mutant 
                        :ARG0-of (s2 / stain-01 
                              :ARG1 (p / person 
                                    :mod (s / safranin) 
                                    :name (n / name 
                                          :op1 "O'Reilly") 
                                    :wiki "Bill_O'Reilly_(political_commentator)") 
                              :ARG1-of (r / reduce-01 
                                    :ARG1-of (c3 / contrast-01 
                                          :ARG0 (c / C))) 
                              :quant (m / much))) 
                  :mod (a3 / articular)) 
            :op2-of (o / or 
                  :op1 (f / fibrillate 
                        :degree (s3 / severe)))))

# ::snt LACZ expression confirms Cre-mediated recombination has occurred in articular cells ( B and D ) .
# ::tok LACZ expression confirms Cre-mediated recombination has occurred in articular cells ( B and D ) .
# ::alignments 13-14|0.2 12-13|0 11-12|0.1.1+0.1.0.0+0.1.0+0.1 9-10|0.0.2 8-9|0.0.2.0 6-7|0.0 4-5|0.0.0 3-4|0.0.1.0.0 2-3|0.0.1.0 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:18:12.328
(a / and 
      :location-of (o / occur-01 
            :ARG0 (r / recombination) 
            :ARG0-of (e / express-01 
                  :ARG0-of (c3 / confirm-01 
                        :ARG1 (c2 / cre-mediat))) 
            :ARG1 (c / cell 
                  :mod (a2 / articular))) 
      :op1 (l / location 
            :name (n / name 
                  :op1 "B") 
            :wiki -) 
      :op2 (d / D))

# ::snt ( E -- P ) Sagittal sections through knee joints of 7-wk - ( E -- J ) or 9-mo-old animals ( K -- P ) ; fe , femur ; ti , tibia ; gp , growth plate .
# ::tok ( E -- P ) Sagittal sections through knee joints of 7-wk - ( E -- J ) or 9-mo-old animals ( K -- P ) ; fe , femur ; ti , tibia ; gp , growth plate .
# ::alignments 38-39|0.0.1 37-38|0.0 35-36|0.3 33-34|0.0.3.2 31-32|0.2 29-30|0.0.3.1 27-28|0.1 26-27|0 24-25|0.0.3.3 22-23|0.4.4 20-21|0.4.3 18-19|0.4 16-17|0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 14-15|0.4.2 9-10|0.0.3.0 8-9|0.0.3 6-7|0.4.1 5-6|0.4.1.0 3-4|0.0.2 1-2|0.4.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:18:12.764
(a / and 
      :ARG1-of (g / grow-01 
            :ARG2 (a3 / aircraft-type 
                  :name (n / name 
                        :op1 "J-10") 
                  :wiki "Chengdu_J-10") 
            :mod-of (p / plate) 
            :op1-of (p3 / P60) 
            :purpose (k2 / knee-01 
                  :ARG1 (j / joint) 
                  :ARG2 (f / femur) 
                  :op1-of (t / tibia) 
                  :op1-of (p2 / P60))) 
      :op1 (f2 / fe) 
      :op2 (t2 / ti) 
      :op3 (g2 / gp) 
      :op6-of (o / or 
            :op1 (e2 / E) 
            :op2 (s / section 
                  :mod (s2 / sagittal)) 
            :op3 (e / E) 
            :op4 (a2 / animal) 
            :op5 (k / k)))

# ::snt Seven weeks after birth , the height of the tibial epiphysis is reduced in mutants ( E and H , bars ) , and their articular layer stains poorly with Safranin O , is fibrillated , and is strikingly thinner ( F and I , black arrowhead , and brackets ) .
# ::tok Seven weeks after birth , the height of the tibial epiphysis is reduced in mutants ( E and H , bars ) , and their articular layer stains poorly with Safranin O , is fibrillated , and is strikingly thinner ( F and I , black arrowhead , and brackets ) .
# ::alignments 49-50|0.0.2.1.1.1.1.0 48-49|0.0.2.1.1.1.1 46-47|0.0.2.1.1.1.2.0 45-46|0.0.2.1.1.1.2.0.0 43-44|0.0.2.1.1.1.1.0.0 42-43|0.0.2.1.1.1.2 41-42|0.0.2.1.1.1.3+0.0.2.1.1.1.0.0+0.0.2.1.1.1.0+0.0.2.1.1.1 39-40|0.0.2.1.1 38-39|0.0.2.1.1.2 36-37|0.0.2.1 34-35|0.0.2.1.0 31-32|0.0.2.0.2.2+0.0.2.0.2.1.0+0.0.2.0.2.1+0.0.2.0.2 30-31|0.0.2.0.2.0 28-29|0.0.2.0.3 27-28|0.0.2.0 26-27|0.0.2.0.0 25-26|0.0.2.0.0.0 23-24|0.0.2 20-21|0.3 18-19|0.2 17-18|0 16-17|0.1 14-15|0.0.1 12-13|0.0 10-11|0.0.2.0.1 9-10|0.0.2.0.1.0 6-7|0.0.0 3-4|0.0.3.0 2-3|0.0.3 1-2|0.0.3.0.0.0+0.0.3.0.0 0-1|0.0.2.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:18:15.040
(a8 / and 
      :ARG0-of (r / reduce-01 
            :ARG1 (h2 / height) 
            :location (m / mutant) 
            :op1-of (a7 / and 
                  :op2 (s3 / stain-01 
                        :ARG0 (l / layer 
                              :mod (a6 / articular)) 
                        :ARG1 (e2 / epiphysi 
                              :mod (t2 / tibial)) 
                        :ARG3 (p / person 
                              :mod (s2 / safranin) 
                              :name (n2 / name 
                                    :op1 "O'Reilly") 
                              :wiki "Bill_O'Reilly_(political_commentator)") 
                        :manner (p2 / poor)) 
                  :op3 (a5 / and 
                        :op1 (f / fibrillate) 
                        :op2 (t / thin-01 
                              :ARG0 7 
                              :ARG1 (a4 / aircraft-type 
                                    :name (n / name 
                                          :op1 "F22") 
                                    :op1-of (a / and 
                                          :op2 (b / bracket-01 
                                                :ARG1 (i / i))) 
                                    :op1-of (a3 / and 
                                          :op2 (a2 / arrowhead 
                                                :ARG1-of (b2 / black-04))) 
                                    :wiki "Lockheed_Martin_F-22_Raptor") 
                              :degree (s / strikingly)))) 
            :time (a9 / after 
                  :op1 (b4 / birth-01 
                        :location-of (t3 / temporal-quantity 
                              :unit (w / week))))) 
      :op1 (e / E) 
      :op2 (h / h) 
      :op3 (b3 / bar))

# ::snt Near adjacent sections with LACZ staining confirm Cre-mediated recombination has occurred in articular cells ( G and J ) .
# ::tok Near adjacent sections with LACZ staining confirm Cre-mediated recombination has occurred in articular cells ( G and J ) .
# ::alignments 17-18|0.1.3.1.1+0.1.3.1.0.0+0.1.3.1.0+0.1.3.1 16-17|0.1.3 15-16|0.1.3.0.1+0.1.3.0.0.0+0.1.3.0.0+0.1.3.0 13-14|0.1.2 12-13|0.1.2.0 10-11|0.1 8-9|0.1.0 7-8|0.1.0.0 6-7|0 5-6|0.1.1 2-3|0.0 1-2|0.0.1 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:18:15.333
(c3 / confirm-01 
      :ARG0 (s2 / section 
            :ARG1-of (n3 / near-02) 
            :mod (a4 / adjacent)) 
      :ARG1 (o2 / occur-01 
            :ARG0 (r / recombination 
                  :mod (c2 / cre-mediat)) 
            :ARG0-of (s / stain-01) 
            :ARG1 (c / cell 
                  :mod (a3 / articular)) 
            :location (a2 / and 
                  :op1 (o / organization 
                        :name (n2 / name 
                              :op1 "G-8") 
                        :wiki "G8") 
                  :op2 (a / aircraft-type 
                        :name (n / name 
                              :op1 "J-10") 
                        :wiki "Chengdu_J-10"))))

# ::snt Note that in mutants , LACZ is absent in cells adjacent to those that do stain with Safranin O , suggesting Bmpr1a may act cell autonomously ( I and J , white arrowheads ) .
# ::tok Note that in mutants , LACZ is absent in cells adjacent to those that do stain with Safranin O , suggesting Bmpr1a may act cell autonomously ( I and J , white arrowheads ) .
# ::alignments 32-33|0.0.0.0 31-32|0.0.0 29-30|0.0.1.0.0.0.0.0.1+0.0.1.0.0.0.0.0.0.0+0.0.1.0.0.0.0.0.0+0.0.1.0.0.0.0.0 28-29|0.0.1.0.0.0.0 27-28|0.0.1.0.0.0 25-26|0.0.1.0.0.1.0.0 24-25|0.0.1.0.0.1.0.0.0 23-24|0.0.1.0.0.1.0 22-23|0.0.1.0.0.1 21-22|0.0.1.0.0.2.0.0+0.0.1.0.0.2.0+0.0.1.0.0.2 20-21|0.0.1.0.0 18-19|0.0.1.3+0.0.1.2.0+0.0.1.2+0.0.1 17-18|0.0.1.1 15-16|0.0.1.0 10-11|0.0.2.0 9-10|0.0.2 7-8|0.0 3-4|0.0.3 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:18:16.270
(n4 / note-01 
      :ARG1 (a7 / absent-01 
            :ARG0 (w / white 
                  :mod-of (a / arrowhead)) 
            :ARG1 (p3 / person 
                  :ARG0-of (s3 / stain-01 
                        :ARG1 (s / suggest-01 
                              :ARG0 (i / i 
                                    :op1-of (a3 / and 
                                          :op2 (a2 / aircraft-type 
                                                :name (n / name 
                                                      :op1 "J-10") 
                                                :wiki "Chengdu_J-10"))) 
                              :ARG1 (p / possible-01 
                                    :ARG1 (a5 / act-02 
                                          :ARG1 (a4 / autonomously 
                                                :mod (c / cell)))) 
                              :ARG2 (p2 / person 
                                    :name (n2 / name 
                                          :op1 "Bmpr1a")))) 
                  :mod (s2 / safranin) 
                  :name (n3 / name 
                        :op1 "O'Reilly") 
                  :wiki "Bill_O'Reilly_(political_commentator)") 
            :ARG2 (c2 / cell 
                  :mod (a6 / adjacent)) 
            :location (m / mutant)))

# ::snt At 9 mo old , the mutant tibial epiphysis is extremely thin ( K and N , bars ) , and the articular layer is completely absent , leaving bone to rub directly on bone ( L and O , bracket ) .
# ::tok At 9 mo old , the mutant tibial epiphysis is extremely thin ( K and N , bars ) , and the articular layer is completely absent , leaving bone to rub directly on bone ( L and O , bracket ) .
# ::alignments 40-41|0.1.2 38-39|0.1.1.1+0.1.1.0.0+0.1.1.0+0.1.1 37-38|0.1 36-37|0.1.0 34-35|0 32-33|0.0.2 31-32|0.0 29-30|0.0.0 28-29|0.0.0.0 26-27|0.0.0.0.1.1 25-26|0.0.0.0.1.1.2 23-24|0.0.0.0.1.1.1 22-23|0.0.0.0.1.1.1.0 20-21|0.0.0.0.1 17-18|0.0.0.0.1.0.0.0.1 15-16|0.0.0.0.1.0.0.0.0 14-15|0.0.0.0.1.0.0.0 13-14|0.0.0.0.1.0.0 11-12|0.0.0.0.1.0 10-11|0.0.0.0.1.0.1 8-9|0.0.0.0.0 7-8|0.0.0.0.0.0 6-7|0.0.0.0.0.1 3-4|0.0.1 2-3|0.0.0.0.1.1.0 1-2|0.1.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:18:17.353
(b2 / bone 
      :ARG2-of (r / rub-01 
            :ARG0 (b3 / bone 
                  :ARG1-of (l2 / leave-11 
                        :ARG0 (e2 / epiphysi 
                              :mod (t2 / tibial) 
                              :mod (m / mutant)) 
                        :op3-of (a4 / and 
                              :op1 (t / thin-03 
                                    :ARG1 (k / k 
                                          :op1-of (a5 / and 
                                                :op2 (n2 / N) 
                                                :op3 (b4 / bar))) 
                                    :degree (e / extreme)) 
                              :op2 (a2 / absent-01 
                                    :ARG0 (m2 / mo) 
                                    :ARG1 (l3 / layer 
                                          :mod (a3 / articular)) 
                                    :ARG1-of (c / complete-02))))) 
            :ARG1 (o / old) 
            :ARG1-of (d / direct-02)) 
      :op1-of (a / and 
            :op2 (l / L) 
            :op3 (p / person 
                  :name (n / name 
                        :op1 "O'Reilly") 
                  :wiki "Bill_O'Reilly_(political_commentator)") 
            :op4 (b / bracket-01 
                  :ARG1 9)))

# ::snt LACZ staining shows Cre-mediated recombination occurred in articular cells of controls ( M ) and in some remaining skeletal tissue of mutants ( P ) .
# ::tok LACZ staining shows Cre-mediated recombination occurred in articular cells of controls ( M ) and in some remaining skeletal tissue of mutants ( P ) .
# ::alignments 23-24|0.0.0 21-22|0.1.3.0.0.0.1 19-20|0.1.3.0.0.0 18-19|0.1.3.0.0.0.0 17-18|0.1.3.0.0 16-17|0.1.3.0.0.0.2 14-15|0.1.1 12-13|0.1.2.1+0.1.2.0.0+0.1.2.0+0.1.2 10-11|0.1.3.0 8-9|0.1.3 7-8|0.1.3.1 5-6|0.1 4-5|0.1.0 3-4|0.1.0.0 2-3|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:18:17.723
(s3 / show-01 
      :ARG0 (s4 / stain-01 
            :ARG0 (p / P60)) 
      :ARG1 (o / occur-01 
            :ARG0 (r2 / recombination 
                  :mod (c3 / cre-mediat)) 
            :ARG1 (a / and) 
            :ARG2 (v / vehicle 
                  :name (n / name 
                        :op1 "M1") 
                  :wiki "M1_Abrams") 
            :source (c2 / cell 
                  :consist-of (c / control-01 
                        :ARG1 (r / remain-01 
                              :ARG1 (t / tissue 
                                    :mod (s / skeletal) 
                                    :mod (m / mutant) 
                                    :quant (s2 / some)))) 
                  :mod (a2 / articular))))

# ::snt Also note aberrantly formed meniscal cartilage in mutants ( E , H , K , and N , arrows ) , and increased sclerosis in mutant epiphyses ( E , H , K , and N , asterisks ) .
# ::tok Also note aberrantly formed meniscal cartilage in mutants ( E , H , K , and N , arrows ) , and increased sclerosis in mutant epiphyses ( E , H , K , and N , asterisks ) .
# ::alignments 37-38|0.0.3.0.0 35-36|0.2.0 34-35|0.2 28-29|0.1.0 26-27|0.0.3.1 25-26|0.0.3.1.0 23-24|0.0.3.0.1 22-23|0.0.3.0 21-22|0.0.3 18-19|0.7 16-17|0.6 15-16|0 13-14|0.5 11-12|0.4 9-10|0.3 7-8|0.1 5-6|0.0.1 3-4|0.0 2-3|0.0.0 1-2|0.0.0.0 0-1|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:18:18.166
(a5 / and 
      :location-of (f / form-01 
            :ARG0 (a6 / aberrantly 
                  :mod (n3 / note)) 
            :ARG1 (c / cartilage) 
            :mod (a7 / also) 
            :op1-of (a3 / and 
                  :op2 (i / increase-01 
                        :ARG0 (a / asterisk) 
                        :ARG1 (s / sclerosi)) 
                  :poss (e2 / epiphys 
                        :mod (m / mutant)))) 
      :op1 (m2 / mutant 
            :mod (e / E)) 
      :op1-of (a2 / and 
            :op2 (n / N)) 
      :op2 (e3 / E) 
      :op3 (h / h) 
      :op4 (k / k) 
      :op5 (n2 / N) 
      :op6 (a4 / arrow))

# ::snt ( A and K ) Scale bar = 50 m ; ( I ) scale bar = 300 m .
# ::tok ( A and K ) Scale bar = 50 m ; ( I ) scale bar = 300 m .
# ::alignments 17-18|0.1 15-16|0 14-15|0.0.0.0.0.0.0 12-13|0.0.0.0.0.0.0.0 10-11|0.0.0.0.0.0 9-10|0.0.0.0.0 8-9|0.0.0.0.0.1 6-7|0.0.0.0 5-6|0.0.0.1 3-4|0.0 2-3|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:18:18.254
(b / bar-01 
      :ARG0 (k / k 
            :op1-of (a2 / and 
                  :ARG0-of (b2 / bar-01 
                        :ARG1 (m / m 
                              :op1-of (a / and 
                                    :op2 (s / scale 
                                          :poss (i / i))) 
                              :quant 50)) 
                  :op2 (s2 / scale))) 
      :ARG1 300)

# ::snt Conflicts of interest .
# ::tok Conflicts of interest .
# ::alignments 2-3|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:18:18.260
(c / conflict-01 
      :ARG1 (i / interest-01))

# ::snt The authors have declared that no conflicts of interest exist .
# ::tok The authors have declared that no conflicts of interest exist .
# ::alignments 9-10|0.0.0 8-9|0.0.0.0.0 6-7|0.0.0.0 5-6|0.0.0.1 3-4|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:18:18.303
(d / declare-01 
      :ARG1 (a / author-01 
            :ARG2 (e / exist-01 
                  :ARG1 (c / conflict-01 
                        :ARG2-of (i / interest-01)) 
                  :polarity -)))

# ::snt Author contributions .
# ::tok Author contributions .
# ::alignments 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:18:18.308
(c / contribute-01 
      :ARG1-of (a / author-01))

# ::snt RBR , MS , and DMK conceived and designed the experiments .
# ::tok RBR , MS , and DMK conceived and designed the experiments .
# ::alignments 10-11|0.2.1 8-9|0.2 7-8|0 6-7|0.2.2.0 5-6|0.1.0.0+0.1.0+0.1 4-5|0.2.2 2-3|0.0.0.0+0.0.0+0.0 0-1|0.2.0.0.0+0.2.0.0+0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:18:18.426
(a / and 
      :op1 (c2 / country 
            :name (n2 / name 
                  :op1 "MS")) 
      :op2 (o / organization 
            :name (n / name 
                  :op1 "DMK")) 
      :op3 (d / design-01 
            :ARG0 (c3 / country 
                  :name (n3 / name 
                        :op1 "RBR")) 
            :ARG1 (e / experiment-01) 
            :op1-of (a2 / and 
                  :ARG0-of (c / conceive-01))))

# ::snt RBR and MEM performed the experiments .
# ::tok RBR and MEM performed the experiments .
# ::alignments 5-6|0.0 3-4|0.0.0 2-3|0.1.0.0+0.1.0+0.1 1-2|0 0-1|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:18:18.678
(a / and 
      :ARG1-of (e / experiment-01 
            :ARG1-of (p / perform-02 
                  :ARG0 (o2 / organization 
                        :name (n2 / name 
                              :op1 "RBR")))) 
      :op1 (o / organization 
            :name (n / name 
                  :op1 "MEM")))

# ::snt RBR , HC , and DMK analyzed the data .
# ::tok RBR , HC , and DMK analyzed the data .
# ::alignments 8-9|0.1 6-7|0 5-6|0.0.1.0.0+0.0.1.0+0.0.1 4-5|0.0 0-1|0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:18:18.721
(a / analyze-01 
      :ARG0 (a2 / and 
            :op1 (o2 / organization 
                  :name (n2 / name 
                        :op1 "RBR")) 
            :op2 (o / organization 
                  :name (n / name 
                        :op1 "DMK"))) 
      :ARG1 (d / data))

# ::snt MS , HC , VH , and YM contributed reagents/materials/analysis tools .
# ::tok MS , HC , VH , and YM contributed reagents/materials/analysis tools .
# ::alignments 10-11|0.1 9-10|0.1.0 8-9|0 7-8|0.0.1.0.0+0.0.1.0+0.0.1 6-7|0.0 0-1|0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:18:18.752
(c / contribute-01 
      :ARG0 (a / and 
            :op1 (c2 / country 
                  :name (n2 / name 
                        :op1 "MS")) 
            :op2 (o / organization 
                  :name (n / name 
                        :op1 "YM"))) 
      :ARG1 (t / tool 
            :purpose (r / reagents/materials/analysi)))

# ::snt RBR and DMK wrote the paper .
# ::tok RBR and DMK wrote the paper .
# ::alignments 5-6|0.1 3-4|0 2-3|0.0.1.0.0+0.0.1.0+0.0.1 1-2|0.0 0-1|0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:18:18.961
(w / write-01 
      :ARG0 (a / and 
            :op1 (o2 / organization 
                  :name (n2 / name 
                        :op1 "RBR")) 
            :op2 (o / organization 
                  :name (n / name 
                        :op1 "DMK"))) 
      :ARG1 (p / paper))

# ::snt Academic Editor : Lee Niswander , University of Colorado Health Sciences Center .
# ::tok Academic Editor : Lee Niswander , University of Colorado Health Sciences Center .
# ::alignments 6-12|0.0.1.0.0.5+0.0.1.0.0.4+0.0.1.0.0.3+0.0.1.0.0.2+0.0.1.0.0.1+0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 3-5|0.0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 1-2|0+0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:18:19.102
(e / editor 
      :ARG2-of (h / have-org-role-91 
            :ARG0 (p / person 
                  :name (n2 / name 
                        :op1 "Lee" 
                        :op2 "Niswander")) 
            :ARG1 (a / academic 
                  :mod-of (o / organization 
                        :name (n / name 
                              :op1 "University" 
                              :op2 "of" 
                              :op3 "Colorado" 
                              :op4 "Health" 
                              :op5 "Sciences" 
                              :op6 "Center")))))

# ::snt $ Current address : ARTEMIS Pharmaceuticals , an Exelixis Company , Kln , Germany .
# ::tok $ Current address : ARTEMIS Pharmaceuticals , an Exelixis Company , Kln , Germany .
# ::alignments 13-14|0.0.0.2+0.0.0.0.0+0.0.0.0+0.0.0 11-12|0.0.1.0.0+0.0.1.0+0.0.1 8-10|0.0.3.2+0.0.3.1+0.0.3+0.0.3.0 4-6|0.0.2.1+0.0.2.0+0.0.2+0.0 2-3|0 1-2|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:18:19.152
(a / address 
      :mod-of (o2 / organization 
            :mod (c / country 
                  :name (n / name 
                        :op1 "Germany") 
                  :poss (c2 / current) 
                  :wiki "Germany") 
            :mod (o / organization 
                  :name (n2 / name 
                        :op1 "Kln")) 
            :name (n4 / name 
                  :op1 "ARTEMIS" 
                  :op2 "Pharmaceuticals") 
            :name (n3 / name 
                  :name-of (t / thing) 
                  :op1 "Exelixis" 
                  :op2 "Company")))

# ::snt Citation : Rountree RB , Schoor M , Chen H , Marks ME , Harley V , et al. ( 2004 ) BMP receptor signaling is required for postnatal maintenance of articular cartilage .
# ::tok Citation : Rountree RB , Schoor M , Chen H , Marks ME , Harley V , et al. ( 2004 ) BMP receptor signaling is required for postnatal maintenance of articular cartilage .
# ::alignments 32-33|0.1.2.0 31-32|0.1.2.0.0 29-30|0.1.2 28-29|0.1.2.1 26-27|0.1 24-25|0 23-24|0.0 22-23|0.0.0 20-21|0.1.0.0+0.1.0 14-16|0.1.2.0.1.0.1+0.1.2.0.1.0.0+0.1.2.0.1.0+0.1.2.0.1 11-13|0.1.2.0.2.0.1+0.1.2.0.2.0.0+0.1.2.0.2.0+0.1.2.0.2 8-10|0.1.2.0.0.0.0.1+0.1.2.0.0.0.0.0+0.1.2.0.0.0.0+0.1.2.0.0.0 6-7|0.1.2.1.0.1+0.1.2.1.0.0.0+0.1.2.1.0.0+0.1.2.1.0 2-4|0.1.1.0.1+0.1.1.0.0+0.1.1.0+0.1.1 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:18:19.832
(s / signal-01 
      :ARG0 (r2 / receptor 
            :mod (b / BMP)) 
      :ARG1-of (r / require-01 
            :ARG0 (d / date-entity 
                  :year 2004) 
            :ARG2 (o / organization 
                  :name (n5 / name 
                        :op1 "Rountree" 
                        :op2 "RB")) 
            :purpose (m / maintain-01 
                  :ARG1 (c / cartilage 
                        :mod (a / articular 
                              :mod (p3 / person 
                                    :name (n3 / name 
                                          :op1 "Chen" 
                                          :op2 "H"))) 
                        :poss (p2 / person 
                              :name (n / name 
                                    :op1 "Harley" 
                                    :op2 "V")) 
                        :poss-of (c2 / country 
                              :name (n2 / name 
                                    :op1 "Marks" 
                                    :op2 "ME"))) 
                  :mod (p / postnatal 
                        :mod-of (v / vehicle 
                              :name (n4 / name 
                                    :op1 "M1") 
                              :wiki "M1_Abrams")))) 
      :ARG2 (c3 / citation))

# ::snt PLoS Biol 2 ( 11 ) : e355 .
# ::tok PLoS Biol 2 ( 11 ) : e355 .
# ::alignments 7-8|0 4-5|0.0.0.1 2-3|0.0 0-2|0.0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T00:18:19.851
(e / e355 
      :quant (2 / 2 
            :mod-of (o / organization 
                  :name (n / name 
                        :op1 "PLoS" 
                        :op2 "Biol") 
                  :op1 11)))

